Table of Contents

As filed with the Securities and Exchange Commission on December 17, 2013

Registration No. 333-            

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM S-3

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

 

EXCO Resources, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Texas   74-1492779

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

12377 Merit Drive, Suite 1700, LB 82

Dallas, TX 75251

(214) 368-2084

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

William L. Boeing

Vice President, General Counsel and Secretary

12377 Merit Drive, Suite 1700, LB 82

Dallas, TX 75251

(214) 368-2084

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

 

With a copy to:

W. Scott Wallace

Jennifer T. Wisinski

Haynes and Boone, LLP

2323 Victory Avenue, Suite 700

Dallas, TX 75219

(214) 651-5000

 

 

Approximate date of commencement of proposed sale to the public:  As soon as practicable after the date this registration statement becomes effective.

If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box:   ¨

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box:   x

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   ¨

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.   ¨

If this Form is a registration statement pursuant to General Instruction I.D. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box.   x

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.D. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box.   ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   x    Accelerated filer   ¨
Non-accelerated filer   ¨   (Do not check if a smaller reporting company)    Smaller reporting company   ¨

 

 

CALCULATION OF REGISTRATION FEE

 

 

Title of Each Class of

Securities to be Registered

 

Amount

to be

Registered

 

Proposed

Maximum

Offering Price

Per Share

 

Proposed

Maximum
Aggregate

Offering Price

  Amount of
Registration Fee

Common Stock, par value $0.001 per share

  44,995,665   $5.00   $224,978,325 (1)   $28,977.21

Common Stock Subscription Rights (2)

        (3)

Total

  44,995,665     $224,978,325   $28,977.21

 

 

(1) Represents the gross proceeds from the sale of shares of our common stock assuming the exercise of all transferable subscription rights to be distributed.
(2) Evidencing the rights to subscribe for the shares of our common stock being registered herewith.
(3) The subscription rights are being issued for no consideration. Pursuant to Rule 457(g) under the Securities Act of 1933, as amended, no separate registration fee is payable with respect to the subscription rights being offered hereby because the subscription rights are being registered on the same registration statement as the securities to be offered pursuant thereto.

 

 

 


Table of Contents

Prospectus

 

LOGO

EXCO Resources, Inc.

Up to 44,995,665 Shares of Common Stock

Issuable Upon the Exercise of Transferable Subscription Rights

at $5.00 per Share

 

 

We are distributing, at no cost or charge to holders of our common stock, par value $0.001 per share, transferable subscription rights to purchase up to 44,995,665 shares of our common stock at a purchase price of $5.00 per share in the rights offering. You will receive one subscription right for each share of common stock held of record by you as of 5:00 p.m., New York City time, on December 19, 2013, the record date. Each subscription right will entitle you to purchase 0.25 of a share of our common stock at a subscription price equal to $5.00 per share pursuant to the basic subscription right. If you held shares of our common stock as of 5:00 p.m., New York City time, on the record date and you timely and fully exercise your basic subscription right (including in respect of subscription rights purchased from others), you may also subscribe for any or all shares of our common stock that are not purchased by other shareholders pursuant to the basic subscription right at $5.00 per share pursuant to the over-subscription privilege, although we cannot assure you that we will have sufficient shares available to fill your over-subscription.

The number of shares that will be available pursuant to the over-subscription privilege in the rights offering, including the shares to be subscribed for and purchased by the Investors (defined below) under the over-subscription privilege, will be the number of shares of common stock that rights holders do not elect to purchase in this rights offering pursuant to the basic subscription right (including in respect of subscription rights purchased from others), or the Unsubscribed Shares. If over-subscription requests (including of the Investors) exceed the number of Unsubscribed Shares, we will allocate the available shares pro rata among the rights holders exercising the over-subscription privilege in proportion to the number of shares of our common stock each of those rights holders owned as of 5:00 p.m., New York City time, on the record date, relative to the number of shares owned on the record date by all rights holders exercising the over-subscription privilege (including the Investors). For additional details regarding the pro rata allocation process, see “Questions and Answers Relating to the Rights Offering—What are the limitations on the over-subscription privilege?” and “The Rights Offering—Over-Subscription Privilege.” Any excess subscription payments received by the subscription agent will be returned to you as soon as practicable, without interest or penalty, following the closing of the rights offering. Fractional shares of common stock resulting from the exercise of the basic subscription right, on an aggregate basis as to any rights holder, and fractional shares of common stock resulting from the exercise of the over-subscription privilege, on an aggregate basis as to any rights holder, will be eliminated by rounding down to the nearest whole share.

We have entered into two exercise commitment agreements, or the Investment Agreements, one with certain affiliates of WL Ross & Co. LLC, and one with Hamblin Watsa Investment Counsel Ltd., a wholly owned subsidiary of Fairfax Financial Holdings Limited, under which, subject to the terms and conditions thereof, each of them has agreed to subscribe for and purchase, in a private placement, its respective pro rata portion of shares under the basic subscription right and all Unsubscribed Shares under the over-subscription privilege, subject to availability and the pro rata allocation among the rights holders who have elected to exercise their over-subscription privilege; provided, that each of the Investors shall not be obligated to purchase an aggregate number of shares that would exceed the lesser of (a) 100% of the Unsubscribed Shares, or (b) an amount of Unsubscribed Shares, which when taken together with the number of shares issued pursuant to the Investor’s basic subscription right, equals 50% of the total shares offered in the rights offering. The shares purchased pursuant to the Investment Agreements will be issued in a transaction exempt from the registration requirements of the Securities Act of 1933, as amended, or the Securities Act, and accordingly the shares issued to the Investors will not be registered pursuant to the registration statement of which this prospectus forms a part. We refer to such affiliates of WL Ross & Co. LLC, collectively, as WL Ross, Hamblin Watsa Investment Counsel Ltd., as Hamblin Watsa, and Fairfax Financial Holdings Limited as Fairfax. We refer to WL Ross or Hamblin Watsa individually as an “Investor” and collectively as the “Investors.”

The rights offering will expire at 5:00 p.m., New York City time, on January 9, 2014 . Any subscription right not exercised at or before this time will expire and be void, of no value and will cease to be exercisable for shares of our common stock. We do not intend to extend the expiration period in the rights offering. You should carefully consider whether to exercise or transfer your subscription rights prior to the expiration of the rights offering. All exercises of subscription rights are irrevocable, subject to applicable law. Our board of directors is making no recommendation regarding any exercise or transfer of subscription rights.

Shares of our common stock are traded on the New York Stock Exchange, or the NYSE, under the symbol “XCO.” On December 16, 2013, the closing sale price for our common stock was $5.01 per share. The shares of common stock issued in the rights offering will also be listed on the NYSE. The subscription rights are transferable and are expected to trade on the NYSE under the symbol “XCO-RT” until 4:00 p.m., New York City time, on January 8, 2014, the business day immediately preceding the expiration date of the rights offering. We cannot give you any assurance that the subscription rights will trade on the NYSE, a market for the subscription rights will develop or, if a market does develop, of the prices at which the subscription rights will trade or whether such market will be sustainable throughout the period when the subscription rights are transferable.

 

 

An investment in our common stock involves risks. See “ Risk Factors ” beginning on page 13 of this prospectus.

Upon completion of the rights offering and the transactions contemplated by the Investment Agreements, shareholders who do not fully exercise their subscription rights will own a smaller proportional interest in us than if they had timely and fully exercised their subscription rights.

 

     Per
Share
     Total  

Subscription Price

   $ 5.00       $ 272,873,670 (1)  

Estimated Expenses

   $ 0.01       $ 763,977   

Net Proceeds

   $ 4.99       $ 272,109,693   

 

(1) Includes the gross proceeds from the sale of the common stock offered in the rights offering and pursuant to the Investment Agreements.

It is anticipated that delivery of shares of common stock purchased in the rights offering will be made on or about January 17, 2014.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

The date of this prospectus is December 17, 2013.


Table of Contents

TABLE OF CONTENTS

 

     Page  

ABOUT THIS PROSPECTUS

     i   

QUESTIONS AND ANSWERS RELATING TO THE RIGHTS OFFERING

     ii   

SUMMARY

     1   

FORWARD-LOOKING STATEMENTS

     11   

RISK FACTORS

     13   

USE OF PROCEEDS

     40   

CAPITALIZATION

     41   

THE RIGHTS OFFERING

     42   

THE INVESTMENT AGREEMENTS; EFFECTS OF THE TRANSACTIONS

     57   

MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS

     61   

PLAN OF DISTRIBUTION

     64   

EXPERTS

     64   

INDEPENDENT PETROLEUM ENGINEERS

     64   

LEGAL MATTERS

     65   

INCORPORATION BY REFERENCE

     65   

WHERE YOU CAN FIND MORE INFORMATION

     66   

ABOUT THIS PROSPECTUS

You should rely only on the information contained or incorporated by reference in this prospectus or in any prospectus supplement we may authorize to be delivered to you, including any free writing prospectus that we use in connection with this offering. We have not authorized any person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information contained in this prospectus is accurate only as of the date on the front of this prospectus, regardless of the time of delivery of this prospectus or the time of any exercise of the subscription rights. Our business, financial condition, results of operations and prospects may have changed since the date of this prospectus. For further information, please see “Where You Can Find More Information.”

Except where the context otherwise requires or as otherwise indicated, all references in this prospectus to “EXCO,” “EXCO Resources,” “Company,” “we,” “us” and “our” refer to EXCO Resources, Inc. and its consolidated subsidiaries. In the discussion of our subscription rights, capital stock and related matters, these terms refer solely to EXCO Resources, Inc.

 

i


Table of Contents

QUESTIONS AND ANSWERS RELATING TO THE RIGHTS OFFERING

The following are examples of what we anticipate will be common questions about the rights offering. The answers are based on selected information from this prospectus and the documents incorporated by reference herein. The following questions and answers do not contain all of the information that may be important to you and may not address all of the questions that you may have about the rights offering. This prospectus and the documents incorporated by reference herein contain more detailed descriptions of the terms and conditions of the rights offering and provide additional information about us and our business, including potential risks related to the rights offering, our common stock and our business.

What is the rights offering?

We are distributing to holders of our common stock as of 5:00 p.m., New York City time, on the record date of December 19, 2013, at no charge, one transferable subscription right to purchase shares of our common stock per share of our common stock owned by such holders on the record date. The subscription rights are evidenced by rights certificates that will be distributed as soon as practicable after the record date. Each subscription right will entitle the holder to a basic subscription right and an over-subscription privilege as described in this prospectus. Fractional shares of our common stock resulting from any holder’s exercise of the basic subscription right or the over-subscription privilege, each as described below, will be eliminated by rounding down to the nearest whole share. Any excess subscription payments received by the subscription agent will be returned as soon as practicable, without interest or penalty, following the completion of the rights offering. See “The Rights Offering.”

What is the basic subscription right?

For each subscription right that you own, you will have a basic subscription right to purchase 0.25 of one share of our common stock, at a subscription price equal to $5.00 per share of common stock. You may exercise the basic subscription right for any number of your subscription rights, or you may choose not to exercise any subscription rights. For example, if you owned 102 shares of our common stock as of 5:00 p.m., New York City time, on the record date of December 19, 2013, you would receive 102 subscription rights and would have the right to purchase 25 shares of common stock (rounded down from 25.50 shares of common stock) for $5.00 per share, or $125.00 in the aggregate, pursuant to your basic subscription right. See “The Rights Offering—Basic Subscription Right.”

What is the over-subscription privilege?

If you exercise your basic subscription right in full (including in respect of subscription rights purchased from others), you may also choose to subscribe to purchase any or all shares of common stock that other rights holders do not purchase through the exercise of their basic subscription rights. The subscription price per share that applies to the over-subscription privilege is $5.00 per share, which is the same subscription price per share that applies to the basic subscription right.

You should indicate on the rights certificate, or, if your shares are held in the name of the nominee, on the form provided by your nominee, how many additional shares of common stock you would like to purchase pursuant to your over-subscription privilege.

What are the limitations on the over-subscription privilege?

We will be able to satisfy your exercise of the over-subscription privilege only to the extent that there are shares available for the over-subscription privilege. We expect that over-subscription requests, when taking into account the amount of shares that the Investors have agreed to subscribe for and purchase under the over-subscription privilege pursuant to the Investment Agreements, will exceed the number of shares available for the over-subscription privilege. The number of shares that will be available pursuant to the over-subscription privilege, including the shares to be subscribed for and purchased by the Investors under the over-subscription privilege, in the rights offering will be the Unsubscribed Shares.

 

ii


Table of Contents

If the requests for over-subscription (including of the Investors) exceed the available shares, we will allocate the Unsubscribed Shares pro rata among the rights holders exercising the over-subscription privilege in proportion to the number of shares of our common stock each of those rights holders owned as of 5:00 p.m., New York City time, on the record date, relative to the number of shares owned as of 5:00 p.m., New York City time, on the record date by all rights holders exercising the over-subscription privilege (including the Investors).

In addition, pursuant to the Investment Agreements, and subject to the terms and conditions thereof, each of the Investors has agreed to subscribe for and purchase, in a private placement, its respective pro rata portion of shares under the basic subscription right and all Unsubscribed Shares under the over-subscription privilege, subject to availability and the pro rata allocation among the rights holders who have elected to exercise their over-subscription privilege, based on the number of shares of common stock each of the Investors owned as of 5:00 p.m., New York City time, on the record date, relative to the number of shares owned on the record date by all rights holders exercising the over-subscription privilege (including the Investors); provided, that each of the Investors shall not be obligated to purchase an aggregate number of shares that would exceed the lesser of (i) 100% of the Unsubscribed Shares, or (ii) an amount of Unsubscribed Shares, which when taken together with the number of shares issued pursuant to the Investor’s basic subscription right, equals 50% of the total shares offered in the rights offering.

If this pro rata allocation results in any rights holder receiving a greater number of shares of common stock than the rights holder subscribed for pursuant to the exercise of the over-subscription privilege, then such rights holder will be allocated only that number of shares for which the rights holder over-subscribed, and the remaining shares will be allocated among all rights holders exercising the over-subscription privilege on the same pro rata basis described above. The proration process will be repeated until all Unsubscribed Shares have been allocated to either the rights holders exercising the over-subscription privilege or the Investors pursuant to the Investment Agreements. Any excess subscription payments will be returned as soon as practicable, without interest or penalty, following the completion of the rights offering. See “The Rights Offering—Over-Subscription Privilege.”

Will you please provide an example of the pro rata allocation under the over-subscription privilege?

Yes. Please see the table below for an example, which assumes that (i) there are 2,500,000 Unsubscribed Shares available for purchase pursuant to the over-subscription privilege, (ii) each of the Investors, pursuant to the terms and conditions of the Investment Agreements, elects to exercise its over-subscription privilege for all Unsubscribed Shares, (iii) other than the four rights holders set forth in the table below, no other rights holders elect to exercise their over-subscription privilege for shares and (iv) four rights holders, each of whom has timely and fully exercised its basic subscription right with respect to all of the subscription rights it holds, elect to exercise their over-subscription privilege for the amount of shares set forth below:

 

Holder

  A
Shares as
of Record
Date  (1)
    B
Basic Subscription
Right
    C
Over-
Subscription
Privilege
Shares
Requested

By Holder
    D
Over-
Subscription
Shares
Allocated (2)
    E
Shares
Allocated in
Excess of
Requested
Shares (if any) (3)
    F
Over-
Subscription
Shares to be
Issued (4)
    G
Over-
Subscription
Shares to be
Issued (5)
    H
Total Over-
Subscription
Shares to be
Issued
 
    Rights     Shares              
                            (1 st  Round)     (1 st  Round)     (1 st  Round)     (2 nd  Round)        

WL Ross

    31,504,077        31,504,077        7,876,019        2,500,000        1,505,462        —          1,505,462        43,402        1,548,864   

Fairfax/Hamblin Watsa

    10,812,200        10,812,200        2,703,050        2,500,000        516,675        —          516,675        14,895        531,570   

Holder A

    1,500,000        1,500,000        375,000        500,000        71,679        —          71,679        2,066        73,746   

Holder B

    5,000,000        5,000,000        1,250,000        375,000        238,931        —          238,931        6,888        245,820   

Holder C

    3,500,000        3,500,000        875,000        100,000        167,252        67,252        100,000        —          100,000   

Holder D

    —          1,000,000        250,000        50,000        —          —          —          —          —     
             

 

 

   

 

 

   

 

 

 

Total

                2,432,748        67,252        2,500,000   
             

 

 

   

 

 

   

 

 

 

 

iii


Table of Contents

 

(1) Assumes 218,298,938 total shares outstanding on the record date. The total shares outstanding used in the denominator in the first over-subscription round and second over-subscription round was determined as follows:

 

Holder

   Shares as
of Record
Date
     Shares
Included in
1 st Round
Denominator
     Shares
Included in
2 nd Round
Denominator
 

WL Ross

     31,504,077         31,504,077         31,504,077   

Fairfax/Hamblin Watsa

     10,812,200         10,812,200         10,812,200   

Holder A

     1,500,000         1,500,000         1,500,000   

Holder B

     5,000,000         5,000,000         5,000,000   

Holder C

     3,500,000         3,500,000         —     

Holder D

     —           —           —     

Other holders (not exercising over-subscription privilege)

     165,982,661         —           —     
  

 

 

    

 

 

    

 

 

 

Total

     218,298,938         52,316,277         48,816,277   

 

(2) Column D represents the holder’s pro rata portion based on the holders participating in the particular over-subscription round. This amount is calculated by multiplying 2,500,000 (the assumed number of Unsubscribed Shares) by a fraction, the numerator of which is, with respect to any holder, the amount in Column A with respect to that holder, and the denominator of which is the total number of shares in Column A held by holders participating in that over-subscription round as shown in note 1 (e.g., for Holder A, 2,500,000*(1,500,000/52,316,277)).
(3) Column E represents the number of shares allocated to the holder in excess of its request (e.g., for Holder C, 167,252-100,000).
(4) Column F represents the number of shares actually issued to the holder in the first over-subscription round and equals Column D less Column E (e.g., for Holder C, 167,252-67,252).
(5) Column G represents the holder’s pro rata portion based on the holders participating in the particular over-subscription round. This amount is calculated by multiplying the shares available for that over-subscription round by a fraction, the numerator of which is, with respect to any holder, the amount in Column A with respect to that holder, and the denominator of which is the total number of shares in Column A held by holders participating in that over-subscription round as shown in note 1 (e.g., for Holder A, 67,252*(1,500,000/48,816,277)). In the second round above, 67,252 shares were allocated, representing the shares allocated to Holder C in excess of its request.

For additional information concerning this example, see “The Rights Offering—Over-Subscription Privilege.”

Why are we conducting the rights offering?

We determined to conduct the rights offering to strengthen our liquidity position, and increase our financial flexibility, including our ability to make opportunistic acquisitions, and our ability to fund the acquisition of wells pursuant to our participation agreement, or the KKR Participation Agreement, with Kohlberg Kravis Roberts & Co. L.P., or KKR. We expect the net proceeds from the rights offering and the transactions contemplated by the Investment Agreements will be approximately $272 million. We intend to use the net proceeds to pay indebtedness under our amended and restated credit agreement, or the EXCO Resources Credit Agreement, including payment in full of the indebtedness related to the Asset Sale Requirement (as defined herein) as well as a portion of the indebtedness outstanding under the revolving commitment under the EXCO Resources Credit Agreement. Upon repayment of the Asset Sale Requirement, the interest rate on the revolving commitment will decrease by 100 basis points. In addition, by paying a portion of the revolving commitment, we will increase the borrowing availability under the revolving commitment by approximately $243.2 million, which will give us additional financial flexibility. See “Use of Proceeds.”

After assessing current alternatives in both the debt and equity markets, our current balance sheet and the amount of our outstanding indebtedness, we determined to conduct an equity offering. We believe that raising capital through a rights offering as compared to other methods, such as an underwritten public offering of our common stock, has the advantage of providing our shareholders with the opportunity to participate in the transaction on a pro rata basis and, if all shareholders exercise their rights, avoid dilution of their ownership interests in us. In addition, the expenses that we will pay in the rights offering will be less than those we would pay in an underwritten public offering, which would include the payment of underwriters’ discounts and commissions. See “The Rights Offering—Background of the Rights Offering.”

How was the $5.00 per share subscription price determined?

At a board meeting in November 2013, the board reviewed a proposal to conduct a rights offering to shareholders to purchase shares of common stock. After being presented with the investment opportunity, all of

 

iv


Table of Contents

our directors who are not affiliated with, and do not have a financial interest in, either of the Investors, considered various factors and determined to conduct the rights offering and to approve the $5.00 subscription price per share. The board of directors determined that raising capital through a rights offering, as compared to an underwritten offering, has the advantages of (i) providing our shareholders with the opportunity to participate on a pro rata basis to avoid dilution of their ownership interests in us and (ii) allowing us to incur significantly lower expenses. In evaluating the subscription price, the disinterested directors considered, among other things, the following factors:

 

    the current and historical trading prices of our common stock;

 

    the price at which shareholders might be willing to participate in the rights offering;

 

    the ability of shareholders to transfer or sell their subscription rights;

 

    our need for additional capital and liquidity;

 

    the cost of capital from other sources; and

 

    comparable precedent transactions, including the percentage of shares offered, the terms of the subscription rights being offered, the subscription price and the discount that the subscription price represented to the immediately prevailing closing prices for those offerings.

In conjunction with the review of these factors, the disinterested directors also reviewed our history and prospects, including our past and present earnings, our prospects for future earnings, the outlook for our industry and our current financial condition. The disinterested directors also believed that the subscription price should be designed to provide an incentive to our current shareholders to participate in the rights offering and exercise their basic subscription right and their over-subscription privilege. The $5.00 subscription price is not intended to bear any relationship to the market value of our common stock, the book value of our assets or our past operations, cash flows, losses, financial condition, net worth or any other established criteria used to value securities. You should not consider the subscription price to be an indication of the fair value of the common stock to be offered in the rights offering. We do not intend to change the subscription price in response to changes in the trading price of our common stock prior to the closing of the rights offering. See “The Rights Offering—Background of the Rights Offering.”

What are the commitments under the Investment Agreements?

We have entered into the Investment Agreements with the Investors pursuant to which, and subject to the terms and conditions thereof, each of the Investors has severally agreed to subscribe for and purchase from us, in a private placement, its respective pro rata portion of shares under the basic subscription right and all Unsubscribed Shares under the over-subscription privilege, subject to availability and the pro rata allocation among other rights holders who have elected to exercise their over-subscription privilege; provided, that each of the Investors shall not be obligated to purchase an aggregate number of shares that would exceed the lesser of (i) 100% of the Unsubscribed Shares, or (ii) an amount of Unsubscribed Shares, which when taken together with the number of shares issued pursuant to the Investor’s basic subscription right, equals 50% of the total shares offered in the rights offering.

The purchase of shares by the Investors pursuant to the Investment Agreements will be effected in transactions exempt from the registration requirements of the Securities Act of 1933, as amended, or the Securities Act, and, accordingly, will not be registered pursuant to the registration statement of which this prospectus forms a part. Shares owned by WL Ross and Hamblin Watsa, including, without limitation, those acquired by WL Ross and Hamblin Watsa, respectively, pursuant to their respective Investment Agreements will be subject to a registration rights agreement. Except as a result of any increase in its ownership of common stock, neither WL Ross nor Hamblin Watsa will obtain any additional governance or control rights as a result of the rights offering or the transactions contemplated by the Investment Agreements. See “The Investment Agreements; Effects of the Transactions—The Investment Agreements” and “The Investment Agreements; Effects of the Transactions—The Registration Rights Agreement.”

 

v


Table of Contents

Why did you enter into the Investment Agreements?

We obtained the commitments of WL Ross and Hamblin Watsa to subscribe for Unsubscribed Shares to ensure that, subject to the terms and conditions of the Investment Agreements, we would receive gross proceeds of $273 million. See “The Investment Agreements; Effects of the Transactions.”

How will the transactions under the Investment Agreements affect the common stock ownership of WL Ross and Fairfax?

Each of WL Ross and Fairfax, directly or through certain affiliates, beneficially own approximately 14.4% and 4.95%, respectively, of our outstanding shares of common stock before giving effect to the rights offering and the transactions contemplated by the Investment Agreements. If the rights offering is fully subscribed, we will issue 7,876,019 shares and 2,703,050 shares to WL Ross and Fairfax (including Hamblin Watsa), respectively, pursuant to the Investment Agreements, and after giving effect to the rights offering and the transactions contemplated by the Investment Agreements, we will have 272,873,672 shares of common stock outstanding. Assuming the rights offering is fully subscribed, the beneficial ownership of WL Ross and Fairfax (including Hamblin Watsa) would remain the same as prior to the rights offering.

If no subscription rights are exercised in the rights offering, we will issue 27,287,367 shares to each of WL Ross and Fairfax (including Hamblin Watsa) pursuant to the Investment Agreements, and after giving effect to the rights offering and the transactions contemplated by the Investment Agreements, we will have 272,873,672 shares of common stock outstanding. Assuming that no other rights holders exercise their subscription rights in this offering, and that each of the Investors exercises its basic subscription right and over-subscription privilege in full as indicated, and after giving effect to the rights offering and the transactions contemplated by the Investment Agreements, WL Ross would beneficially own approximately 21.5% of our outstanding common stock and Fairfax (including Hamblin Watsa) would beneficially own approximately 14.0% of our outstanding common stock.

The number of shares of common stock outstanding listed in each case above assumes that (i) all of the other shares of our common stock issued and outstanding on the record date will remain issued and outstanding as of the closing of the rights offering and (ii) we will not issue any shares of common stock in the period between the record date and the closing of the rights offering. Please see “The Investment Agreements; Effects of the Transactions—Dilutive Effects of the Rights Offering and the Transactions Contemplated by the Investment Agreements.”

Will WL Ross or Hamblin Watsa receive a fee in connection with the rights offering?

No. We will not pay WL Ross or Hamblin Watsa a fee nor reimburse their expenses in connection with the rights offering. See “The Investment Agreements; Effects of the Transactions—The Investment Agreements—Fees.”

Are there any conditions to the commitments by WL Ross and Hamblin Watsa?

Yes. The commitments by WL Ross and Hamblin Watsa under the applicable Investment Agreement are subject to the satisfaction or waiver of specified conditions, including the following: (i) the effectiveness of the registration statement relating to the rights offering; (ii) the rights offering having been conducted by the Company in accordance with the Investment Agreements in all material respects; (iii) the absence of any legal impediment to the implementation of the rights offering, the issuance of the shares under the Investment Agreements or the consummation of the transactions contemplated by the Investment Agreements; (iv) the accuracy of the Company’s representations and warranties; (v) the Company’s performance and compliance in all material respects with covenants and agreements, in each case required to be performed or complied with on or prior to closing; (vi) the approval of shares issued in the rights offering for listing on the NYSE; (vii) the

 

vi


Table of Contents

expiration or termination of any waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, or the HSR Act; (viii) the absence of certain breaches or defaults under the other Investment Agreement that are the basis for a party to terminate or refuse to close the transactions contemplated under the other Investment Agreement; (ix) the absence of any Material Adverse Effect (as defined in the applicable Investment Agreement) since November 22, 2013; (x) we have not, and are not reasonably expected to, recognize any impairments to our assets which in the aggregate equal or exceed $150 million (excluding the $10,707,000 impairment previously taken by us for the quarter ended March 31, 2013); and (xi) other customary conditions. See “The Investment Agreements; Effects of the Transactions.”

How many shares of common stock will be outstanding after the rights offering and what will the effect be on my ownership?

We expect that approximately 272,873,672 shares of our common stock will be outstanding immediately after the completion of the rights offering and the transactions contemplated by the Investment Agreements, subject to adjustments for the number of shares of common stock outstanding on the record date and for fractional shares. See “The Investment Agreements; Effects of the Transactions.”

The issuance of shares in the rights offering and pursuant to the Investment Agreements will dilute, and thereby reduce, your proportionate ownership in our shares of common stock if you do not exercise your basic subscription right in full.

Am I required to exercise all of the subscription rights I receive in the rights offering?

No. You may exercise any number of your subscription rights or you may choose not to exercise any subscription rights. If you do not timely exercise any subscription rights, the number of shares of our common stock you own will not change. However, if you choose not to timely and fully exercise any subscription rights (including in respect of subscription rights purchased from others) and other rights holders timely and fully exercise their subscription rights, the percentage of our common stock owned by other shareholders will increase, the relative percentage of our common stock that you own will decrease, and your voting and other rights will be diluted. In addition, if you do not timely exercise your subscription rights in full, you will not be entitled to participate in the over-subscription privilege. See “Risk Factors—Shareholders who do not exercise their subscription rights will experience a dilution of their relative ownership interests.”

How soon must I act to exercise my subscription rights?

The subscription rights may be exercised at any time during the subscription period, which commences on December 17, 2013 and expires at 5:00 p.m., New York City time, on January 9, 2014. If shares are allocated to your account under the EXCO Resources, Inc. 401(k) Plan, or the 401(k) Plan, please see “The Rights Offering—Special Instructions for Participants in Our 401(k) Plan.” If you elect to exercise any or all of your subscription rights, the subscription agent must receive all required documents and payments from you at or prior to the expiration date. If you hold your shares in the name of a broker, dealer, custodian bank or other nominee, your nominee may establish a deadline before the expiration of the rights offering by which you must provide such nominee with your instructions to exercise your subscription rights. We do not intend to extend the expiration of the rights offering.

Although we will make reasonable attempts to provide this prospectus to our shareholders and the holders of rights, the rights offering and all subscription rights will expire on the expiration date, whether or not we have been able to locate each person entitled to subscription rights.

May I transfer my subscription rights?

Yes. Subscription rights are transferable from the commencement of the rights offering until 4:00 p.m., New York City time, on January 8, 2014, the business day immediately preceding the expiration date of the rights offering. See “The Rights Offering—Method of Transferring Rights.”

 

vii


Table of Contents

How may I sell, transfer or assign my subscription rights?

You may seek to sell your subscription rights through normal investment channels. See “The Rights Offering—Method of Transferring Rights.” The subscription rights are transferable, and we expect that the subscription rights will be admitted to trade on the NYSE under the symbol “XCO-RT” until 4:00 p.m., New York City time, on January 8, 2014, the business day immediately preceding the expiration date of the rights offering. The subscription rights are a new issue of securities, however, and do not have an established trading market. We cannot give you any assurance that the subscription rights will trade on the NYSE, a market for the subscription rights will develop or, if a market does develop, of the prices at which the subscription rights will trade or whether such market will be sustainable throughout the period when the subscription rights are transferable. Therefore, we cannot assure you that you will be able to sell any of your subscription rights or as to the value you may receive in a sale. See “The Rights Offering—Transferability of and Market for the Rights” and “The Rights Offering—Method of Transferring Rights.”

Are we requiring a minimum overall subscription to complete the rights offering?

No. We are not requiring an overall minimum subscription to complete the rights offering. However, as a result of the rights offering and the transactions contemplated by the Investment Agreements, we expect to receive net proceeds of approximately $272 million.

Are there any conditions to completing the rights offering?

No. There are no conditions precedent to the rights offering but there are conditions to the consummation of the transactions contemplated by the Investment Agreements. See “The Investment Agreements; Effects of the Transactions—The Investment Agreements.”

Can the rights offering be extended, amended, withdrawn or cancelled?

We do not intend to extend the rights offering period. Subject to the provisions of the Investment Agreements, we reserve the right to amend, extend, withdraw or cancel the rights offering at any time for any reason, including pursuant to the terms and conditions of the Investment Agreements. See “The Investment Agreements; Effects of the Transactions—The Investment Agreements.” If we amend, extend, withdraw or cancel the rights offering, we will issue a press release notifying shareholders. If we cancel or withdraw the rights offering, the subscription agent will return all subscription payments without interest or penalty, as soon as practicable. If we cancel or withdraw the rights offering, the subscription rights will be void, of no value and will cease to be exercisable for shares of our common stock. If you purchase subscription rights during the subscription period and we cancel or withdraw the rights offering, you will lose the entire purchase price paid to acquire such subscription rights in the market. See “The Rights Offering—Conditions, Amendment, Withdrawal and Cancellation.”

Will fractional subscription rights be issued?

No. Fractional shares resulting from (1) the exercise of the basic subscription right, on an aggregate basis as to any rights holder, or (2) the exercise of the over-subscription privilege, on an aggregate basis as to any rights holder, will be eliminated by rounding down to the nearest whole share. See “The Rights Offering—No Fractional Shares.”

Has our board of directors made a recommendation to our shareholders regarding the rights offering?

No. Our board of directors is making no recommendation regarding your exercise of the subscription rights. See “The Rights Offering—No Board Recommendation to Rights Holders.” Rights holders who exercise subscription rights will incur investment risk on new money invested. We cannot predict the price at which our

 

viii


Table of Contents

shares of common stock will trade after the rights offering. The market price for our common stock may decrease to an amount below the subscription price, and if you purchase shares of common stock at the subscription price, you may not be able to sell the shares in the future at the same price or a higher price. You should make your decision based on your assessment of our business and financial condition, our prospects for the future, the terms of the rights offering and the information contained in, or incorporated by reference into, this prospectus. See “Risk Factors” for a discussion of some of the risks involved in investing in our common stock.

As of December 5, 2013, WL Ross, directly or through certain affiliates, beneficially owned approximately 14.4% of our outstanding shares of common stock. Wilbur L. Ross, Jr., one of our directors, is the chairman and chief executive officer of WL Ross & Co. LLC. As of December 5, 2013, Fairfax beneficially owned, directly or through certain affiliates, approximately 4.95% of the outstanding shares of our common stock. Samuel A. Mitchell, one of our directors, is a managing director of Hamblin Watsa. You should not view the intentions of WL Ross, Fairfax or Hamblin Watsa as a recommendation or other indication, by them or any member of our board of directors, regarding whether the exercise of the subscription rights is or is not in your best interests.

Will I receive subscription rights if I own shares of restricted stock?

Yes. If you own shares of common stock as of 5:00 p.m., New York City time, on the record date of December 19, 2013, including shares of restricted common stock, you will receive one transferable subscription right per share of our common stock that you own on the record date, regardless of whether the restricted stock is unvested on the record date.

How do I exercise my subscription rights if I own shares in certificate form?

If you hold an EXCO stock certificate and you wish to participate in the rights offering, you must take the following steps:

 

    deliver payment to the subscription agent before 5:00 p.m., New York City time, on January 9, 2014; and

 

    deliver a properly completed and signed rights certificate to the subscription agent before 5:00 p.m., New York City time, on January 9, 2014.

In certain cases, you may be required to provide additional documentation or signature guarantees. If you send an uncertified personal check, payment will not be deemed to have been delivered to the subscription agent until the check has cleared. See “The Rights Offering—Method of Exercising Rights.”

Please follow the delivery instructions on the rights certificate that we plan to distribute as soon as practicable after the record date. Do not deliver documents to EXCO. You are solely responsible for completing delivery to the subscription agent of your subscription documents, rights certificate and payment. You should allow sufficient time for delivery of your subscription materials to the subscription agent so that the subscription agent receives them by 5:00 p.m., New York City time, on January 9, 2014.

If you send a payment that is insufficient to purchase the number of shares of common stock you requested, or if the number of shares you requested is not specified in the forms, the payment received will be applied to exercise your subscription rights to the fullest extent possible based on the amount of the payment received, subject to the availability of shares of common stock under the over-subscription privilege and the elimination of fractional shares.

What should I do if I want to participate in the rights offering but my shares are held in the name of a broker, dealer, custodian bank or other nominee?

If you hold your shares of common stock through a broker, dealer, custodian bank or other nominee, then your nominee is the record holder of the shares you own. The record holder must exercise or sell the subscription

 

ix


Table of Contents

rights on your behalf. If you wish to purchase our common stock through the rights offering, you should contact your broker, dealer, custodian bank or nominee as soon as possible. Please follow the instructions of your nominee. Your nominee may establish a deadline that may be before the expiration date of the rights offering. See “The Rights Offering—Method of Exercising Rights.”

What should I do if I want to participate in the rights offering, but my shares are allocated to my account under the 401(k) Plan?

If shares of our common stock are allocated to your account under the 401(k) Plan as of 5:00 p.m., New York City time, on the record date, you may exercise the subscription rights with respect to those shares of common stock to the same extent as other rights holders by electing what amount (if any) of your subscription rights you would like to exercise and properly completing the Form for Participants in the EXCO Resources, Inc. 401(k) Plan Transferable Subscription Rights Election Form, or the 401(k) Election Form, that is provided to you. In addition, you may instruct the 401(k) Plan trustee to sell all or a portion of the subscription rights allocated to your account by completing the 401(k) Election Form. You must return your properly completed 401(k) Election Form to the subscription agent as prescribed in the instructions accompanying the 401(k) Election Form. Your 401(k) Election Form must be received by the subscription agent by 5:00 p.m., New York City time, on January 6, 2014, or the 401(k) Deadline, which is the third business day prior to the expiration date of the rights offering. If your 401(k) Election Form is not received by the 401(k) Deadline, your election to exercise the subscription rights that are allocated to your 401(k) Plan account will not be effective.

The 401(k) Deadline is a special deadline that applies to participants (and other account holders) in the 401(k) Plan (notwithstanding the expiration date of the rights offering generally applicable to holders of subscription rights) and solely with respect to shares of our common stock held through the 401(k) Plan. If no instructions are received by the subscription agent prior to the 401(k) Deadline, no subscription rights will be exercised by the 401(k) Plan trustee on your behalf, and the 401(k) Plan trustee will attempt to sell the subscription rights allocated to your 401(k) Plan account through the NYSE. The 401(k) Plan trustee’s attempt to sell the subscription rights may be unsuccessful. Any subscription rights allocated to your 401(k) Plan account will expire unless they are timely and fully exercised by the 401(k) Deadline or otherwise sold by the 401(k) Plan trustee. Any amounts obtained from the sale of subscription rights by the 401(k) Plan trustee will be allocated on an individual basis to each participant who did not timely submit instructions to exercise subscription rights allocated to its account or who instructed the 401(k) Plan trustee to sell all or a portion of the subscription rights allocated to its account. The amounts obtained from the sale of a participant’s subscription rights will be allocated to the Guaranteed Income Fund in the participant’s 401(k) Plan account.

If you elect to exercise some or all of the subscription rights allocated to your 401(k) Plan account, you must ensure that the number of shares for which you subscribe under the basic subscription right on your 401(k) Election Form accurately reflects the number of shares to which you are entitled. You must also ensure that your current investment in your 401(k) Plan account in the Guaranteed Income Fund is sufficient to fully satisfy the subscription payment for the subscription rights you elect to exercise on your 401(k) Election Form, as you may only pay for the exercise of such subscription rights through the liquidation of funds held by your 401(k) Plan account in the Guaranteed Income Fund. If your 401(k) Plan account investment in this fund is insufficient to fully satisfy the subscription payment, the subscription rights allocated to your 401(k) Plan account will be exercised to the fullest extent possible based on the liquidated value of your 401(k) Plan account invested in this fund, rounded down to the nearest whole share.

Furthermore, the Employee Retirement Income Security Act of 1974, as amended, or ERISA, prohibits the purchase of shares of common stock by the 401(k) Plan from EXCO for more than “adequate consideration,” which is defined in ERISA for a publicly traded company as the prevailing price on a national securities exchange (in this case, the NYSE) on or about the date the subscription rights are exercised by the 401(k) Plan trustee (which we anticipate will occur after the 401(k) Deadline and prior to the expiration of the rights

 

x


Table of Contents

offering), or the Prevailing Market Price. Accordingly, the 401(k) Plan trustee will exercise or not exercise your subscription rights as follows:

 

    if the Prevailing Market Price is less than the subscription price of $5.00 per share, notwithstanding your direction to the 401(k) Plan trustee to exercise the subscription rights, the subscription rights will not be exercised; and

 

    if the Prevailing Market Price is greater than or equal to the subscription price of $5.00 per share, the 401(k) Plan trustee will follow your direction, if any, to exercise your subscription rights.

See “The Rights Offering—Special Instructions for Participants in Our 401(k) Plan.”

What form of payment must I use to pay the subscription price?

Unless shares of common stock are allocated to your account under the 401(k) Plan, payments submitted to the subscription agent must be made in U.S. currency, by one of the following methods, in accordance with the instructions accompanying the rights certificate:

 

    certified or personal check drawn on a U.S. bank payable to “Continental Stock Transfer & Trust Company”;

 

    postal, telegraphic or express money order payable to “Continental Stock Transfer & Trust Company”; or

 

    wire transfer of immediately available funds directly to the account maintained by “Continental Stock Transfer & Trust Company as agent for EXCO Resources Rights Offering”; at Bank Name: JP Morgan Chase Bank; ABA #: 021000021; Account #: 475-581202. Any wire transfer should clearly indicate the identity of the subscriber who is paying the subscription price by wire transfer.

Payments will be deemed to have been received upon:

 

    clearance of any uncertified personal check deposited by Continental Stock Transfer & Trust Company;

 

    receipt by Continental Stock Transfer & Trust Company of any certified check or bank draft drawn upon a U.S. bank;

 

    receipt by Continental Stock Transfer & Trust Company of any postal, telegraphic or express money order; or

 

    receipt by Continental Stock Transfer & Trust Company of any wire transfer of immediately available funds.

If you elect to exercise your subscription rights, we urge you to consider using a certified or cashier’s check, money order or wire transfer of funds to ensure that Continental Stock Transfer & Trust Company receives your funds prior to the expiration of the rights offering. If paying by uncertified personal check, the funds paid thereby may take five or more business days to clear. Accordingly, if you wish to pay the subscription price by means of uncertified personal check, you are urged to make payment sufficiently in advance of the expiration of the rights offering to ensure that such payment is received and clears by such time. See “The Rights Offering—Payment Method.”

If you hold your shares in the name of a broker, dealer, custodian, bank or other nominee, separate payment instructions may apply. Please contact your nominee, if applicable, for further payment instructions.

When will I receive my new shares?

If you are a holder of record of our common stock and purchase shares of common stock in the rights offering, you will receive a direct registration account statement representing your new shares as soon as practicable after the closing of the rights offering, which is expected to occur on or about January 17, 2014. If

 

xi


Table of Contents

your shares are allocated to your account under the 401(k) Plan or held through a broker, dealer, custodian bank or other nominee and you purchase shares of common stock in the rights offering, your account under the 401(k) Plan or at your nominee will be credited with your new shares as soon as practicable following the closing of the rights offering.

After I send in my payment and elect to exercise my subscription rights, may I cancel my exercise of subscription rights?

No. All exercises of subscription rights are irrevocable, subject to applicable law, unless the rights offering is cancelled, even if you later learn information that you consider to be unfavorable to the exercise of your subscription rights. You should not exercise your subscription rights unless you are certain that you wish to purchase shares in the rights offering. See “The Rights Offering—No Revocation or Change.”

Are there risks in exercising my rights?

Yes. Exercising your rights involves the purchase of shares of our common stock. You should consider this investment as carefully as you would consider any other equity investment. Among other things, you should carefully consider the risks described under “Risk Factors” in this prospectus and in the documents incorporated by reference into this prospectus.

If the rights offering is not completed, will my subscription payment be refunded to me?

Yes. The subscription agent will hold all funds it receives in a segregated bank account until completion of the rights offering. If the rights offering is not completed, all subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable. If you own shares in the name of a broker, dealer, custodian bank or other nominee, it may take longer for you to receive your subscription payment because the subscription agent will return payments through the record holder of your shares.

What fees or charges apply directly to me if I purchase shares of common stock in the rights offering?

We are not charging any fee or sales commission to issue subscription rights to you or to issue shares to you if you exercise your subscription rights. If you exercise your subscription rights through your broker, dealer, custodian bank or other nominee, you are responsible for paying any fees your intermediary may charge you.

What are the material U.S. federal income tax considerations for exercising my subscription rights?

For U.S. federal income tax purposes, you will not recognize income or loss in connection with the receipt or exercise of subscription rights in the rights offering. You should consult your tax advisor as to your particular tax consequences resulting from the rights offering. For a detailed discussion, see “Material U.S. Federal Income Tax Considerations.”

To whom should I send my forms and payment?

If your shares are held in the name of a broker, dealer, custodian bank or other nominee, you should send your subscription documents, rights certificate and subscription payment to that record holder. If you are the record holder of your shares, then you should send your subscription documents, rights certificate and subscription payment by hand delivery, first class mail or courier service to:

Continental Stock Transfer & Trust Company

17 Battery Place—8th Floor

New York, NY 10004

Attn: Corporate Actions Department

Telephone: (917) 262-2378

See “The Rights Offering—Subscription Agent and Information Agent.”

 

xii


Table of Contents

You, and if applicable, your nominee, are solely responsible for completing delivery to the subscription agent of your subscription documents, rights certificate and payment. You should allow sufficient time for delivery of your subscription materials to the subscription agent and clearance of payment before the expiration of the rights offering. If you hold your shares of common stock through a broker, dealer, custodian, bank or other nominee, your nominee may establish an earlier deadline before the expiration date of the rights offering.

Whom should I contact if I have other questions?

If you have more questions about the rights offering or need additional copies of the rights offering documents, please contact the information agent D.F. King & Co., Inc., by calling 1-800-755-7250 toll-free or, if you are a bank or broker, at 1-212-269-5550. In addition, you may contact the subscription agent at the phone number above.

 

xiii


Table of Contents

SUMMARY

This summary highlights selected information contained elsewhere or incorporated by reference in this prospectus. This summary does not contain all of the information that you should consider before deciding whether to exercise your subscription rights. You should carefully read the entire prospectus, including the information under “The Rights Offering” in this prospectus and “Risk Factors” in this prospectus and the documents incorporated by reference herein. We have provided definitions of terms commonly used in the oil and natural gas industry in the “Glossary of Selected Oil and Natural Gas Terms” beginning on page 67 of this prospectus.

Our Company

We are an independent oil and natural gas company engaged in the exploitation, exploration, acquisition, development and production of onshore U.S. oil and natural gas properties with a focus on shale resource plays. Our principal operations are conducted in certain key U.S. oil and natural gas areas including Texas, Louisiana and the Appalachia region.

We recently adjusted our primary strategy to emphasize our focus on exploiting our shale resource plays, while continuing to evaluate complementary acquisitions in our existing operating areas that meet our strategic and financial objectives. We plan to carry out this strategy by leveraging our management and technical team’s experience, exploiting our multi-year inventory of development drilling locations in our shale plays, actively seeking acquisition opportunities inside our existing operating areas, managing our liquidity and enhancing financial flexibility.

Recent Developments

EXCO/HGI Partnership

On February 14, 2013, we formed a partnership, or the EXCO/HGI Partnership, with Harbinger Group Inc., or HGI. We contributed our conventional non-shale assets in East Texas and North Louisiana and our shallow Canyon Sand and other assets in the Permian Basin of West Texas to the EXCO/HGI Partnership in exchange for net proceeds of $574.8 million, after final purchase price adjustments, and a 25.5% economic interest in the EXCO/HGI Partnership. HGI’s economic interest in the EXCO/HGI Partnership is 74.5%. The primary strategy of the EXCO/HGI Partnership is to exploit its current asset base and acquire conventional producing oil and natural gas properties to enhance asset value and cash flow. Proceeds from the formation of the EXCO/HGI Partnership were used to reduce our outstanding indebtedness under the EXCO Resources Credit Agreement.

Immediately following the closing, the EXCO/HGI Partnership entered into an agreement to purchase the remaining shallow Cotton Valley assets within our joint venture with an affiliate of BG Group plc, or BG Group, for $130.7 million, after final purchase price adjustments. The assets acquired as a result of this transaction represented an incremental working interest in properties owned by the EXCO/HGI Partnership. The transaction closed on March 5, 2013 and was funded with borrowings from the EXCO/HGI Partnership’s credit agreement.

Haynesville and Eagle Ford Acquisitions

On July 2, 2013, we entered into definitive agreements with Chesapeake Energy Corporation, or Chesapeake, to acquire producing and undeveloped oil and natural gas assets in the Haynesville and Eagle Ford shale formations, or the Chesapeake Properties, for an aggregate purchase price of approximately $1.0 billion, subject to customary preliminary purchase price adjustments.

We amended and restated the EXCO Resources Credit Agreement to facilitate these acquisitions, which increased the borrowing base to $1.6 billion, including a $1.3 billion revolving commitment and a $300.0 million

 

 

1


Table of Contents

term loan. The EXCO Resources Credit Agreement provides that net proceeds from certain asset sales in excess of the borrowing base value (if any) will be used to reduce $400 million of outstanding borrowings by July 31, 2014, or the Asset Sale Requirement.

We closed the acquisition of the Haynesville assets on July 12, 2013 for a purchase price of $288.2 million, after customary preliminary purchase price adjustments. The acquisition was funded with borrowings from the EXCO Resources Credit Agreement. The acquisition included certain producing wells and non-producing oil, natural gas and mineral leases located in our core Haynesville shale operating area in Caddo Parish and DeSoto Parish, Louisiana. At the time of the acquisition, these properties included Chesapeake’s non-operated interests in 170 wells operated by EXCO on approximately 5,600 net acres, therefore increasing our working interest in the wells we operate, and operated interests in 11 producing wells on approximately 4,000 net acres. The acquisition added approximately 55 identified drilling locations in the Haynesville shale formation to our drilling inventory. BG Group elected not to exercise its preferential right to acquire a 50% interest in these assets.

We closed the acquisition of the Eagle Ford assets on July 31, 2013 for a purchase price of $685.3 million, after customary preliminary purchase price adjustments, adding oil production and oil drilling locations to our portfolio. The acquisition included certain producing wells and non-producing oil, natural gas and mineral leases in the Eagle Ford shale in the counties of Zavala, Dimmit, La Salle and Frio in South Texas. At the time of the acquisition, these properties included operated interests in 120 wells on approximately 55,000 net acres and the acquisition added approximately 300 identified drilling locations to our drilling inventory. In addition, we entered into a farm-out agreement with Chesapeake that currently covers approximately 102,000 net acres adjacent to the acquired properties.

In connection with closing the acquisition of the Eagle Ford assets, we entered into the KKR Participation Agreement and sold an undivided 50% interest in the undeveloped acreage we acquired for approximately $130.9 million, after preliminary closing adjustments, or the KKR Participation Agreement. Proceeds from the sale of properties were used to reduce the EXCO Resources Credit Agreement borrowing base and outstanding borrowings by $130.9 million.

The KKR Participation Agreement provides that EXCO and KKR will jointly fund future costs to develop the Eagle Ford assets. With respect to each well drilled, EXCO will assign half of its undivided 50% interest in such well to KKR such that KKR will fund and own 75% of each well drilled and EXCO will fund and own 25% of each well drilled. On a quarterly basis, EXCO and KKR will determine the development plan covering the following twelve months. EXCO will be required to offer to purchase KKR’s 75% working interest in wells drilled that have been in production for one year. These offers will be made on a quarterly basis for groups of wells at fair market value, as defined in the KKR Participation Agreement, subject to specific well criteria and return hurdles. We are required to make our first offer during the first quarter of 2015 for wells that have been on line for approximately one year. The parties have agreed on approximately 300 identified locations to be drilled over a five year period.

TGGT Sale

On November 15, 2013, EXCO and BG US Gathering Company, LLC, an affiliate of BG Group, closed the conveyance of 100% of the equity interests in TGGT Holdings, LLC, or TGGT, to Azure Midstream Holdings, LLC, or Azure, for an aggregate sales price of approximately $910 million, of which approximately $875 million was paid in cash and the remaining portion was paid in the form of an approximate 7% equity interest in Azure, which was divided equally between EXCO and BG Group. We received approximately $240.2 million in net cash proceeds at the closing after the repayment of TGGT’s credit agreement. Proceeds from the sale were used to reduce the EXCO Resources Credit Agreement borrowing base and outstanding borrowings by approximately $240.2 million leaving us with approximately $28.9 million currently outstanding on the Asset Sale Requirement.

 

 

2


Table of Contents

Management Change

Douglas H. Miller resigned from serving as our chief executive officer, chairman of the board of directors and as a director on November 20, 2013. Our board of directors appointed Jeffrey D. Benjamin to serve as non-executive chairman of the board of directors and initiated a search to identity a new chief executive officer.

2014 Capital Budget

Our board of directors has approved a capital budget of $368 million for 2014 of which $294 million is allocated to development and completion activities. We believe the capital budget is appropriate for current commodity prices and our capital structure. EXCO estimates that the 2014 capital budget will result in an approximate 15% production decline year-over-year while increasing our exposure to crude oil. These capital expenditures exclude the EXCO/HGI Partnership, which funds its capital expenditures through internally generated cash flow and its credit agreement, and also exclude any capital expenditures for our Permian joint development, which is in early stages of evaluation. The 2014 capital budget is currently allocated among the different budget categories as follows:

 

(Dollars in millions)

      

Drilling and completion

   $ 294   

Field operations, gathering and water projects

     24   

Land and seismic

     21   

Corporate and other

     11   

Capitalized interest

     18   
  

 

 

 

Total

   $ 368   
  

 

 

 

We expect to fund our 2014 capital budget with cash flow from operations as well as borrowings under the EXCO Resources Credit Agreement to the extent necessary. Our 2014 operated rig count is expected to average nine rigs, of which four will drill in the Haynesville and Bossier shales and five will drill in the Eagle Ford shale. We will also utilize a rig in Appalachia for a partial year to drill two appraisal wells. Details of our plans within the various areas follow:

 

(Dollars in millions)

   Gross Wells
Spud (1)
     Net Wells
Spud (1)
     Net Wells
Completed (1)
     Drilling &
Completion
     Other
Capital
     Total
Capital
 

East TX/North LA

     42         20.5         18.3       $ 173       $ 11       $ 184   

South Texas

     90         15.2         14.3         109         29         138   

Appalachia

     2         0.5         0.5         12         5         17   

Corporate and other (2)

                                     29         29   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

Total

     134         36.2         33.1       $ 294       $ 74       $ 368   
  

 

 

    

 

 

    

 

 

    

 

 

    

 

 

    

 

 

 

 

(1) EXCO operated.
(2) Includes $18 million of capitalized interest.

East Texas and North Louisiana:

Our Haynesville shale position continues to be the most significant asset driving 2014 performance. We plan to spend a total of $184 million developing wells in the Haynesville and Bossier shales, of which $173 million will be spent on drilling and completion. We plan to spud 42 gross (20.5 net) horizontal wells and turn to sales 35 gross (18.3 net) horizontal wells in this area.

We currently have 434 operated horizontal wells producing in East Texas and North Louisiana and November 2013 net production averaged 306 Mmcfe/d. Our continuous improvement in drilling days as well as

 

 

3


Table of Contents

optimization of completion designs have resulted in recent well costs of $7.5 million in our Holly core area, an approximate 10% reduction as compared to 2012. Approximately 70% of the drilling and completion budget will be focused in our Holly core area in DeSoto Parish, Louisiana, where we will develop seven units on 107 acre spacing with 4,200 foot laterals and 14 frac stages. This modified spacing is designed to optimize long-term performance and increase value per fully developed unit.

The remaining drilling and completion capital will spud and turn to sales eight gross (3.2 net) horizontal wells in the Shelby area in San Augustine County, Texas. We have been encouraged by recent industry success using enhanced completion methods in this area. The 2014 program will utilize laterals as long as 7,000 feet, more proppant per completed lateral foot and more restricted flowback. If the enhanced completion methods are successful on our acreage, this program will provide attractive economics in the current price environment and provide a growth platform for future development.

South Texas:

The capital budget program for our newly acquired Eagle Ford shale asset totals $138 million, of which $109 million will be spent to spud 90 gross (15.2 net) horizontal wells and turn to sales 82 gross (14.3 net) horizontal wells. The budgeted capital expenditures and net well counts reflect our lower working interest in our focus area wells during the first year of production relative to our joint venture partner (affiliates of KKR).

We currently have 126 operated horizontal wells producing in South Texas and November 2013 net production averaged 7,300 Boe/d. In 2014, we plan to drill 84 gross (14.2 net) horizontal wells in our focus area acreage with 500 foot (80-acre) spacing. We will continue our evaluation of the farm-out acreage, which is approximately 102,000 net acres, and plan to drill six gross (1.0 net) farm-out wells in 2014. An additional $29 million will fund pumping unit installations and infill leasing.

Appalachia:

November net production averaged 64 Mmcfe/d from 121 Marcellus shale wells and approximately 6,149 conventional wells. The 2014 capital budget program for our Marcellus shale program totals $17 million, of which $12 million will be spent to drill and complete two gross appraisal wells and fund our working interest in wells operated by others. The appraisal wells will be used to evaluate future development activities.

Permian:

In the Permian region, the first five horizontal wells drilled in 2013 are funded under a joint development agreement with an operator that is carrying us on drilling and completion costs totaling $18.9 million. We expect this carry to be fully utilized by the end of 2013. We will evaluate the results of the five Wolfcamp shale horizontal wells and, if appropriate, will recommend to our board of directors additional 2014 capital for the approximately 20,000 gross acres once our evaluation is complete.

Corporate Information

EXCO Resources, Inc. is a Texas corporation incorporated in October 1955. Shares of our common stock trade on the NYSE under the symbol “XCO.” Our principal executive office is located at 12377 Merit Drive, Suite 1700, LB 82, Dallas, Texas 75251. Our telephone number is (214) 368-2084. Our website address is www.excoresources.com. The information available on or through our website is not part of this prospectus.

 

 

4


Table of Contents

THE RIGHTS OFFERING

The following summary describes the principal terms of the rights offering, but is not intended to be complete. See the information under “The Rights Offering” in this prospectus for a more detailed description of the terms and conditions of the rights offering.

 

Securities Offered

We are distributing to you, at no charge, one transferable subscription right for each share of common stock that you owned as of 5:00 p.m., New York City time, on the record date, December 19, 2013, either as a holder of record or, in the case of shares held of record by brokers, dealers, custodian banks or other nominees on your behalf, as beneficial owner of those shares.

 

Basic Subscription Right

The basic subscription right will entitle you to purchase, with respect to each subscription right, 0.25 of a share of our common stock at a subscription price of $5.00 per whole share. Fractional shares resulting from the exercise of the basic subscription right on an aggregate basis by any holder will be eliminated by rounding down to the nearest whole share.

 

Over-Subscription Privilege

If you timely and fully exercise your basic subscription right (including in respect of subscription rights purchased from others), subject to the terms below, you may also choose to subscribe for any or all of the Unsubscribed Shares. The number of shares that will be available pursuant to the over-subscription privilege in the rights offering, including the shares to be subscribed for and purchased by the Investors under the over-subscription privilege, will be the Unsubscribed Shares.

 

 

If the requests for over-subscription (including of the Investors) exceed the available shares, we will allocate the Unsubscribed Shares pro rata among the rights holders exercising the over-subscription privilege in proportion to the number of shares of our common stock each of those rights holders owned as of 5:00 p.m., New York City time, on the record date, relative to the number of shares owned as of 5:00 p.m., New York City time, on the record date by all rights holders exercising the over-subscription privilege (including the Investors). In addition, pursuant to the Investment Agreements, and subject to the terms and conditions thereof, each of the Investors has agreed to subscribe for and purchase, in a private placement, its respective pro rata portion of shares under the basic subscription right and all Unsubscribed Shares under the over-subscription privilege, subject to availability and the pro rata allocation among the rights holders who have elected to exercise their over-subscription privilege, based on the number of shares of common stock each of the Investors owned as of 5:00 p.m., New York City time, on the record date, relative to the number of shares owned on the record date by all rights holders exercising the over-subscription privilege (including the Investors); provided, that each of the Investors shall not be obligated to purchase an aggregate number of shares that would exceed the lesser of (i) 100% of the Unsubscribed Shares or (ii) an

 

 

5


Table of Contents
 

amount of Unsubscribed Shares, which when taken together with the number of shares issued pursuant to the Investor’s basic subscription right, equal 50% of the total shares offered in the rights offering.

 

  If this pro rata allocation results in any rights holder receiving a greater number of shares of common stock than the rights holder subscribed for pursuant to the exercise of the over-subscription privilege, then such rights holder will be allocated only that number of shares for which the rights holder over-subscribed, and the remaining shares will be allocated among all other rights holders exercising the over-subscription privilege on the same pro rata basis described above. The proration process will be repeated until all Unsubscribed Shares have been allocated. Fractional shares resulting from the exercise of the over-subscription privilege, on an aggregate basis to any rights holder, will be eliminated by rounding down to the nearest whole share.

 

Subscription Price

$5.00 per share. To be effective, any payment related to the exercise of a subscription right must clear before the rights offering expires. See “The Rights Offering—Payment Method.”

 

Record Date

5:00 p.m., New York City time, on December 19, 2013.

 

Expiration of the Rights Offering

5:00 p.m., New York City time, on January 9, 2014. See “The Rights Offering—Expiration Date and Extension.”

 

Use of Proceeds

We intend to use the net proceeds from the sale of common stock offered in the rights offering and pursuant to the Investment Agreements to repay a portion of the indebtedness under the EXCO Resources Credit Agreement. See “Use of Proceeds.”

 

Transferability and Sale of Subscription Rights

The subscription rights are transferable until 4:00 p.m., New York City time, on January 8, 2014, the business day immediately preceding the expiration date of the rights offering. You may seek to sell or otherwise transfer your subscription rights through normal investment channels. See “The Rights Offering—Method of Transferring Rights.” We expect that the subscription rights will be admitted to trade on the NYSE under the symbol “XCO-RT.”

 

  The subscription rights are a new issue of securities, however, and do not have an established trading market. We cannot give you any assurance that the subscription rights will trade on the NYSE, a market for the rights will develop or, if a market does develop, whether it will be sustainable throughout the period when the subscription rights are transferable or at what prices the subscription rights will trade. Therefore, we cannot assure you that you will be able to sell any of your subscription rights or as to the value you may receive in a sale. Commissions and applicable taxes or broker fees may apply if you sell your subscription rights. See “The Rights Offering—Transferability of and Market for Rights” and “The Rights Offering—Method of Transferring Rights.”

 

 

6


Table of Contents

No Board Recommendation

Our board of directors is making no recommendation regarding your exercise of the subscription rights. See “The Rights Offering—No Board Recommendation to Rights Holders.”

 

  You are urged to make your decision based on your own assessment of our business and the rights offering. Please see “Risk Factors” for a discussion of some of the risks involved in investing in our common stock.

 

Conditions, Amendment, Withdrawal and Cancellation

There are no conditions precedent to the rights offering but there are conditions to the consummation of the transactions contemplated by the Investment Agreements. See “The Investment Agreements; Effects of the Transactions.”

 

  Subject to the provisions of the Investment Agreements, we reserve the right to amend, withdraw or cancel the rights offering at any time for any reason. If we cancel or withdraw the rights offering, the subscription agent will return all subscription payments without interest or penalty, as soon as practicable. If we cancel or withdraw the rights offering, the subscription rights will be void, of no value and will cease to be exercisable for shares of our common stock. See “The Rights Offering—Conditions, Amendment, Withdrawal and Cancellation” and “The Investment Agreements; Effects of the Transactions—The Investment Agreements.”

 

No Revocation

All exercises of subscription rights are irrevocable, subject to applicable law, even if you later learn information that you consider to be unfavorable to the exercise of your subscription rights. You should not exercise your subscription rights unless you are certain that you wish to purchase the shares of common stock at the subscription price of $5.00 per share. See “The Rights Offering—No Revocation or Change.”

 

Extension

We do not intend to extend the rights offering period. However, if we elect to extend the rights offering, we will issue a press release announcing the extension no later than 9:00 a.m., New York City time, on the next business day after the most recently announced expiration date of the rights offering. See “The Rights Offering—Expiration Date and Extension.”

 

Method of Exercising Rights

If you hold a stock certificate, the number of shares of common stock you may subscribe to purchase pursuant to your basic subscription right is indicated on the rights certificate we plan to distribute as soon as practicable after the record date. You may exercise your basic subscription right and over-subscription privilege, if any, by properly completing and executing the rights certificate, together with any required signature guarantees, and forwarding it, together with your full payment, to the subscription agent. All documents and payments must be received before 5:00 p.m., New York City time, on January 9, 2014, the expiration date of the rights offering.

 

 

7


Table of Contents
  If your subscription rights are held of record through the facilities of the Depository Trust Company, or DTC, you may exercise your subscription rights by instructing DTC, or having your broker, dealer, custodian bank or other nominee instruct DTC, to transfer your subscription rights from your account to the account of the subscription agent, together with certification as to the aggregate number of subscription rights you are exercising, the number of shares of our common stock for which you are subscribing under your basic subscription right and your over-subscription privilege, if any, and your full subscription payment.

 

  If you are a beneficial owner of shares of our common stock that are registered in the name of a broker, dealer, custodian bank or other nominee, you will not receive a rights certificate. Instead, we will issue one subscription right to the nominee record holder for each share of common stock that you own on the record date. If you are not contacted by your nominee, you should promptly contact your nominee in order to subscribe for shares in the rights offering and follow the instructions provided by your nominee. Your subscription rights will not be considered exercised unless the subscription agent receives from you, your broker, dealer, custodian bank or other nominee, as the case may be, all of the required subscription documents and your full subscription payment prior to the expiration of the rights offering.

 

  If shares are allocated to your 401(k) Plan account, you must deliver a properly completed 401(k) Election Form to the subscription agent before 5:00 p.m., New York City time, on January 6, 2014.

 

  If you wish to exercise your subscription rights but you do not have sufficient time to deliver the rights certificate to the subscription agent prior to the expiration of the rights offering, you may follow the guaranteed delivery procedures described under “The Rights Offering—Guaranteed Delivery Procedures.”

 

Investment Agreements

Pursuant to the Investment Agreements, each of WL Ross and Hamblin Watsa has severally agreed to subscribe for and purchase from us, in a private placement, its respective pro rata portion of shares under the basic subscription right and all Unsubscribed Shares under the over-subscription privilege, subject to availability and the pro rata allocation among rights holders who have elected to exercise their over-subscription privilege; provided, that each of the Investors shall not be obligated to purchase an aggregate number of shares that would exceed the lesser of (i) 100% of the Unsubscribed Shares, or (ii) an amount of Unsubscribed Shares, which when taken together with the shares issued to the Investor pursuant to the basic subscription right, equals 50% of the total shares offered in the rights offering. See “The Investment Agreements; Effects of the Transactions—The Investment Agreements.”

 

 

8


Table of Contents

Issuance of Shares of Common Stock

If you are a holder of record of our common stock and you purchase shares of our common stock through the rights offering, we will issue a direct registration account statement representing those shares to you as soon as practicable after the completion of the rights offering. If your shares are allocated to your account under the 401(k) Plan or held through a broker, dealer, custodian bank or other nominee and you purchase shares of common stock in the rights offering, your account under the 401(k) Plan or at your nominee will be credited with your new shares as soon as practicable following the closing of the rights offering.

 

Listing of Shares of Common Stock

Shares of our common stock trade on the NYSE under the symbol “XCO,” and the shares of common stock to be issued in connection with the rights offering will also be listed on the NYSE under the same symbol.

 

U.S. Federal Income Tax Considerations

You should not recognize taxable income for U.S. federal income tax purposes in connection with the receipt of subscription rights in the rights offering. You should, however, seek specific tax advice from your personal tax advisor in light of your personal tax situation and as to the applicability and effect of any other tax laws. See “Material U.S. Federal Income Tax Considerations.”

 

Subscription Agent

Continental Stock Transfer & Trust Company

 

Information Agent

D.F. King & Co., Inc.

 

Shares of Common Stock Outstanding Before the Rights Offering

As of December 5, 2013, 218,298,938 shares of our common stock were outstanding.

 

Shares of Common Stock Outstanding After Completion of the Rights Offering and the Transactions Contemplated by the Investment Agreements

We will issue up to an aggregate of 54,574,734 shares of common stock in the rights offering and the transactions contemplated under the Investment Agreements, subject to adjustment for fractional shares. Based on the number of shares of common stock outstanding as of December 5, 2013, if we issue all 54,574,734 shares of common stock, we would have 272,873,672 shares of common stock outstanding following the completion of the rights offering and the transactions contemplated by the Investment Agreements.

 

Risk Factors

Shareholders considering making an investment by exercising subscription rights in the rights offering or by purchasing subscription rights in the open market or otherwise should carefully read and consider the information set forth in “Risk Factors” beginning on page 13 of this prospectus, the documents incorporated by reference herein and the risks that we have highlighted in other sections of this prospectus.

 

 

9


Table of Contents

Fees and Expenses

We will pay the fees and expenses of the rights offering, other than the fees and expenses of the Investors. We will not pay the Investors a fee nor reimburse any of their expenses in connection with the rights offering.

 

Questions

If you have any questions, please contact the information agent, D.F. King & Co., Inc., at 1-800-755-7250 toll-free or, if you are a bank or broker, at 1-212-269-5550.

 

 

10


Table of Contents

FORWARD-LOOKING STATEMENTS

This prospectus and the documents incorporated herein by reference contain forward-looking statements, as defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. These forward-looking statements relate to, among other things, the following:

 

    our future financial and operating performance and results;

 

    our business strategy;

 

    market prices for oil, natural gas and natural gas liquids;

 

    our future use of derivative financial instruments; and

 

    our plans and forecasts.

We have based these forward-looking statements on our current assumptions, expectations and projections about future events.

We use the words “may,” “expect,” “anticipate,” “estimate,” “believe,” “continue,” “intend,” “plan,” “budget” and other similar words to identify forward-looking statements. The statements that contain these words should be read carefully because they discuss future expectations, contain projections of results of operations or our financial condition and/or state other “forward-looking” information. We do not undertake any obligation to update or revise publicly any forward-looking statements, except as required by applicable securities laws. These statements also involve risks and uncertainties that could cause our actual results or financial condition to materially differ from our expectations in this prospectus and the documents incorporated herein by reference, including, but not limited to:

 

    fluctuations in the prices of oil, natural gas and natural gas liquids;

 

    the availability of foreign oil, natural gas and natural gas liquids;

 

    future capital requirements and availability of financing;

 

    our ability to meet our current and future debt service obligations;

 

    disruption of credit and capital markets and the ability of financial institutions to honor their commitments;

 

    estimates of reserves and economic assumptions;

 

    geological concentration of our reserves;

 

    risks associated with drilling and operating wells;

 

    exploratory risks, primarily related to our activities in shale formations, including the Eagle Ford shale play in South Texas;

 

    discovery, acquisition, development and replacement of oil and natural gas reserves;

 

    cash flow and liquidity;

 

    timing and amount of future production of oil and natural gas;

 

    availability of drilling and production equipment;

 

    marketing of oil and natural gas;

 

    political and economic conditions and events in oil-producing and natural gas-producing countries;

 

    title to our properties;

 

    litigation;

 

11


Table of Contents
    competition;

 

    general economic conditions, including costs associated with drilling and operations of our properties;

 

    environmental or other governmental regulations, including legislation to reduce emissions of greenhouse gases, legislation of derivative financial instruments, regulation of hydraulic fracture stimulation and elimination of income tax incentives available to our industry;

 

    receipt and collectability of amounts owed to us by purchasers of our production and counterparties to our derivative financial instruments;

 

    decisions whether or not to enter into derivative financial instruments;

 

    potential acts of terrorism;

 

    our ability to manage joint ventures with third parties, including the resolution of any material disagreements and our partners’ ability to satisfy obligations under these arrangements;

 

    actions of third party co-owners of interests in properties in which we also own an interest;

 

    fluctuations in interest rates; and

 

    our ability to effectively integrate companies and properties that we acquire.

We believe that it is important to communicate our expectations of future performance to our investors. However, events may occur in the future that we are unable to accurately predict, or over which we have no control. We caution users of the financial statements not to place undue reliance on any forward-looking statements. When considering our forward-looking statements, keep in mind the risk factors and other cautionary statements in this prospectus and the documents incorporated herein by reference. The risk factors noted in this prospectus and the documents incorporated herein by reference provide examples of risks, uncertainties and events that may cause our actual results to differ materially from those contained in any forward-looking statement. Please see “Risk Factors” for a discussion of certain risks related to our business, the rights offering and an investment in our common stock.

Our revenues, operating results and financial condition depend substantially on prevailing prices for oil and natural gas and the availability of capital from the EXCO Resources Credit Agreement. Declines in oil or natural gas prices may have a material adverse affect on our financial condition, liquidity, results of operations, the amount of oil or natural gas that we can produce economically and the ability to fund our operations. Historically, oil and natural gas prices and markets have been volatile, with prices fluctuating widely, and they are likely to continue to be volatile.

 

12


Table of Contents

RISK FACTORS

Our business, operations and financial condition are subject to various risks and uncertainties. Some of these are described below and in the documents incorporated by reference in this prospectus, and you should take these risks into account in evaluating us or any decision to exercise subscription rights or in deciding whether to invest in our common stock. This section does not describe all risks or uncertainties applicable to us, our industry or our business, and it is intended only as a summary of certain material factors. If one or more of these risks or uncertainties materialize, or if underlying assumptions prove incorrect, actual outcomes may vary materially from those contained in any forward-looking statement included in this prospectus and the documents incorporated by reference in this prospectus.

Risks Related to the Rights Offering and the Investment Agreements

Shareholders who do not exercise their subscription rights will experience a dilution of their relative ownership interests.

The rights offering is designed to enable us to raise capital while allowing the holders of our common stock on the record date for the rights offering to maintain their relative proportionate voting and economic interests in the Company. Each of the Investors has severally agreed to subscribe for and purchase from us, in a private placement, its respective pro rata portion of shares under the basic subscription right and all Unsubscribed Shares under the over-subscription privilege, subject to availability and the pro rata allocation among rights holders who have elected to exercise their over-subscription privilege; provided, that each of the Investors shall not be obligated to purchase an aggregate number of shares that would exceed the lesser of (i) 100% of the Unsubscribed Shares, or (ii) an amount of Unsubscribed Shares, which when taken together with the number of shares issued pursuant to the Investor’s basic subscription right, equals 50% of the total shares offered in the rights offering. The issuance of shares of common stock in the rights offering will dilute, and thereby reduce, your proportionate ownership in our shares of common stock if you do not exercise your basic subscription right in full.

WL Ross, Fairfax and their respective affiliates have significant influence over matters requiring shareholder approval because of their ownership of our common stock and their beneficial ownership may increase unless all rights holders exercise their basic subscription right in full.

As of December 5, 2013, each of WL Ross and Fairfax, directly or through certain affiliates, beneficially owned approximately 14.4% and 4.95%, respectively, of our outstanding shares of common stock. If no other rights holders timely and fully exercise their subscription rights and WL Ross and Hamblin Watsa fulfill their subscription and purchase commitments under the Investment Agreements, then the beneficial ownership of WL Ross and Fairfax (including Hamblin Watsa) in our shares of common stock will increase to approximately 21.5% and 14.0%, respectively, and the ownership interest of the remaining current shareholders, who currently own in the aggregate 80.6% of the outstanding shares of our common stock, will decrease to approximately 64.5%. The beneficial ownership of WL Ross and Fairfax (including Hamblin Watsa) and their affiliates would increase along with their influence on matters submitted for shareholder approval, including proposals regarding:

 

    any merger, consolidation or sale of all or substantially all of our assets;

 

    the election of members of our board of directors; and

 

    any amendment to our articles of incorporation.

The current or increased ownership position of WL Ross, Fairfax (including Hamblin Watsa) and their respective affiliates could delay, deter or prevent a change of control or adversely affect the price that investors might be willing to pay in the future for shares of our common stock. The interests of WL Ross, Fairfax (including Hamblin Watsa) and their respective affiliates may significantly differ from the interests of our other shareholders and they may vote the shares of common stock they beneficially own in ways with which our other shareholders disagree.

 

13


Table of Contents

The Investors’ obligations under the Investment Agreements are subject to a number of conditions, many of which are beyond our control.

The obligations of the Investors pursuant to the applicable Investment Agreement are subject to satisfaction or waiver of the following conditions: (i) the effectiveness of the registration statement for the rights offering; (ii) the rights offering having been conducted by the Company in accordance with the Investment Agreement in all material respects; (iii) the absence of any legal impediment to the implementation of the rights offering, the issuance and sale of shares under the Investment Agreements or the consummation of the transactions contemplated by the Investment Agreements; (iv) the accuracy of the Company’s representations and warranties; (v) the Company’s performance and compliance in all material respects with covenants and agreements, in each case as required to be performed or complied with on or prior to closing; (vi) the approval of shares issued in the rights offering for listing on the NYSE; (vii) the expiration or termination of any waiting period under the HSR Act; (viii) the absence of certain breaches or defaults under the other Investment Agreement that are the basis for a party to terminate or refuse to close the transactions contemplated under the other Investment Agreement; (ix) the absence of any Material Adverse Effect (as defined in the applicable Investment Agreement) since November 22, 2013; (x) we have not, and are not reasonably expected to, recognize any impairments to our assets which in the aggregate equal or exceed $150 million (excluding the $10,707,000 impairment previously taken by us for the quarter ended March 31, 2013); and (xi) other customary conditions. If any of these conditions are not satisfied by March 31, 2014, the Investors will have the right to terminate their respective Investment Agreement and their obligations to purchase shares of common stock under their respective Investment Agreement. In the event of such a termination of the Investment Agreements, we would not be able to consummate the rights offering on the terms described in this prospectus and we would be required to amend the terms of the rights offering or terminate the rights offering. See “The Investment Agreements; Effects of the Transactions—The Investment Agreements.”

The subscription price determined for the rights offering may not be indicative of the fair value of our common stock.

The subscription price for shares of our common stock in the rights offering was determined by the unanimous vote of our directors other than Messrs. Ross and Mitchell. In determining the subscription price, the disinterested directors considered a number of factors, including:

 

    the current and historical trading prices of our common stock;

 

    the price at which shareholders might be willing to participate in the rights offering;

 

    the ability of shareholders to transfer or sell their subscription rights;

 

    our need for additional capital and liquidity;

 

    the cost of capital from other sources; and

 

    comparable precedent transactions, including the percentage of shares offered, the terms of the subscription rights being offered, the subscription price and the discount that the subscription price represented to the immediately prevailing closing prices for those offerings.

The subscription price does not necessarily bear any relationship to the book value of our assets, net worth, past operations, cash flows, losses, financial condition or any other established criteria for fair value. You should not consider the subscription price as an indication of the fair value of shares of our common stock. The market price of our common stock could decline during or after the rights offering, and you may not be able to sell shares purchased in the rights offering at a price equal to or greater than the subscription price. We do not intend to change the subscription price in response to changes in the market price of our common stock prior to the closing of the rights offering.

The rights offering may cause the price of our common stock to decline.

The subscription price of $5.00 per share equals an approximate 29% discount on the sixty-day average trading price for the period ended November 22, 2013, the last trading day before the announcement of the rights

 

14


Table of Contents

offering. The subscription price also represents an approximately 6.7% discount on the closing price of $5.36 per share of common stock on the NYSE on November 22, 2013. The rights offering and its terms, including the subscription price, together with the number of shares of common stock we could issue if the rights offering is completed, may result in an immediate decrease in the market price of our common stock. This decrease may continue after the completion of the rights offering. If that occurs, your purchase of our shares of common stock in the rights offering may be at a price greater than the prevailing market price. Further, if a substantial number of subscription rights are exercised and the holders of the shares received upon exercise of those subscription rights choose to sell some or all of those shares, the resulting sales could also depress the market price of our common stock.

You may not revoke your exercise of your subscription rights and could be committed to buying shares above the prevailing market price.

The public trading market price of our common stock may fail to remain above, or later decline below, the subscription price before the subscription rights expire. If you exercise your subscription rights and, subsequently, the public trading market price of our common stock does not increase above, or later declines below, $5.00 per share, you will have committed to buying our shares of our common stock at a price above the prevailing market price. Once you have exercised your subscription rights, you may not revoke your exercise of such rights, subject to applicable law. Moreover, you may be unable to sell your shares of our common stock at a price equal to or greater than the subscription price.

If you acquire subscription rights, you may suffer a complete loss of your investment.

Our obligations under the Investment Agreements, including our obligation to consummate the rights offering, are conditioned upon certain requirements, which are discussed under “The Investment Agreements; Effects of the Transactions—The Investment Agreements.” There can be no assurance that these requirements will be satisfied or that the rights offering will be consummated.

We expect that the subscription rights will be traded on the NYSE under the trading symbol “XCO-RT” until 4:00 p.m., New York City time, on January 8, 2014. If you acquire subscription rights in the open market or otherwise and the rights offering is not consummated, the purchase price you paid for any subscription rights you have purchased will not be refunded to you. Accordingly, you may suffer a complete loss of your investment if you acquire subscription rights.

Significant sales of our common stock, or the perception that significant sales may occur in the future, could adversely affect the market price for our common stock.

The sale of substantial amounts of our common stock could adversely affect the price of the common stock. Sales of substantial amounts of our common stock in the public market, and the availability of shares for future sale, including up to 54,574,734 shares of our common stock expected to be issued in the rights offering and pursuant to the transactions contemplated by the Investment Agreements, could cause the market price of our common stock to remain low for a substantial amount of time. We cannot foresee the impact of such potential sales on the market, but it is possible that if holders of a significant percentage of such available shares attempt to sell such shares within a short period of time, the market for our shares of common stock would be adversely affected. Even if a substantial number of sales do not occur within a short period of time, the mere existence of this “market overhang” could have a negative impact on the market for our common stock and our ability to raise additional capital.

You may be unable to resell any of our shares of common stock that you purchase pursuant to the exercise of subscription rights immediately upon expiration of the rights offering period or unable to sell your shares at a price equal to or greater than the subscription price.

If you exercise subscription rights, you may not be able to resell the shares of our common stock purchased by exercising your subscription rights until you, or your broker, dealer, custodian bank or other nominee, if

 

15


Table of Contents

applicable, have received those shares. Moreover, you will have no rights as a shareholder of the shares you purchased in the rights offering until we issue the shares to you. Although we will endeavor to issue a direct registration account statement representing those shares as soon as practicable after completion of the rights offering, including the guaranteed delivery period and after all necessary calculations have been completed, there may be a delay between the expiration date of the rights offering and the time that the shares are issued. In addition, we cannot assure you that, following the exercise of your subscription rights, you will be able to sell your shares of our common stock at a price equal to or greater than the subscription price.

Because we may terminate the rights offering at any time, your participation in the rights offering is not assured.

Once you exercise your subscription rights, you may not revoke the exercise for any reason, subject to applicable law, unless we amend the rights offering. Subject to the provisions of the Investment Agreements, we may terminate the rights offering at any time. If we decide to terminate the rights offering, neither we nor the subscription agent will have any obligation with respect to the subscription rights, except that we will be required to return any subscription payments, without interest or penalty.

You will need to act promptly and follow subscription instructions.

Rights holders who desire to purchase shares in the rights offering must act promptly to ensure that all required forms and payments are actually received by the subscription agent prior to 5:00 p.m., New York City time, on January 9, 2014, the expiration date of the rights offering. If you fail to complete and sign the required subscription forms, send an incorrect payment amount, or otherwise fail to follow the subscription procedures that apply to your desired transaction, the subscription agent may, depending on the circumstances, reject your subscription or accept it only to the extent of the payment received. Neither we nor our subscription agent undertakes to contact you concerning, or attempt to correct, an incomplete or incorrect subscription form or payment. We have the sole discretion to determine whether a subscription exercise properly follows the subscription procedures.

If you desire to purchase shares in the rights offering through your subscription rights that are allocated to your 401(k) Plan account, you must elect what amount (if any) of your subscription rights allocated to such account that you would like to exercise by properly completing the 401(k) Election Form provided to you. In addition, you may instruct the 401(k) Plan trustee to sell all or a portion of the subscription rights allocated to your account by completing the 401(k) Election Form. You must return your properly completed 401(k) Election Form to the subscription agent as prescribed in the instructions accompanying the 401(k) Election Form. Your 401(k) Election Form must be received by the subscription agent by the 401(k) Deadline (5:00 p.m., New York City time, on January 6, 2014, which is the third business day prior to the expiration date of the rights offering). If your 401(k) Election Form is not received by the 401(k) Deadline, your election to exercise the subscription rights that are allocated to your 401(k) Plan account will not be effective. The 401(k) Deadline is a special deadline that applies to participants (and other account holders) in the 401(k) Plan (notwithstanding the expiration date of the rights offering generally applicable to holders of subscription rights) and solely with respect to the shares of our common stock held through the 401(k) Plan. Any subscription rights allocated to your 401(k) Plan account will expire unless they are properly exercised by the 401(k) Deadline or otherwise sold by the 401(k) Plan trustee.

If no instructions are received by the subscription agent prior to the 401(k) Deadline, no subscription rights will be exercised by the 401(k) Plan trustee on your behalf, and the 401(k) Plan trustee will attempt to sell the subscription rights attributable to your 401(k) Plan account through the NYSE. The 401(k) Plan trustee’s attempt to sell the subscription rights may be unsuccessful. Any amounts obtained from the sale of subscription rights by the 401(k) Plan trustee will be allocated on an individual basis to each participant who did not timely submit instructions to exercise subscription rights allocated to its account or who instructed the 401(k) Plan trustee to

 

16


Table of Contents

sell all or a portion of the subscription rights allocated to its account. The amounts obtained from the sale of a participant’s subscription rights will be allocated to the Guaranteed Income Fund in the participant’s 401(k) Plan account.

If you elect to exercise some or all of the subscription rights allocated to your 401(k) Plan account, you must ensure that the number of shares for which you are subscribing under the basic subscription right on your 401(k) Election Form accurately reflects the number of shares to which you are entitled. You must also ensure that your current investment in your 401(k) Plan account in the Guaranteed Income Fund is sufficient to fully satisfy the subscription payment for the subscription rights you elect to exercise on your 401(k) Election Form, as you may only pay for the exercise of such subscription rights through the liquidation of funds held by your 401(k) Plan account in the Guaranteed Income Fund. If your 401(k) Plan account investment in this fund is insufficient to fully satisfy the subscription payment, the subscription rights allocated to your 401(k) Plan account will be exercised to the fullest extent possible based on the liquidated value of your 401(k) Plan account invested in this fund, rounded down to the nearest whole share. For additional information, see “The Rights Offering—Special Instructions for Participants in Our 401(k) Plan.”

Our 401(k) Plan, which is receiving subscription rights, is not permitted to acquire, hold or dispose of subscription rights absent an exemption from the U.S. Department of Labor.

The 401(k) Plan is receiving subscription rights with respect to the shares of common stock held by the 401(k) Plan on behalf of the participants (and other account holders) as of the record date even though 401(k) plans and other plans subject to ERISA, such as ours, are not permitted under ERISA or Section 4975 of the Internal Revenue Code of 1986, as amended, or the Code, to acquire, hold or dispose of subscription rights absent an exemption from the U.S. Department of Labor, or DOL. We are submitting a request to the DOL that an exemption be granted on a retroactive basis, effective as of the commencement of the rights offering, with respect to the acquisition, holding and exercise of the subscription rights by the 401(k) Plan and its participants (and other account holders); however, the DOL may deny our exemption application. If our exemption request is denied by the DOL, the DOL may require us to take appropriate remedial action and the Internal Revenue Service, or IRS, and DOL could impose certain taxes and penalties on us.

You may not receive all of the shares for which you subscribe pursuant to the over-subscription privilege.

If any rights holders (including rights holders who acquired subscription rights by purchasing subscription rights from others) do not exercise their basic subscription right in full, then rights holders who have exercised their basic subscription right in full (including in respect of subscription rights purchased from others) will be entitled to exercise an over-subscription privilege, subject to certain limitations and subject to a pro rata allocation, to purchase any or all of the shares of common stock that are not purchased by the other rights holders through the exercise of their basic subscription right at the same subscription price of $5.00 per share.

If over-subscription requests exceed the number of shares available, we will allocate the Unsubscribed Shares pro rata among the rights holders exercising the over-subscription privilege in proportion to the number of shares of our common stock each of those rights holders owned as of 5:00 p.m., New York City time, on the record date, relative to the number of shares owned as of 5:00 p.m., New York City time, on the record date by all rights holders exercising the over-subscription privilege (including the Investors). You may not receive any or all of the number of shares for which you over-subscribe. If the pro-rated number of shares allocated to you in connection with your over-subscription privilege is less than your over-subscription request, then the excess funds held by the subscription agent on your behalf will be returned to you, without interest or penalty, as soon as practicable. You have to exercise your basic subscription privilege in full (including in respect of subscription rights purchased from others) in order to exercise your over-subscription privilege. Because shares available pursuant to the over-subscription privilege, if any, will be allocated based on the number of shares of our common stock held as of 5:00 p.m., New York City time, on the record date, your ability to subscribe for shares pursuant to the over-subscription privilege will only be available to the extent that you own shares of our common stock as of 5:00 p.m., New York City time, on the record date.

 

17


Table of Contents

No prior market exists for the subscription rights, and a liquid and reliable market for the subscription rights may not develop.

The subscription rights are a new issue of securities with no established trading market. Unless indicated otherwise, the subscription rights are transferable and we expect the rights to trade until 4:00 p.m., New York City time, on January 8, 2014, which is the business day immediately preceding the expiration date of the rights offering. Unless exercised, the subscription rights will cease to have any value following the expiration date. We are not responsible if you elect to sell your subscription rights and no public or private market exists to facilitate the purchase of subscription rights. In such event, the subscription rights will expire and will no longer be exercisable or transferable.

If you use an uncertified personal check to pay the subscription price for shares, it may not clear in time.

Any uncertified personal check used to pay for shares must clear prior to the expiration date of the rights offering, and the clearing process may require five or more business days. If you wish to pay the subscription price by uncertified personal check, we urge you to make payment sufficiently in advance of the time the rights offering expires to ensure that your payment is received and clears by that time.

Because our management will have broad discretion over the use of the net proceeds from the rights offering and the transactions contemplated by the Investment Agreements, you may not agree with how we use the proceeds, and we may not invest the proceeds successfully.

We currently anticipate that we will use the net proceeds from the rights offering and the transactions contemplated by the Investment Agreements to repay a portion of the indebtedness under the EXCO Resources Credit Agreement. We can reborrow under the EXCO Resources Credit Agreement and use the borrowings for working capital and general corporate purposes. Our management may allocate the proceeds from the rights offering as it deems appropriate. In addition, market factors may require our management to allocate portions of the proceeds for other purposes. Accordingly, you will be relying on the judgment of our management with regard to the use of the proceeds from the rights offering, and you will not have the opportunity, as part of your investment decision, to assess whether we are using the proceeds appropriately. It is possible that we may invest the proceeds in a way that does not yield a favorable, or any, return for us.

 

18


Table of Contents

Risks Relating to Our Business

Fluctuations in oil and natural gas prices, which have been volatile at times, may adversely affect our revenues as well as our ability to maintain or increase our borrowing capacity, repay current or future indebtedness and obtain additional capital on attractive terms.

Our future financial condition, access to capital, cash flow and results of operations depend upon the prices we receive for our oil and natural gas. We are particularly dependent on prices for natural gas. As of December 31, 2012, 92.7% of our Proved Reserves were natural gas and approximately 96% of our production was natural gas. Historically, oil and natural gas prices have been volatile and are subject to fluctuations in response to changes in supply and demand, market uncertainty and a variety of additional factors that are beyond our control. Factors that affect the prices we receive for our oil and natural gas include:

 

    supply and demand for oil and natural gas and expectations regarding supply and demand;

 

    the level of domestic production;

 

    the availability of imported oil and natural gas;

 

    political and economic conditions and events in foreign oil and natural gas producing nations, including embargoes, continued hostilities in the Middle East and other sustained military campaigns, and acts of terrorism or sabotage;

 

    the ability of members of the Organization of Petroleum Exporting Countries to agree to and maintain oil price and production controls;

 

    the cost and availability of transportation and pipeline systems with adequate capacity;

 

    the cost and availability of other competitive fuels;

 

    fluctuating and seasonal demand for oil, natural gas and refined products;

 

    concerns about global warming or other conservation initiatives and the extent of governmental price controls and regulation of production;

 

    regional price differentials and quality differentials of oil and natural gas;

 

    the availability of refining capacity;

 

    technological advances affecting oil and natural gas production and consumption;

 

    weather conditions and natural disasters;

 

    foreign and domestic government relations; and

 

    overall economic conditions.

In the past, prices of oil and natural gas have been extremely volatile, and we expect this volatility to continue. During the eleven months ended November 30, 2013, the NYMEX price for natural gas fluctuated from a high of $4.41 per Mmbtu to a low of $3.11 per Mmbtu, while the NYMEX West Texas Intermediate crude oil price ranged from a high of $110.53 per Bbl to a low of $86.68 per Bbl. For the five years ended December 31, 2012, the NYMEX Henry Hub natural gas price ranged from a high of $13.58 per Mmbtu to a low of $1.91 per Mmbtu, while the NYMEX West Texas Intermediate crude oil price ranged from a high of $145.29 per Bbl to a low of $33.87 per Bbl. On November 30, 2013, the spot market price for natural gas at Henry Hub was $3.57 per Mmbtu, a 4% increase from December 31, 2012. On November 30, 2013, the spot market price for crude oil at Cushing was $89.25 per Bbl, a 1% increase from December 31, 2012. For 2012, our average realized prices (before the impact of derivative financial instruments) for oil and natural gas were $88.24 per Bbl and $2.53 per Mcf, respectively, compared with 2011 average realized prices of $91.01 per Bbl and $3.72 per Mcf, respectively.

 

19


Table of Contents

Our revenues, cash flow and profitability and our ability to maintain or increase our borrowing capacity, to repay current or future indebtedness and to obtain additional capital on attractive terms depend substantially upon oil and natural gas prices.

Changes in the differential between NYMEX or other benchmark prices of oil and natural gas and the reference or regional index price used to price our actual oil and natural gas sales could have a material adverse effect on our results of operations and financial condition.

The reference or regional index prices that we use to price our oil and natural gas sales sometimes reflect a discount to the relevant benchmark prices, such as NYMEX. The difference between the benchmark price and the price we reference in our sales contracts is called a differential. We cannot accurately predict oil and natural gas differentials. Changes in differentials between the benchmark price for oil and natural gas and the reference or regional index price we reference in our sales contracts could have a material adverse effect on our results of operations and financial condition.

There are risks associated with our drilling activity that could impact our results of operations and financial condition.

Our drilling involves numerous risks, including the risk that we will not encounter commercially productive oil or natural gas reservoirs. We must incur significant expenditures to identify and acquire properties and to drill and complete wells. Additionally, seismic and other technology does not allow us to know conclusively prior to drilling a well that oil or natural gas is present or economically producible. The costs of drilling and completing wells are often uncertain, and drilling operations may be curtailed, delayed or canceled as a result of a variety of factors, including unexpected drilling conditions, pressure or irregularities in formations, equipment failures or accidents, weather conditions and shortages or delays in the delivery of equipment. We have experienced some delays in contracting for drilling rigs, obtaining fracture stimulation crews and materials, which result in increased costs to drill wells. All of these risks could adversely affect our results of operations and financial condition.

Our ability to develop properties in new or emerging formations may be subject to more uncertainties than drilling in areas that are more developed or have a longer history of established production.

The results of our drilling in new or emerging formations, including the Eagle Ford shale formation, are more uncertain initially than drilling results in areas that are developed, have established production or where we have a longer history of operation. Because new or emerging formations have limited or no production history, we are less able to use past drilling results in those areas to help predict future drilling results. Further, part of our strategy for the Eagle Ford shale formation involves the use of horizontal drilling and completion techniques that have been successful in other shale formations. Our experience with horizontal drilling in these areas to date, as well as the industry’s drilling and production history, while growing, is limited. The ultimate success of these drilling and completion techniques will be better evaluated over time as more wells are drilled and production profiles are better established.

If our drilling results are less than anticipated or we are unable to execute our drilling program because of capital constraints, lease expirations, and/or natural gas and oil prices decline, our investment in these areas may not be as attractive as we anticipate and we could incur material write-downs of undeveloped properties and the value of our undeveloped acreage could decline in the future, which could have a material adverse effect on our business and results of operations.

 

20


Table of Contents

Market conditions or operational impediments, such as lack of available transportation or infrastructure, may hinder our production or adversely impact our ability to receive market prices for our production or to achieve expected drilling results.

Market conditions or the unavailability of satisfactory oil and natural gas transportation arrangements or infrastructure may hinder our access to oil and natural gas markets or delay our production. The availability of a ready market for our oil and natural gas production depends on a number of factors, including the demand for and supply of oil and natural gas and the proximity of reserves to pipelines and terminal facilities. Our ability to market our production depends, in substantial part, on the availability and capacity of gathering systems, pipelines, processing facilities and oil and condensate trucking operations owned and operated by third-parties. Our failure to obtain these services on acceptable terms could have a material adverse effect on our business. We may be required to shut in wells due to lack of a market or inadequacy or unavailability of crude oil or natural gas pipelines, gathering systems or trucking capacity. A portion of our production may also be interrupted, or shut in, from time to time for numerous other reasons, including as a result of accidents, excessive pressures, maintenance, weather, field labor issues or other disruptions of service. Curtailments and disruptions may last from a few days to several months, and we have no control over when or if third-party facilities are restored.

In the past we have experienced production curtailments due to infrastructure and market constraints in the Eagle Ford shale formation, which has caused natural gas production to either be shut in or flared. Any significant curtailment in gathering, processing or pipeline system capacity, significant delay in the construction of necessary facilities or lack of availability of transport would interfere with our ability to market the oil and natural gas we produce, and could have a material adverse effect on our cash flow and results of operations.

We depend on Chesapeake to market our oil and natural gas production in the Eagle Ford shale. If Chesapeake is unable or otherwise fails to market our Eagle Ford production, our revenues could be adversely affected.

We have entered into marketing agreements with an affiliate of Chesapeake to sell all of the anticipated oil and natural gas production associated with the acreage we acquired from Chesapeake in the Eagle Ford shale formation. If Chesapeake is unable or otherwise fails to market the oil and natural gas we produce from the Eagle Ford shale formation, we would be required to find alternate means to market our production, which could increase our costs, reduce the revenues we might obtain from the sale of our oil and natural gas or have a material adverse effect on our business, results of operations or financial condition.

We conduct a substantial portion of our operations through joint ventures, and our failure to continue such joint ventures or resolve any material disagreements with our partners could have a material adverse effect on the success of these operations, our financial condition and our results of operations.

We conduct a substantial portion of our operations through joint ventures with third parties, principally BG Group, HGI and KKR, and as a result, the continuation of such joint ventures is vital to our continued success. We may also enter into other joint venture arrangements in the future. In many instances we depend on these third parties for elements of these arrangements that are important to the success of the joint venture, such as agreed payments of substantial development costs pertaining to the joint venture and their share of other costs of the joint venture. The performance of these third party obligations or the ability of third parties to meet their obligations under these arrangements is outside our control. If these parties do not meet or satisfy their obligations under these arrangements, the performance and success of these arrangements, and their value to us, may be adversely affected. If our current or future joint venture partners are unable to meet their obligations, we may be forced to undertake the obligations ourselves and/or incur additional expenses in order to have some other party perform such obligations. In such cases we may also be required to enforce our rights, which may cause disputes among our joint venture partners and us. If any of these events occur, they may adversely impact us, our financial performance and results of operations, these joint ventures and/or our ability to enter into future joint ventures. In addition, we are required to present opportunities related to the development of certain

 

21


Table of Contents

conventional assets to the EXCO/HGI Partnership. BG Group also has the right to elect to participate in all acreage and other acquisitions in defined areas of mutual interest in the Haynesville and Appalachia regions. If they elect not to participate in a particular transaction or transactions, we would bear the entire cost of the acquisition and all development costs of the acquired properties.

Such joint venture arrangements may involve risks not otherwise present when exploring and developing properties directly, including, for example:

 

    our joint venture partners may share certain approval rights over major decisions;

 

    the possibility that our joint venture partners might become insolvent or bankrupt, leaving us liable for their shares of joint venture liabilities;

 

    the possibility that we may incur liabilities as a result of an action taken by our joint venture partners;

 

    joint venture partners may be in a position to take action contrary to our instructions or requests or contrary to our policies or objectives;

 

    disputes between us and our joint venture partners may result in litigation or arbitration that would increase our expenses, delay or terminate projects and prevent our officers and directors from focusing their time and effort on our business;

 

    that under certain joint venture arrangements, neither joint venture partner may have the power to control the venture, and an impasse could be reached which might have a negative influence on our investment in the joint venture; and

 

    our joint venture partners may decide to terminate their relationship with us in any joint venture company or sell their interest in any of these companies and we may be unable to replace such joint venture partner or raise the necessary financing to purchase such joint venture partner’s interest.

The failure to continue some of our joint ventures or to resolve disagreements with our joint venture partners could adversely affect our ability to transact the business that is the subject of such joint venture, which would in turn negatively affect our financial condition and results of operations.

We may make significant capital expenditures and be subject to certain legal and financial terms as the result of our joint ventures with BG Group that could adversely affect us.

We are a party to a joint venture with BG Group covering an undivided 50% interest in a substantial portion of our shale assets in the East Texas/North Louisiana area including the Haynesville/Bossier shale, or the East Texas/North Louisiana JV. The East Texas/North Louisiana JV operates as a joint venture pursuant to a joint development agreement under which EXCO acts as the operator.

We are also party to a joint venture with BG Group covering our Marcellus shale acreage and shallow producing assets in the Appalachia region, or the Appalachia JV. Pursuant to the agreements governing the Appalachia JV, EXCO and BG Group agreed to jointly explore and develop their Appalachian properties, particularly the Marcellus shale. EXCO and BG Group each own a 50% interest in the operating entity that operates the Appalachia JV’s properties subject to oversight from a management board having equal representation from EXCO and BG Group. In addition, certain midstream assets owned by EXCO and BG Group are party to a midstream joint venture in Appalachia through which they will pursue the construction and expansion of gathering systems, pipeline systems and treating facilities for anticipated future production from the Marcellus shale. EXCO has unconditionally guaranteed its subsidiaries’ performance of the joint venture agreements under the Appalachia joint ventures.

Each of these joint ventures may require us to make significant capital expenditures. If we do not timely meet our financial commitments under the respective joint venture agreements, our rights to participate in such joint ventures will be adversely affected and other parties to the joint ventures may have a right to acquire a share of our interest in such joint ventures proportionate to, and in satisfaction of, our unmet financial obligations.

 

22


Table of Contents

Our use of derivative financial instruments is subject to risks that our counterparties may default on their contractual obligations to us and may cause us to forego additional future profits or result in us making cash payments.

To reduce our exposure to changes in the prices of oil and natural gas, we have entered into, and may in the future enter into, derivative financial instrument arrangements for a portion of our oil and natural gas production. The agreements that we have entered into generally have the effect of providing us with a fixed price for a portion of our expected future oil and natural gas production over a fixed period of time. Our derivative financial instruments are subject to mark-to-market accounting treatment. The change in the fair market value of these instruments is reported as a non-cash item in our Consolidated Statements of Operations each quarter, which typically results in significant variability in our net income. Derivative financial instruments expose us to the risk of financial loss and may limit our ability to benefit from increases in oil and natural gas prices in some circumstances, including the following:

 

    market prices may exceed the prices which we are contracted to receive, resulting in our need to make significant cash payments;

 

    there may be a change in the expected differential between the underlying price in the derivative financial instrument agreement and actual prices received; or

 

    the counterparty to the derivative financial instrument contract may default on its contractual obligations to us.

Our use of derivative financial instruments could have the effect of reducing our revenues and the value of our securities. During the nine months ended September 30, 2013 and the years ended December 31, 2012 and 2011, we received cash receipts to settle our derivative financial instrument contracts totaling $28.4 million, $202.1 million and $135.4 million, respectively. For the nine months ended September 30, 2013, a $1.00 increase in the average commodity price per Mcfe would have resulted in an increase in cash settlement payments (or a decrease in settlements received) of approximately $65.9 million. As of September 30, 2013, the net unrealized gains on our oil and natural gas derivative financial instrument contracts were $26.7 million. The ultimate settlement amount of these unrealized derivative financial instrument contracts is dependent on future commodity prices. We may incur significant realized and unrealized losses in the future from our use of derivative financial instruments to the extent market prices increase and our derivatives contracts remain in place.

To fund the acquisitions of oil and natural gas assets in the Haynesville and Eagle Ford shale formations, we incurred a substantial amount of indebtedness which may adversely affect our cash flow and our ability to operate our business, remain in compliance with debt covenants and make payments on our debt.

To finance the acquisitions of the oil and natural gas assets in the Haynesville and Eagle Ford shale formations, we entered into the amended EXCO Resources Credit Agreement on July 31, 2013. The borrowing base under the EXCO Resources Credit Agreement was increased to $1.6 billion, which included a $1.3 billion revolving commitment and a $300.0 million term loan commitment. As of December 6, 2013, the revolving commitment under the EXCO Resources Credit Agreement had an available borrowing base of approximately $928.9 million, with approximately $763.9 million of outstanding indebtedness and $158.2 million of unused borrowing base, net of letters of credit.

Our business may not generate sufficient cash flow from operations to enable us to repay our indebtedness, including our 7.5% senior unsecured notes due September 15, 2018, or the 2018 Notes, and the EXCO Resources Credit Agreement, to fund planned capital expenditures and to fund our other liquidity needs. If our cash flow, capital resources and planned asset sales are insufficient to repay our debt obligations and finance capital expenditure programs, we may be forced to sell additional assets, issue additional equity or debt securities or restructure our indebtedness. These options may not be available on commercially reasonable terms, or at all. In addition, the sale of assets or issuance of debt securities would have to be completed in compliance with the financial and other restrictive covenants in the EXCO Resources Credit Agreement and the indenture governing the 2018 Notes.

 

23


Table of Contents

If we cannot make scheduled payments on our indebtedness, we will be in default and holders of the 2018 Notes could declare all outstanding principal and interest to be due and payable, the lenders under the EXCO Resources Credit Agreement could terminate their commitments to loan money, our secured lenders could foreclose against the assets securing their borrowings and we could be forced into bankruptcy or liquidation. Our inability to generate sufficient cash flows to satisfy our debt obligations, or to refinance our indebtedness on commercially reasonable terms or at all, would materially and adversely affect our financial position and results of operations. Further, failing to comply with the financial and other restrictive covenants in the EXCO Resources Credit Agreement or the indenture governing the 2018 Notes could result in an event of default, which could adversely affect our business, financial condition and results of operations.

If we are unable to complete the joint development of our assets in the Eagle Ford shale formations with KKR, we may need to find alternative sources of capital, which may not be available on favorable terms, or at all.

On July 31, 2013, we closed the acquisition of certain producing and non-producing oil, natural gas and mineral leases and wells in the Eagle Ford shale located in Zavala, Dimmit, La Salle and Frio counties in South Texas. In connection with the closing of the acquisition of the Eagle Ford assets, we sold an undivided 50% interest in the undeveloped acreage to affiliates of KKR for approximately $130.9 million. With respect to each well drilled, EXCO will assign half of its undivided 50% interest in such well to KKR such that KKR will fund and own 75% of each well drilled and EXCO will fund and own 25% of each well drilled. There can be no assurance that KKR will elect to proceed with subsequent phases of the development of our Eagle Ford assets. If we cannot identify an alternative joint venture partner or partners for our Eagle Ford assets, sell assets at acceptable valuations or are unable to complete the joint development of our Eagle Ford assets, we will need to utilize cash flow from other operations or will need to find alternative sources of capital to finance the development of the Eagle Ford assets, which may slow the development of these assets and have a material adverse effect on our operations and prospects.

While we are required to make offers to purchase KKR’s interest in certain wells, we may not have sufficient funds or borrowing capacity under the EXCO Resources Credit Agreement to complete the acquisitions pursuant to the KKR Participation Agreement. In the event we fail to purchase a group of wells that KKR is obligated to sell, there are remedies available to KKR which allow KKR to reject future EXCO offers, terminate the KKR Participation Agreement, or pursue other legal remedies. This could require us to seek alternative financing to make offers to preserve KKR’s obligation to sell to us, or negatively impact our ability to increase our Eagle Ford assets via acquisitions of KKR’s producing properties.

We may be unable to obtain additional financing to implement our growth strategy.

The growth of our business will require substantial capital on a continuing basis. Due to the amount of debt we have incurred, it may be difficult for us in the foreseeable future to obtain additional debt financing or to obtain additional secured financing other than purchase money indebtedness. If we are unable to obtain additional capital on satisfactory terms and conditions or at all, we may lose opportunities to acquire oil and natural gas properties and businesses and, therefore, be unable to implement our growth strategy.

We may be unable to acquire or develop additional reserves, which would reduce our revenues and access to capital.

Our success depends upon our ability to find, develop or acquire additional oil and natural gas reserves that are profitable to produce. Factors that may hinder our ability to acquire or develop additional oil and natural gas reserves include competition, access to capital, prevailing oil and natural gas prices and the number and attractiveness of properties for sale. If we are unable to conduct successful development activities or acquire properties containing Proved Reserves, our total Proved Reserves will generally decline as a result of production. Also, our production will generally decline. In addition, if our reserves and production decline, then the amount we are able to borrow under the EXCO Resources Credit Agreement will also decline. We may be unable to locate additional reserves, drill economically productive wells or acquire properties containing Proved Reserves.

 

24


Table of Contents

Development and exploration drilling and strategic acquisitions are the main methods of replacing reserves. However, development and exploration drilling operations may not result in any increases in reserves for various reasons. Our future oil and natural gas production depends on our success in finding or acquiring additional reserves. If we fail to replace reserves through drilling or acquisitions, our level of production and cash flows will be adversely affected.

We may not identify all risks associated with the acquisition of oil and natural gas properties, and any indemnifications we receive from sellers may be insufficient to protect us from such risks, which may result in unexpected liabilities and costs to us.

Generally, it is not feasible for us to review in detail every individual property involved in an acquisition. Our business strategy focuses on acquisitions of producing oil and natural gas properties. Any future acquisitions will require an assessment of recoverable reserves, title, future oil and natural gas prices, operating costs, potential environmental hazards and liabilities, potential tax and ERISA liabilities, other liabilities and similar factors. Ordinarily, our review efforts are focused on the higher-valued properties. Even a detailed review of properties and records may not reveal existing or potential problems, nor will it permit us to become sufficiently familiar with the properties to assess fully their deficiencies and capabilities. We do not inspect every well that we acquire. Potential problems, such as deficiencies in the mechanical integrity of equipment or environmental conditions that may require significant remedial expenditures, are not necessarily observable even when we inspect a well. Any unidentified problems could result in material liabilities and costs that could negatively impact our financial condition and results of operations.

Even if we are able to identify problems with an acquisition, the seller may be unwilling or unable to provide effective contractual protection or indemnity against all or part of these problems. Even if a seller agrees to provide indemnity, the indemnity may not be fully enforceable and may be limited by floors and caps on such indemnity.

We may not be able to satisfy our commitments to Azure to deliver a minimum amount of production volumes to TGGT, which could result in substantial shortfall payments.

In connection with the sale of TGGT, we entered into an agreement with Azure and BG Group pursuant to which we and BG Group agreed to deliver to TGGT’s gathering systems an aggregate minimum volume commitment of 600,000 Mmbtu/day of natural gas production from the Holly and Shelby fields during the five year period from December 1, 2013 through November 30, 2018. If the actual production volumes gathered on TGGT’s gathering systems of BG Group and us, each of our respective affiliates and certain other persons, for any year during such period are not sufficient to meet the minimum volume commitment, we and BG Group are each severally responsible for an equal share of a shortfall payment at the end of each year to Azure, subject to our ability to apply certain credits for volumes delivered in the prior year. The amount of the shortfall payment is based on the difference between the actual throughput volume for the year after applying available credits for the prior period (if any), and the minimum volume commitment for that year, multiplied by $0.40 per MMBtu. In the event that we are required to make a shortfall payment under these provisions, it could adversely affect our business, financial condition and results of operations.

We may encounter obstacles to marketing our oil and natural gas, which could adversely impact our revenues.

Our ability to market our oil and natural gas production will depend upon the availability and capacity of natural gas gathering systems, pipelines and other transportation facilities. We are primarily dependent upon third parties to transport our products. Transportation space on the gathering systems and pipelines we utilize is occasionally limited or unavailable due to repairs, outages caused by accidents or other events, or improvements to facilities or due to space being utilized by other companies that have priority transportation agreements. We have experienced production curtailments in East Texas/North Louisiana resulting from capacity restraints, offsetting fracturing stimulation operations and short term shutdowns of certain pipelines for maintenance

 

25


Table of Contents

purposes. As we have increased our knowledge of the Haynesville/Bossier shale plays, we have begun to shut in production on adjacent wells when conducting completion operations. Due to the high production capabilities of these wells, these volumes can be significant. Our access to transportation options can also be affected by U.S. federal and state regulation of oil and natural gas production and transportation, general economic conditions and changes in supply and demand. These factors and the availability of markets are beyond our control. If market factors dramatically change, the impact on our revenues could be substantial and could adversely affect our ability to produce and market oil and natural gas, the value of our common stock and our ability to pay dividends on our common stock.

We may not correctly evaluate reserve data or the exploitation potential of properties as we engage in our acquisition, exploration, development and exploitation activities.

Our future success will depend on the success of our acquisition, exploration, development and exploitation activities. Our decisions to purchase, explore, develop or otherwise exploit properties or prospects will depend in part on the evaluation of data obtained from production reports and engineering studies, geophysical and geological analyses and seismic and other information, the results of which are often inconclusive and subject to various interpretations. These decisions could significantly reduce our ability to generate cash needed to service our debt and fund our capital program and other working capital requirements.

We may be unable to integrate successfully the operations of acquisitions with our operations and we may not realize all the anticipated benefits of any acquisitions.

Integration of our acquisitions with our business and operations has been a complex, time consuming and costly process. Failure to successfully assimilate our past or future acquisitions could adversely affect our financial condition and results of operations.

Our acquisitions involve numerous risks, including:

 

    operating a significantly larger combined organization and adding operations;

 

    difficulties in the assimilation of the assets and operations of the acquired business, especially if the assets acquired are in a new business segment or geographic area;

 

    the risk that oil and natural gas reserves acquired may not be of the anticipated magnitude or may not be developed as anticipated;

 

    the loss of significant key employees from the acquired business;

 

    the diversion of management’s attention from other business concerns;

 

    the failure to realize expected profitability or growth;

 

    the failure to realize expected synergies and cost savings;

 

    coordinating geographically disparate organizations, systems and facilities; and

 

    coordinating or consolidating corporate and administrative functions.

Further, unexpected costs and challenges may arise whenever businesses with different operations or management are combined, and we may experience unanticipated delays in realizing the benefits of an acquisition. If we consummate any future acquisitions, our capitalization and results of operations may change significantly, and you may not have the opportunity to evaluate the economic, financial and other relevant information that we will consider in evaluating future acquisitions.

 

26


Table of Contents

Our estimates of oil and natural gas reserves involve inherent uncertainty, which could materially affect the quantity and value of our reported reserves, our financial condition and the value of our common stock.

Numerous uncertainties are inherent in estimating quantities of Proved Reserves, including many factors beyond our control. This prospectus contains estimates of our Proved Reserves and the PV-10 and Standardized Measure of our Proved Reserves. These estimates are based upon reports of our independent petroleum engineers. These reports rely upon various assumptions, including assumptions required by the Securities and Exchange Commission, or the SEC, as to oil and natural gas prices, drilling and operating expenses, capital expenditures, taxes and availability of funds. These estimates should not be construed as the current market value of our estimated Proved Reserves.

The process of estimating oil and natural gas reserves is complex, requiring significant decisions and assumptions in the evaluation of available geological, engineering and economic data for each reservoir. As a result, the estimates are inherently imprecise evaluations of reserve quantities and future net revenue and such estimates prepared by different engineers or by the same engineers at different times, may vary substantially.

Our actual future production, revenues, taxes, development expenditures, operating expenses and quantities of recoverable oil and natural gas reserves may vary substantially from those we have assumed in the estimates. Any significant variance in our assumptions could materially affect the quantity and value of reserves, the amount of PV-10 and Standardized Measure described in this prospectus, and our financial condition. In addition, our reserves, the amount of PV-10 and Standardized Measure may be revised downward or upward, based upon production history, results of future exploitation and development activities, prevailing oil and natural gas prices, decisions and assumptions made by engineers and other factors. A material decline in prices paid for our production can adversely impact the estimated volumes and values of our reserves. Similarly, a decline in market prices for oil or natural gas may adversely affect our PV-10 and Standardized Measure. Any of these negative effects on our reserves or PV-10 and Standardized Measure may negatively affect the value of our common stock.

Our internal and external engineers are currently in the process of determining our year-end 2013 reserve estimates in connection with our normal course year-end financial and operational reporting procedures. These reserve estimates may not be available until after the expiration of this offering. In the process of estimating our reserves, we expect both upward revisions and downward revisions of the estimated reserves in our various fields for a number of reasons. We are analyzing certain impacts to our Haynesville shale properties, including operational and mechanical matters, interference from nearby wells and overall field depletion that will negatively impact our Haynesville shale reserve estimates as compared to year-end 2012. Our 2013 acquisitions, 2013 drilling activity, improvements in natural gas prices and upward revisions in the Marcellus shale would offset any revisions as compared to our reported reserves at year-end 2012. Any reduction in our reserve estimates may require us to record a non-cash ceiling test impairment to our net oil and natural gas properties shown on our balance sheet, reduce our borrowing base or otherwise materially and adversely affect our future cash flows and financial performance.

We are exposed to operating hazards and uninsured risks that could adversely impact our results of operations and cash flow.

Our operations are subject to the risks inherent in the oil and natural gas industry, including the risks of:

 

    fires, explosions and blowouts;

 

    pipe failures;

 

    abnormally pressured formations; and

 

    environmental accidents such as oil spills, natural gas leaks, ruptures or discharges of toxic gases, brine or well fluids into the environment (including groundwater contamination).

 

27


Table of Contents

We have in the past experienced some of these events during our drilling, production and midstream operations. These events may result in substantial losses to us from:

 

    injury or loss of life;

 

    severe damage to or destruction of property, natural resources and equipment;

 

    pollution or other environmental damage;

 

    environmental clean-up responsibilities;

 

    regulatory investigation;

 

    penalties and suspension of operations; or

 

    attorneys’ fees and other expenses incurred in the prosecution or defense of litigation.

As is customary in our industry, we maintain insurance against some, but not all, of these risks. Our insurance may not be adequate to cover these potential losses or liabilities. Furthermore, insurance coverage may not continue to be available at commercially acceptable premium levels or at all. Due to cost considerations, from time to time we have declined to obtain coverage for certain drilling activities. We do not carry business interruption insurance. Losses and liabilities arising from uninsured or under-insured events could require us to make large unbudgeted cash expenditures that could adversely impact our results of operations and cash flow.

We currently carry general liability insurance and excess liability insurance with a combined annual limit of $101 million per occurrence and in the aggregate. These insurance policies contain maximum policy limits and deductibles ranging from $1,000 to $50,000 that must be met prior to recovery, and are subject to customary exclusions and limitations. Our general liability insurance covers us and our subsidiaries for third-party claims and liabilities arising out of lease operations and related activities. The excess liability insurance is in addition to, and is triggered if, the general liability insurance per occurrence limit is reached.

We also maintain control of well insurance and pollution insurance. Our control of well insurance has per occurrence and combined single limits ranging from $3 million to $25 million, depending upon formation, and is subject to a $500,000 deductible per occurrence. Our pollution insurance has a per occurrence and aggregate annual limit of $30 million and is subject to a $50,000 deductible per occurrence.

We require our third-party contractors to sign master service agreements in which they generally agree to indemnify us for the injury and death of the service provider’s employees as well as contractors and subcontractors that are hired by the service provider. Similarly, we agree to indemnify our third-party contractors against claims made by our employees and our other contractors. Additionally, each party generally is responsible for damage to its own property.

Our third-party contractors that perform hydraulic fracturing operations for us sign master service agreements containing the indemnification provisions noted above. We do not currently have any insurance policies in effect that are intended to provide coverage for losses solely related to hydraulic fracturing operations. We believe that our general liability, excess liability and pollution insurance policies would cover third-party claims related to hydraulic fracturing operations and associated legal expenses, in accordance with, and subject to, the terms of such policies. However, these policies may not cover fines, penalties or costs and expenses related to government-mandated environmental clean-up responsibilities.

Our operations may be interrupted by severe weather or drilling restrictions.

Our operations are conducted primarily in Texas, North Louisiana and Appalachia. The weather in these areas can be extreme and can cause interruption in our exploration and production operations. Severe weather can result in damage to our facilities entailing longer operational interruptions and significant capital investment.

 

28


Table of Contents

Likewise, our operations are subject to disruption from hurricanes, winter storms and severe cold, which can limit operations involving fluids and impair access to our facilities. Additionally, many municipalities in Appalachia impose weight restrictions on the paved roads that lead to our jobsites due to the conditions caused by spring thaws.

We are subject to complex federal, state, local and other laws and regulations that could adversely affect the cost, manner or feasibility of conducting our operations.

Our oil and natural gas development and production operations are subject to complex and stringent laws and regulations. In order to conduct our operations in compliance with these laws and regulations, we must obtain and maintain numerous permits, approvals and certificates from various federal, state and local governmental authorities. We may incur substantial costs in order to comply with these existing laws and regulations. In addition, our costs of compliance may increase if existing laws and regulations are revised or reinterpreted, or if new laws and regulations become applicable to our operations.

Our business is subject to federal, state and local laws and regulations as interpreted and enforced by governmental authorities possessing jurisdiction over various aspects of the exploration for, production and sale of, oil and natural gas. Failure to comply with such laws and regulations, as interpreted and enforced, could have a material adverse effect on our business, financial condition and results of operations.

Certain federal income tax deductions currently available with respect to oil and natural gas exploration and development may be eliminated as a result of future legislation.

The Obama administration’s budget proposals for fiscal year 2014 contain numerous proposed tax changes, and from time to time, legislation has been introduced that would enact many of these proposed changes. The proposed budget and legislation would repeal many tax incentives and deductions that are currently used by U.S. oil and gas companies and impose new fees. Among others, the provisions include: elimination of the ability to fully deduct intangible drilling costs in the year incurred; repeal of the percentage depletion deduction for oil and gas properties; repeal of the domestic manufacturing tax deduction for oil and gas companies; increase in the geological and geophysical amortization period for independent producers; and implementation of a fee on non-producing federal oil and gas leases. The passage of legislation containing some or all of these provisions or any other similar change in U.S. federal income tax law could eliminate or postpone certain tax deductions that are currently available to us with respect to oil and natural gas exploration and development, and any such change could have a material adverse effect on our business, financial condition and results of operations.

The EPA’s implementation of climate change regulations could result in increased operating costs and reduced demand for our oil and natural gas production.

Although federal legislation regarding the control of emissions of greenhouse gases, or GHGs, for the present appears unlikely, the Environmental Protection Agency, or the EPA, has been implementing regulations under existing Clear Air Act, or CAA, authority, some of which may affect our operations. GHGs are certain gases, including carbon dioxide, a product of the combustion of natural gas, and methane, a primary component of natural gas, that may be contributing to the warming of the Earth’s atmosphere, resulting in climatic changes. These GHG regulations could require us to incur increased operating costs and could have an adverse effect on demand for our oil and natural gas production.

The EPA has implemented its so-called GHG tailoring rule that phases in federal prevention of significant deterioration permit requirements for new sources and modifications, and Title V operating permits for all sources, that have the potential to emit specific quantities of GHGs. Those permitting provisions could require controls or other measures to reduce GHG emissions from new or modified sources, and we could incur additional costs to satisfy those requirements. The EPA has adopted rules establishing GHG reporting requirements for sources in the petroleum and natural gas industry requiring those sources to monitor, maintain

 

29


Table of Contents

records on, and annually report their GHG emissions. We are subject to these rules and the applicable GHG reporting requirements. Although these rules do not limit the amount of GHGs that can be emitted, they require us to incur costs to monitor, recordkeep and report GHG emissions associated with our operations.

The adoption of derivatives legislation and regulations thereunder could have an adverse impact on our ability to hedge risks associated with our business and could affect our business, financial condition or results of operations.

On July 21, 2010, President Obama signed into law the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the Dodd-Frank Act. The Dodd-Frank Act establishes federal oversight and regulation of the over-the-counter derivatives market and entities that participate in the market and requires the Commodities Future Trading Commission, or CFTC, federal regulators of banks and other financial institutions and the SEC to implement the new law by promulgating regulations relating to derivatives transactions, including the derivatives transactions we use to hedge our exposure to commodity price volatility.

Under the Dodd-Frank Act and related reforms, over-the-counter derivatives dealers and other over-the-counter major market participants could be subjected to substantial regulatory supervision. The reforms expand the power of the CFTC to regulate derivatives transactions related to energy commodities, including oil and natural gas, to mandate clearance of derivatives contracts through registered derivatives clearing organizations and to impose burdensome capital and margin requirements and business conduct standards on over-the-counter derivatives transactions.

The Dodd-Frank Act also permits the CFTC to set position limits on certain derivatives instruments. In October 2011, the CFTC issued a rule to implement position limits for certain futures and options contracts on certain commodities and for swaps that are their economic equivalents (with exemptions for certain bona fide hedging transactions). Following a challenge in federal court by the Securities Industry Financial Markets Association and the International Swaps and Derivatives Association, the CFTC’s rule on position limits was vacated by the U.S. District Court for the District of Columbia in September 2012 and remanded to the CFTC to resolve ambiguity as to whether statutory requirements for such limits to be determined necessary and appropriate were satisfied. As a result, such position limits have not yet taken effect, although the CFTC did issue a new set of proposed position limit rules in November 2013 and has taken the position that the Dodd-Frank Act requires the CFTC to impose such position limits. The impact of such regulations upon our business is not yet clear. Certain of our hedging and trading activities, and those of our counterparties, may be subject to such position limits, which may reduce our ability to enter into hedging transactions.

The reforms may also require us to comply with margin and clearing and trade-execution requirements in connection with our derivatives activities, although whether and the extent to which these requirements will apply to our business is uncertain at this time. Further, the reforms may also require our counterparties to spin off derivatives activities to separate entities which may not be as creditworthy as the original counterparties.

The full impact of the Dodd-Frank Act and related reforms and regulatory requirements upon our business will not be known until the regulations are implemented and the market for derivatives contracts has adjusted. If the reforms ultimately require that we post margin for our hedging activities or require our counterparties to hold margin or maintain required minimum capital levels, the cost of which could be passed through to us, or impose other requirements that are more burdensome that current regulations, hedges could become significantly more expensive (including through requirements to post collateral, which could adversely affect available liquidity), uneconomic or unavailable, which could lead to increased costs, commodity price volatility, reductions in commodity prices, or any combination of the foregoing. Further, such developments could reduce our ability to monetize or restructure our existing derivatives contracts, subject us to additional capital or margin requirements, restrict our flexibility in conducting trading activity and taking commodity positions, and increase our exposure to less creditworthy counterparties. If we reduce our use of derivatives contracts as a result of the new requirements, our results of operations may become more volatile and cash flows less predictable, which could

 

30


Table of Contents

adversely affect our ability to plan for and fund capital expenditures. In addition, the Dodd-Frank Act was intended, in part, to reduce the volatility of oil and natural gas prices, which some legislators attributed to speculative trading in derivatives and commodity instruments related to oil and natural gas. Our revenues could therefore be adversely affected if a consequence of the legislation and regulations is lower commodity prices. Individually and collectively, these factors could have a material adverse effect on our ability to hedge risks and on our business, financial condition or results of operations.

Federal and state legislation and regulatory initiatives relating to hydraulic fracturing could result in increased costs and additional operating restrictions or delays.

Hydraulic fracturing involves the injection of water, sand and chemicals under pressure into rock formations to stimulate natural gas production. Most hydraulic fracturing (other than hydraulic fracturing using diesel) is exempted from regulation under the Safe Drinking Water Act, or the SDWA. Congress has considered legislation to amend the federal SDWA to remove the exemption from regulation and permitting that is applicable to hydraulic fracturing operations and require reporting and disclosure of chemicals used by the oil and natural gas industry in the hydraulic fracturing process. Sponsors of bills previously introduced before the Senate and House of Representatives have asserted that chemicals used in the fracturing process could adversely affect drinking water supplies. Such bills or similar legislation, if adopted, could increase the possibility of litigation and establish an additional level of regulation at the federal level that could lead to operational delays or increased operating costs and could result in additional regulatory burdens, making it more difficult to perform hydraulic fracturing and increasing our costs of compliance. At the state and local levels, some jurisdictions have adopted, and others are considering adopting, requirements that could impose more stringent permitting, public disclosure or well construction requirements on hydraulic fracturing activities, as well as bans on hydraulic fracturing activities. In the event that new or more stringent state or local legal restrictions relating to the hydraulic fracturing process are adopted in areas where we have properties, we could incur potentially significant added costs to comply with such requirements, experience delays or curtailment in the pursuit of exploration, development or production activities, and perhaps even be precluded from drilling wells.

In addition, the EPA has recently been taking action to assert federal regulatory authority over hydraulic fracturing using diesel under the SDWA’s Underground Injection Control Program, or UIC. Further, in March 2010, the EPA announced that it would conduct a wide-ranging study on the effects of hydraulic fracturing on drinking water resources. Interim results of the study are expected in 2012, with final results expected in 2014. The agency also announced that one of its enforcement initiatives for 2012 and 2013 would be to focus on environmental compliance by the energy extraction sector. This study and enforcement initiative could result in additional regulatory scrutiny that could make it difficult to perform hydraulic fracturing and increase our costs of compliance and doing business. Consequently, these studies and initiatives could spur further legislative or regulatory action regarding hydraulic fracturing or similar production operations.

In addition, the EPA recently issued draft guidance under the SDWA providing direction on how it will address the use of diesel in hydraulic fracturing activities and how its UIC will be applied to such hydraulic fracturing activities.

Moreover, the EPA has announced that it will develop effluent limitations for the treatment and discharge of wastewater resulting from hydraulic fracturing activities by 2014. Other governmental agencies, including the U.S. Department of Energy and the U.S. Department of the Interior, are evaluating various other aspects of hydraulic fracturing. The Bureau of Land Management has indicated that it will continue with rulemaking to regulate hydraulic fracturing on federal lands and the EPA has announced an initiative under the Toxic Substances Control Act to develop regulations governing the disclosure and evaluation of hydraulic fracturing chemicals. If hydraulic fracturing is regulated at the federal level, our fracturing activities could become subject to additional permit requirements or operations restrictions and also to associated permitting delays and potential increases in costs. Restrictions on hydraulic fracturing could reduce the amount of oil and natural gas that we ultimately are able to produce.

 

31


Table of Contents

Our business exposes us to liability and extensive regulation on environmental matters, which could result in substantial expenditures.

Our operations are subject to numerous complex U.S. federal, state and local laws and regulations relating to the protection of the environment, including those governing the discharge of materials into the water and air, the generation, management and disposal of hazardous substances and wastes and the clean-up of contaminated sites. Laws, rules and regulations protecting the environment have changed frequently and the changes often include increasingly stringent requirements. We could incur material costs, including clean-up costs, fines and civil and criminal sanctions (including injunctive relief) and third-party claims for property damage and personal injury as a result of violations of, or liabilities under, environmental laws and regulations. Such laws and regulations not only expose us to liability for our own activities, but may also expose us to liability for the conduct of others or for actions by us that were in compliance with all applicable laws at the time those actions were taken. In addition, we could incur substantial expenditures complying with environmental laws and regulations, including future environmental laws and regulations which may be more stringent, for example, the regulation of GHG emissions under the federal CAA, or state or regional regulatory programs. Regulation of GHG emissions by the EPA, or various states in the United States in areas in which we conduct business, for example, could have an adverse effect on our operations and demand for our oil and natural gas production. Moreover, the EPA has shown a general increased scrutiny on the oil and gas industry through its GHG, CAA and SDWA regulations.

The EPA has adopted rules subjecting oil and natural gas operations to regulation under the New Source Performance Standards, or NSPS, and the National Emissions Standards for Hazardous Air Pollutants, or NESHAPS, programs under the CAA, and imposing new and amended requirements under both programs. Among other things, the rule amends standards applicable to natural gas processing plants and expands the NSPS to include all oil and natural gas operations, imposing requirements on those operations. The rule also imposes NSPS standards for completions of hydraulically fractured natural gas wells. These standards include the reduced emission completion techniques. The NESHAPS also includes maximum achievable control technology standards for certain glycol dehydrators and storage vessels, and revises applicability provisions, alternative test protocols and the availability of the startup, shutdown and maintenance exemption. The implementation of these new requirements may result in increased operating and compliance costs, increased regulatory burdens and delays in our operations.

We may have write-downs of our asset values, which could negatively affect our results of operations and net worth.

We follow the full cost method of accounting for our oil and natural gas properties. Depending upon oil and natural gas prices in the future, and at the end of each quarterly and annual period when we are required to test the carrying value of our assets using full cost accounting rules, we may be required to write-down the value of our oil and natural gas properties if the present value of the after-tax future cash flows from our oil and natural gas properties falls below the net book value of these properties. We have in the past experienced, and may experience in the future, ceiling test write-downs with respect to our oil and natural gas properties. For the nine months ended September 30, 2013 and 2012, respectively, we recognized non-cash ceiling test write-downs of approximately $10.7 million and $1.0 billion, respectively.

Given the short passage of time between the closing of the acquisition of Haynesville and Eagle Ford assets from Chesapeake during July 2013 and the required ceiling test computation, we requested, and received, an exemption from the SEC to exclude these acquired properties from the ceiling test assessments for a period of twelve months following the corresponding acquisition dates. The request for exemption was made because the ceiling test requires companies using the full cost accounting method to price period ending Proved Reserves using the simple average spot price for the trailing twelve month period, which may not be indicative of actual market values. We will assess these acquisitions for impairment during the requested exemption period. Further, if we cannot demonstrate that fair value exceeds the unamortized carrying costs during the requested exemption periods prior to issuance of our financial statements, we will recognize an impairment.

We may have additional write-downs of our oil and natural gas properties in future periods if the cost of our unamortized proved oil and natural gas properties exceeds the limitation under the full cost method of accounting.

 

32


Table of Contents

Our evaluation of impairment is based upon estimates of Proved Reserves. The value of our Proved Reserves may be lowered in future periods as a result of a decline in prices of oil and natural gas, a downward revision of our oil and natural gas reserves or other factors. As a result, our evaluation of impairment for future periods is subject to uncertainties inherent in estimating quantities of Proved Reserves, in projecting the future rates of production and in the timing of development activities. The accuracy of any reserve estimate is a function of the quality of available data and of engineering and geological interpretation and judgment. Because several of these factors are beyond our control, we cannot accurately predict or control the amount of ceiling test write-downs in future periods. Future ceiling test write-downs could negatively affect our results of operations and net worth.

We also test goodwill for impairment annually or when circumstances indicate that an impairment may exist. If the book value of our reporting units exceeds the estimated fair value of those reporting units, an impairment charge will occur, which would negatively impact our results of operations and net worth.

We may experience a financial loss if any of our significant customers fail to pay us for our oil or natural gas.

Our ability to collect the proceeds from the sale of oil and natural gas from our customers depends on the payment ability of our customer base, which includes several significant customers. If any one or more of our significant customers fails to pay us for any reason, we could experience a material loss. In addition, in recent years, it has become more difficult to maintain and grow a customer base of creditworthy customers because a number of energy marketing and trading companies have discontinued their marketing and trading operations, which has significantly reduced the number of potential purchasers for our oil and natural gas production. As a result, we may experience a material loss as a result of the failure of our customers to pay us for prior purchases of our oil or natural gas.

We may experience a decline in revenues if we lose one of our significant customers.

For 2012, sales to BG Energy Merchants LLC accounted for approximately 36.0% of total consolidated revenues. BG Energy Merchants LLC is a subsidiary of BG Group. In addition, a significant amount of sales during the nine months ended September 30, 2013 were to Chesapeake. The loss of any significant customer may cause a temporary interruption in sales of, or a lower price for, our oil and natural gas.

We have entered into significant natural gas firm transportation and marketing agreements primarily in East Texas and North Louisiana that require us to pay fixed amounts of money to the shippers or marketers regardless of quantities actually shipped or marketed. If we are unable to deliver the necessary quantities of natural gas, our results of operations and liquidity could be adversely affected.

We have entered into significant natural gas firm transportation contracts primarily in East Texas and North Louisiana that require us to pay fixed amounts of money to the shippers regardless of quantities actually shipped. The use of firm transportation agreements allow us priority space in a shippers’ pipeline which we believe is a strategic advantage. In addition, we have also entered into a marketing agreement with Chesapeake with respect to our Haynesville production whereby we are required to deliver a minimum amount of natural gas from the Haynesville shale to Chesapeake. We will be required to make material expenditures for these agreements if we fail to deliver the required quantities of natural gas in the future. To the extent that we do not produce and deliver sufficient natural gas production, the requirements to pay for quantities not delivered could have a material impact on our results of operations and liquidity.

Competition in our industry is intense and we may be unable to compete in acquiring properties, contracting for drilling equipment and hiring experienced personnel.

The oil and natural gas industry is highly competitive. We encounter strong competition from other independent operators and from major oil companies in acquiring properties, contracting for drilling equipment and securing trained personnel. Many of these competitors have greater financial and technical resources and a larger headcount than we do. As a result, our competitors may be able to pay more for desirable leases, or to evaluate, bid

 

33


Table of Contents

for and purchase a greater number of properties or prospects than our financial or personnel resources will permit. The oil and natural gas industry has periodically experienced shortages of drilling rigs, equipment, pipe and personnel, which has delayed development drilling and other exploitation activities and has caused significant expense/cost increases. We may experience difficulties in obtaining drilling rigs and other services in certain areas as well as an increase in the cost for these services and related material and equipment. We are unable to predict when, or if, such shortages may again occur or how such shortages and price increases will affect our development and exploitation program. Competition has also been strong in hiring experienced personnel, particularly in petroleum engineering, geoscience, accounting and financial reporting, tax and land professions. In addition, competition is strong for attractive oil and natural gas producing properties, oil and natural gas companies, and undeveloped leases and drilling rights. We are often outbid by competitors in our attempts to acquire properties or companies. All of these challenges could make it more difficult to execute our growth strategy.

If third-party pipelines or other facilities interconnected to our gathering and transportation pipelines become unavailable to transport or process natural gas, our revenues and cash flow could be adversely affected.

We depend upon third party pipelines and other facilities to provide gathering and transportation. Much of the natural gas transported by our pipelines must be treated or processed before delivery into a pipeline for natural gas. If the processing and treating plants to which we deliver natural gas were to become temporarily or permanently unavailable for any reason, or if throughput were reduced because of testing, line repair, damage to pipelines, reduced operating pressures, lack of capacity or other causes, our customers would be unable to deliver natural gas to end markets. If any of such events occur, they could materially and adversely affect our business, results of operations and financial condition.

We are currently involved in a search for a new chief executive officer and if this search is delayed or if we were to lose the services of other key personnel, our business could be negatively impacted.

On November 20, 2013, Douglas H. Miller agreed to resign from the positions of chief executive officer, chairman of the board of directors and as a director. The board of directors has initiated a search to identify a new chief executive officer. To the extent there is a delay in choosing a new chief executive officer, our business could be negatively impacted. In addition, our future success depends in part upon the continued service of key members of our senior management team. Our senior management team is critical to our management and they also play a key role in maintaining our culture and setting our strategic direction. All of our executive officers and key employees are at-will employees. The loss of key personnel could seriously harm our business.

Our ability to use net operating loss carryovers to reduce future tax payments may be limited.

Our net operating loss and other tax attribute carryovers, or NOLs, may be limited if we undergo an ownership change. Generally, an ownership change occurs if certain persons or groups increase their aggregate ownership in us by more than 50 percentage points looking back over a rolling three-year period. If an ownership change occurs, our ability to use our NOLs to reduce income taxes is limited to an annual amount, or the Section 382 limitation, equal to the fair market value of our common stock immediately prior to the ownership change multiplied by the long term tax-exempt interest rate, which is published monthly by the IRS. In the event of an ownership change, NOLs can be used to offset taxable income for years within a carryforward period subject to the Section 382 limitation. Any excess NOLs that exceed the Section 382 limitation in any year will continue to be allowed as carryforwards for the remainder of the carryforward period. Whether or not an ownership change occurs, the carryforward period for NOLs is 20 years from the year in which the losses giving rise to the NOLs were incurred. If the carryforward period for any NOL were to expire before that NOL had been fully utilized, the unused portion of that NOL would be lost. Our use of new NOLs arising after the date of an ownership change would not be affected by the Section 382 limitation (unless there is another ownership change after the new NOLs arise).

We exist in a litigious environment.

Any constituent could bring suit regarding our existing or planned operations or allege a violation of an existing contract. Any such action could delay when planned operations can actually commence or could cause a

 

34


Table of Contents

halt to existing production until such alleged violations are resolved by the courts. Not only could we incur significant legal and support expenses in defending our rights, but halting existing production or delaying planned operations could impact our future operations and financial condition. In addition, we are defendants in numerous cases involving claims by landowners for surface or subsurface damages arising from our operations and for claims by unleased mineral owners and royalty owners for unpaid or underpaid revenues customary in our business. We incur costs in defending these claims and from time to time must pay damages or other amounts due. Such legal disputes can also distract management and other personnel from their primary responsibilities.

Our business could be negatively impacted by security threats, including cybersecurity threats, and other disruptions.

As an oil and natural gas production company, we face various security threats, including cybersecurity threats to gain unauthorized access to sensitive information or to render data or systems unusable; threats to the safety of our employees; threats to the security of our facilities and infrastructure or third party facilities and infrastructure, such as processing plants and pipelines; and threats from terrorist acts. Although we utilize various procedures and controls to monitor these threats and mitigate our exposure to such threats, there can be no assurance that these procedures and controls will be sufficient in preventing security threats from materializing. If any of these events were to materialize, they could lead to losses of sensitive information, critical infrastructure, personnel or capabilities, essential to our operations and could have a material adverse effect on our reputation, financial position, results of operations, or cash flows. Cybersecurity attacks in particular are evolving and include but are not limited to, malicious software, attempts to gain unauthorized access to data, and other electronic security breaches that could lead to disruptions in critical systems, unauthorized release of confidential or otherwise protected information and corruption of data. These events could damage our reputation and lead to financial losses from remedial actions, loss of business or potential liability.

There are inherent limitations in all internal control over financial reporting, and misstatements due to error or fraud may occur and not be detected.

While we have taken actions designed to address compliance with the internal control, disclosure control and other requirements of the Sarbanes-Oxley Act of 2002, as amended, and the rules and regulations promulgated by the SEC implementing these requirements, there are inherent limitations in our ability to control all circumstances. Our management, including our chief financial officer and interim chief accounting officer, does not expect that our internal controls and disclosure controls will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints and the benefit of controls must be relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, in our company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple errors or mistakes. Further, controls can be circumvented by individual acts of some persons, by collusion of two or more persons, or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, a control may be inadequate because of changes in conditions, such as growth of our company or increased transaction volume, or the degree of compliance with the policies or procedures may deteriorate. Because of inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

Risks Relating to Our Indebtedness

We have a substantial amount of indebtedness, which may adversely affect our cash flow and our ability to operate our business, remain in compliance with debt covenants and make payments on our debt.

As of November 30, 2013, we had approximately $2.0 billion of indebtedness, excluding our proportionate share of indebtedness for the EXCO/HGI Partnership, including $1.1 billion of indebtedness subject to variable

 

35


Table of Contents

interest rates and $750.0 million of indebtedness under the 2018 Notes. Our total interest expense, excluding amortization of deferred financing costs and our proportionate share of interest expense for the EXCO/HGI Partnership, on an annual basis based on currently available interest rates would be approximately $99.5 million and would change by approximately $8.5 million for every 1% change in interest rates.

Our level of debt could have important consequences, including the following:

 

    it may be more difficult for us to satisfy our obligations with respect to our indebtedness, and any failure to comply with the obligations of any of our debt agreements, including financial and other restrictive covenants, could result in an event of default under the EXCO Resources Credit Agreement or the indenture governing the 2018 Notes, or the Indenture, and the agreements governing our other indebtedness;

 

    we may have difficulty borrowing money in the future for acquisitions (including obligations to acquire interests in wells pursuant to the KKR Participation Agreement), capital expenditures or to meet our operating expenses or other general corporate obligations;

 

    the amount of our interest expense may increase because certain of our borrowings are at variable rates of interest;

 

    we will need to use a substantial portion of our cash flows to pay principal and interest on our debt, which will reduce the amount of money we have for operations, working capital, capital expenditures, expansion, acquisitions or general corporate or other business activities;

 

    we may have a higher level of debt than some of our competitors, which may put us at a competitive disadvantage;

 

    we may be more vulnerable to economic downturns and adverse developments in our industry or the economy in general, especially declines in oil and natural gas prices;

 

    when oil and natural gas prices decline, our ability to maintain compliance with our financial covenants becomes more difficult and our borrowing base is subject to reductions, which may reduce or eliminate our ability to fund our operations; and

 

    our debt level could limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate.

Our ability to meet our expenses and debt obligations will depend on our future performance, which will be affected by financial, business, economic, regulatory and other factors. We will be unable to control many of these factors, such as economic conditions and governmental regulation. We cannot be certain that our earnings will be sufficient to allow us to pay the principal and interest on our debt and meet our other obligations. If we do not have enough money to service our debt, we may be required but unable to refinance all or part of our existing debt, sell assets, borrow more money or raise equity on terms acceptable to us, if at all and may be required to surrender assets pursuant to the security provisions of the EXCO Resources Credit Agreement. Further, failing to comply with the financial and other restrictive covenants in the EXCO Resources Credit Agreement and the Indenture could result in an event of default, which could adversely affect our business, financial condition and results of operations.

We may incur substantially more debt, which may intensify the risks described above, including our ability to service our indebtedness.

Together with our subsidiaries, we may incur substantially more debt in the future in connection with our exploration, exploitation, development, acquisitions of undeveloped acreage and producing properties. The restrictions in our debt agreements on our incurrence of additional indebtedness are subject to a number of qualifications and exceptions, and under certain circumstances, indebtedness incurred in compliance with these restrictions could be substantial. Also, these restrictions do not prevent us from incurring obligations that do not constitute indebtedness. To the extent new indebtedness is added to our current indebtedness levels, the risks

 

36


Table of Contents

described above could substantially increase. Significant additions of undeveloped acreage financed with debt may result in increased indebtedness without any corresponding increase in borrowing base, which could curtail drilling and development of this acreage or could cause us to not comply with our debt covenants.

To service our indebtedness, fund our planned capital expenditure programs and fund acquisitions under the KKR Participation Agreement, we will require a significant amount of cash. Our ability to generate cash depends on many factors beyond our control, and any failure to meet our debt obligations could harm our business, financial condition and results of operations.

Our ability to make payments on and to refinance our indebtedness, including the 2018 Notes and the EXCO Resources Credit Agreement, and to fund planned capital expenditures will depend on our ability to generate cash flow from operations and other resources in the future. This, to a certain extent, is subject to general economic, financial, competitive, legislative, regulatory and other factors that are beyond our control, including the prices that we receive for oil and natural gas.

Our business may not generate sufficient cash flow from operations and future borrowings may not be available to us in an amount sufficient to enable us to pay our indebtedness, including our 2018 Notes and the EXCO Resources Credit Agreement, to fund planned capital expenditures or to fund our other liquidity needs. If our cash flow and capital resources are insufficient to fund our debt obligations and capital expenditure programs, we may be forced to sell assets, seek additional equity or debt capital or restructure our debt. These remedies may not be available on commercially reasonable terms, or at all. In addition, any failure to make scheduled payments of interest and principal on our outstanding indebtedness would likely result in a reduction of our credit rating, which could harm our ability to incur additional indebtedness on acceptable terms. Our cash flow and capital resources may be insufficient for payment of interest on and principal of our debt in the future, which could cause us to default on our obligations and could impair our liquidity.

Our borrowing base under the EXCO Resources Credit Agreement is subject to semi-annual redeterminations. If our borrowing base were to be reduced to a level which was less than the current borrowings, we would be required to reduce our borrowings to a level sufficient to cure any deficiency. We may be required to sell assets or seek alternative debt or equity which may not be available at commercially reasonable terms, if at all.

In addition, we conduct certain of our operations through our joint ventures and subsidiaries. Accordingly, repayment of our indebtedness, including the 2018 Notes, is dependent on the generation of cash flow by our joint ventures and subsidiaries and their ability to make such cash available to us, by dividend, debt repayment or otherwise. Unless they are guarantors of the 2018 Notes or our other indebtedness, our joint ventures and subsidiaries do not have any obligation to pay amounts due on the 2018 Notes or our other indebtedness or to make funds available for that purpose. Our joint ventures and subsidiaries may not be able to, or may not be permitted to, make distributions to enable us to make payments in respect of our indebtedness. Each joint venture and subsidiary is a distinct legal entity, and, under certain circumstances, legal and contractual restrictions may limit our ability to obtain cash from our joint ventures and subsidiaries. While the Indenture and the agreements governing certain of our other existing indebtedness limit the ability of certain of our joint ventures and subsidiaries to incur consensual restrictions on their ability to pay dividends or make other intercompany payments to us, these limitations are subject to qualifications and exceptions. In the event that we do not receive distributions from our joint ventures and subsidiaries, we may be unable to make required principal and interest payments on our indebtedness.

If we cannot make scheduled payments on our debt, we will be in default and holders of the 2018 Notes could declare all outstanding principal and interest to be due and payable, the lenders under the EXCO Resources Credit Agreement could terminate their commitments to loan money, our secured lenders could foreclose against the assets securing their borrowings and we could be forced into bankruptcy or liquidation. Our inability to generate sufficient cash flows to satisfy our debt obligations, or to refinance our indebtedness on commercially reasonable terms or at all, would materially and adversely affect our financial position and results of operations.

 

37


Table of Contents

Restrictive debt covenants could limit our growth and our ability to finance our operations, fund our capital needs, respond to changing conditions and engage in other business activities that may be in our best interests.

The EXCO Resources Credit Agreement and the Indenture contain a number of significant covenants that, among other things, restrict our ability to:

 

    dispose of assets;

 

    incur or guarantee additional indebtedness and issue certain types of preferred stock;

 

    pay dividends on our capital stock;

 

    create liens on our assets;

 

    enter into sale or leaseback transactions;

 

    enter into specified investments or acquisitions;

 

    repurchase, redeem or retire our capital stock or subordinated debt;

 

    merge or consolidate, or transfer all or substantially all of our assets and the assets of our subsidiaries;

 

    engage in specified transactions with subsidiaries and affiliates; or

 

    pursue other corporate activities.

Also, the EXCO Resources Credit Agreement requires us to maintain compliance with specified financial ratios and satisfy certain financial condition tests. Our ability to comply with these ratios and financial condition tests may be affected by events beyond our control, and, as a result, we may be unable to meet these ratios and financial condition tests. These financial ratio restrictions and financial condition tests could limit our ability to obtain future financings, make needed capital expenditures, withstand a future downturn in our business or the economy in general or otherwise conduct necessary corporate activities. We may also be prevented from taking advantage of business opportunities that arise because of the limitations imposed on us by the restrictive covenants under the EXCO Resources Credit Agreement and the Indenture. A breach of any of these covenants or our inability to comply with the required financial ratios or financial condition tests could result in a default under the applicable indebtedness. The consolidated funded indebtedness to consolidated EBITDAX ratio, as defined in the EXCO Resources Credit Agreement, is computed using a trailing twelve-month computation. When oil and/or natural gas prices decline for an extended period of time, our ability to comply with this covenant becomes more difficult. Such a default, if not cured or waived, may allow the creditors to accelerate the related indebtedness and could result in acceleration of any other indebtedness to which a cross-acceleration or cross-default provision applies. An event of default under the Indenture would permit the lenders under the EXCO Resources Credit Agreement to terminate all commitments to extend further credit under the agreement. Furthermore, if we were unable to repay the amounts due and payable under the EXCO Resources Credit Agreement, those lenders could proceed against the collateral granted to them to secure that indebtedness. In the event that our lenders or noteholders accelerate the repayment of our borrowings, we and our subsidiaries may not have sufficient assets to repay that indebtedness. As a result of these restrictions, we may be:

 

    limited in how we conduct our business;

 

    unable to raise additional debt or equity financing during general economic, business or industry downturns; or

 

    unable to compete effectively or to take advantage of new business opportunities.

The credit risk of financial institutions could adversely affect us.

We have exposure to different counterparties, and we have entered into transactions with counterparties in the financial services industry, including commercial banks, investment banks, insurance companies and other institutions. These transactions expose us to credit risk in the event of default of our counterparty. Deterioration

 

38


Table of Contents

in the credit markets may impact the credit ratings of our current and potential counterparties and affect their ability to fulfill their existing obligations to us and their willingness to enter into future transactions with us. We have exposure to financial institutions in the form of derivative transactions in connection with our hedges and insurance companies in the form of claims under our policies. In addition, if any lender under the EXCO Resources Credit Agreement is unable to fund its commitment, our liquidity will be reduced by an amount up to the aggregate amount of such lender’s commitment under the credit agreement.

Risks Relating to Our Common Stock

Our common stock price may fluctuate significantly.

Our common stock trades on the NYSE but an active trading market for our common stock may not be sustained. The market price of shares of our common stock could fluctuate significantly as a result of:

 

    announcements relating to our business or the business of our competitors;

 

    changes in expectations as to our future financial performance or changes in financial estimates of public market analysis;

 

    actual or anticipated quarterly variations in our operating results;

 

    conditions generally affecting the oil and natural gas industry;

 

    the success of our operating strategy; and

 

    the operating and stock price performance of other comparable companies.

Many of these factors are beyond our control and we cannot predict their potential effects on the price of our common stock. In addition, the stock markets in general can experience considerable price and volume fluctuations.

The equity trading markets may be volatile, which could result in losses for our shareholders.

The equity trading markets may experience periods of volatility, which could result in highly variable and unpredictable pricing of equity securities. The market price of our common stock could change in ways that may or may not be related to our business, our industry or our operating performance and financial condition.

Our articles of incorporation permits us to issue preferred stock that may restrict a takeover attempt that you may favor.

Our articles of incorporation permit our board to issue up to 10,000,000 shares of preferred stock and to establish by resolution one or more series of preferred stock and the powers, designations, preferences and participating, optional or other special rights of each series of preferred stock. The preferred stock may be issued on terms that are unfavorable to the holders of our common stock, including the grant of superior voting rights, the grant of preferences in favor of preferred shareholders in the payment of dividends and upon our liquidation and the designation of conversion rights that entitle holders of our preferred stock to convert their shares into shares of our common stock on terms that are dilutive to holders of our common stock. The issuance of preferred stock in future offerings may make a takeover or change in control of us more difficult.

We may reduce or discontinue paying our quarterly cash dividend if our board of directors determines that paying a dividend is no longer appropriate.

We currently have a quarterly cash dividend program on shares of our common stock. Any future dividend payments will depend on our earnings, capital requirements, financial condition, prospects and other factors that our board of directors may deem relevant. At any time, our board of directors may decide to reduce or discontinue paying our quarterly cash dividend. If we do not pay dividends, our common stock may be less valuable because a return on your investment will only occur if our stock price appreciates. In addition, the EXCO Resources Credit Agreement and the Indenture restrict our ability to pay dividends.

 

39


Table of Contents

USE OF PROCEEDS

We estimate that the net proceeds to us from the sale of the common stock offered in the rights offering and pursuant to the Investment Agreements, after deducting our estimated expenses will be approximately $272 million. We intend to use approximately $28.9 million of the net proceeds to fully repay indebtedness related to the Asset Sale Requirement under the EXCO Resources Credit Agreement, and the remainder to pay indebtedness of the revolving commitment under the EXCO Resources Credit Agreement. Elimination of the Asset Sale Requirement will reduce the interest rate on the revolving commitment by 1%.

After giving effect to the rights offering, the transactions contemplated by the Investment Agreements and the use of proceeds set forth above, on a pro forma basis we expect the available borrowing base under the EXCO Resources Credit Agreement to be $900.0 million with approximately $491.8 million of outstanding indebtedness and approximately $401.4 million of unused borrowing base, net of letters of credit.

As of September 30, 2013, the revolving commitment under the EXCO Resources Credit Agreement had an available borrowing base of approximately $1.2 billion, with approximately $1.0 billion of outstanding indebtedness and $158.1 million of unused borrowing base, net of letters of credit. The revolving commitment of outstanding indebtedness of $1.0 billion included $269.1 million outstanding on our Asset Sale Requirement. We used a portion of the borrowings under the EXCO Resources Credit Agreement to facilitate the acquisitions of the Chesapeake Properties in July 2013.

The interest rate grid for the revolving commitment under the EXCO Resources Credit Agreement ranges from LIBOR plus 175 bps to 275 bps (or ABR plus 75 bps to 175 bps), depending on our borrowing base usage. The term loan bears interest at LIBOR, with a floor of 100 bps, plus 400 bps (or ABR plus 300 bps). The interest rate grid is increased by 100 bps per annum until the net proceeds from certain asset sales reduce outstanding borrowings by $400.0 million. On September 30, 2013, the one month LIBOR was 0.2%, which resulted in an interest rate of approximately 3.7% on the revolving commitment. The interest rate on the term loan portion of the EXCO Resources Credit Agreement was approximately 5.0% as of September 30, 2013. The revolving commitment under the EXCO Resources Credit Agreement matures on July 31, 2018. The term loan portion of the EXCO Resources Credit Agreement matures on August 19, 2019.

As of December 6, 2013, the revolving commitment under the EXCO Resources Credit Agreement had an available borrowing base of approximately $928.9 million, with approximately $763.9 million of outstanding indebtedness and $158.2 million of unused borrowing base, net of letters of credit. The reduction in our borrowing base and outstanding indebtedness reflects proceeds of $240.2 million from the sale of TGGT.

 

40


Table of Contents

CAPITALIZATION

The following table sets forth our cash and cash equivalents and capitalization as of September 30, 2013 on an actual basis and on an as adjusted basis to give effect to (i) $240 million of cash proceeds from the sale of TGGT, which closed on November 15, 2013, (ii) the sale of 54,574,734 shares in the rights offering and the transactions contemplated by the Investment Agreements at a price of $5.00 per share, after deducting our estimated expenses and (iii) the use of proceeds as set forth in this prospectus. The table below should be read in conjunction with, and is qualified in its entirety by reference to, “Use of Proceeds” and the consolidated financial statements and the accompanying notes incorporated by reference in this prospectus.

 

     At September 30, 2013  
     Actual     As Adjusted  
     (Unaudited)        
     (Dollars in thousands)  

Cash and cash equivalents (1)

   $ 63,326      $ 63,326   
  

 

 

   

 

 

 

Total debt:

    

EXCO Resources Credit Agreement:

    

Term Loan under EXCO Resources Credit Agreement (2)

     299,250        299,250   

Asset Sale Requirement under the EXCO Resources Credit Agreement

     269,096        —   (4)  

Revolving commitment under EXCO Resources Credit Agreement

     735,000        491,756 (4)  
  

 

 

   

 

 

 

Total drawings under the EXCO Resources Credit Agreement

     1,303,346        791,006   

2018 Notes (3)

     750,000        750,000   
  

 

 

   

 

 

 

Total debt

   $ 2,053,346      $ 1,541,006   

Shareholders’ equity:

    

Preferred stock, $0.001 par value; 10,000,000 authorized shares; none issued and outstanding

     —          —     

Common stock, $0.001 par value; 350,000,0000 authorized shares; 218,838,159 shares issued and 218,298,938 shares outstanding, actual; and 273,412,893 shares issued and 272,873,672 shares outstanding, as adjusted

     216        270   

Additional paid-in capital

     3,216,842        3,489,661   

Accumulated deficit

     (2,930,929     (2,930,929

Treasury stock, at cost; 539,221 shares

     (7,479     (7,479
  

 

 

   

 

 

 

Total shareholders’ equity

     278,650        551,523   
  

 

 

   

 

 

 

Total capitalization

   $ 2,331,996      $ 2,092,529   
  

 

 

   

 

 

 

 

(1) Includes restricted cash of $36.1 million.
(2) Excludes unamortized discount of approximately $2.9 million.
(3) Excludes unamortized discount of approximately $7.6 million.
(4) Reduced by proceeds from (i) the sale of shares of common stock in the rights offering and in the transactions contemplated by the Investment Agreements and (ii) the sale of TGGT, which closed on November 15, 2013.

 

41


Table of Contents

THE RIGHTS OFFERING

Background of the Rights Offering

In connection with its regular review of our liquidity and financial condition, our board of directors considered various alternatives in both debt and equity markets to strengthen our liquidity and our financial ability following several significant acquisitions and dispositions during 2013. After assessing the alternatives, we determined to conduct an equity offering to strengthen our liquidity position and increase our financial flexibility, including the flexibility to make opportunistic acquisitions, and our ability to fund the acquisition of wells pursuant to the KKR Participation Agreement. As of December 6, 2013, the revolving commitment under the EXCO Resources Credit Agreement had a borrowing base of approximately $928.9 million, with approximately $763.9 million of outstanding indebtedness and $158.2 million of unused borrowing base, net of letters of credit.

The board of directors determined that raising capital through a rights offering had two primary advantages over an underwritten public offering. First, a rights offering would provide our shareholders with the opportunity to participate in the transaction on a pro rata basis and, if all rights holders exercise their subscription rights, to avoid dilution of their ownership interests in us. Second, the expenses in a rights offering are generally significantly less than those in an underwritten public offering, which would include the payment of underwriters’ discounts and commissions.

At a board meeting in November 2013, the board reviewed a proposal to conduct a rights offering to shareholders to purchase shares of common stock. After being presented with the investment opportunity, all of our directors who are not affiliated with, and do not have a financial interest in, either of the Investors, considered various factors and determined to conduct the rights offering.

We expect the net proceeds from the rights offering and the transactions contemplated by the Investment Agreements will be approximately $272 million. We intend to use the net proceeds to pay indebtedness under the EXCO Resources Credit Agreement, including payment in full of the indebtedness related to the Asset Sale Requirement as well as a portion of the indebtedness outstanding under the revolving commitment. Upon repayment of the Asset Sale Requirement indebtedness, the interest rate on the revolving commitment will decrease by 100 basis points. In addition, by paying a portion of the revolving commitment, we will increase the borrowing availability under the revolving commitment by approximately $243 million, which will give us additional financial flexibility.

The subscription price for the rights offering was approved by the unanimous vote of the members of our board of directors who are not affiliated with, and do not have a financial interest in, either of the Investors. Each of Messrs. Ross and Mitchell abstained from the vote to approve the rights offering and the Investment Agreements. In evaluating the subscription price, the disinterested directors considered, among other things, the following factors:

 

    the current and historical trading prices of our common stock;

 

    the price at which shareholders might be willing to participate in the rights offering;

 

    the ability of shareholders to transfer or sell their subscription rights;

 

    our need for additional capital and liquidity;

 

    the cost of capital from other sources; and

 

    comparable precedent transactions, including the percentage of shares offered, the terms of the subscription rights being offered, the subscription price and the discount that the subscription price represented to the immediately prevailing closing prices for those offerings.

 

42


Table of Contents

The disinterested directors also believed that the subscription price should be designed to provide an incentive to our current shareholders to participate in the rights offering and exercise their basic subscription right and their over-subscription privilege.

The disinterested directors believed that the Investors’ familiarity with and current ownership position in the Company would help accelerate the process for completing the rights offering, and had discussions regarding our future liquidity needs and our reasons for requesting the Investors to make a commitment in connection with the rights offering.

After several meetings of the board of directors at which the rights offering was discussed, on November 22, 2013, the disinterested directors approved the subscription price and the basic terms of the rights offering, the Investors agreed to the basic terms of their commitments to purchase certain shares in the rights offering, and the disinterested directors approved the commitments with the Investors. At all meetings of the board of directors at which the subscription price and the terms of any commitments were discussed, the disinterested directors were provided the opportunity to meet and did meet on several occasions separately with our legal counsel without the members of our board of directors who are affiliated with, or that have a financial interest in, the Investors present to discuss potential pricing and the terms of any commitments under the rights offering.

The $5.00 subscription price is not intended to bear any relationship to the market value of our common stock, the book value of our assets or our past operations, cash flows, losses, financial condition, net worth, or any other established criteria used to value securities. You should not consider the subscription price to be an indication of the fair value of the common stock to be offered in the rights offering. We do not intend to change the subscription price in response to changes in the trading price of our common stock prior to the closing of the rights offering.

The Rights

We are distributing to the holders of our common stock transferable subscription rights to purchase up to an aggregate of 44,995,665 shares of common stock at a price of $5.00 per share. Each subscription right consists of a basic subscription right and an over-subscription privilege, subject to the terms in this prospectus. You will receive one subscription right for each share of common stock held by you of record as of 5:00 p.m., New York City time, on December 19, 2013, the record date.

Subject to the provisions of the Investment Agreements, we may cancel or withdraw the rights offering at any time for any reason before the rights offering expires. If we cancel the rights offering, we will issue a press release notifying shareholders of the cancellation or withdrawal, and the subscription agent will return all subscription payments to the subscribers, without interest or penalty, as soon as practicable. If we cancel or withdraw the rights offering, the subscription rights will be void, of no value and will cease to be exercisable for shares of our common stock. If you purchase subscription rights during the subscription period and we cancel or withdraw the rights offering, you will lose the entire purchase price paid to acquire such subscription rights in the market.

Basic Subscription Right

The basic subscription right gives you the right to purchase 0.25 of a share of common stock per subscription right, subject to delivery of the required documents and payment of the subscription price of $5.00 per share of common stock. You may exercise all or a portion of your basic subscription right or you may choose not to exercise any of your subscription rights. If you do not exercise your basic subscription right in full (including in respect of subscription rights purchased from others), you will not be entitled to purchase any shares under your over-subscription privilege. Fractional shares resulting from the exercise of the basic subscription right on an aggregate basis as to any rights holder will be eliminated by rounding down to the nearest whole share.

 

43


Table of Contents

For example, if you owned 1,002 shares of our common stock on the record date, you would have received 1,002 subscription rights and would have the right to purchase up to 250 shares of common stock for $5.00 per share. You would not receive any other consideration for the exercise of the remaining two subscription rights to purchase an aggregate of 0.50 of a share of common stock.

Over-Subscription Privilege

If you timely and fully exercise your basic subscription right with respect to all subscription rights you hold (including in respect of subscription rights purchased from others), you may also choose to purchase any or all of the shares of common stock that our other shareholders do not purchase through the exercise of their basic subscription rights. We will be able to satisfy your exercise of the over-subscription privilege only to the extent that there are shares available for the over-subscription privilege. The number of shares that will be available pursuant to the over-subscription privilege in the rights offering will be the Unsubscribed Shares.

If the requests for over-subscription (including of the Investors) exceed the available shares, we will allocate the Unsubscribed Shares pro rata among the rights holders exercising the over-subscription privilege in proportion to the number of shares of our common stock each of those rights holders owned as of 5:00 p.m., New York City time, on the record date, relative to the number of shares owned as of 5:00 p.m., New York City time, on the record date by all rights holders exercising the over-subscription privilege (including the Investors). In addition, pursuant to the Investment Agreements, and subject to the terms and conditions thereof, we have agreed to allocate and each of the Investors has agreed to subscribe for and purchase, in a private placement, their respective pro rata portion of shares under the basic subscription right and all Unsubscribed Shares under the over-subscription privilege, subject to availability and the pro rata allocation among the rights holders who have elected to exercise their over-subscription privilege, based on the number of shares of common stock each of the Investors owned as of 5:00 p.m., New York City time, on the record date, relative to the number of shares owned on the record date by all rights holders exercising the over-subscription privilege (including the Investors); provided, that each of the Investors shall not be obligated to purchase an aggregate number of shares that would exceed the lesser of (i) 100% of the Unsubscribed Shares, or (ii) an amount of Unsubscribed Shares, which when taken together with the number of shares issued pursuant to the Investor’s basic subscription right, equals 50% of the total shares offered in the rights offering.

If this pro rata allocation results in any rights holder receiving a greater number of shares of common stock than the rights holder subscribed for pursuant to the exercise of the over-subscription privilege, then such rights holder will be allocated only that number of shares for which the rights holder over-subscribed, and the remaining shares will be allocated among all other rights holders exercising the over-subscription privilege on the same pro rata basis described above. The proration process will be repeated until all Unsubscribed Shares have been allocated to either the rights holders exercising the over-subscription privilege or the Investors pursuant to the Investment Agreements. Continental Stock Transfer & Trust Company, our subscription agent for the rights offering, will determine the over-subscription allocation based on the formula described above.

To properly exercise your over-subscription privilege, you must deliver the subscription payment related to your over-subscription privilege before the rights offering expires. Because we will not know the total number of Unsubscribed Shares before the rights offering expires, if you wish to maximize the number of shares you purchase pursuant to your over-subscription privilege, you will need to deliver payment in an amount equal to the aggregate subscription price for the maximum number of shares that may be available to you (i.e., for the maximum number of shares available to you, assuming you exercise all of your basic subscription right and are allotted the full amount of your over-subscription without reduction).

We can provide no assurances that you will actually be entitled to purchase the number of shares of common stock issuable upon the exercise of your over-subscription privilege in full at the expiration of the rights offering. We will not be able to satisfy any orders for shares pursuant to the over-subscription privilege if all of our shareholders exercise their basic subscription right in full, and we will only honor an over-subscription privilege to the extent sufficient shares are available following the exercise of the basic subscription rights.

 

44


Table of Contents

To the extent the aggregate subscription price of the actual number of Unsubscribed Shares available to you pursuant to the over-subscription privilege is less than the amount you actually paid in connection with the exercise of the over-subscription privilege, you will be allocated only the number of whole Unsubscribed Shares available to you, and any excess subscription payments will be returned to you, without interest or penalty, as soon as practicable.

To the extent the amount you actually paid in connection with the exercise of the over-subscription privilege is less than the aggregate subscription price of the maximum number of Unsubscribed Shares available to you pursuant to the over-subscription privilege; you will be allocated the number of Unsubscribed Shares for which you actually paid in connection with the over-subscription privilege.

Fractional shares resulting from the exercise of the over-subscription privilege on an aggregate basis as to any rights holder will be eliminated by rounding down to the nearest whole share.

For example, the table below assumes that (i) there are 2,500,000 Unsubscribed Shares available for purchase pursuant to the over-subscription privilege, (ii) each of the Investors, pursuant to the terms and conditions of the Investment Agreements, elects to exercise its over-subscription privilege for all Unsubscribed Shares, (iii) other than the four rights holders set forth in the table below, no other rights holders elect to exercise their over-subscription privilege for shares and (iv) four rights holders, each of whom has timely and fully exercised its basic subscription right with respect to all of the subscription rights it holds, elect to exercise their over-subscription privilege for the amount of shares set forth below:

 

Holder

  A
Shares as
of Record
Date (1)
    B
Basic Subscription
Right
    C
Over-
Subscription
Privilege
Shares
Requested

By Holder
    D
Over-
Subscription
Shares
Allocated (2)
    E
Shares
Allocated in
excess of
Requested
Shares (if any) (3)
    F
Over-
Subscription
Shares to be
Issued (4)
    G
Over-
Subscription
Shares to be
Issued (5)
    H
Total Over-
Subscription
Shares to be
Issued
 
    Rights     Shares              
                            (1 st  Round)     (1 st  Round)     (1 st  Round)     (2 nd  Round)        

WL Ross

    31,504,077        31,504,077        7,876,019        2,500,000        1,505,462        —          1,505,462        43,402        1,548,864   

Fairfax/Hamblin Watsa

    10,812,200        10,812,200        2,703,050        2,500,000        516,675        —          516,675        14,895        531,570   

Holder A

    1,500,000        1,500,000        375,000        500,000        71,679        —          71,679        2,066        73,746   

Holder B

    5,000,000        5,000,000        1,250,000        375,000        238,931        —          238,931        6,888        245,820   

Holder C

    3,500,000        3,500,000        875,000        100,000        167,252        67,252        100,000        —          100,000   

Holder D

    —          1,000,000        250,000        50,000        —          —          —          —          —     
             

 

 

   

 

 

   

 

 

 

Total

                2,432,748        67,252        2,500,000   
             

 

 

   

 

 

   

 

 

 

 

(1) Assumes 218,298,938 total shares outstanding on the record date. The total shares outstanding used in the denominator in the first over-subscription round and second over-subscription round was determined as follows:
     Shares as
of Record
Date
     Shares
Included in
1st Round
Denominator
     Shares
Included in
2nd Round
Denominator
 

WL Ross

     31,504,077         31,504,077         31,504,077   

Fairfax/Hamblin Watsa

     10,812,200         10,812,200         10,812,200   

Holder A

     1,500,000         1,500,000         1,500,000   

Holder B

     5,000,000         5,000,000         5,000,000   

Holder C

     3,500,000         3,500,000         —     

Holder D

     —           —           —     

Other holders (not exercising over-subscription privilege)

     165,982,661         —           —     
  

 

 

    

 

 

    

 

 

 

Total

     218,298,938         52,316,277         48,816,277   
(2) Column D represents the holder’s pro rata portion based on the holders participating in the particular over-subscription round. This amount is calculated by multiplying 2,500,000 (the assumed number of Unsubscribed Shares) by a fraction, the numerator of which is, with respect to any holder, the amount in Column A with respect to that holder, and the denominator of which is the total number of shares in Column A held by holders participating in that over-subscription round as shown in note 1 (e.g., for Holder A, 2,500,000*(1,500,000/52,316,277)).
(3) Column E represents the number of shares allocated to the holder in excess of its request (e.g., for Rights Holder C, 167,252-100,000).
(4)

Column F represents the number of shares actually issued to the holder in the first over-subscription round and equals Column D less Column E (e.g., for Holder C, 167,252-67,252).

 

45


Table of Contents
(5) Column G represents the holder’s pro rata portion based on the holders participating in the particular over-subscription round. This amount is calculated by multiplying the shares available for that over-subscription round by a fraction, the numerator of which is, with respect to any holder, the amount in Column A with respect to that holder, and the denominator of which is the total number of shares in Column A held by holders participating in that over-subscription round as shown in note 1 (e.g., for Holder A, 67,252*(1,500,000/48,816,277)). In the second round above, 67,252 shares were allocated, representing the shares allocated to Holder C in excess of its request.

The initial approximate pro rata allocation under the over-subscription privilege allocates 2,500,000 Unsubscribed Shares among the rights holders who have elected to exercise their over-subscription privilege, based on an aggregate of 52,316,277 shares held on the record date by WL Ross, Fairfax (including Hamblin Watsa) and the four other over-subscribing rights holders listed in the table above, as follows:

 

    Holder A would receive 71,679 shares;

 

    Holder B would receive 238,931 shares;

 

    Holder C would receive 100,000 shares;

 

    Holder D would receive no shares;

 

    WL Ross would receive 1,505,462 shares; and

 

    Fairfax (including Hamblin Watsa) would receive 516,675 shares.

Following the initial pro rata allocation among the rights holders who elected to exercise their over-subscription privilege, there would be a remainder of 67,252 shares that were not allocated to WL Ross, Fairfax (including Hamblin Watsa) and the four other over-subscribing rights holders. The second pro rata allocation does not (i) include Holder C because Holder C was allocated all of the shares it requested in the initial pro rata allocation and (ii) Holder D because Holder D did not own any shares on the record date. The second pro rata allocation allocates 67,252 shares among WL Ross, Fairfax (including Hamblin Watsa), Holder A and Holder B, based on an aggregate of 48,816,277 shares held on the record date by WL Ross, Fairfax (including Hamblin Watsa), Holder A and Holder B, as follows:

 

    Holder A would receive 2,066 shares;

 

    Holder B would receive 6,888 shares;

 

    Holder C would receive no shares;

 

    Holder D would receive no shares;

 

    WL Ross would receive 43,402 shares; and

 

    Fairfax (including Hamblin Watsa) would receive 14,895 shares.

The foregoing example is for illustrative purposes only and does not reflect any actual or estimated allocation of shares pursuant to the over-subscription privilege. If you timely and fully exercise your basic subscription right (including in respect of subscription rights purchased from others), you may also choose to subscribe for any or all of the Unsubscribed Shares, subject to availability and the pro rata allocation among rights holders who have timely and full exercised their basic subscription rights and validly elected to exercise their over-subscription privilege. The actual amount of shares allocated to a rights holder pursuant to the valid exercise of its over-subscription privilege will be delivered at once and may be less than the number of shares such rights holder validly subscribes for pursuant to the exercise of its over-subscription privilege.

Delivery of Shares

We will mail you a direct registration account statement or credit your account at your record holder with shares of our common stock that you purchased in the rights offering as soon as practicable after the rights offering has expired. Any excess subscription payments received by the subscription agent will be returned, without interest, as soon as practicable.

 

46


Table of Contents

Method of Exercising Rights

The exercise of subscription rights is irrevocable, subject to applicable law, and may not be cancelled or modified. Except with respect to subscription rights allocated to your 401(k) Plan account, you may exercise your subscription rights as follows:

Subscription by Registered Holders.  If you hold a stock certificate, the number of shares of common stock you may subscribe to purchase pursuant to your basic subscription right is indicated on the rights certificate we plan to distribute as soon as practicable after the record date. You may exercise your basic subscription right and over-subscription privilege, if any, by properly completing and executing the rights certificate, together with any required signature guarantees, and forwarding it, together with your full payment, to the subscription agent at the address given below under “—Subscription Agent and Information Agent.” All documents and payments must be received before 5:00 p.m., New York City time, on January 9, 2014, the expiration date of the rights offering.

Subscription by DTC Participants . We expect that the exercise of your subscription rights may be made through the facilities of DTC. If your subscription rights are held of record through DTC, you may exercise your subscription rights by instructing DTC, or having your broker, dealer, custodian bank or other nominee instruct DTC, to transfer your subscription rights from your account to the account of the subscription agent, together with certification as to the aggregate number of subscription rights you are exercising and the number of shares for which you are subscribing under your basic subscription right and your over-subscription privilege, if any, and your full subscription payment.

Subscription by Beneficial Owners.  If you are a beneficial owner of shares of our common stock that are registered in the name of a broker, dealer, custodian bank or other nominee, you will not receive a rights certificate. Instead, we will issue one subscription right to the nominee record holder for each share of common stock that you own on the record date. If you are not contacted by your nominee, you should promptly contact your nominee in order to subscribe for shares in the rights offering and follow the instructions provided by your nominee. Your subscription rights will not be considered exercised unless the subscription agent receives from you, your broker, dealer, custodian bank or other nominee, as the case may be, all of the required subscription documents and your full subscription payment prior to the expiration of the rights offering.

Payment Method

Your payment of the subscription price must be made in U.S. dollars for the full number of shares of common stock that you wish to acquire in the rights offering. Unless subscription rights are allocated to your 401(k) Plan account, payments submitted to the subscription agent must be made by one of the following methods, in accordance with the instructions accompanying the rights certificate:

 

    certified or personal check drawn on a U.S. bank payable to “Continental Stock Transfer & Trust Company”;

 

    postal, telegraphic or express money order payable to “Continental Stock Transfer & Trust Company”; or

 

    wire transfer of immediately available funds directly to the account maintained by “Continental Stock Transfer & Trust Company as agent for EXCO Resources Rights Offering”; at Bank Name: JP Morgan Chase Bank; ABA #: 021000021; Account #: 475-581202. Any wire transfer should clearly indicate the identity of the subscriber who is paying the subscription price by wire transfer.

Payment received after the expiration of the rights offering will not be honored, and the subscription agent will return your payment to you, without interest or penalty, as soon as practicable. The subscription agent will be deemed to receive payment upon:

 

    clearance of any uncertified personal check deposited by Continental Stock Transfer & Trust Company;

 

47


Table of Contents
    receipt by Continental Stock Transfer & Trust Company of any certified check or bank draft drawn upon a U.S. bank;

 

    receipt by Continental Stock Transfer & Trust Company of any postal, telegraphic or express money order; or

 

    receipt by Continental Stock Transfer & Trust Company of any wire transfer of immediately available funds.

If you elect to exercise your subscription rights, we urge you to consider using a certified or cashier’s check, money order or wire transfer of funds to ensure that Continental Stock Transfer & Trust Company receives your funds prior to the expiration of the rights offering.

If you elect to exercise your subscription rights, you should ensure that Continental Stock Transfer & Trust Company receives your funds before the rights offering expires. Any uncertified personal check used to pay for shares of common stock must clear the appropriate financial institutions before 5:00 p.m., New York City time, on January 9, 2014, when the rights offering will expire. The clearinghouse may require five or more business days. Accordingly, rights holders who wish to pay the subscription price by means of an uncertified personal check should make payment sufficiently in advance of the expiration of the rights offering to ensure that the payment is received and clears by that date.

You should read the instruction letter accompanying the rights certificate carefully and strictly follow it. DO NOT SEND RIGHTS CERTIFICATES OR PAYMENTS DIRECTLY TO EXCO . We will not consider your subscription received until the subscription agent has received delivery of a properly completed and duly executed rights certificate and payment of the full subscription amount.

The method of delivery of rights certificates and payment of the subscription amount to the subscription agent will be at the risk of the rights holders. If sent by mail, we recommend that you send rights certificates and payments by overnight courier or by registered mail, properly insured, with return receipt requested, and that you allow a sufficient number of days to ensure delivery to the subscription agent and clearance of payment before the rights offering expires.

Incorrect or Incomplete Subscription Information

If you fail to properly complete and duly sign the rights certificate and all other required subscription documents or otherwise fail to follow the subscription procedures that apply to the exercise of your subscription rights before the rights offering expires, the subscription agent will reject your subscription or accept it only to the extent of the payment received. Neither we nor our subscription agent accepts any responsibility to contact you concerning an incomplete or incorrect subscription document, nor are we under any obligation to correct such documents. We have the sole discretion to determine whether a subscription exercise properly complies with the subscription procedures.

If you send a payment that is insufficient to purchase the number of shares of common stock you requested, or if the number of shares you requested is not specified in the forms, the payment received will be applied to exercise your subscription rights to the fullest extent possible based on the amount of the payment received, subject to the availability of shares under the over-subscription privilege and the elimination of fractional shares. Any excess subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable following the expiration of the rights offering.

 

48


Table of Contents

Expiration Date and Extension

The rights offering period, during which you may exercise your subscription rights, expires at 5:00 p.m., New York City time, on January 9, 2014. If shares are allocated to your account under the 401(k) Plan, please see “—Special Instructions for Participants in Our 401(k) Plan.” If you do not exercise your subscription rights before that time, your subscription rights will expire and will no longer be exercisable. We will not be required to issue shares to you if the subscription agent receives your rights certificate or your subscription payment after that time.

We do not intend to extend the expiration date of the rights offering. However, if we elect (subject to the provisions of the Investment Agreements) to extend the rights offering, we will issue a press release announcing the extension no later than 9:00 a.m., New York City time, on the next business day after the most recently announced expiration date of the rights offering.

If you hold your shares of common stock in the name of a broker, dealer, custodian bank or other nominee, the nominee will exercise or sell the subscription rights on your behalf in accordance with your instructions. Please note that the nominee may establish a deadline that may be before the 5:00 p.m., New York City time, on January 9, 2014, expiration date that we have established for the rights offering.

Conditions, Amendment, Withdrawal and Cancellation

There are no conditions precedent to the rights offering but there are conditions to the consummation of the transactions contemplated by the Investment Agreements. Subject to the provisions of the Investment Agreements, we reserve the right to amend, withdraw or cancel the rights offering at any time for any reason. See “The Investment Agreements; Effects of the Transactions—The Investment Agreements.” If we amend, withdraw or cancel the rights offering, we will issue a press release notifying rights holders as required by law. If we cancel or withdraw the rights offering, the subscription agent will return all subscription payments without interest or penalty, as soon as practicable. If we cancel or withdraw the rights offering, the subscription rights will be void, of no value and will cease to be exercisable for shares of our common stock. If you purchase subscription rights during the subscription period and we cancel or withdraw the rights offering, you will lose the entire purchase price paid to acquire such subscription rights in the market.

Subscription Agent and Information Agent

The subscription agent for the rights offering is Continental Stock Transfer & Trust Company. The address to which rights certificates and payments, other than wire transfers, should be mailed or delivered by overnight courier is provided below. If sent by mail, we recommend that you send documents and payments by registered mail, properly insured, with return receipt requested, and that you allow a sufficient number of days to ensure delivery to the subscription agent. Do not send or deliver these materials to EXCO.

Continental Stock Transfer & Trust Company

17 Battery Place—8th Floor

New York, NY 10004

Attn: Corporate Actions Department

Telephone: (917) 262-2378

If you deliver subscription documents or rights certificates in a manner different than that described in this prospectus, we may not honor the exercise of your subscription rights.

You should direct any questions or requests for assistance concerning the method of subscribing for the shares of common stock or for additional copies of this prospectus to the information agent, D.F. King & Co., Inc., by calling 1-800-755-7250 toll-free or, if you are a bank or broker, at 1-212-269-5550.

 

49


Table of Contents

Medallion Guarantee May Be Required

Your signature on each rights certificate must be guaranteed by an eligible institution, such as a member firm of a registered national securities exchange or a member of the Financial Industry Regulatory Authority, Inc., or a commercial bank or trust company having an office or correspondent in the United States, subject to standards and procedures adopted by the subscription agent, unless:

 

    you provide on the rights certificate that shares are to be delivered to you as record holder of those subscription rights; or

 

    you are an eligible institution.

If a financial institution is not a member of a recognized Medallion signature guarantee program, it would not be able to provide signature guarantees. Also, if you are not a customer of a participating financial institution, it is likely the financial institution will not guarantee your signature. Therefore, the best source of a Medallion Guarantee would be a bank, savings and loan association, brokerage firm or credit union with whom you do business. The participating financial institution will use a Medallion imprint or stamp to guarantee the signature, indicating that the financial institution is a member of a Medallion signature guarantee program and is an acceptable signature guarantor.

Guaranteed Delivery Procedures

If you wish to exercise subscription rights, but you do not have sufficient time to deliver the rights certificate evidencing your subscription rights and all other required subscription documents to the subscription agent prior to the expiration of the rights offering, you may exercise your subscription rights by the following guaranteed delivery procedures:

 

    deliver to the subscription agent prior to the expiration of the rights offering the subscription payment for each share you elected to purchase pursuant to the exercise of subscription rights in the manner set forth above under “—Payment Method.”

 

    deliver to the subscription agent prior to the expiration of the rights offering the form entitled “Notice of Guaranteed Delivery,” and

 

    deliver the properly completed and duly executed rights certificate evidencing your subscription rights being exercised, with any required signatures guaranteed, and all other required subscription documents to the subscription agent within three business days following the date you submit your notice of guaranteed delivery.

Your notice of guaranteed delivery must be delivered in substantially the same form provided with the instructions on your rights certificate. Your notice of guaranteed delivery must include a signature guarantee from an eligible institution described above.

In your notice of guaranteed delivery, you must provide:

 

    your name;

 

    the number of subscription rights represented by your rights certificate, the number of shares of common stock for which you are subscribing under your basic subscription right and the number of shares of common stock for which you are subscribing under your over-subscription privilege, if any; and

 

    your guarantee that you will deliver to the subscription agent a rights certificate evidencing the subscription rights you are exercising and all other required subscription documents within three business days following the date the subscription agent receives your notice of guaranteed delivery.

You may deliver your notice of guaranteed delivery to the subscription agent in the same manner as your rights certificate at the address set forth above under “—Subscription Agent and Information Agent” or as otherwise provided in the notice of guaranteed delivery.

 

50


Table of Contents

Notice to Nominees

If you are a broker, dealer, custodian bank or other nominee holder that holds shares of our common stock for the account of others on the record date, you should notify the beneficial owners of the shares for whom you are the nominee of the rights offering as soon as possible to learn their intentions with respect to exercising their subscription rights. You should obtain instructions from the beneficial owners of our common stock. If a registered holder of our common stock so instructs, you should complete the rights certificate and submit it to the subscription agent with the proper subscription payment by the expiration date of the rights offering. You may exercise the number of subscription rights to which all beneficial owners in the aggregate otherwise would have been entitled had they been direct holders of our common stock on the record date, provided that you, as a nominee record holder, make a proper showing to the subscription agent by submitting the form entitled “Nominee Holder Certification,” which is provided with your rights offering materials. If you did not receive this form, you should contact the subscription agent to request a copy.

Beneficial Owners

If you are a beneficial owner of shares of our common stock and will receive your subscription rights through a broker, dealer, custodian bank or other nominee, we will ask your nominee to notify you of the rights offering. If you wish to exercise or sell your subscription rights, you will need to have your nominee act for you, as described above. To indicate your decision with respect to your subscription rights, you should follow the instructions of your nominee. If you wish instead to obtain a separate rights certificate, you should contact your nominee as soon as possible and request that a rights certificate be issued to you. You should contact your nominee if you do not receive notice of the rights offering, but you believe you are entitled to participate in the rights offering. We are not responsible if you do not receive the notice by mail or otherwise from your nominee or if you receive notice without sufficient time to respond to your nominee by the deadline established by your nominee, which may be before 5:00 p.m., New York City time, on January 9, 2014, the expiration date of the rights offering.

Special Instructions for Participants in Our 401(k) Plan

Any participant or other account holder (such as a beneficiary) in the 401(k) Plan that had shares of our common stock allocated to its account as of 5:00 p.m., New York City time, on the record date, will be allocated subscription rights based upon the number of shares held in its account as of that time on the record date. Those participants (or other account holders) with 401(k) Plan accounts who are allocated subscription rights will have the ability to direct the trustee of the 401(k) Plan, Prudential Bank & Trust, FSB, to exercise some or all of the subscription rights allocable to them.

If shares of our common stock are allocated to your account under the 401(k) Plan as of 5:00 p.m., New York City time, on the record date, you will receive subscription solicitation materials from the subscription agent, which will include specific instructions for participating in the rights offering with respect to subscription rights held through the 401(k) Plan, a copy of this prospectus and the 401(k) Election Form. If you wish to exercise your subscription rights, in whole or in part, you must return your properly completed 401(k) Election Form to the subscription agent, as prescribed in the instructions accompanying the 401(k) Election Form. Your properly completed 401(k) Election Form must be received by the subscription agent by the 401(k) Deadline (5:00 p.m., New York City time, on January 6, 2014, which is the third business day prior to the expiration date of the rights offering). If the subscription agent does not receive your 401(k) Election Form by the 401(k) Deadline, your election to exercise your subscription rights with respect to shares of our common stock that you hold through the 401(k) Plan will not be effective. This is a special deadline that applies to participants (and other account holders) in the 401(k) Plan (notwithstanding the expiration date of the rights offering generally applicable to holders of subscription rights) and solely with respect to the subscription rights held through the 401(k) Plan. Any subscription rights allocated to your 401(k) Plan account will expire unless they are timely and fully exercised by the 401(k) Deadline or otherwise sold by the 401(k) Plan trustee. You should receive the 401(k) Election Form with the other offering materials related to the rights offering. If you do

 

51


Table of Contents

not receive this form, and you believe you are entitled to participate in the rights offering with respect to shares allocated to your account under the 401(k) Plan, you should contact the information agent D.F. King & Co., Inc., by calling 1-800-755-7250 toll-free or, if you are a bank or broker, at 1-212-269-5550.

If no instructions are received by the subscription agent prior to the 401(k) Deadline, no subscription rights will be exercised by the 401(k) Plan trustee on your behalf, and the 401(k) Plan trustee will attempt to sell the subscription rights attributable to your 401(k) Plan account through the NYSE. The 401(k) Plan trustee’s attempt to sell the subscription rights may be unsuccessful. Any amounts obtained from the sale of subscription rights by the 401(k) Plan trustee will be allocated on an individual basis to each participant who did not timely submit instructions to exercise subscription rights allocated to its account or who instructed the 401(k) Plan trustee to sell all or a portion of the subscription rights allocated to its account. The amounts obtained from the sale of a participant’s subscription rights will be allocated to the Guaranteed Income Fund in the participant’s 401(k) Plan account.

If you elect to exercise some or all of the subscription rights allocated to your 401(k) Plan account, you must ensure that the number of shares for which you subscribe under the basic subscription right on your 401(k) Election Form accurately reflects the number of shares to which you are entitled. You must also ensure that your current investment in your 401(k) Plan account in Guaranteed Income Fund is sufficient to fully satisfy the subscription payment for the subscription rights you elect to exercise on your 401(k) Election Form, as you may only pay for the exercise of such subscription rights through the liquidation of funds held by your 401(k) Plan account in the Guaranteed Income Fund. Your investment in the Guaranteed Income Fund in your 401(k) Plan account will be liquidated in the amount specified in your 401(k) Election Form after the 401(k) Deadline and prior to the expiration of the rights offering, and cash equal to the necessary subscription payment amount will be transferred to the trustee of the 401(k) Plan.

Notwithstanding your election to exercise all of your subscription rights, the 401(k) Plan trustee will be directed to only exercise that number of subscription rights and purchase the number of shares of common stock that can be acquired with the money generated by liquidating your investment in the Guaranteed Income Fund in your 401(k) Plan account. If the value of your investment in the Guaranteed Income Fund in your 401(k) Plan account does not equal or exceed the purchase price of the shares of common stock that you have elected to purchase in the rights offering, the subscription rights allocated to your 401(k) Plan account will be exercised to the fullest extent possible based on the liquidated value of your 401(k) Plan account invested in this fund, rounded down to the nearest whole share.

Any shares of common stock purchased upon exercise of the subscription rights allocated to your 401(k) Plan account will also be allocated to your 401(k) Plan account, where they will remain subject to your further investment directions in accordance with the terms of the 401(k) Plan.

Once you submit your completed 401(k) Election Form, you may not revoke your exercise instructions. If you elect to exercise your subscription rights, you should be aware that the market value of our shares of common stock may go up or down during the period after you submit your 401(k) Election Form. Notwithstanding the foregoing, ERISA prohibits the purchase of shares of common stock by the 401(k) Plan from EXCO for more than “adequate consideration,” which is defined in ERISA for a publicly traded company as the Prevailing Market Price. Accordingly, the 401(k) Plan trustee will exercise or not exercise your subscription rights as follows:

 

    if the Prevailing Market Price is less than the subscription price of $5.00 per share, notwithstanding your direction to the 401(k) Plan trustee to exercise the subscription rights, the subscription rights will not be exercised; and

 

    if the Prevailing Market Price is greater than or equal to the subscription price of $5.00 per share, the 401(k) Plan trustee will follow your direction, if any, to exercise your subscription rights.

 

52


Table of Contents

All subscription payments received on your behalf and not applied to the purchase of shares of common stock in the rights offering will be returned to the 401(k) Plan and deposited based upon your current 401(k) Plan investment allocation election.

Neither we, nor the subscription agent or anyone else will be under any duty to notify you of any defect or irregularity in connection with your submission of the 401(k) Election Form, and we will not be liable for failure to notify you of any defect or irregularity with respect to the completion of such form. We and the subscription agent reserve the right to reject your exercise of the subscription rights if your exercise is not in accordance with the terms of the rights offering or in the proper form. We will also not accept the exercise of subscription rights if our issuance of shares of common stock to you could be deemed unlawful under applicable law.

The 401(k) Election Form must be received by the subscription agent by the 401(k) Deadline, which is 5:00 p.m., New York City time, on January 6, 2014. A self-addressed envelope has been included in the materials provided to our 401(k) Plan participants (and other account holders) that may be used to mail the 401(k) Election Form. In any event, you must use the address set forth below:

Continental Stock Transfer & Trust Company

17 Battery Place—8th Floor

New York, NY 10004

Attn: Corporate Actions Department

Telephone: (917) 262-2378

Delivery to any address or by a method other than those set forth above does not constitute valid delivery.

No Fractional Shares

All shares of common stock will be sold at a purchase price of $5.00 per whole share. We will not issue fractional shares. Fractional shares resulting from (1) the exercise of the basic subscription right with respect to any holder on an aggregate basis and (2) the exercise of the over-subscription privilege with respect to any holder on an aggregate basis will be eliminated by rounding down to the nearest whole share. Any excess subscription payments received by the subscription agent will be returned, without interest, as soon as practicable.

Market for the Shares of Common Stock

Shares of our common stock are, and we expect that the shares of common stock to be issued in the rights offering will be, traded on the NYSE under the symbol “XCO.”

Transferability of and Market for Rights

The subscription rights are transferable, and we expect that the subscription rights will be admitted to trade on the NYSE under the symbol “XCO-RT” until 4:00 p.m., New York City time, on January 8, 2014, the business day immediately preceding the expiration date of the rights offering (or, if the rights offering is extended, on the business day immediately preceding the extended expiration date). The subscription rights are issued in the form of a rights certificate that we plan to distribute as soon as practicable after the record date for the rights offering. As a result, you may transfer or sell your subscription rights if you do not want to purchase any shares of common stock. However, the subscription rights are a new issue of securities with no prior trading market, and we can give no assurance that the subscription rights will trade on the NYSE, a market for the subscription rights will develop or, if a market does develop, of the prices at which the subscription rights will trade or whether such market will be sustainable throughout the period when the subscription rights are transferable. In addition, the transferee of a subscription right will be able to exercise the basic subscription right but will only be allocated shares of common stock pursuant to the exercise of the over-subscription privilege to the extent such transferee holds shares of our common stock as of the record date. It should be noted that the resale provisions of Rule 144 will apply to the transfers of the subscription rights by our affiliates. See “—Rule 144.”

 

53


Table of Contents

Method of Transferring Rights

You may transfer all or a portion of the subscription rights distributed to you by following the instructions on your rights certificate. Any portion of the subscription rights evidenced by your rights certificate representing whole and not any fractional subscription rights may be transferred by delivering to the subscription agent a rights certificate properly endorsed for transfer, with instructions to register that portion of the subscription rights indicated in the name of the transferee and to issue a new rights certificate to the transferee evidencing the transferred subscription rights.

If you wish to transfer all or a portion of your subscription rights, you should allow a sufficient amount of time prior to the expiration of the transferability period for the transfer instructions to be received and processed by the subscription agent. Once processed by the subscription agent, the transferee receiving all or a portion of your subscription rights will need sufficient time to exercise or sell the subscription rights evidenced by the new rights certificates that they receive. You will also need adequate time to obtain a new rights certificate representing your remaining subscription rights, if any. The required time will depend upon the method by which delivery of the rights certificates and payment is made and the number of transactions you instruct the subscription agent to effect. Please bear in mind that the rights offering has a limited period. Neither we nor the subscription agent shall have any liability to a transferee or you if rights certificates, other required subscription documents or subscription payments are not received in time for exercise or sale prior to the expiration of the rights offering.

A new rights certificate will be issued to you if you transfer a portion of your subscription rights. Your new rights certificate representing your retained subscription rights will be mailed to you unless you instruct the subscription agent otherwise.

Validity of Subscriptions

We will resolve all questions regarding the validity and form of the exercise of your subscription rights, including time of receipt and eligibility to participate in the rights offering. Our determination will be final and binding. Once made, subscriptions and directions are irrevocable, subject to applicable law, and we will not accept any alternative, conditional or contingent subscriptions or directions. We reserve the absolute right to reject any subscriptions or directions not properly submitted or the acceptance of which would be unlawful. You must resolve any irregularities in connection with your subscriptions before the rights offering period expires, unless we waive them in our sole discretion. Neither we nor the subscription agent is under any duty to notify you or your representative of defects in your subscriptions. A subscription will be considered accepted, subject to our right to withdraw or cancel the rights offering, only when the subscription agent receives a properly completed and duly executed rights certificate and any other required documents and the full subscription payment. Our interpretations of the terms and conditions of the rights offering will be final and binding.

Escrow Arrangements; Return of Funds

The subscription agent will hold funds received in payment for shares in a segregated account pending completion of the rights offering. The subscription agent will hold this money in escrow until the rights offering is completed or is withdrawn and cancelled. If the rights offering is cancelled for any reason, all subscription payments received by the subscription agent will be returned, without interest or penalty, as soon as practicable.

Shareholder Rights

You will have no rights as a holder of the shares of our common stock you purchase in the rights offering until we issue a direct registration account statement representing shares of our common stock to you, or your account at your nominee is credited with the shares of our common stock purchased in the rights offering.

 

54


Table of Contents

Foreign Shareholders

We will mail a copy of this prospectus, but will not mail the rights certificates, to holders of record of our common stock with addresses that are outside the United States or that have an army post office or foreign post office address. The subscription agent will hold these rights certificates for their account. To exercise subscription rights, such shareholders must notify the subscription agent prior to 11:00 a.m., New York City time, on January 6, 2014, at least three business days prior to the expiration of the rights offering and demonstrate to the satisfaction of the subscription agent that the exercise of the subscription rights does not violate the laws of the jurisdiction of such shareholder. These procedures do not apply to beneficial owners of our common stock that are located outside of the United States who will receive subscription rights through a broker, dealer, custodian bank or other nominee that is located in the United States.

No Revocation or Change

Once you submit the rights certificate or have instructed your nominee of your subscription request, you are not allowed to revoke or change the exercise or request a refund of monies paid. All exercises of subscription rights are irrevocable, subject to applicable law, even if you learn information about us that you consider to be unfavorable or in the event that the board of directors determines to extend the rights offering. You should not exercise your subscription rights unless you are certain that you wish to purchase shares at the subscription price.

Regulatory Limitations

We will not be required to issue to you shares of our common stock pursuant to the rights offering if, in our opinion, you are required to obtain prior clearance or approval, or otherwise comply with regulatory requirements from any state or federal regulatory authority to own or control such shares and if, at the time the rights offering expires, you have not obtained such clearance or approval or complied with such regulatory requirements. For example, if as a result of exercising your subscription rights, you would hold shares of our common stock, including shares you currently own, with a value in excess of $70.9 million, you and we may be required to make a filing under the HSR Act and wait for any applicable waiting periods to expire or terminate before you may complete your purchase of shares.

Rule 144

The common stock sold in the rights offering will be freely transferable without restrictions or further registration under the Securities Act, except for any of our shares purchased by an affiliate of the Company and for shares subsequently transferred by an affiliate. The resale limitations of Rule 144 promulgated under the Securities Act will apply to transfers of common stock by affiliates and to recipients of common stock transferred from an affiliate. The resale restrictions of Rule 144 also will apply to the transfer of subscription rights by affiliates of the Company and to recipients of subscription rights transferred from affiliates.

Fees and Expenses

We are not charging any fee or sales commission to issue subscription rights to you or to issue shares to you if you exercise your subscription rights. If you exercise your subscription rights through the record holder of your shares, you are responsible for paying any commissions, fees, taxes or other expenses your record holder may charge you. We will pay all reasonable fees charged by Continental Stock Transfer & Trust Company as the subscription agent and D.F. King & Co., Inc. as the information agent.

No Board Recommendation to Rights Holders

Our board of directors is making no recommendation regarding your exercise of your subscription rights. Rights holders who exercise subscription rights risk investment loss on new money invested. The market price for our common stock may decline to a price that is less than the subscription price and, if you purchase shares of common stock at the subscription price, you may not be able to sell the shares in the future at the same price or a higher price. You should not view the commitments of the Investors as a recommendation or other indication, by

 

55


Table of Contents

Messrs. Ross or Mitchell or by any other member of our board of directors, that the exercise or sale of your subscription rights is in your best interests. You should make your decision based on your assessment of our business and financial condition, our prospects for the future and the terms of the rights offering. Please see “Risk Factors” for a discussion of some of the risks involved in investing in our common stock.

 

56


Table of Contents

THE INVESTMENT AGREEMENTS; EFFECTS OF THE TRANSACTIONS

The Investment Agreements

The Investment Agreements. We have entered into a separate Investment Agreement, each dated as of December 17, 2013, with each of WL Ross and Hamblin Watsa pursuant to which, subject to the terms and conditions of its respective Investment Agreement, each of them has severally agreed to subscribe for and purchase from us, in a private placement, its pro rata portion of shares under the basic subscription right and all Unsubscribed Shares under the over-subscription privilege, subject to availability and the pro rata allocation among rights holders who have elected to exercise their over-subscription privilege; provided, that each of the Investors shall not be obligated to purchase an aggregate number of shares that would exceed the lesser of (i) 100% of the Unsubscribed Shares, or (ii) an amount of Unsubscribed Shares, which when taken together with the number of shares issued pursuant to the Investor’s basic subscription right, equals 50% of the total shares offered in the rights offering. In addition, for clarity, when calculating the number of shares of our common stock owned by each Investor as of 5:00 p.m., New York City time, on the record date for purposes of the over-subscription privilege pro rata allocation, the shares of our common stock owned as of 5:00 p.m., New York City time, on the record date by any fund or other entity that is directly or indirectly controlled by the same manager or other person as such Investor will be included. The obligations of WL Ross and Hamblin Watsa are several and not joint.

The purchase of any shares by the Investors pursuant to the Investment Agreements will be (i) effected in a transaction exempt from the registration requirements of the Securities Act, and, accordingly, will not be registered pursuant to the registration statement of which this prospectus forms a part and (ii) subject to the satisfaction of the closing conditions described below.

Conditions to Investor’s Obligations under the Investment Agreements . The closing of the transactions contemplated by each Investment Agreement is subject to satisfaction or (to the extent permitted) waiver of the following conditions: (i) the effectiveness of the registration statement for the rights offering; (ii) the rights offering having been conducted by the Company in accordance with the Investment Agreements in all material respects; (iii) the absence of any legal impediment to the implementation of the rights offering, the issuance and sale of shares under the Investment Agreement or the consummation of the transactions contemplated by the Investment Agreements; (iv) the accuracy of the Company’s representations and warranties; (v) the Company’s performance and compliance in all material respects with covenants and agreements, in each case as required to be performed or complied with on or prior to closing; (vi) the approval of shares issued in the rights offering for listing on the NYSE; (vii) the expiration or termination of any waiting period under the HSR Act; (viii) the absence of certain breaches or defaults under the other Investment Agreement that are the basis for a party to terminate or refuse to close the transactions contemplated under the other Investment Agreement; (ix) the absence of any Material Adverse Effect (as defined in the applicable Investment Agreement) since November 22, 2013; (x) we have not, and are not reasonably expected to, recognize any impairments to our assets which in the aggregate equal or exceed $150 million (excluding the $10,707,000 impairment previously taken by us for the quarter ended March 31, 2013); (xi) other customary conditions.

Conditions to the Company’s Obligations under the Investment Agreements. The closing of the transactions contemplated by each Investment Agreement is subject to the satisfaction or (to the extent permitted) waiver of the following conditions: (i) the effectiveness of the registration statement relating to the rights offering; (ii) the absence of any legal impediment to the implementation of the rights offering, the issuance and sale of shares under the Investment Agreements or the consummation of the transactions contemplated by the Investment Agreements; (iii) the accuracy of the Investor’s representations and warranties; (iv) the Investor’s performance and compliance in all material respects with all covenants and agreements, in each case as required to be performed or complied with on or prior to closing; (v) the approval of the shares issued in the rights offering for listing on the NYSE; and (vi) the expiration or termination of any waiting period under the HSR Act.

 

57


Table of Contents

HSR Compliance . We and Fairfax each expect to file a notification form under the HSR Act on or about December 17, 2013 in connection with Hamblin Watsa’s commitment to purchase shares of our common stock. Both parties intend to request early termination of the 30-day waiting period under the HSR Act, but we cannot assure you that early termination will be granted. If early termination is not granted, the waiting period will not expire until 11:59 p.m. on the 30th calendar day after the date that the filings are submitted, which is estimated to be on or about January 16, 2014. Hamblin Watsa may not complete the purchase of shares of our common stock before the expiration or early termination of the waiting period to the extent that such purchases would result in Fairfax holding shares of our common stock with a value in excess of the size of the transaction threshold under the HSR Act, which is currently $70.9 million.

Termination.  Each Investment Agreement may be terminated at any time prior to the closing of the transactions contemplated by the applicable Investment Agreement as follows:

 

    by mutual written consent of the Company and the Investor;

 

    by the Investor if there shall have occurred any Material Adverse Effect (as defined in the Investment Agreement) since November 22, 2013;

 

    by the Investor if (i) the registration statement of which this prospectus forms a part is not filed with the SEC prior to the close of business on the date of the Investment Agreement, (ii) the rights offering shall not have been consummated by March 31, 2014 or (iii) the issuance and sale of the shares pursuant to the Investor’s basic subscription right and, if applicable, the Investor’s over-subscription privilege, shall not have been consummated (x) prior to April 7, 2014 or (y) if earlier, on or prior to the sixth (6th) business day after January 9, 2014, subject to extension as set forth in the Investment Agreement;

 

    by the Investor if there shall have occurred certain breaches or defaults under the other Investment Agreement by any party thereto, on the basis of which any party thereto has terminated or refused to close the transactions under the other Investment Agreement;

 

    by either party, if any legal impediment arises that prohibits the implementation of the rights offering, the issuance and sale of the shares pursuant to the Investor’s basic subscription right and the Investor’s over-subscription privilege under the Investment Agreement or the consummation of the other transactions contemplated by certain agreements, documents, and instruments relating to the rights offering, and such legal impediment has become final, binding and non-appealable;

 

    by either party, if there is a breach by the Investor (in the case of termination by us) or by us (in case of termination by the Investor) of any covenant or representation or warranty that would cause the failure of the satisfaction of a closing condition and is not cured within ten (10) calendar days following delivery of written notice thereof or (ii) is not capable of cure on or prior to March 31, 2014;

 

    by either party upon the occurrence of any event that results in a failure to satisfy any of such party’s closing conditions, which failure (i) is not cured within ten (10) calendar days following delivery of written notice thereof or (ii) is not capable of cure on or prior to March 31, 2014; or

 

    by either party if (i) the SEC shall have entered a stop order with respect to the registration statement of which this prospectus forms a part or (ii) there shall have occurred a suspension of trading in shares of our common stock on the NYSE, subject to certain exceptions.

Fees.  We will not pay WL Ross or Hamblin Watsa a fee nor reimburse their expenses in connection with the rights offering.

Indemnification.  We have agreed to indemnify each Investor, its respective affiliates and their respective officers, directors, members, partners, employees, agents, and controlling persons from and against any and all losses arising out of or related to circumstances existing on or prior to the closing date of the applicable Investment Agreement to which an indemnified party becomes subject arising out of or in connection

 

58


Table of Contents

with a claim with respect to the rights offering or the transactions contemplated by the applicable Investment Agreement and to reimburse the indemnified party for any reasonable legal or other out-of-pocket expenses incurred in connection with investigating, responding to or defending any of the foregoing (other than with respect to losses due to statements or omissions made in reliance on information furnished to us in writing by the applicable Investor for use herein and losses attributable to the gross negligence, bad faith or willful misconduct of the indemnified party or to any breach by the indemnified party of the applicable Investment Agreement).

The Registration Rights Agreement

At the closing of the transactions contemplated by the Investment Agreements, each of WL Ross and Hamblin Watsa will execute a joinder agreement to the First Amended and Restated Registration Rights Agreement, dated December 30, 2005, by and among EXCO Holdings Inc. (our predecessor by merger) and the Initial Holders (as defined therein), or the Registration Rights Agreement, whereby shares owned by WL Ross and Hamblin Watsa, including, without limitation, those acquired by WL Ross and Hamblin Watsa pursuant to their respective Investment Agreements, will become subject to the Registration Rights Agreement.

Registrations.  Pursuant to the Registration Rights Agreement, all holders of unregistered shares of our common stock subject to the Registration Rights Agreement can require us to register their shares in certain circumstances. In addition, if we file a registration statement registering other shares of our common stock, the holders of shares subject to the Registration Rights Agreement can require that we include their shares in such registration statement, subject to certain exceptions.

Postponements and limitations.  Under certain circumstances and subject to certain limitations, we may postpone a registration if our board of directors determines in good faith that effecting such a registration or continuing the disposition of common stock would have a material adverse effect on us, or would not be in our best interests. Furthermore, the underwriters of any underwritten offering may, subject to certain limitations, limit the number of shares included in the registration.

Amendments and waivers.  The provisions of the Registration Rights Agreement may not be amended, terminated or waived without the written consent of us, the holders of a majority of the Registrable Securities (as defined therein) then held by Investor Holders (as defined in the Registration Rights Agreement) and the holders of a majority of the Registrable Securities then held by the Management Holders (as defined in the Registration Rights Agreement).

Holdback arrangements.  Upon entering into the Registration Rights Agreement, each holder of Registrable Securities (as defined in the Registration Rights Agreement) agreed that, subject to the terms of the Registration Rights Agreement, at the request of the sole or lead managing underwriter in an underwritten offering, it would not make any short sale of, loan, grant any option for the purchase of or effect any public sale or distribution, including a sale pursuant to Rule 144 under the Securities Act, of any Registrable Securities during the five days prior to, and the time period (up to 90 days) requested by the underwriter following, certain underwritten offerings.

Indemnification.  We have agreed to indemnify holders of shares subject to the Registration Rights Agreement against certain liabilities under the Securities Act in respect of any resale registration.

Shares of Our Common Stock Outstanding After the Rights Offering and the Transactions Contemplated by the Investment Agreements

We expect that approximately 218,298,938 shares of our common stock will be issued and outstanding as of the record date. We expect to issue an additional 54,574,734 shares of our common stock in connection with the closing of the rights offering and the transactions contemplated by the Investment Agreements, for a total of 272,873,672 shares of common stock issued and outstanding. This assumes that, during the rights offering, we issue no other shares of our common stock and that no options for our common stock are exercised.

 

59


Table of Contents

Dilutive Effects of the Rights Offering and the Transactions Contemplated by the Investment Agreements

The ownership interests and voting interests of the existing shareholders who do not timely and fully exercise their basic subscription rights will be diluted. See “Questions and Answers Relating to the Rights Offering.”

As of December 5, 2013, WL Ross and Fairfax, directly or through certain affiliates, beneficially owned approximately 14.4% and 4.95%, respectively, of our common stock. Assuming the conditions to the consummation of the transactions contemplated by the Investment Agreements are satisfied, we will issue a minimum of 7,876,019 shares to WL Ross and 2,703,050 shares to Fairfax (including Hamblin Watsa) and up to a maximum of 27,287,367 shares to WL Ross and 27,287,367 to Fairfax (including Hamblin Watsa).

Assuming the maximum amount of shares is issued to each of WL Ross and Fairfax (including Hamblin Watsa), WL Ross’s beneficial ownership would increase from 14.4% to approximately 21.5%, and Fairfax’s (including Hamblin Watsa) beneficial ownership would increase from 4.95% to approximately 14.0%.

Assuming the rights offering is fully subscribed, the beneficial ownership of WL Ross and Fairfax (including Hamblin Watsa) would remain the same as prior to the rights offering.

Material Relationships

Wilbur L. Ross, Jr., the chairman and chief executive officer of WL Ross & Co. LLC, has served as a director of EXCO since March 2012. As of December 5, 2013, WL Ross, directly or through certain affiliates, beneficially owned approximately 14.4% of our common stock. Samuel A. Mitchell, a managing director of Hamblin Watsa, has served as a director of EXCO since June 2013. As of December 5, 2013, Fairfax, directly or through certain affiliates, beneficially owned approximately 4.95% of our common stock.

 

60


Table of Contents

MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS

General

This summary is based upon provisions of the Code, applicable U.S. Treasury Regulations, administrative rulings, judicial authorities and other applicable existing U.S. federal income tax authorities, all of which are subject to change or differing interpretations, possibly with retroactive effect, which could result in U.S. federal income tax consequences different from those discussed below.

This summary does not provide a complete analysis of all potential tax considerations. This summary is only applicable to U.S. holders (as defined below) of shares of our common stock who acquire the subscription rights pursuant to the terms of the rights offering, have held the common stock and will hold the subscription rights and any shares of common stock acquired upon the exercise of subscription rights, as capital assets (generally, property held for investment) within the meaning of Section 1221 of the Code. This summary does not deal with all tax consequences that may be relevant to holders in light of their personal circumstances or particular situations, such as holders who may be subject to special tax treatment under the Code, including (without limitation) partnerships, dealers in securities or currencies, financial institutions, insurance companies, regulated investment companies, real estate investment trusts, tax-exempt entities, traders in securities that elect to use a mark-to-market method of accounting for their securities, persons holding subscription rights or common stock as part of a hedging, integrated or conversion transaction or a straddle, persons deemed to sell subscription rights or common stock under the constructive sale provisions of the Code, persons whose “functional currency” is not the U.S. dollar, investors in pass-through entities, and holders who acquired our common stock pursuant to the exercise of compensatory stock options or otherwise as compensation. This summary does not deal with any federal non-income, state, local or foreign tax consequences, estate or gift tax consequences, or alternative minimum tax consequences.

As used herein, the term “U.S. holder” means a beneficial owner of shares of our common stock that is, for U.S. federal income tax purposes: (1) an individual who is a citizen or resident of the United States; (2) a corporation or other entity treated as a corporation for U.S. federal income tax purposes, created or organized in or under the laws of the United States, any state thereof or the District of Columbia; (3) an estate the income of which is subject to U.S. federal income taxation regardless of its source; or (4) a trust, if it (i) is subject to the primary supervision of a court within the United States and one or more U.S. persons have the authority to control all substantial decisions of the trust, or (ii) has a valid election in effect under applicable U.S. Treasury Regulations to be treated as a U.S. person.

If a partnership (or entity or arrangement treated as a partnership for U.S. federal income tax purposes) holds shares of our common stock, the tax treatment of a partner in the partnership will depend upon the status of the partner and the activities of the partnership. Partnerships and their partners should consult their tax advisors concerning the tax treatment of the receipt and exercise of subscription rights in the rights offering and the ownership and disposition of shares of our common stock received on exercise of subscription rights.

Distribution of Subscription Rights . If you hold shares of our common stock on the record date for the rights offering, you should not recognize taxable income for U.S. federal income tax purposes upon receipt of the subscription rights.

Tax Basis and Holding Period of the Subscription Rights . If the fair market value of the subscription rights you receive is less than 15% of the fair market value of your common stock on the date you receive your subscription rights, your subscription rights will be allocated a zero tax basis for U.S. federal income tax purposes unless you elect to allocate tax basis between your existing common stock and your subscription rights in proportion to the relative fair market values of the existing common stock and your subscription rights determined on the date of receipt of your subscription rights. If you choose to allocate tax basis between your existing common stock and your subscription rights, you must make this election on a statement included with your tax return for the taxable year in which you receive your subscription rights. Such an election is irrevocable.

 

61


Table of Contents

If the fair market value of your subscription rights is 15% or more of the fair market value of your existing common stock on the date you receive your subscription rights, then you must allocate your tax basis in your existing common stock between your existing common stock and your subscription rights in proportion to the relative fair market values determined on the date you receive your subscription rights. The fair market value of the subscription rights on the date the subscription rights will be distributed is uncertain, and we have not obtained, and do not intend to obtain, an appraisal of the fair market value of the subscription rights on that date. In determining the fair market value of the subscription rights, you should consider all relevant facts and circumstances, including the trading price of the subscription rights (if a market for the subscription rights develops), any difference between the subscription price of the subscription rights and the trading price of our common stock on the date that the subscription rights are distributed, the length of the period during which the subscription rights may be exercised and the fact that the subscription rights are transferable.

Your holding period for the subscription rights that you receive will include your holding period for the common stock with respect to which the subscription rights were distributed.

Sale or Other Disposition of the Subscription Rights. You will recognize gain or loss on the sale or other taxable disposition of a subscription right in an amount equal to the difference, if any, between the amount of cash plus the fair market value of any property received and your tax basis, if any, in the right sold or otherwise disposed of. Any such gain or loss generally will be capital gain or loss, and will be short-term or long-term depending on whether the right is treated as having been held for more than one year. Long-term capital gains of non-corporate U.S. holders are generally subject to taxation at reduced rates. Your ability to use any capital loss is subject to certain limitations.

Lapse of the Subscription Rights . If you allow the subscription rights you receive to expire unexercised, you will not recognize any gain or loss on the expiration of your subscription rights, and you will re-allocate any portion of the tax basis in your existing shares of common stock previously allocated to the subscription rights that have expired to the existing share of common stock.

Exercise of the Subscription Rights; Basis and Holding Period of Common Stock Acquired Upon Exercise . You will not recognize any gain or loss upon the exercise of your subscription rights. Your basis in the shares of common stock acquired through exercise of the subscription rights will be equal to the sum of the subscription price you paid to exercise the subscription rights and your tax basis in the subscription rights, if any. The holding period for the common stock acquired through exercise of the subscription rights will begin on the date you exercise your subscription rights.

Dividends on Common Stock . You will recognize income upon the receipt of any distribution on the shares of common stock you acquire upon exercise of the subscription rights to the extent attributable to our current and accumulated earnings and profits. If you are a non-corporate holder, distributions paid out of our current and accumulated earnings and profits should constitute qualified dividends and, under current law, should be taxed at a preferential rate, provided that you meet certain applicable holding period and other requirements. Any distribution in excess of our current and accumulated earnings and profits will constitute a non-taxable return of capital to the extent of your tax basis in your shares acquired upon exercise of the subscription rights, and thereafter will constitute capital gain from the sale or exchange of such shares of common stock.

Sale of Shares of Common Stock . If you sell or exchange shares of common stock acquired upon exercise of the subscription rights, you generally will recognize gain or loss on the transaction equal to the difference between the amount realized and your tax basis in the shares of common stock. Any such gain or loss generally will be capital gain or loss, and will be short-term or long-term depending on whether the right is treated as having been held for more than one year. Long-term capital gains of non-corporate U.S. holders are generally subject to taxation at reduced rates. Your ability to use any capital loss is subject to certain limitations.

 

62


Table of Contents

New Legislation Relating to Net Investment Income

Under recently enacted legislation a 3.8% tax is imposed on the “net investment income” of certain U.S. citizens and resident aliens and on the undistributed “net investment income” of certain estates and trusts. Among other items, “net investment income” generally includes dividend income and gains from the sale, exchange, redemption, retirement or other taxable disposition of a security, less certain deductions.

Information Reporting and Backup Withholding

Backup withholding tax (currently at a rate of 28%) and certain information reporting requirements may apply in the case of certain U.S. holders (not including corporations and other exempt recipients) to payments of dividends and proceeds from the sale, exchange or redemption of shares of our common stock or of subscription rights. Backup withholding applies if a holder fails to provide certain identifying information (such as a taxpayer identification number), has been notified by the IRS that it is subject to backup withholding for failing to report income in full or fails to meet certain certification requirements. Backup withholding is not an additional tax. Any amount withheld from a payment to you under the backup withholding rules will be allowed as a credit against your U.S. federal income tax liability and may entitle you to a refund, provided the required information is properly and timely submitted to the IRS. We may require you to establish your exemption from backup withholding or to make arrangements satisfactory to us with respect to the payment of backup withholding.

THE FOREGOING SUMMARY IS INCLUDED FOR GENERAL INFORMATION ONLY. ACCORDINGLY, YOU ARE URGED TO CONSULT WITH YOUR OWN TAX ADVISOR WITH RESPECT TO THE PARTICULAR FEDERAL, STATE, LOCAL AND FOREIGN TAX CONSEQUENCES APPLICABLE TO THE RECEIPT OF SUBSCRIPTION RIGHTS AND THE OWNERSHIP, EXERCISE AND DISPOSITION OF SUCH RIGHTS.

 

63


Table of Contents

PLAN OF DISTRIBUTION

As soon as practicable after the record date for the rights offering, we will distribute rights certificates with this prospectus to individuals who owned our common stock at 5:00 p.m., New York City time, on December 19, 2013. If you wish to exercise your subscription rights and purchase shares of our common stock, you should complete the rights certificate and return it with payment for the common stock to the subscription agent at the following address:

Continental Stock Transfer & Trust Company

17 Battery Place—8th Floor

New York, NY 10004

Attn: Corporate Actions Department

Telephone: (917) 262-2378

See “The Rights Offering—Subscription Agent and Information Agent.” If you have any questions or require assistance regarding the method of exercising your subscription rights or requests for additional copies of this document or the Instruction for Use of Subscription Rights Certificates, you should contact our information agent, D.F. King & Co., Inc., by calling 1-800-755-7250 toll-free or, if you are a bank or broker, at 1-212-269-5550.

We have agreed to pay the subscription agent and information agent customary fees plus certain expenses in connection with the rights offering. Other than as described herein, we are not aware of any existing agreements between any shareholder, broker, dealer, underwriter or agreement relating to the sale or distribution of the shares underlying the rights.

EXPERTS

The consolidated financial statements of EXCO Resources, Inc. and its subsidiaries as of December 31, 2012 and 2011, and for each of the years in the three-year period ended December 31, 2012, and management’s assessment of the effectiveness of internal control over financial reporting as of December 31, 2012 have been incorporated by reference in this prospectus and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.

The financial statements of the Acquired Chesapeake Oil and Natural Gas Properties for each of the years in the three-year period ended December 31, 2012 have been incorporated by reference in this prospectus and in the registration statement in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.

INDEPENDENT PETROLEUM ENGINEERS

Lee Keeling and Associates, Inc., independent petroleum engineers, Tulsa, Oklahoma, prepared the Proved Reserves estimates with respect to our non-shale properties included in our Annual Report on Form 10-K for the year ended December 31, 2012, which is incorporated by reference in this prospectus and elsewhere in the registration statement in reliance upon the authority of said firm as experts in petroleum engineering.

Netherland, Sewell & Associates, Inc., independent petroleum engineers, Dallas, Texas, prepared the Proved Reserves estimates with respect to our shale properties included in our Annual Report on Form 10-K for the year ended December 31, 2012, which is incorporated by reference in this prospectus and elsewhere in the registration statement in reliance upon the authority of said firm as experts in petroleum engineering.

Haas Petroleum Engineering Services, Inc., independent petroleum engineers, Dallas, Texas, prepared the Proved Reserves estimates with respect to our shale properties included in our Annual Report on Form 10-K for the year ended December 31, 2012, which is incorporated by reference in this prospectus and elsewhere in the registration statement in reliance upon the authority of said firm as experts in petroleum engineering.

 

64


Table of Contents

LEGAL MATTERS

Our legal counsel, Haynes and Boone, LLP, Dallas, Texas, will pass upon certain legal matters in connection with the offered securities.

INCORPORATION BY REFERENCE

The SEC allows us to “incorporate by reference” the information we have filed with it, which means that we can disclose important information to you by referring you to those documents. The information we incorporate by reference is an important part of this prospectus. We incorporate by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of this prospectus and prior to the termination of the offering (excluding any disclosures that are furnished and not filed):

 

  Our Annual Report on Form 10-K for the year ended December 31, 2012 filed with the SEC on February 21, 2013; and our Amendment No. 1 to our Annual Report on Form 10-K/A for the year ended December 31, 2012 filed with the SEC on August 30, 2013;

 

  Our Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2013, filed with the SEC on May 1, 2013; our Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2013, filed with the SEC on August 7, 2013; and our Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2013, filed with the SEC on October 30, 2013;

 

  Our Current Reports on Form 8-K filed with the SEC on February 19, 2013, February 21, 2013 (excluding Item 7.01 and Exhibit 99.1), March 6, 2013, June 12, 2013, July 8, 2013 (excluding Item 7.01, Exhibit 99.1 and Exhibit 99.2), July 16, 2013 (excluding Item 7.01 and Exhibit 99.1), August 6, 2013 (excluding Item 7.01 and Exhibit 99.1), August 23, 2013, September 4, 2013, October 15, 2013, October 22, 2013 (excluding Item 7.01 and Exhibit 99.1), November 21, 2013 (excluding Item 7.01 and Exhibit 99.1) and November 25, 2013; and our Amendment No. 1 to our Current Report on Form 8-K/A filed with the SEC on September 25, 2013;

 

  The section entitled “Description of Capital Stock—Common Stock” located in our Current Report on Form 8-K filed with the SEC on September 28, 2007.

Information contained in this prospectus modifies or supersedes, as applicable, the information contained in earlier-dated documents incorporated by reference. Information contained in later-dated documents incorporated by reference will automatically supplement, modify or supersede, as applicable, the information contained in this prospectus or in earlier-dated documents incorporated by reference.

We will furnish without charge to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, upon request in writing, by telephone or via the internet, a copy of the information that has been incorporated by reference in this prospectus (other than an exhibit to these filings, unless we have specifically incorporated that exhibit by reference in this prospectus). You should direct any requests for copies to:

EXCO Resources, Inc.

12377 Merit Drive, Suite 1700

Dallas, Texas 75251

(214) 368-2084

Attn: William L. Boeing, Vice President, General Counsel and Secretary

 

65


Table of Contents

WHERE YOU CAN FIND MORE INFORMATION

This prospectus does not contain all of the information included in the registration statement of which this prospectus forms a part and all of the exhibits and schedules thereto. For further information about EXCO, you should refer to the registration statement of which this prospectus forms a part. Summaries of agreements or other documents in this prospectus are not necessarily complete. Please refer to the exhibits to the registration statement of which this prospectus forms a part for complete copies of such documents.

We are subject to the informational requirements of the Exchange Act, and in accordance with the requirements of the Exchange Act, we file annual, quarterly and current reports, proxy statements and other information with the SEC. Our SEC filings, including the registration statement of which this prospectus forms a part, are available over the Internet at the SEC’s website at www.sec.gov. You may also read and copy any document we file with the SEC at the Public Reference Room of the SEC at 100 F Street, N.E., Washington, D.C. 20549. You may also obtain copies of the documents at prescribed rates by writing to the SEC at that address. Please call 1-800-SEC-0330 for further information on the operations of the Public Reference Room.

Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act are made available free of charge on our website at www.excoresources.com as soon as reasonably practicable after we electronically file such material with, or otherwise furnish it to, the SEC. Information on our website is not incorporated by reference in this prospectus and is not a part of this prospectus.

 

66


Table of Contents

GLOSSARY OF SELECTED OIL AND NATURAL GAS TERMS

The following are abbreviations and definitions of terms commonly used in the oil and natural gas industry and in this prospectus.

Bbl . One stock tank barrel, or 42 U.S. gallons liquid volume, used in reference to oil or other liquid hydrocarbons.

Btu . British thermal unit, which is the heat required to raise the temperature of a one pound mass of water from 58.5 to 59.5 degrees Fahrenheit.

Completion . The installation of permanent equipment for the production of oil or natural gas, or, in the case of a dry hole, the reporting to the appropriate authority that the well has been abandoned.

Deterministic method . The method of estimating reserves or resources when a single value for each parameter (from the geoscience, engineering, or economic data) in the reserves calculation is used in the reserves estimation procedure.

Development Well . A well drilled within the proved area of an oil or natural gas reservoir to the depth of a stratigraphic horizon known to be productive.

Dry hole; Dry well . A well found to be incapable of producing either oil or natural gas in sufficient quantities to justify completion as an oil or natural gas well.

Economically producible . As it relates to a resource, a resource which generates revenue that exceeds, or is reasonably expected to exceed, the costs of the operation.

Exploitation . The continuing development of a known producing formation in a previously discovered field. To maximize the ultimate recovery of oil or natural gas from the field by development wells, secondary recovery equipment or other suitable processes and technology.

Farm-out . An assignment of an interest in a drilling location and related acreage conditional upon the drilling of a well on that location.

Formation . A succession of sedimentary beds that were deposited under the same general geologic conditions.

Fracture stimulation . A stimulation treatment routinely performed involving the injection of water, sand and chemicals under pressure to stimulate hydrocarbon production in low-permeability reservoirs.

Gross acres or gross wells . The total acres or wells, as the case may be, in which a working interest is owned.

Horizontal wells . Wells which are drilled at angles greater than 70 degrees from vertical.

Mcf . One thousand cubic feet of natural gas.

Mcfe . One thousand cubic feet equivalent calculated by converting one Bbl of oil or NGLs to six Mcf of natural gas.

 

67


Table of Contents

Mmbtu . One million British thermal units.

Mmcf . One million cubic feet of natural gas.

Mmcfe/d . One million cubic feet of natural gas equivalent per day.

Mmcfe . One million cubic feet equivalent calculated by converting one Bbl of oil or NGLs to six Mcf of natural gas. This ratio of Bbl to Mcf is commonly used in the oil and natural gas industry and represents the approximate energy equivalent of natural gas to oil or NGLs, and does not represent the sales price equivalency of natural gas to oil or NGLs. Currently the sales price of a Bbl or NGL is significantly higher than the sales price of six Mcf of natural gas.

Net acres or net wells . Exists when the sum of the fractional working interests owned in gross acres or gross wells equals one.

NYMEX . New York Mercantile Exchange.

NGLs . The combination of ethane, propane, butane and natural gasolines that when removed from natural gas become liquid under various levels of higher pressure and lower temperature.

Play . A term applied to a portion of the exploration and production cycle following the identification by geologists and geophysicists of areas with potential oil and natural gas reserves.

Present value of estimated future net revenues or PV-10 . The present value of estimated future net revenues is an estimate of future net revenues from a property at the date indicated, without giving effect to derivative financial instrument activities, after deducting production and ad valorem taxes, future capital costs, abandonment costs and operating expenses, but before deducting future income taxes. The future net revenues have been discounted at an annual rate of 10% to determine their “present value.” The present value is shown to indicate the effect of time on the value of the net revenue stream and should not be construed as being the fair market value of the properties. Estimates have been made using constant oil and natural gas prices and operating and capital costs at the date indicated, at its acquisition date, or as otherwise indicated.

Probabilistic method . The method of estimation of reserves or resources when the full range of values that could reasonably occur for each unknown parameter (from the geoscience and engineering data) is used to generate a full range of possible outcomes and their associated probabilities of occurrence.

Productive well . A productive well is a well that is not a dry well.

Proved Reserves . Those quantities of oil and natural gas, which, by analysis of geoscience and engineering data, can be estimated with reasonable certainty to be economically producible, from a given date forward, from known reservoirs, and under existing economic conditions, operating methods, and government regulations, prior to the time at which contracts providing the right to operate expire, unless evidence indicates that renewal is reasonably certain, regardless of whether deterministic or probabilistic methods are used for the estimation. The project to extract the hydrocarbons must have commenced or the operator must be reasonably certain that it will commence the project within a reasonable time.

The area of the reservoir considered as proved includes: (i) the area identified by drilling and limited by fluid contacts, if any, and (ii) adjacent undrilled portions of the reservoir that can, with reasonable certainty, be judged to be continuous with it and to contain economically producible oil or gas on the basis of available geoscience and engineering data.

 

68


Table of Contents

In the absence of data on fluid contacts, proved quantities in a reservoir are limited by the lowest known hydrocarbons (LKH) as seen in a well penetration unless geoscience, engineering, or performance data and reliable technology establishes a lower contact with reasonable certainty. Where direct observation from well penetrations has defined a highest known oil (HKO) elevation and the potential exists for an associated gas cap, proved oil reserves may be assigned in the structurally higher portions of the reservoir only if geoscience, engineering, or performance data and reliable technology establish the higher contact with reasonable certainty.

Reserves which can be produced economically through application of improved recovery techniques (including, but not limited to, fluid injection) are included in the proved classification when: (i) successful testing by a pilot project in an area of the reservoir with properties no more favorable than in the reservoir as a whole, the operation of an installed program in the reservoir or an analogous reservoir, or other evidence using reliable technology establishes the reasonable certainty of the engineering analysis on which the project or program was based; and (ii) the project has been approved for development by all necessary parties and entities, including governmental entities.

Existing economic conditions include prices and costs at which economic producibility from a reservoir is to be determined. The price shall be the average price during the 12-month period prior to the ending date of the period covered by the report, determined as an unweighted arithmetic average of the first-day-of-the-month price for each month within such period, unless prices are defined by contractual arrangements, excluding escalations based upon future conditions.

Reasonable certainty . If deterministic methods are used to classify a reserve as proved, reasonable certainty means a high degree of confidence that the quantities will be recovered. If probabilistic methods are used, there should be at least a 90% probability that the quantities actually recovered will equal or exceed the estimate. A high degree of confidence exists if the quantity is much more likely to be achieved than not, and, as changes due to increased availability of geoscience (geological, geophysical, and geochemical), engineering, and economic data are made to estimated ultimate recovery (EUR) with time, reasonably certain EUR is much more likely to increase or remain constant than to decrease.

Reservoir . A porous and permeable underground formation containing a natural accumulation of producible oil or natural gas that is confined by impermeable rock or water barriers and is individual and separate from other reservoirs.

Resources . All quantities of petroleum naturally occurring on or within the earth’s crust, discovered and undiscovered (recoverable and unrecoverable), plus those quantities already produced. It also includes all types of petroleum whether currently considered “conventional” or “unconventional.”

Shale . Fine-grained sedimentary rock composed mostly of consolidated clay or mud. Shale is the most frequently occurring sedimentary rock.

Shut in well . A producing well that has been closed down temporarily for, among other things, economics, cleaning out, building up pressure, lack of a market or lack of equipment.

Spud . To start the well drilling process.

Standardized Measure of discounted future net cash flows or the Standardized Measure . Under the Standardized Measure, future cash flows are estimated by applying the simple average spot prices for the trailing twelve month period using the first day of each month beginning on January 1 and ending on December 1 of each respective year, adjusted for price differentials, to the estimated future production of year-end Proved Reserves. Future cash inflows are reduced by estimated future production and development costs based on period-end and future plugging and abandonment costs to determine pre-tax cash inflows. Future income taxes are computed by applying the statutory tax rate to the excess of pre-tax cash inflows over our tax basis in the associated properties. Future net cash inflows after income taxes are discounted using a 10% annual discount rate to arrive at the Standardized Measure.

 

69


Table of Contents

Stock tank barrel . 42 U.S. gallons liquid volume.

Undeveloped acreage . Leased acreage on which wells have not been drilled or completed to a point that would permit the production of economic quantities of oil and natural gas regardless of whether such acreage contains Proved Reserves.

Working interest . The operating interest that gives the owner the right to drill, produce and conduct activities on the property and a share of production.

 

70


Table of Contents

 

 

 

LOGO

EXCO Resources, Inc.

Up to 44,995,665 Shares of Common Stock

Issuable Upon the Exercise of Subscription Rights

at $5.00 per Share

 

 

Prospectus

 

 

December 17, 2013

 

 

 


Table of Contents

PART II

INFORMATION NOT REQUIRED IN PROSPECTUS

Item 14. Other Expenses of Issuance and Distribution.

The following table sets forth the expenses in connection with the rights offering. All of the amounts shown are estimates, except for the Securities and Exchange Commission, or SEC, registration fee.

 

SEC registration fee

   $ 28,977   

Printing and engraving expenses

     75,000

Accounting fees and expenses

     60,000

Legal fees and expenses

     550,000

Information and subscription agent fees

     40,000

Miscellaneous expenses

     10,000
  

 

 

 

Total

   $ 763,977
  

 

 

 

 

* Estimate.

Item 15. Indemnification of Directors and Officers.

EXCO Resources, Inc.

Article XIV of our Third Amended and Restated Articles of Incorporation provides that to the fullest extent permitted by Texas law, our directors will have no personal liability to us or our shareholders for any acts or omissions in the director’s performance of his or her duties as a director. Section 7.001 of the Texas Business Organizations Code, or the TBOC, permits us to limit the personal liability of directors to us or our shareholders for monetary damages for any act or omission in a director’s capacity as director, except for liability for any of the following:

(i) A breach of the director’s duty of loyalty to us or our shareholders;

(ii) An act or omission not in good faith that constitutes a breach of duty of the director to us or an act or omission that involves intentional misconduct or knowing violation of law;

(iii) A transaction from which the director received an improper benefit, regardless of whether the benefit resulted from an action taken within the scope of the director’s duties; or

(iv) An act or omission for which the liability of a director is expressly provided by an applicable statute.

Article XIV further provides that if Texas law is amended to authorize further elimination of the personal liability of directors for or with respect to any acts or omissions in the performance of their duties as directors, then the liability of a director shall be eliminated to the fullest extent permitted by Texas law, as so amended. Any repeal or modification of Article XIV by our shareholders will not adversely affect any right or protection of a director existing immediately prior to such repeal or modification.

Article XIII of our Third Amended and Restated Articles of Incorporation and Article VI of our bylaws provide that we must indemnify our directors and officers to the fullest extent permitted by Texas law. Our bylaws further provide that we must pay or reimburse reasonable expenses incurred by one of our directors or officers who was, is or is threatened to be made a named defendant or respondent in a proceeding to the maximum extent permitted under Texas law.

 

II-1


Table of Contents

Under Sections 8.101, 8.102 and 8.103 of the TBOC, subject to the procedures and limitations stated therein, we may indemnify a director who was, is or is threatened to be made a respondent in a proceeding against a judgment and reasonable expenses actually incurred by the person in connection with the proceeding if it is determined that the person seeking indemnification:

 

  (ii) acted in good faith;

 

  (ii) reasonably believed that his or her conduct was in or was not opposed to our best interests; and

 

  (iii) in the case of a criminal proceeding, did not have a reasonable cause to believe his or her conduct was unlawful.

Under Section 8.105 of the TBOC, we may indemnify an officer as provided by our governing documents, by action of our board of directors, by action of our shareholders, by contract or by common law.

We are required by Sections 8.051 and 8.105 of the TBOC to indemnify a director or officer against reasonable expenses actually incurred by the director or officer in connection with a proceeding in which the director or officer is a respondent because the director or officer is or was in that position if the director or officer has been wholly successful, on the merits or otherwise, in the defense of the proceeding.

The TBOC prohibits us from indemnifying a director in respect of a proceeding in which the director is found liable to us or is found liable because a personal benefit was improperly received by him or her, other than for reasonable expenses actually incurred by him or her in connection with the proceeding, not including a judgment, penalty, fine or tax. The TBOC prohibits us entirely from indemnifying a director in respect of any such proceeding in which the director is found liable for willful or intentional misconduct in the performance of his or her duties to us, breach of the duty of loyalty to us or an act or omission not committed in good faith that constitutes a breach of a duty owed by the director to us.

Under Sections 8.052 and 8.105 of the TBOC, a court may order us to indemnify a director or officer if the court determines that the director or officer is fairly and reasonably entitled to indemnification in view of all the relevant circumstances. If, however, the director or officer is found liable to us or is found liable on the basis that a personal benefit was improperly received by him or her, the indemnification will be limited to reasonable expenses actually incurred by him or her in connection with the proceeding.

Insurance

We maintain insurance for our officers and directors against certain liabilities, including liabilities under the Securities Act of 1933, as amended, or the Securities Act, and the Securities Exchange Act of 1934, as amended, or the Exchange Act, under insurance policies, the premiums of which we pay. The effect of these policies is to indemnify any of our officers and directors against expenses, judgments, attorney’s fees and other amounts paid in settlements incurred by an officer or director upon a determination that such person acted in good faith.

In addition, we have entered into indemnification agreements with each of Mark F. Mulhern, our executive vice president, chief financial officer and interim chief accounting officer and a former director, and Vincent J. Cebula, a former director, pursuant to which we have agreed to indemnify them to the fullest extent permitted by the laws of the State of Texas and advance certain expenses as described therein. We entered into the indemnification agreements with Messrs. Mulhern and Cebula in consideration of their agreement to serve on a special committee of the board of directors in connection with a proposal submitted in 2010 by Douglas Miller, our former chairman and chief executive officer, to acquire all of the outstanding shares of our common stock.

Item 16. Exhibits.

A list of exhibits filed herewith is contained in the Exhibit Index that immediately precedes such exhibits and is incorporated by reference herein.

 

II-2


Table of Contents

Item 17. Undertakings.

 

  (a) The undersigned registrant hereby undertakes:

 

  (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement,

 

  (i) To include any prospectus required by Section 10(a)(3) of the Securities Act;

 

  (ii) To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;

 

  (iii) To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

provided, however, that the undertakings set forth in paragraphs (a)(1)(i), (a)(1)(ii) and (a)(1)(iii) above do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

 

  (2) That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

  (3) To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

  (4) That, for the purpose of determining liability under the Securities Act to any purchaser:

 

  (i) Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

 

  (ii)

Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a

 

II-3


Table of Contents
  purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.

 

  (5) That, for the purpose of determining liability of the registrant under the Securities Act to any purchaser in the initial distribution of the securities, in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

  (i) Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

 

  (ii) Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

 

  (iii) The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

 

  (iv) Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

 

  (b) The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

  (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

 

II-4


Table of Contents

Signatures

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Dallas, State of Texas, on December 17, 2013.

 

EXCO RESOURCES, INC.
By:          

/s/ Harold L. Hickey

  Name:       Harold L. Hickey
  Title:   President and Chief Operating Officer

Power of Attorney

Each person whose signature appears below constitutes and appoints Mark F. Mulhern and William L. Boeing, severally, each with full power to act alone and without the others, his true and lawful attorney-in-fact, with full power of substitution, and with the authority to execute in the name of each such person, any and all amendments (including without limitation, post-effective amendments) to this registration statement, to sign any and all additional registration statements relating to the same offering of securities as this registration statement that are filed pursuant to Rule 462(b) of the Securities Act, and to file such registration statements with the SEC, together with any exhibits thereto and other documents therewith, necessary or advisable to enable the registrant to comply with the Securities Act, and any rules, regulations and requirements of the SEC in respect thereof, which amendments may make such other changes in the registration statement as the aforesaid attorney-in-fact executing the same deems appropriate.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

/s/ Harold L. Hickey

Harold L. Hickey

 

President and Chief Operating Officer

(Principal Executive Officer)

  December 17, 2013

/s/ Mark F. Mulhern

Mark F. Mulhern

 

Executive Vice President, Chief Financial Officer and

Interim Chief Accounting Officer

(Principal Financial Officer and Principal Accounting

Officer)

 

December 17, 2013

/s/ Jeffrey D. Benjamin

Jeffrey D. Benjamin

  Chairman of the Board   December 17, 2013

/s/ Earl E. Ellis

Earl E. Ellis

  Director   December 17, 2013

/s/ B. James Ford

B. James Ford

  Director   December 17, 2013

/s/ Samuel A. Mitchell

Samuel A. Mitchell

  Director   December 17, 2013

/s/ Boone Pickens

Boone Pickens

  Director   December 17, 2013


Table of Contents

Signature

 

Title

 

Date

/s/ Wilbur L. Ross, Jr.

Wilbur L. Ross, Jr.

  Director   December 17, 2013

/s/ Jeffrey S. Serota

Jeffrey S. Serota

  Director   December 17, 2013

/s/ Robert L. Stillwell

Robert L. Stillwell

  Director   December 17, 2013


Table of Contents

EXHIBIT INDEX

 

Exhibit No.

 

Exhibit Description

    4.1   Third Amended and Restated Articles of Incorporation of EXCO Resources, Inc., filed as Exhibit 3.1 to EXCO’s Current Report on Form 8-K (File No. 001-32743), dated February 8, 2006 and filed on February 14, 2006 and incorporated by reference herein.
    4.2   Articles of Amendment to Third Amended and Restated Articles of Incorporation of EXCO Resources, Inc., filed as Exhibit 10.1 to EXCO’s Current Report on Form 8-K (File No. 001-32743), dated August 30, 2007 and filed on September 5, 2007 and incorporated by reference herein.
    4.3   Second Amended and Restated Bylaws of EXCO Resources, Inc., filed as Exhibit 3.1 to EXCO’s Current Report on Form 8-K, dated March 4, 2009 and filed on March 6, 2009 and incorporated by reference herein.
    4.4   Statement of Designation of Series A-1 7.0% Cumulative Convertible Perpetual Preferred Stock of EXCO Resources, Inc., filed as Exhibit 3.1 to EXCO’s Current Report on Form 8-K (File No. 001-32743), dated March 28, 2007 and filed on April 2, 2007 and incorporated by reference herein.
    4.5   Statement of Designation of Series A-2 7.0% Cumulative Convertible Perpetual Preferred Stock of EXCO Resources, Inc., filed as Exhibit 3.2 to EXCO’s Current Report on Form 8-K (File No. 001-32743), dated March 28, 2007 and filed on April 2, 2007 and incorporated by reference herein.
    4.6   Statement of Designation of Series B 7.0% Cumulative Convertible Perpetual Preferred Stock of EXCO Resources, Inc., filed as Exhibit 3.3 to EXCO’s Current Report on Form 8-K (File No. 001-32743), dated March 28, 2007 and filed on April 2, 2007 and incorporated by reference herein.
    4.7   Statement of Designation of Series C 7.0% Cumulative Convertible Perpetual Preferred Stock of EXCO Resources, Inc., filed as Exhibit 3.4 to EXCO’s Current Report on Form 8-K (File No. 001-32743), dated March 28, 2007 and filed on April 2, 2007 and incorporated by reference herein.
    4.8   Statement of Designation of Series A-1 Hybrid Preferred Stock of EXCO Resources, Inc., filed as Exhibit 3.5 to EXCO’s Current Report on Form 8-K (File No. 001-32743), dated March 28, 2007 and filed on April 2, 2007 and incorporated by reference herein.
    4.9   Statement of Designation of Series A-2 Hybrid Preferred Stock of EXCO Resources, Inc., filed as Exhibit 3.6 to EXCO’s Current Report on Form 8-K (File No. 001-32743), dated March 28, 2007 and filed on April 2, 2007 and incorporated by reference herein.
    4.10   Statement of Designation of Series A Junior Participating Preferred Stock of EXCO Resources, Inc., filed as an Exhibit to EXCO’s Current Report on Form 8-K, dated January 12, 2011 and filed on January 13, 2011 and incorporated by reference herein.
  *4.11   Specimen Common Stock Certificate.
  *4.12   Form of Transferable Subscription Rights Certificate.
  *4.13   Investment Agreement, dated December 17, 2013, by and among WLR Recovery Fund IV XCO AIV I, L.P., WLR Recovery Fund IV XCO AIV II, L.P., WLR Recovery Fund IV XCO AIV III, L.P., WLR Select Co-Investment XCO AIV, L.P., WLR/GS Master Co-Investment XCO AIV, L.P., WLR IV Parallel ESC, L.P. and EXCO Resources, Inc.
  *4.14   Investment Agreement, dated December 17, 2013, by and between Hamblin Watsa Investment Counsel Ltd., as representative of several investors, and EXCO Resources, Inc.


Table of Contents

Exhibit No.

 

Exhibit Description

    4.15   Indenture, dated September 15, 2010, by and between EXCO Resources, Inc. and Wilmington Trust Company, as trustee, filed as Exhibit 4.1 to EXCO’s Current Report on Form 8-K, dated September 10, 2010 and filed on September 15, 2010 and incorporated by reference herein.
    4.16   First Supplemental Indenture, dated September 15, 2010, by and among EXCO Resources, Inc., certain of its subsidiaries and Wilmington Trust Company, as trustee, including the form of 7.500% Senior Notes due 2018, filed as Exhibit 4.2 to EXCO’s Current Report on Form 8-K, dated September 10, 2010 and filed on September 15, 2010 and incorporated by reference herein.
    4.17   First Amended and Restated Registration Rights Agreement, effective January 5, 2006, by and among EXCO Holdings Inc. and the Initial Holders (as defined therein), filed as Exhibit 10.47 to EXCO’s Amendment No. 1 to its Registration Statement on Form S-1 (File No. 333-129935), filed on January 6, 2006 and incorporated by reference herein.
  *5.1   Opinion of Haynes and Boone, LLP.
  *8.1   Opinion of Haynes and Boone, LLP as to certain tax matters.
*23.1   Consent of KPMG LLP.
*23.2   Consent of KPMG LLP.
*23.3   Consent of Lee Keeling and Associates, Inc.
*23.4   Consent of Netherland, Sewell & Associates, Inc.
*23.5   Consent of Haas Petroleum Engineering Services, Inc.
*23.6   Consent of Haynes and Boone, LLP (included in its opinions filed as Exhibit 5.1 and Exhibit 8.1).
*24.1   Powers of Attorney (included on the signature page hereto).
*99.1   Form of Instructions for Use of EXCO Resources, Inc. Subscription Rights Certificates.
*99.2   Form of Notice of Guaranteed Delivery.
*99.3   Form of Letter to Shareholders who are Record Holders.
*99.4   Form of Letter to Nominee Holders whose Clients are Beneficial Holders.
*99.5   Form of Letter to Clients of Nominee Holders.
*99.6   Form of Beneficial Owner Election Form.
*99.7   Form of Nominee Holder Certification.
*99.8   Form of Notice of Important Tax Information.
*99.9   Form of EXCO Resources, Inc. 401(k) Plan Transferable Subscription Rights Election Form.

 

* Filed herewith.

Exhibit 4.11

 

LOGO

COMMON STOCK NUMBER XCO01226 THIS CERTIFICATE IS TRANSFERABLE IN NEW YORK, NY AND JERSEY CITY, NJ COMMON STOCK PAR VALUE $0.001 SHARES EXCO RESOURCES, INC. INCORPORATED UNDER THE LAWS OF THE STATE OF TEXAS CUSIP 269279 40 2 SEE REVERSE FOR CERTAIN DEFINITIONS THIS CERTIFIES THAT is the record holder of FULLY PAID AND NON-ASSESSABLE SHARES OF COMMON STOCK, $0.001 PAR VALUE PER SHARE, OF EXCO RESOURCES, INC. transferable on the books of the Corporation by the holder hereof, in person or by duly authorized attorney, upon surrender of this certificate properly endorsed. This certificate is not valid unless countersigned and registered by the Transfer Agent and Registrar. This certificate and the shares represented hereby are issued and shall be held subject to all of the terms, conditions, and limitations of the Articles of Incorporation and the Bylaws of the Corporation as restated or amended, or as same may be restated or amended hereafter to all of which the holder hereof by acceptance hereof agrees and assents. Witness the facsimile seal of the Corporation and the facsimile signatures of its duly authorized officers. DATED: PRESIDENT AND SECRETARY COUNTERSIGNED AND REGISTERED: Continental Stock Transfer & Trust Company Transfer Agent and Registrar By Authorized Officer


EXCO RESOURCES, INC.

A full statement of the designations, preferences, limitations, and relative rights of the shares of each class or series of stock of this Corporation, to the extent they have been fixed and determined, and the authority of the Board of Directors to fix and determine the designations, preferences. limitations, and relative rights of subsequent series, is set forth in the Articles of Incorporation on file in the office of the Secretary of State of the State of Texas. The Corporation will furnish a copy of such statement without charge to each shareholder who so requests in writing to the Corporation at its principal place of business or registered office.

The following abbreviations, when used in the inscription on the face of this certificate, shall be construed as though they were written out in full according to applicable laws or regulations:

 

TEN COM       as tenants in common    UNIF GIFT MIN ACT –                              Custodian                           
                  (Cust)                                  (Minor)
TEN ENT       as tenants by the entireties             under Uniform Gifts to Minors Act
JT TEN      

as joint tenants with right

of survivorship and not as tenants in common

     

                                             

(State)

Additional abbreviations may also be used though not in the above list.

For Value Received,                              hereby sell, assign and transfer unto

 

PLEASE INSERT SOCIAL SECURITY OR OTHER

IDENTIFYING NUMBER OF ASSIGNEE

  
                  
      

PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING ZIP CODE OF ASSIGNEE

 

      

 

    shares
of the capital stock represented by the within Certificate and do hereby irrevocably constitute and appoint                                                                 

 

    Attorney
to transfer the said stock on the books of the within named Corporation with full power of substitution in the premises.

 

Dated                                                                                                                          
   X   

 

      NOTICE: THE SIGNATURE TO THIS ASSIGNMENT MUST CORRESPOND WITH THE NAME AS WRITTEN UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT, OR ANY CHANGE WHATEVER.
   X   
     

 

BY                                                                                                                                NOTICE: THE SIGNATURE TO THIS ASSIGNMENT
SIGNATURE GUARANTEE       MUST CORRESPOND WITH THE NAME AS WRITTEN
THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANK, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS OR CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION.       UPON THE FACE OF THE CERTIFICATE IN EVERY PARTICULAR, WITHOUT ALTERATION OR ENLARGEMENT, OR ANY CHANGE WHATEVER.

KEEP THIS CERTIFICATE IN A SAFE PLACE. IF IT IS LOST, STOLEN, MUTILATED OR DESTROYED, THE CORPORATION WILL REQUIRE A BOND OF INDEMNITY AS A CONDITION TO THE ISSUANCE OF REPLACEMENT CERTIFICATE.

Exhibit 4.12

 

LOGO

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE COMPANY’S PROSPECTUS DATED DECEMBER 17, 2013 (AS IT MAY BE SUPPLEMENTED FROM TIME TO TIME, THE
“PROSPECTUS”) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS
ARE AVAILABLE UPON REQUEST FROM D.F. KING & CO., INC., THE INFORMATION AGENT.
EXCO Resources, Inc.
Incorporated under the laws of the State of Texas
CUSIP 269279 139
TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE
Evidencing Transferable Subscription Rights to Purchase Shares of Common Stock of EXCO Resources, Inc.
Subscription Price: $5.00 per Share
THE SUBSCRIPTION RIGHTS WILL EXPIRE IF NOT EXERCISED ON OR BEFORE 5:00 P.M., NEW YORK CITY TIME, ON JANUARY 9, 2014, UNLESS EXTENDED BY THE BOARD OF DIRECTORS
REGISTERED OWNER:
THIS CERTIFIES THAT the registered owner whose name is inscribed hereon is the owner of the number of transferable subscription rights (“Rights”) set forth above. Each Right entitles the holder thereof to subscribe for and purchase 0.25 of a share (rounded down to the nearest whole share with respect to any holder) of common stock, with a par value of $0.001 per share (“Common Stock”), of EXCO Resources, Inc., a Texas corporation, at a subscription price of $5.00 per share (the “Basic Subscription Right), pursuant to a rights offering (the “Rights Offering”), on the terms and subject to the conditions set forth in the Prospectus. If any shares of Common Stock available for purchase in the Rights Offering are not purchased by other holders of Rights pursuant to the exercise of their Basic Subscription Right (the “Unsubscribed Shares”), any Rights holder that timely and fully exercises its Basic Subscription Right (including in respect of Rights purchased from others) may subscribe for a number of Unsubscribed Shares pursuant to the terms and conditions of the Rights Offering, subject to availability and proration as described in the Prospectus (the “Over-Subscription Privilege”). The Rights represented by this Subscription Rights Certificate may be exercised by completing Form 1 and any other appropriate forms on the reverse side hereof and by returning the full payment of the subscription price for each share of Common Stock in accordance with the instructions set forth in Form 1 hereto, the Prospectus, and the Instructions for Use of EXCO Resources, Inc. Subscription Rights Certificates.
Transferable on the books of EXCO Resources, Inc. by the holder hereof, in person or by duly authorized attorney, upon surrender of this Certificate properly endorsed. This Subscription Rights Certificate is not valid unless countersigned by the subscription agent and registered by the registrar.
Witness the facsimile corporate seal and the facsimile signatures of the duly authorized officers of EXCO Resources, Inc.
COUNTERSIGNED AND REGISTERED:
Dated: Continental Stock Transfer & Trust Company
President Secretary Authorized Signature


LOGO

FORM 1—EXERCISE OF SUBSCRIPTION RIGHTS PLEASE PRINT ALL INFORMATION CLEARLY AND LEGIBLY (a) BASIC SUBSCRIPTION RIGHT: I exercise rights X 0.25 = (no. of rights) (ratio) (total number of new shares rounded down to nearest whole share) Therefore, I apply for X $5.00 = $ (b) OVER-SUBSCRIPTION PRIVILEGE: I have purchased all Common Shares available to me pursuant to my basic subscription right (including in respect of rights purchased from others) and am entitled to and wish to purchase additional Common Shares pursuant to my over-subscription privilege. Yes No X $5.00 = $ (c) TOTAL AMOUNT ENCLOSED: $ (sum of basic plus over-subscription amounts) To subscribe for shares pursuant to your Basic Subscription Right, please complete lines (a) and (c) and sign under Form 4 below. If you fully exercise your Basic Subscription Right (including in respect of Rights purchased from others), to subscribe for shares pursuant to your Over-Subscription Privilege, please also complete line (b) and sign under Form 4 below. To the extent you subscribe for more Shares than you are entitled under either the Basic Subscription Right or the Over-Subscription Privilege, you will be deemed to have elected to purchase the maximum number of shares for which you are entitled to subscribe under the Basic Subscription Right or Over-Subscription Privilege, as applicable. FORM 2—TRANSFER TO DESIGNATED TRANSFEREE To transfer your subscription rights to another person, complete this Form 2 and have your signature guaranteed under Form 5. For value received of the subscription rights represented by this Subscription Rights Certificate are assigned to: Print Name of Assignee Address of Assignee Address of Assignee Social Security # or Tax ID # of Assignee Signature(s) of Assignor: IMPORTANT: The signature(s) must correspond with the name(s) as printed on the reverse of this Subscription Rights Certificate in every particular, without alteration or enlargement, or any other change whatsoever. FORM 3—DELIVERY TO DIFFERENT ADDRESS If you wish for the Common Stock underlying your subscription rights, a certificate representing unexercised subscription rights or the proceeds of any sale of subscription rights to be delivered to an address different from that shown on the face of this Subscription Rights Certificate, please enter the alternate address below, sign under Form 4 and have your signature guaranteed under Form 5. FORM 4—SIGNATURE TO SUBSCRIBE: I acknowledge that I have received the Prospectus for this Rights Offering and I hereby irrevocably subscribe for the number of shares indicated above on the terms and conditions specified in the Prospectus. Signature(s) Signature(s) IMPORTANT: The signature(s) must correspond with the name(s) as printed on the reverse of this Subscription Rights Certificate in every particular, without alteration or enlargement, or any other change whatsoever. FORM 5—SIGNATURE GUARANTEE This form must be completed if you have completed any portion of Forms 2 or 3. Signature Guaranteed (Name of Bank or Firm) By: (Signature of Officer) DELIVERY OPTIONS FOR SUBSCRIPTION RIGHTS CERTIFICATE Delivery other than in the manner or to the addresses listed below will not constitute valid delivery. By mail, hand or overnight courier: Continental Stock Transfer & Trust Company 17 Battery Place—8th Floor New York, NY 10004 Attn: Corporate Actions Department Telephone: (917) 262-2378 PLEASE PRINT ALL INFORMATION CLEARLY AND LEGIBLY. (no. of new whole shares) Unsubscribed Shares pursuant to my over-subscription privilege (rounded down to the nearest whole number) Therefore, I apply for (subscription price) (subscription price) (amount enclosed) (price of new shares) METHOD OF PAYMENT (CHECK ONE): certified or personal check drawn on a U.S. bank payable to “Continental Stock Transfer & Trust Company,” as Subscription Agent. postal, telegraphic or express money order payable to “Continental Stock Transfer & Trust Company.” wire transfer of immediately available funds directly to the account maintained by “Continental Stock Transfer & Trust Company as agent for EXCO Resources Rights Offering”; at Bank Name: JP Morgan Chase Bank; ABA #: 021000021; Account #: 475-581202. Any wire transfer should clearly indicate the identity of the subscriber who is paying the subscription price by wire transfer. See “Method of Subscription—Exercise of Rights” in the Instructions for Use of EXCO Resources, Inc. Subscription Rights Certificates for further information on the method of payment. IMPORTANT: The signature(s) should be guaranteed by an eligible guarantor institution (bank, stock broker, savings & loan association or credit union) with membership in an approved signature guarantee medallion program pursuant to Rule 17Ad-15 under the Securities Exchange Act of 1934, as amended. FOR ASSISTANCE WITH RESPECT TO THE EXERCISE OR TRANSFER OF THIS. SUBSCRIPTION RIGHTS CERTIFICATE PLEASE CALL D.F. KING & CO., INC., THE INFORMATION AGENT, AT 1-800-755-7250.

Exhibit 4.13

INVESTMENT AGREEMENT

This INVESTMENT AGREEMENT (this “Agreement”), dated as of December 17, 2013, is made by and among WLR Recovery Fund IV XCO AIV I, L.P., WLR Recovery Fund IV XCO AIV II, L.P., WLR Recovery Fund IV XCO AIV III, L.P., WLR Select Co-Investment XCO AIV, L.P., WLR/GS Master Co-Investment XCO AIV, L.P., and WLR IV Parallel ESC, L.P. (each an “Investor” and, collectively, the “Investors”), on the one hand, and EXCO Resources, Inc., a Texas corporation (the “Company”), on the other hand.

WHEREAS, the Investors and the Company are parties to that certain letter agreement (the “Prior Agreement”), dated as of November 22, 2013, and desire to supersede, amend and restate the Prior Agreement in its entirety;

WHEREAS, (i) the Board of Directors of the Company (the “Board”) generally authorized a rights offering by the Company, (ii) the directors of the Board who are not affiliated with the Investors or with any other shareholder (each, an “Other Applicable Shareholder”) who is entering into an agreement (each, an “Other Applicable Agreement”) with the Company in connection with the rights offering that is substantially similar to this Agreement (the “Disinterested Directors”) unanimously approved the Prior Agreement and (iii) the Disinterested Directors delegated all authority of the Board in connection with the rights offering to a newly formed Rights Committee, comprised entirely of Disinterested Directors (the “Rights Committee”);

WHEREAS, the Rights Committee has approved the distribution, at no charge, to each holder of record of shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) as of 5:00 p.m., New York City time, on December 19, 2013 (such time and date, the “Record Date”), transferable rights (the “Rights”) to subscribe for and purchase shares of Common Stock, with one (1) Right to be distributed for each share of Common Stock (the “Rights Offering”);

WHEREAS, each holder of a Right will be entitled (the “Basic Subscription Right”) to subscribe for and purchase 0.25 of a share of Common Stock per Right at a subscription price of $5.00 per whole share of Common Stock (the “Subscription Price” and such shares of Common Stock purchasable pursuant to the Basic Subscription Right, the “Offered Shares”), with fractional shares of Common Stock resulting from the exercise of the Basic Subscription Right to be eliminated by rounding down to the nearest whole share of Common Stock with respect to the exercise by any holder;

WHEREAS, to the extent that holders of Rights do not timely and fully exercise their rights to subscribe for and purchase all of the Offered Shares available under the Basic Subscription Right, each holder of Rights that exercises in full its Basic Subscription Right will be entitled to subscribe for additional shares of Common Stock at the Subscription Price (the “Over-Subscription Privilege”), with fractional shares of Common Stock resulting from the exercise of the Over-Subscription Privilege right to be eliminated by rounding down to the nearest whole share of Common Stock with respect to the exercise of any holder;

WHEREAS, in order to facilitate the Rights Offering, the Investors and the Company entered into the Prior Agreement and wish to enter into this Agreement, pursuant to which, and upon the terms and subject to the conditions set forth herein, the Investors have agreed to subscribe for and purchase, in a private placement, shares of Common Stock pursuant to their Basic Subscription Right and Over-Subscription Privilege; and

WHEREAS, the Rights Committee has unanimously approved the Rights Offering, this Agreement and the transactions contemplated hereby.

 

1


NOW, THEREFORE, in consideration of the mutual promises, agreements, representations, warranties and covenants contained herein, it is hereby agreed that the Prior Agreement is superseded, amended and restated in its entirety by this Agreement, and each of the parties hereto hereby agrees as follows:

 

  1. Rights Offering .

 

  (a) On the terms and subject to the conditions set forth herein and in the Rights Offering Registration Statement, the Company shall distribute, at no charge, to the holders of record of each share of Common Stock as of the Record Date (each, an “Eligible Holder”) one (1) Right for each whole share of Common Stock owned by the Eligible Holder as of the close of business on the Record Date. Each Right shall entitle the Eligible Holder to purchase, at the Subscription Price per whole share, 0.25 of a share of Common Stock. Fractional shares resulting from the exercise of the Rights will be eliminated by rounding down to the nearest whole share with respect to the exercise by any holder. No Rights will be distributed or issued with respect to any treasury stock. To the extent permitted by the New York Stock Exchange, each Right will be transferable separately from the underlying shares of Common Stock in respect of which such Right was distributed. Eligible Holders (to the extent they continue to own Rights during the duration of the Rights Offering) and holders to whom Rights have been validly transferred are collectively referred to as “Holders,” each individually being a “Holder.”

 

  (b) The Company will commence the Rights Offering on the date hereof by filing the Rights Offering Registration Statement with the Commission and mailing a prospectus and related materials to record and beneficial owners of Common Stock. The Rights (including under both the Basic Subscription Rights and the Over-Subscription Privilege) may be exercised during a period (the “Rights Exercise Period”) beginning from and after the Record Date and ending at 5:00 p.m. New York City Time on January 9, 2014, subject to extension (i) solely to the extent necessary to permit the satisfaction prior to the Closing Date of the conditions set forth in Sections 7(a)(i) and (viii) and Sections 7(b)(i) and (vi) or (ii) with the prior written consent of the Investors (5:00 p.m. New York City Time on January 9, 2014, as may be so extended, the “Expiration Date”). “Business Day” has the meaning ascribed to such term in Rule 14d-1(g) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

  (c) As described in the Rights Offering Prospectus, each Holder that wishes to exercise all or a portion of its Rights under the Basic Subscription Right shall (i) during the Rights Exercise Period return a duly executed document to Continental Stock Transfer & Trust Company (the “Subscription Agent”), electing to exercise all or a portion of the Rights held by such Holder and (ii) pay in immediately available funds (or such other method as set forth in the Rights Offering Prospectus) an amount equal to the full Subscription Price for the whole number of shares of Common Stock that such Holder elects to purchase pursuant to the instructions set forth in the Rights Offering Registration Statement and related materials by the Expiration Date to an escrow account established by the Subscription Agent for the Rights Offering. On or promptly after the Closing Date, subject to the satisfaction (or, to the extent permitted, waiver) of the conditions to the Rights Offering, the Company shall issue to each Holder that validly exercised its Rights under the Basic Subscription Right the number of Offered Shares to which such Holder is entitled based on such exercise.

 

  (d)

Each Holder that timely exercises in full its Basic Subscription Right will be entitled under the Over-Subscription Privilege to subscribe (at the Subscription Price pursuant to the instructions set forth in the Rights Offering Registration Statement and related materials) for any or all additional shares of Common Stock to the extent that other Holders elect not to exercise all of their respective Rights to subscribe for and purchase all of the Offered Shares under the Basic Subscription Right. If the number of Offered Shares remaining after the exercise of Rights under the Basic

 

2


  Subscription Right (the “Remaining Offered Shares”) is not sufficient to satisfy all requests for Offered Shares under the Over-Subscription Privilege, including the election of the Investors to purchase Remaining Offered Shares pursuant to the Over-Subscription Privilege, the Holders that exercised their Rights under the Over-Subscription Privilege will be allocated such Remaining Offered Shares pro rata among such Holders exercising the Over-Subscription Privilege in proportion to the number of shares of Common Stock each such Holder (including, in the case of the Investors or any Other Applicable Shareholders, their respective Affiliated Entities) owned as of 5:00 p.m., New York City time, on the Record Date, relative to the number of shares of Common Stock owned as of 5:00 p.m., New York City time, on the Record Date by all such Holders (including, in the case of the Investors or any Other Applicable Shareholders, their respective Affiliated Entities) exercising the Over-Subscription Privilege. If such pro rata allocation would result in any Holder receiving a greater number of Remaining Offered Shares than any Holder subscribed for pursuant to the exercise of the Over-Subscription Privilege, then such Holder will be allocated only that number of Remaining Offered Shares for which such Holder subscribed for pursuant to the exercise of the Over-Subscription Privilege, and the remaining shares will be allocated among all other Holders exercising the Over-Subscription Privilege on the same pro rata allocation basis described above. Such pro rata allocation process shall be repeated until all of the Remaining Offered Shares have been allocated.

 

  2. Agreement to Purchase Investor Offered Shares and Investor Over-Subscription Shares; Fees and Expenses .

 

  (a) Upon the terms and subject to the conditions set forth in this Agreement, each of the Investors hereby agrees, severally and on behalf of and with respect to itself only, and not jointly with any other Investor, to subscribe for and purchase in a private placement (i) shares of Common Stock pursuant to the Basic Subscription Right (the “Investor Offered Shares”) and (ii) shares of Common Stock under the Over-Subscription Privilege for all Remaining Offered Shares (any such Remaining Offering Shares purchased by the Investors, the “Investor Over-Subscription Shares”); provided, however, that in no event shall the Investors under this Agreement, taken together, be required to acquire, in the aggregate, a number of Investor Over-Subscription Shares exceeding the lesser of (1) 100% of the Remaining Offered Shares and (2) a number of Investor Over-Subscription Shares which, when taken together with the aggregate number of Investor Offered Shares, is equal to 50% of the total number of Offered Shares; and provided, further, that such percentages and amounts may be reduced by mutual agreement of the Company and the Investors in the event that any other existing shareholder of the Company provides an exercise commitment in connection with the Rights Offering. For the avoidance of doubt, (A) any Investor Offered Shares and Investor Over-Subscription Shares acquired by the Investors shall be purchased at a per share price equal to the Subscription Price and (B) the Investor Offered Shares shall be included when determining the number of shares of Common Stock validly subscribed for and purchased under the Basic Subscription Right, and the Investor Over-Subscription shares shall be included when determining the number of shares of Common Stock validly subscribed for under the Over-Subscription Privilege.

 

  (b) The Company hereby agrees and undertakes to notify the Investors as promptly as practicable and, in any event, by noon, New York City Time, on the fourth (4th) Business Day after the Expiration Date by electronic or facsimile transmission of (i) the aggregate number of Rights validly exercised by Holders under the Basic Subscription Right and Over-Subscription Privilege pursuant to the Rights Offering as of the Expiration Date and the aggregate Subscription Price therefor, and (ii) a true and accurate determination of the aggregate number of Investor Over-Subscription Shares, if any, (such notification, the “Notice of Offering Results”).

 

3


  (c) Subject to applicable law, each Investor shall have the right to arrange for one or more of its Affiliated Entities (each, an “Affiliated Purchaser”) to purchase all or any portion of such Investor’s Investor Offered Shares and/or Investor Over-Subscription Shares, on the terms and subject to the conditions in this Agreement, by written notice to the Company at least one (1) Business Day prior to the Closing Date, which notice shall be signed by the applicable Investor and each of its applicable Affiliated Purchasers (i.e., for clarity, those purchasing all or any portion of such Investor’s Investor Offered Shares and/or Investor Over-Subscription Shares) and pursuant to which each such Affiliated Purchaser shall agree to all the terms of this Agreement as if it were an Investor, including that it can make each representation in Section 4 of this Agreement as if it were an Investor. In no event will any such arrangement relieve such Investor of its obligations under this Agreement if its Affiliated Purchaser(s) fail to perform such obligations in accordance with the terms and conditions of this Agreement. The term “Affiliated Entity”, with respect to any person, means any fund or other entity that is directly or indirectly controlled by the same manager or other person(s) as such first person.

 

  (d) The closing of the purchase of the Offered Shares to be purchased in the Rights Offering, including, subject to the terms and conditions of this Agreement, the purchase of the Investor Offered Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, and, if applicable, the purchase of the Investor Over-Subscription Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder (the “Closing”), will occur at the offices of Haynes & Boone, LLP, 2323 Victory Avenue, Suite 700, Dallas, Texas 75219, 9:00 a.m., Central Time, as promptly as practicable (but in no event later than on the sixth (6 th ) Business Day) following later of the (i) the Expiration Date and (ii) the satisfaction (or, to the extent permitted, waiver) of the conditions set forth in Section 7 (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction (or, to the extent permitted, waiver) of those conditions at such time) (the “Closing Date”), or such other time as shall be agreed upon by the Company and the Investors. On the Closing Date, subject to the terms and conditions of this Agreement, the Investors will purchase, and the Company will sell, only such number of Investor Over-Subscription Shares as is listed in the Notice of Offering Results, without prejudice to the rights of the Investors to seek later an upward or downward adjustment if the number of Investor Over-Subscription Shares in such Notice of Offering Results is inaccurate. Delivery of the Investor Over-Subscription Shares and Investor Offered Shares will be made by the Company on the Closing Date by delivering stock certificates representing shares of Common Stock with a Securities Act legend to the Investors and/or Affiliated Purchasers, as applicable, against payment by the Investors and/or the Affiliated Purchasers, as applicable, of the Subscription Price therefor by wire transfer of immediately available funds to the account designated in writing by the Company. On the Closing Date, the Company will also deliver to the Investors a certificate, dated as of the Closing Date, of the transfer agent of the Company confirming the issuance to the Investors and/or the Affiliated Purchasers, as applicable, of the Investor Over-Subscription Shares, if any, and the issuance to the Investors and/or the Affiliated Purchasers, as applicable, of the Investor Offered Shares, and all other documents and certificates required to be delivered to the Investors pursuant to Section 7(a).

 

  (e) The Company shall notify, or cause the Subscription Agent to notify, the Investors on each Friday during the Rights Exercise Period and on each Business Day during the five Business Days prior to any then-scheduled Expiration Date (or, if reasonably requested by the Investors, use reasonable best efforts to provide such information more frequently, to the extent so reasonably requested), of the aggregate number of Rights known by the Company or the Subscription Agent to have been validly exercised pursuant to the Rights Offering as of the close of business on the preceding Business Day or the most recent practicable time before such request, as the case may be.

 

4


  (f) The Company shall pay all of its own fees and expenses associated with the Rights Offering, including filing and printing fees, fees and expenses of any subscription and information agents, its counsel and financial advisor(s) and/or dealer-managers (if any) and accounting fees and expenses, costs associated with clearing the Offered Shares for sale under applicable state securities laws, and listing fees.

 

  (g) The Investors and the Company hereby agree that it is the intent of all parties that none of the Investors, by virtue of acting hereunder, shall be deemed an “underwriter” within the definition of Section 2(a)(11) of the Securities Act or be deemed to be engaged in broker-dealer activity requiring registration under Section 15 of the Exchange Act, and the Investors and the Company shall in the fulfillment of their obligations hereunder act in accordance with this mutual understanding.

 

  (h) No public release or announcement (for the avoidance of doubt, excluding in respect of any Schedule 13D (or 13G), Form 4 or similar Commission filing requirements of the Investors or their Affiliates so long as the Company is provided a reasonable opportunity to comment on such disclosure in advance) concerning the Rights Offering, the purchase of shares of Common Stock by the Investors pursuant to this Agreement, or the other transactions contemplated hereby, shall be issued by any party hereto without the prior consent of the other party (which consent shall not be unreasonably withheld, conditioned or delayed), except as such release or announcement may be required by law, regulation or stock exchange rule, in which case the party required to make the release or announcement shall, to the extent reasonably practicable, allow the other party reasonable time to comment on such release or announcement in advance of such issuance; provided that in no event shall any such press release or announcement name the Investors or any of their Affiliates without their prior written consent, except to the extent necessary to comply with law, regulation or stock exchange rule. The provisions of this subsection (h) shall not restrict the ability of the Company to summarize or describe the transactions contemplated by this Agreement in any prospectus or similar offering document or other report, in each case to the extent required by law, regulation or stock exchange rule, so long as the other party is provided a reasonable opportunity to comment on such disclosure in advance.

 

  3. Representations and Warranties of the Company . The Company represents and warrants to, and agrees with, the Investors as set forth below. Except for representations, warranties and agreements that are expressly limited as to a particular date, each representation, warranty and agreement is made as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby:

 

  (a)

Organization and Qualification. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Texas, with the corporate power and authority to own its properties and conduct its business as currently conducted, and, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties, or conducts any business so as to require such qualification. Each subsidiary of the Company that is a “significant subsidiary” within the meaning of Rule 1-02(w) of Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”) has been duly organized and is validly existing in good standing under the laws of its jurisdiction of organization, with the corporate or analogous power and authority to own its properties and conduct its business as currently conducted, and, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, has been duly qualified as a foreign corporation, limited liability company or partnership, as applicable, for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties, or conducts any business so as to require such qualification. For the purpose of this

 

5


  Agreement, “Material Adverse Effect” means any change, effect, event, development (including, for the avoidance of doubt, the discovery of new or previously unknown information), circumstance or occurrence, or any of the foregoing involving a prospective change, effect, event, development, circumstance or occurrence, in the condition (financial or otherwise) or in the earnings, business or operations of Company or its subsidiaries, taken as a whole, that, as determined by the Investors acting reasonably, is material and adverse and makes it, in the reasonable determination of the Investors, impracticable to proceed with the Rights Offering.

 

  (b) Corporate Power and Authority. The Company has the requisite corporate power and authority to enter into, execute and deliver this Agreement, the Registration Rights Joinder Agreement and each other agreement, document, and instrument to which it is or will be a party or which it has executed and delivered, or will execute and deliver, in connection with the Rights Offering and the transactions contemplated by this Agreement (this Agreement, the Registration Rights Joinder Agreement and such other agreements, documents, and instruments, collectively, the “Transaction Agreements”) and to perform its obligations and consummate the transactions contemplated hereunder and thereunder, including the issuance of the Rights and the Offered Shares (including the Investor Offered Shares and Investor Over-Subscription Shares). The Company has taken all necessary action required for the due authorization of the Transaction Agreements, the performance of its obligations thereunder and the consummation of the transaction contemplated thereby, including the issuance of the Rights and the Offered Shares (including the Investor Offered Shares and Investor Over-Subscription Shares).

 

  (c) Execution and Delivery; Enforceability. Each Transaction Agreement to which the Company is a party has been duly and validly authorized, executed and delivered by the Company, and constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as may be limited by the effect of bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or similar laws affecting the enforcement of creditors’ rights generally, subject to principles of equity and public policy and except to the extent that the indemnification and contribution provisions in this Agreement may be limited by federal or state securities laws (the “Exceptions”).

 

  (d)

Capitalization. The authorized capital stock of the Company consists of 350,000,000 shares of Common Stock of which, as of the date of this Agreement, 218,298,938 shares were issued and outstanding, of which 3,007,110 are shares of restricted stock issued pursuant to and subject to the vesting requirements of compensatory equity plans of the Company in effect as of the date hereof (the “Company Stock Plans”) (excluding, for the avoidance of doubt, shares held in treasury), and 10,000,000 shares of Preferred Stock, par value $0.001 per share (the “Preferred Stock”), of which, as of the date of this Agreement, no shares are either designated or issued and outstanding. As of the date of this Agreement, the Company held 539,221 shares of Common Stock in its treasury. As of the date of this Agreement, no shares of Common Stock or Preferred Stock were reserved for issuance, except for 55,574,734 shares of Common Stock reserved for issuance for the Rights Offering and 14,014,393 shares of Common Stock reserved for issuance under the Company Stock Plans upon the exercise of stock options outstanding as of such date and granted under the Company Stock Plans, with a weighted average exercise price of $12.06 per share. The outstanding shares of Common Stock have been duly authorized and are validly issued and outstanding, fully paid and nonassessable, and subject to no preemptive rights (and were not issued in violation of any preemptive rights, the Company’s articles of incorporation or by-laws, or any applicable laws). Except as set forth above or pursuant to this Agreement, there are no (A) shares of capital stock or other equity interests or voting securities of the Company authorized, reserved for issuance, issued or outstanding, (B) options, warrants, calls, preemptive rights, subscription or other rights, instruments, agreements, arrangements or commitments of any

 

6


  character, obligating the Company or any of its subsidiaries to issue, transfer or sell or cause to be issued, transferred or sold any shares of capital stock or other equity interest or voting security in the Company or any securities or instruments convertible into or exchangeable for such shares of capital stock or other equity interests or voting securities, or obligating the Company or any of its subsidiaries to grant, extend or enter into any such option, warrant, call, preemptive right, subscription or other right, instrument, agreement, arrangement or commitment, (C) outstanding contractual obligations of the Company or any of its subsidiaries to repurchase, redeem or otherwise acquire any capital stock or other equity interest or voting securities of the Company or (D) issued or outstanding restricted stock awards, units, rights to receive any capital stock or other equity interest or voting securities of the Company on a deferred basis, or rights to purchase or receive any capital stock or equity interest or voting securities issued or granted by the Company to any current or former director, officer, employee or consultant of the Company. No subsidiary of the Company owns any shares of capital stock or other equity interest or voting securities of the Company. There are no voting trusts or other agreements or understandings to which the Company or any of its subsidiaries is a party with respect to the voting of the capital stock or other equity interest or voting securities of the Company.

 

  (e) Issuance. The distribution of the Rights and the issuance of the Offered Shares, including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares, have been duly and validly authorized and, when such Offered Shares are issued and delivered against payment therefor, will be duly authorized, validly issued and delivered and fully paid and nonassessable, free and clear of all taxes, liens, preemptive rights, rights of first refusal, subscription and similar encumbrances, other than liens arising as a matter of applicable securities law. Upon the distribution by the Company of the Rights, such Rights will be duly and validly issued, free and clear of all taxes, liens, preemptive rights, rights of first refusal and similar encumbrances, other than liens arising as a matter of applicable securities law, and enforceable in accordance with their terms, and holders of Rights will be entitled to the rights described in the Rights certificates.

 

  (f) No Conflict. The distribution of the Rights, the sale, issuance and delivery of the Offered Shares upon exercise of the Rights (including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares), the consummation of the Rights Offering by the Company, and the execution and delivery by the Company of the Transaction Agreements and performance of and compliance with all of the provisions thereof by the Company and the consummation of the transactions contemplated therein (i) will not conflict with, or result in a breach or violation of, any of the terms or provisions of, or constitute a default under (in each case, with or without notice or lapse of time, or both), or result in the acceleration of, or the creation of any lien under, any indenture, mortgage, deed of trust, loan agreement or other agreement, instrument, contract or other arrangement to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (ii) will not result in any violation of the provisions of the Company’s articles of incorporation or by-laws or any of the organizational or governance documents of any of its subsidiaries, and (iii) will not result in any violation of, or any termination or impairment of any rights under, any applicable law, including any license, authorization, injunction, judgment, order, decree, rule or regulation of any Governmental Entity. For purposes of this Agreement, “Governmental Entity” means any federal, state, local, domestic, foreign or supranational court, administrative or regulatory agency or commission or other federal, state, local, domestic, foreign or supranational governmental authority or instrumentality, except, in any such case in clauses (i) and (iii), for any conflict, breach, violation, default, acceleration, lien, termination or impairment which would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

7


  (g) Consents and Approvals. No consent, approval, authorization, order, registration or qualification of or with any third party or any Governmental Entity is required for the distribution of the Rights, the sale, issuance and delivery of the Offered Shares upon exercise of the Rights (including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares), the consummation of the Rights Offering, and the execution and delivery by the Company of the Transaction Agreements and performance of and compliance by the Company with all of the provisions thereof and the consummation of the transactions contemplated therein, except (i) the registration under the Securities Act of the issuance of the Offered Shares (excluding any Investor Offered Shares and any Investor Over-Subscription Shares) pursuant to the exercise of Rights, (ii) such consents, approvals, authorizations, registrations or qualifications as may be required under state securities or “blue sky” laws in connection with distribution of the Rights and the issuance of the Offered Shares (including any Investor Offered Shares and any Investor Over-Subscription Shares) pursuant to the exercise of Rights, (iii) if applicable, filings required under, and compliance with other applicable requirements of, the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the “HSR Act”), (iv) filings required with the New York Stock Exchange in connection with listing of the Rights and the shares to be issued in the Rights Offering and pursuant to this Agreement and (v) the registration of the resale of the shares issued to the Investors pursuant to this Agreement, including such “blue sky” consents, approval authorizations, registrations or qualifications as may be necessary or appropriate.

 

  (h) Arm’s Length. In connection with all aspects of each transaction contemplated by this Agreement, the Company acknowledges and agrees that: (i) the Rights Offering and other the transactions contemplated by this Agreement are arm’s-length commercial transactions between the Company and the Investors, (ii) the Company is capable of evaluating, and understands and accepts, the terms, risks and conditions of the Rights Offering and other the transactions contemplated by this Agreement, (iii) in connection with the Rights Offering and other the transactions contemplated by this Agreement and the process leading to the foregoing, the Investors have been, are, and will be acting solely as principals and have not been, are not, and will not be acting as an advisor, agent or fiduciary for the Company or any of the Company’s Affiliates, shareholders, creditors or employees or any other person, and (iv) the Investors have no obligation to the Company or the Company’s Affiliates, shareholders, creditors or employees or any other person with respect to the Rights Offering and the other transactions contemplated hereby except those obligations expressly set forth in this Agreement. To the fullest extent permitted by law, the Company hereby waives and releases any claims that the Company or the Company’s Affiliates, shareholders, creditors or employees or any other person may have against the Investors or any of their Affiliates with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated by this Agreement. The term “Affiliate” has the meaning ascribed to such term in Rule 12b-2 under the Exchange Act.

 

  (i)

Company SEC Documents. Since January 1, 2011, the Company has filed or furnished all required reports, schedules, forms, statements and other documents (including exhibits and all other information incorporated therein) (the “Company SEC Documents”) with the United States Securities and Exchange Commission (the “Commission”). As of their respective dates, each of the Company SEC Documents complied in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission promulgated thereunder applicable to such Company SEC Documents. The Company has filed with the Commission all “material contracts” (as such term is defined in Item 601(b)(10) of Regulation S-K under the Exchange Act) that are required to be filed as exhibits to the Company SEC Documents. No Company SEC Document filed after December 31, 2010, when filed, and, in the case of any Company SEC Document amended or superseded prior to the date of this

 

8


  Agreement, on the date of such amending or superseding filing, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. Any Company SEC Documents filed with the Commission after the date hereof but prior to the Closing Date, when filed, will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they are made, not misleading. As of the date of this Agreement, the Company is and shall remain a Well Known Seasoned Issuer. For purposes of this Agreement, “Well Known Seasoned Issuer” means a “well known seasoned issuer”, and not an “ineligible issuer”, under Rule 405 promulgated under the Securities Act.

 

  (j)

Financial Statements. Each of (i) the financial statements and the related notes of the Company and its consolidated subsidiaries included or incorporated by reference in the Company SEC Documents, and (ii) the financial statements and the related notes of the Company and its consolidated subsidiaries to be included or incorporated by reference in the Rights Offering Registration Statement and the Rights Offering Prospectus, comply or will comply, as the case may be, in all material respects with the applicable requirements of the Securities Act, the Exchange Act, and the rules and regulations of the Commission thereunder, and fairly present, or will fairly present, as the case may be, in all material respects the financial position, results of operations and cash flows of the Company and its subsidiaries as of the dates indicated and for the periods specified, subject, in the case of the unaudited financial statements, to the absence of disclosures normally made in footnotes and to customary year-end adjustments that are not and shall not be material; such financial statements have been prepared, or will be prepared, as the case may be, in conformity with U.S. generally accepting accounting principles applied on a consistent basis throughout the periods covered thereby (except as disclosed in the Company SEC Documents filed before the date of this Agreement), and each of (A) the supporting schedules included or incorporated by reference in the Company SEC Documents, and (B) the supporting schedules to be included or incorporated by reference in the Rights Offering Registration Statement and the Rights Offering Prospectus, fairly present, or will fairly present, as the case may be, in all material respects, the information required to be stated therein; and each of (x) the other financial information included or incorporated by reference in the Company SEC Documents, and (y) the other financial information to be included or incorporated by reference in the Rights Offering Registration Statement and the Rights Offering Prospectus, has been, or will be, as the case may be, derived from the accounting records of the Company and its subsidiaries and presents fairly, or will present fairly, as the case may be, the information shown thereby. Neither the Company nor any of the Company’s subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off-balance sheet partnership or any similar agreement or arrangement, where the result, purpose or effect of such agreement or arrangement is to avoid disclosure of any material transaction involving, or material liabilities of, the Company or any of its subsidiaries in the Company SEC Documents (including the financial statements contained therein). Except to the extent specifically reflected or reserved against on the September 30, 2013 consolidated balance sheet of the Company (including the notes thereto) included in the Company’s Form 10-Q as filed with the Commission on October 30, 2013, neither the Company nor any of its subsidiaries has any (i) liabilities (whether or not accrued, fixed, contingent, asserted or known) or (ii) any impairments (including impairments that would reasonably be expected to occur or be taken) to assets or reserves, except for liabilities or impairments, respectively, that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (provided, that for purposes of clause (ii), the definition of “Material Adverse Effect” shall be deemed to exclude the phrases “as determined by the Investors acting reasonably” and “in the reasonable determination of the Investors,” and any impairments or writedowns to the Company’s oil and natural gas properties (and/or, to the extent applicable, the Company’s other assets) (for the avoidance of doubt, excluding the $10,707,000 impairment previously taken by the Company in respect of the quarter ended March 31, 2013) which in the aggregate equal or exceed $150 million shall be deemed a Material Adverse Effect). The Company has designed and maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) sufficient to provide reasonable assurances regarding the reliability of financial reporting. The Company (1) has designed and maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e)

 

9


  of the Exchange Act) to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits with the Commission is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules, regulations and forms, and is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure, and (2) has disclosed, based on its most recent evaluation of internal control over financial reporting, to the Company’s outside auditors and the Audit Committee of the Board (I) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that would reasonably be expected to adversely affect the Company’s ability to record, process, summarize and report financial information and (II) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting, all of which information described in clauses (I) and (II) above has been disclosed by the Company to the Investors prior to the date hereof. Any material change in internal control over financial reporting required to be disclosed in any Company SEC Document has been so disclosed. Since December 31, 2011, to the knowledge of the Company, neither the Company nor any of its subsidiaries has received any complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or any of its subsidiaries or their respective internal accounting controls relating to periods after December 31, 2011, except for any complaints, allegations, assertions or claims that have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Each of the principal executive officer of the Company and the principal financial officer of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company, as applicable) has made all certifications required by Rules 13a-14 and 15d-14 under the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, as amended (“SOX”), with respect to the Company SEC Documents, and the statements contained in such certifications are true and complete. For purposes of this Agreement, “principal executive officer” and “principal financial officer” shall have the meanings given to such terms in SOX.

 

  (k) Rights Offering Registration Statement and Rights Offering Prospectus. The Rights Offering Registration Statement, as of the Securities Act Effective Date, and each Issuer Free Writing Prospectus, if any, at the time of use thereof, will comply in all material respects with the Securities Act and the rules and regulations promulgated thereunder and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and as of the applicable date of the Rights Offering Prospectus and any amendment or supplement thereto and as of the Closing Date, the Rights Offering Prospectus will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. At the time of its distribution and at the Expiration Date, the Investment Decision Package will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, the Company makes no representation and warranty with respect to any statements or omissions made in reliance on and in conformity with information regarding the Investors furnished to the Company in writing by the Investors expressly for use in the Rights Offering Registration Statement and the Rights Offering Prospectus, and any amendment or supplement thereto.

For the purposes of this Agreement, (i) the term “Rights Offering Registration Statement” means an automatically effective Shelf Registration Statement on Form S-3ASR to be filed with the Commission relating to the Rights Offering, including all exhibits thereto and any documents incorporated by reference therein, as amended as of the Securities Act Effective Date,

 

10


and any post-effective amendment thereto that becomes effective; (ii) the term “Rights Offering Prospectus” means the final prospectus contained in the Rights Offering Registration Statement at the Securities Act Effective Date (including information, if any, omitted pursuant to Rule 430A and subsequently provided pursuant to Rule 424(b) under the Securities Act), and any amended form of such prospectus provided under Rule 424(b) under the Securities Act or contained in a post-effective amendment to the Rights Offering Registration Statement, including any documents incorporated by reference therein; (iii) the term “Investment Decision Package” means the Rights Offering Prospectus, together with any Issuer Free Writing Prospectus used by the Company to offer the Offered Shares to Holders pursuant to the Rights Offering; (iv) the term “Issuer Free Writing Prospectus” means each “issuer free writing prospectus” (as defined in Rule 433 of the rules promulgated under the Securities Act) prepared by or on behalf of the Company or used or referred to by the Company in connection with the Rights Offering, including any documents incorporated by reference therein; (v) the term “Securities Act Effective Date” means the date and time as of which the Rights Offering Registration Statement, or the most recent post-effective amendment thereto, was declared effective by the Commission; and (vi) the term “SEC Transaction Documents” means the Rights Offering Registration Statement, the Rights Offering Prospectus, the Investment Decision Package and any Issuer Free Writing Prospectuses.

 

  (l) No Registration Rights Agreements.

 

  (i) Other than the 2005 Registration Rights Agreement and the 2007 Registration Rights Agreement, the Company is not bound by any agreement, contract or other arrangement with respect to its equity securities granting any demand, shelf, incidental/piggyback or other registration rights (“Registration Rights”) to any person. Except as expressly disclosed in writing to the Investors prior to the date hereof, there have not been any amendments, modification or supplements to, or any waivers under, either the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement. Other than persons who would not be adversely affected and would not reasonably be expected to have or bring any material claim, no person has the right to require the Company or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Rights Offering Registration Statement. Schedule A hereto sets forth a true, complete and correct list of each person who delivered to the company a binding written waiver with respect to any such right, which binding written waivers are in full force and effect and copies of which have been provided to the Investors.

 

  (ii) Schedule B hereto sets forth to the best of the Company’s knowledge, a true, complete and correct list of the names of each person (i) named as a selling shareholder in the Registration Statement on Form S-3 filed by the Company on April 16, 2010 or (ii) that the Company expects will be named as a selling shareholder on the Initial Shelf Registration Statement, and, in the case of either of clauses (i) or (ii), with respect to each such person, the number of Registrable Securities or Registrable Shares (as defined in the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement, respectively), respectively, owned by each such person as set forth in filings with the Commission with respect to the Common Stock. For purposes of this Agreement, the “2005 Registration Rights Agreement” means the First Amended and Restated Registration Rights Agreement of the Company, originally dated as of October 3, 2005, as amended and restated as of December 30, 2005, and the “2007 Registration Rights Agreement” means the Registration Rights Agreement of the Company, dated March 28, 2007, in respect of 7.0% Cumulative Convertible Perpetual Preferred Stock and Hybrid Preferred Stock.

 

  (iii)

The entry by the Investors and the Company into the Registration Rights Joinder Agreement, and the Investors

 

11


  accordingly becoming parties to the 2005 Registration Rights Agreement as “Holders” and “Investor Holders” thereunder, will not conflict with, or result in a breach or violation of, or require any consent under, any of the terms or provisions of either the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement. After giving effect to the entry by the Investors and the Company into the Registration Rights Joinder Agreement as contemplated hereby, the Investors will become parties to the 2005 Registration Rights Agreement as “Holders” and “Investor Holders” thereunder, and the 2005 Registration Rights Agreement is will be full force and effect, and constitute a valid and binding obligation of the Company, enforceable against the Company by the Investors in accordance with its terms, except as may be limited by the Exceptions, and the Company has not granted, and will not grant, to any person any Registration Rights that conflict with, are inconsistent with or violate the rights to be granted to the Investors under the 2005 Registration Rights Agreement.

 

  (m) No Material Adverse Effect. Since January 1, 2013, other than as disclosed in the Company SEC Documents filed prior to the date hereof and except for actions to be taken in connection with the transactions contemplated under this Agreement, there has not occurred any Material Adverse Effect.

 

  (n) No Broker’s Fees. Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person that would give rise to a claim against the Company or the Investors for a financial advisory fee, brokerage commission, finder’s fee or like payment in connection with the Rights Offering, including the issuance of the Offered Shares upon exercise of Rights (including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares), or the other transactions contemplated in any of the Transaction Agreements.

 

  (o) Anti-takeover Provisions. The actions taken by the Disinterested Directors and the Board to approve this Agreement, the other Transaction Agreements and the transactions contemplated hereby and thereby constitute all the action necessary to render inapplicable to this Agreement, the other Transaction Agreements, the purchase of the Investor Offered Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, and, if applicable, the purchase of the Investor Over-Subscription Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, the provisions of any potentially applicable anti-takeover, control share, fair price, moratorium, interested shareholder or similar law and any potentially applicable provision of the Company’s articles of incorporation or by-laws (collectively, “Anti-takeover Provisions”).

 

  4. Representations and Warranties of the Investors and the Affiliated Purchasers . Each of the Investors, severally on behalf of and with respect to itself only, and not jointly with any other Investor, represents and warrants and agrees with the Company as set forth below. To the extent that an Affiliated Purchaser acquires Investor Over-Subscription Shares or Investor Offered Shares from the Company pursuant to this Agreement, such Affiliated Purchaser shall be deemed to have made each of the representations and warranties below substituting “Affiliated Purchaser” for “Investor” in this Section 4. Except for representations, warranties and agreements that are expressly limited as to a particular date, each representation, warranty and agreement is made as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby:

 

  (a) Formation. Such Investor has been duly organized and is validly existing in good standing under the laws of the jurisdiction of its formation.

 

12


  (b) Power and Authority. Such Investor has the requisite corporate (or analogous) power and authority to enter into, execute and deliver this Agreement and the other Transaction Agreements to which it is or will be a party and to perform its obligations and consummate the transactions contemplated hereunder and thereunder and has taken all necessary corporate (or analogous) action required for the due authorization of the Transaction Agreements, the performance of its obligations thereunder and the consummation of the transaction contemplated thereby.

 

  (c) Execution and Delivery. Each Transaction Agreement to which such Investor is a party has been duly and validly authorized, executed and delivered by such Investor, and constitutes a valid and binding obligation of such Investor, enforceable against such Investor in accordance with its terms, except as may be limited by the Exceptions.

 

  (d) Restricted Securities. Such Investor understands that the Investor Offered Shares and Investor Over-Subscription Shares have not been registered under the Securities Act and may not be resold without registration under the Securities Act except pursuant to a specific exemption from the registration provisions of the Securities Act. As a result, such Investor acknowledges and understands that, upon the original issuance thereof and until such time as the same is no longer required under any applicable requirements of the Securities Act or applicable state securities laws, the Company and its transfer agent shall make such notation in the stock book and transfer records of the Company as may be necessary to record that the Investor Offered Shares and Over-Subscription Shares have not been registered under the Securities Act and may not be resold without registration under the Securities Act except pursuant to a specific exemption from the registration provisions of the Securities Act.

 

  (e) Investment Intent. Except as provided in Section 2(c), such Investor is acquiring its portion of the Investor Offered Shares and Investor Over-Subscription Shares for investment for its own account, and not with the view to, or for resale in connection with, any distribution thereof not in compliance with the Securities Act and any applicable state securities or “blue sky” laws, and such Investor has no present intention of selling, granting any participation in, or otherwise distributing the same, except in compliance with the Securities Act and any applicable state securities or “blue sky” laws.

 

  (f) Securities Laws Compliance. The Investor Offered Shares and Investor Over-Subscription Shares will not be offered for sale, sold or otherwise transferred by such Investor except pursuant to a registration statement or in a transaction exempt from, or not subject to, registration under the Securities Act and any applicable state securities or “blue sky” laws. Such Investor further acknowledges that Rule 144 promulgated under the Securities Act may not be applicable to the Investor Offered Shares and Investor Over-Subscription Shares. Such Investor further recognizes that the Company is under no obligation to register the Investor Offered Shares and Investor Over-Subscription Shares except pursuant to the Registration Rights Joinder Agreement to be entered into in accordance with the terms of this Agreement (and, accordingly, the 2005 Registration Rights Agreement). Such Investor understands that the certificates representing the Investor Offered Shares and Investor Over-Subscription Shares may carry one or more legends incorporating such restrictions. Such Investor acknowledges that applicable securities laws provide certain restrictions on the ability of stockholders to sell, transfer, assign, mortgage, hypothecate, or otherwise encumber their Investor Offered Shares and Investor Over-Subscription Shares.

 

  (g)

Sophistication. Such Investor is an “accredited investor” within the meaning of Rule 501(a) promulgated under the Securities Act, and such Investor has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of its investment in the Investor Offered Shares and Investor Over-Subscription Shares being acquired hereunder. Such Investor understands and is able to bear any economic risks associated with such investment.

 

13


  With the assistance of such Investor’s own professional advisors, to the extent that such Investor has deemed appropriate, such Investor has made its own legal, tax, accounting and financial evaluation of the merits and risks of an investment in the Investor Offered Shares and Investor Over-Subscription Shares and the consequences of this Investment Agreement. Such Investor has considered the suitability of the Investor Offered Shares and Investor Over-Subscription Shares as an investment in light of its own circumstances and financial condition and such Investor is able to bear any economic risks associated with such investment. Such Investor agrees to furnish any additional information reasonably requested by the Company or any of its affiliates, to the extent necessary to assure compliance with applicable U.S. federal and state securities laws in connection with such Investor’s purchase of the Investor Offered Shares and Investor Over-Subscription Shares hereunder. Without derogating from or limiting the representations and warranties of the Company, such Investor acknowledges that it has been afforded the opportunity to ask questions and receive answers concerning the Company and to obtain additional information that it has requested to verify the information contained herein. Notwithstanding the foregoing, nothing contained herein will operate to modify or limit in any respect the representations and warranties of the Company or to relieve it from any obligations to such Investor for breach thereof or the making of misleading statements or the omission of material facts in connection with the transactions contemplated herein.

 

  (h) Agency Determinations. Such Investor understands that no federal or state agency has passed upon the merits or risks of an investment in the Investor Offered Shares and Investor Over-Subscription Shares or made any finding or determination concerning the fairness or advisability of this investment.

 

  (i) No Conflict. The purchase of its portion of the Investor Offered Shares and Investor Over-Subscription Shares, the execution and delivery by such Investor of each of the Transaction Agreements to which it is a party and the performance of and compliance with all of the provisions thereof by such Investor, and the consummation of the transactions contemplated therein (i) will not conflict with, or result in a breach or violation of, any of the terms or provisions of, or constitute a default under (in each case, with or without notice or lapse of time, or both), or result, in the acceleration of, or the creation of any lien under, any indenture, mortgage, deed of trust, loan agreement or other agreement, instrument, contract or other arrangement to which such Investor is a party or by which such Investor is bound or to which any of the property or assets of such Investor is subject, (ii) will not result in any violation of the provisions of the certificate of limited partnership, limited partnership agreement, or similar governance documents of such Investor, and (iii) will not result in any material violation of, or any termination or material impairment of any rights under, any applicable law, including any license, authorization, injunction, judgment, order, decree, rule or regulation of any Governmental Entity, except in the case of each of clauses (i) through (iii), for any conflict, breach, violation, default, acceleration, lien, termination or impairment which would not reasonably be expected to prohibit or materially and adversely affect such Investor’s performance of its obligations under this Agreement.

 

  (j)

Consents and Approvals. No consent, approval, authorization, order, registration or qualification of any third party (in the case of third parties, assuming the truth and accuracy in all respects (disregarding all qualifications and exceptions contained therein relating to materiality, Material Adverse Effect or similar qualifications) of the Company’s representations and warranties in Sections 3(f), (g) and (l)) or with any Governmental Entity is required to be obtained or made by such Investor for the purchase of its portion of Investor Offered Shares and Investor Over-Subscription Shares in accordance with the terms hereof and the execution and delivery by such Investor of this Agreement or the other Transaction Agreements to which it is a party and performance of and compliance by such Investor with all of the provisions hereof and thereof and the

 

14


  consummation of the transactions contemplated herein and therein, except for (i) such consents, approvals, authorizations, registrations or qualifications as may be required under state securities or “blue sky” laws in connection with the purchase of the Investor Offered Shares and Investor Over-Subscription Shares by such Investor, (ii) any consent, approval, authorization, registration or qualification which, if not made or obtained, would not reasonably be expected to prohibit or materially and adversely affect such Investor’s performance of its obligations under this Agreement, (iii) if applicable, filings required under, and compliance with other applicable requirements of, the HSR Act, (iv) filings required with the New York Stock Exchange in connection with listing of the Rights and the shares to be issued in the Rights Offering and pursuant to this Agreement and (v) the registration of the resale of the shares issued to the Investors pursuant to this Agreement, including such “blue sky” consents, approval authorizations, registrations or qualifications as may be necessary or appropriate. Notwithstanding the immediately foregoing clause (iii), assuming that the Closing occurs on or prior to the 44 th calendar day following the date of this Agreement, such Investor will not be subject to the requirements of the HSR Act with respect to the acquisition of the Investor Offered Shares and Investor Over-Subscription Shares pursuant to this Agreement.

 

  (k) Information Furnished. Information relating to such Investor furnished to the Company in writing by such Investor expressly for use in the Rights Offering Registration Statement will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

  (l) Short Sales. Since November 15, 2013 through the date hereof, the Investors have not, directly or indirectly, sold or agreed to sell any shares of Common Stock, effected any short sale, whether or not against the box or established any “put equivalent position” (as defined in Rule 16a-1(b) under the Exchange Act) with respect to shares of Common Stock.

 

  (m) Sufficient Funds. At the Closing, the Investors (or their applicable Affiliated Purchaser(s), as applicable) will have available funds necessary to consummate the Closing on the terms and conditions contemplated by this Agreement.

 

  (n) Brokers and Finders. Neither such Investor nor any of its Affiliates is a party to any contract, agreement or understanding with any person that would give rise to a claim against the Company for a financial advisory fee, brokerage commission, finder’s fee or like payment in connection with the Rights Offering, including the issuance of the Offered Shares upon exercise of Rights (including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares), or the other transactions contemplated in any of the Transaction Agreements.

 

  (o) Broker Dealer. Such Investor is not a broker-dealer and does not need to be registered as a broker-dealer.

 

  5. Additional Covenants of the Company . Without derogating from the obligations of the Company set forth elsewhere in this Agreement, the Company agrees with the Investors as set forth below.

 

  (a) Rights Offering Registration Statement.

 

  (i) On the date of this Agreement, promptly following the execution hereof, the Company shall file with the Commission the Rights Offering Registration Statement (the date of such filing, the “Filing Date”).

 

  (ii)

The Rights Offering Registration Statement filed with the Commission shall be consistent in all material respects with the last form of such document provided to the Investors and

 

15


  their counsel to review prior to the filing thereof. Without limiting the foregoing, the Company shall (x) provide the Investors with a reasonable opportunity to review any SEC Transaction Document prior to its filing with the Commission and shall consider in good faith any comments of the Investors and their counsel; (y) advise the Investors promptly of the time when the Rights Offering Registration Statement has been filed and when the Rights Offering Registration Statement has become effective or any other SEC Transaction Document has been filed and shall furnish the Investors with copies thereof; and (z) advise the Investors promptly after it receives notice of any comments or inquiries by the Commission (and promptly furnish the Investors with copies of any correspondence related thereto), of the issuance by the Commission of any stop order or of any order preventing or suspending the use of any SEC Transaction Document, of the initiation or threatening of any proceeding for any such purpose, or of any request by the Commission for amending or supplementing any SEC Transaction Document or for additional information, and in each such case, provide the Investors with a reasonable opportunity to review any such comments, inquiries, request or other communication from the Commission and to review any responses thereto and any amendment or supplement to any SEC Transaction Document before any filing or communication with the Commission, and to consider in good faith any comments of the Investors and their counsel and in the event of the issuance of any stop order or of any order preventing or suspending the use of any SEC Transaction Document, to use promptly its reasonable best efforts to obtain its withdrawal.

 

  (iii) The Company shall use its reasonable best efforts to have the Rights Offering Registration Statement cleared or declared effective, as the case may be, by the Commission as promptly as practicable after it is filed with the Commission. The Company shall take all action as may be necessary or advisable so that the Rights Offering, including the issuance of the Offered Shares (including the Investor Offered Shares and the Investor Over-Subscription Shares), and the other transactions contemplated by this Agreement, may be effected in accordance with the applicable provisions of the Securities Act and the Exchange Act and any state or foreign securities or “blue sky” laws.

 

  (iv) If at any time prior to the Expiration Date, any event occurs as a result of which the Investment Decision Package, as then amended or supplemented, would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it shall be necessary to amend or supplement the Investment Decision Package to comply with applicable law, the Company will promptly notify the Investors of any such event and, subject to Section 5(a)(ii), prepare an amendment or supplement to the Investor Decision Package that will correct such statement or omission or effect such compliance.

 

  (b) Record Date and Listing. The Company shall not amend or modify the Record Date without the prior written consent of the Investors. The Company shall use its reasonable efforts to (A) list and maintain the listing of the Common Stock, including the Offered Shares, on the New York Stock Exchange (the “NYSE”) and (B) list and maintain the listing of the Rights on the NYSE commencing on the first Business Day after the Securities Act Effective Date of the and, in the case of this clause (B), until 4:00 p.m., New York City time on the last trading day immediately preceding the Expiration Date.

 

  (c) No Stabilization. The Company will not take, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in any stabilization or manipulation of the price of the shares of Common Stock.

 

16


  (d) Ordinary Course of Business; Actions Regarding Conditions. During the period from the date of this Agreement to the Closing Date, the Company shall conduct its business, and shall cause its subsidiaries to conduct their business, in the ordinary course and consistent with the Company’s and its subsidiaries’ past practice; and the Company for itself and on behalf of its subsidiaries agrees to use its reasonable best efforts to preserve substantially intact their business organizations and goodwill, to keep available the services of those of their present officers, employees, and consultants who are integral to the operation of their businesses as presently conducted; and the Company shall not take any action or omit to take any action that would reasonably be expected to result in the Company’s failure to satisfy the conditions to the Agreement set forth in Section 7.

 

  (e) Reasonable Best Efforts. The Company shall use its reasonable best efforts (and shall cause its subsidiaries to use their respective reasonable best efforts) to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on its or their part to cooperate with the Investors and to consummate and make effective the transactions contemplated by this Agreement, including the Rights Offering and the issuance of the Offered Shares (including the Investor Offered Shares and the Investor Over-Subscription Shares) as promptly as practicable, including by:

 

  (i) preparing and filing as promptly as practicable all documentation to effect all necessary notices, reports and other filings and to obtain as promptly as practicable all consents, registrations, approvals, permits and authorizations necessary or advisable to be obtained from any third party or Governmental Entity;

 

  (ii) using reasonable best efforts to defend any lawsuits or other actions or proceedings, whether judicial or administrative, challenging this Agreement or any other Transaction Agreement or the consummation of the transactions contemplated hereby and thereby, including seeking to have any stay or temporary restraining order entered by any court or other Governmental Entity vacated or reversed;

 

  (iii) executing, delivering and filing, as applicable, any additional ancillary instruments, documents, or agreements necessary to consummate the transactions contemplated by this Agreement and the other Transaction Agreements and to fully carry out the purposes of this Agreement and the transactions contemplated hereby and thereby;

 

  (iv) subject to the requirements of applicable law, not amending, terminating or waiving any term of the Rights Offering as set forth herein, or any other material term of the Rights Offering, without the prior approval of the Company’s Rights Committee, or Board of Directors, as appropriate, and without the prior written consent of the Investors, and, if requested by the Investors, extending the Expiration Date solely to the extent necessary to permit the Closing to occur as contemplated by this Agreement following the satisfaction (or, to the extent permitted, waiver) of the conditions set forth in Section 7; and

 

  (v) not taking any action that would cause this Agreement or any of the other Transaction Agreements, or the purchase of the Investor Offered Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, or, if applicable, the purchase of the Investor Over-Subscription Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, to be subject to any Anti-takeover Provision, or in any manner to any “poison pill” or similar shareholder rights plan or agreement.

 

  (f) Registration Rights Agreement.

 

17


  (i) Immediately prior to the Closing, the Company shall deliver to the Investors and/or their respective Affiliated Purchasers, as the case may be, the joinder agreement, in the form attached as Annex A hereto (the “Registration Rights Joinder Agreement”), duly and validly executed by the Company.

 

  (ii) The Company agrees to uses its best efforts to file, as a Shelf Registration under the 2005 Registration Rights Agreement and in accordance with the provisions of the 2005 Registration Rights Agreement, within ten (10) Business Days after the Closing Date, a Registration Statement (as defined in the 2005 Registration Rights Agreement) on Form S-3 providing for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act relating to the offer and sale, from time to time, of all Registrable Securities (as defined in the 2005 Registration Rights Agreement) then held by the Investors, the Affiliated Purchasers and such other Affiliates of the Investors as designated by the Investors (to the extent that no later than one (1) Business Day prior to the Closing Date, the Investors have provided the Company written notice of the names of such other Affiliates and number of shares to be registered on behalf of such other Affiliates), and such Registration Statement may register for resale any or all of the Registrable Securities of any other Holder (as defined in the 2005 Registration Rights Agreement) (the “Initial Shelf Registration Statement”). To the extent that, as of the filing date of the Initial Shelf Registration Statement, the Company is a Well Known Seasoned Issuer, the Company agrees that the Initial Shelf Registration Statement shall be an “automatic shelf registration statement” as defined in Rule 405 promulgated under the Securities Act. The Investors acknowledge and agree that the Initial Shelf Registration Statement will also register for resale shares of Common Stock of other Holders (as defined in the 2005 Registration Rights Agreement), including those listed on Schedule B.

 

  (iii) In accordance with the terms of the 2005 Registration Rights Agreement, including without limitation Section 4.1 thereof, the Company acknowledges that the obligations of the Company set forth in Section 4.1 of the 2005 Registration Rights Agreement (A) apply to the sale or distribution, including “take-downs” off of an effective Shelf Registration, of Registrable Securities requested from time to time by one or more Holders covered under the applicable Registration Statement, and (B) require the Company to, during any period that the Company fails to comply with its obligation to keep a Shelf Registration continuously effective for the period specified in Section 4.1(b) of the 2005 Registration Rights Agreement, otherwise use its best efforts to expedite and facilitate the registration and disposition of the Holders’ Registrable Securities, including by, upon the request of any Holder, filing and having declared effective a Registration Statement on an appropriate form then available to the Company, and, upon the Company becoming eligible to do so, recommencing the registration of the Holders’ Registrable Securities as a continuously effective Shelf Registration.

 

  (iv) Prior to the effectiveness of the Registration Rights Joinder Agreement and the Investors accordingly becoming parties to the 2005 Registration Rights Agreement as “Holders” and “Investor Holders” thereunder, the Company shall not enter into or agree to any amendment, modification or supplement to, or waiver under, either the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement.

 

  (g)

Clear Market. Other than (i) the consummation of the Rights Offering in accordance with the terms hereof, (ii) the filing of the Initial Shelf Registration Statement in accordance with the terms hereof or (iii) as required pursuant to the terms of the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement, in either case only after the filing of the Initial Shelf Registration Statement following the Closing Date in accordance with the terms hereof, without

 

18


  the prior written consent of the Investors, the Company shall not effect any registration of Common Stock or other equity securities of the Company (or securities convertible into or exchangeable or exercisable for Common Stock or other equity securities) for sale under the Securities Act, or public sale or distribution of any Common Stock or other equity securities of the Company (or securities convertible into or exchangeable or exercisable for Common Stock or other equity securities), in each case other than in connection with a registration statement on Form S-4, Form S-8 or any successor forms thereto, whether for its own account or for the account of any other person, during the period beginning on the date hereof and ending ninety calendar days after the Closing Date.

 

  (h) Other Applicable Agreements. Without the prior written consent of the Investors, the Company shall not amend, modify, supplement or waive any provision of any Other Applicable Agreement in a manner that adversely affects the Investors or that gives any Other Applicable Shareholder terms or rights that are more favorable to such person than those afforded to the Investors under this Agreement.

 

  (i) Impairment Analysis and Reserve Report. The Company agrees to use its reasonable best efforts to complete the Impairment Analysis and Reserve Report as soon as reasonably possible (and in any event within five Business Days prior to the Closing), and it shall keep the Investors informed on a timely basis as to the status and results of such Impairment Analysis and Reserve Report. “Impairment Analysis and Reserve Report” means the review and analysis of the Company’s reserve estimates, including, without limitation, analysis of whether the Company will be required to record a non-cash ceiling test impairment to its oil and natural gas properties (including, for the avoidance of doubt, the Haynesville and Eagle Ford assets acquired by the Company in July 2013), and an updated reserve report in respect of such properties.

 

  6. Additional Covenants of the Investor . Each of the Investors, severally on behalf of and with respect to itself only, and not jointly with any other Investor, agrees with the Company as set forth below:

 

  (a) Information. To provide the Company with such information as the Company reasonably requests regarding such Investor for inclusion in the Rights Offering Registration Statement.

 

  (b) Registration Rights Joinder Agreement. To deliver (and/or cause its applicable Affiliated Purchaser(s) to deliver), immediately prior to the Closing, the Registration Rights Joinder Agreement, duly and validly executed by such Investor (and/or such applicable Affiliated Purchaser(s)).

 

  (c) Short Sales. From the date of this Agreement through the Expiration Date, such Investor shall not, directly or indirectly, sell or agree to sell any shares of Common Stock, offer any short sale, whether or not against the box or establish any “put equivalent position” (as defined in Rule 16a-1(b) under the Exchange Act) with respect to shares of Common Stock, in each case so long as (i) the Company has not breached and is not then in breach of its obligations under this Agreement and (ii) there shall not have occurred, since November 22, 2013, any Material Adverse Effect.

 

  (d) Market Stabilization. Such Investor shall not take, directly or indirectly, in connection with the “distribution” of the Rights and Common Stock in the Rights Offering, any action designed to, or that might reasonably be expected to result in, stabilization or manipulation of the price of shares of Common Stock in violation of Regulation M.

 

  7. Conditions to the Obligations of the Parties .

 

  (a) Conditions to the Investors’ Obligations under this Agreement. The obligations of each Investor to consummate the transactions contemplated hereby shall be subject to the satisfaction prior to the Closing Date of each of the following conditions (which may be waived with respect to the Investors in whole or in part by the Investors in their sole discretion):

 

  (i) Registration Statement Effectiveness. The Rights Offering Registration Statement shall continue to be effective and no stop order shall have been entered by the Commission with respect thereto.

 

19


  (ii) Rights Offering. The Rights Offering shall have been conducted in all material respects in accordance with this Agreement without the waiver of any condition thereto.

 

  (iii) No Legal Impediment to Issuance. No statute, rule, regulation, order or other legal restraint shall have been enacted, adopted, or issued by any Governmental Entity, and no judgment, injunction, decree or order of any Governmental Entity shall have been issued that, in each case, prohibits the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements, and no action or proceeding by or before any Governmental Entity shall be pending or threatened wherein an adverse judgment, decree, or order would be reasonably likely to result in the prohibition of the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements.

 

  (iv) Representations and Warranties. The representations and warranties of the Company contained in Sections 3(b), 3(c), 3(d), 3(e), 3(l), 3(n), 3(o) shall be true and correct in all respects, in each case as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby with the same effect as if made on and as of the Closing Date (except for representations and warranties made as of a specified date, which shall be true and correct only as of such specified date). The other representations and warranties of the Company in this Agreement (disregarding all qualifications and exceptions contained therein relating to materiality, Material Adverse Effect or similar qualifications) shall be true and correct in all material respects, in each case as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby with the same effect as if made on and as of the Closing Date (except for representations and warranties made as of a specified date, which shall be true and correct only as of such specified date).

 

  (v) Covenants. The Company shall have performed and complied in all material respects with all of its covenants and agreements contained in this Agreement and in any other Transaction Agreement required to be performed or complied with on or prior to the Closing Date.

 

  (vi) NYSE. The Offered Shares shall have been approved for listing on the NYSE, subject to official notice of issuance.

 

  (vii) Officers Certificate. The Investors shall have received a certificate, dated as of the Closing Date, signed on behalf of the Company by a senior executive officer thereof certifying to the effect that the conditions set forth in Sections 7(a)(iv), (v) and (x) have been satisfied.

 

  (viii) HSR Clearance. Any waiting period (including any extension thereof) applicable to the acquisition of Offered Shares and/or Remaining Offered Shares by any Investor (or any Affiliated Purchaser of any Investor) or any Other Applicable Shareholder (or any Affiliated Entity of any Other Applicable Shareholder) under the HSR Act shall have expired or early termination thereof shall have been granted.

 

20


  (ix) Other Applicable Agreements. There shall not have occurred any breach or default, or threatened breach or default, under the terms and conditions of any Other Applicable Agreement by any party thereto, on the basis of which any party thereto has terminated such Other Applicable Agreement or has refused (or is threatening to refuse) to consummate the transactions contemplated thereunder.

 

  (x) No MAE. Since November 22, 2013, there shall not have occurred any Material Adverse Effect.

 

  (xi) No Material Impairment. The Company shall have completed in all material respects the Impairment Analysis and Reserve Report, and such Impairment Analysis and Reserve Report shall not support or require, and the Company shall not have recognized or reasonably be expected to recognize, any impairments to the Company’s oil and natural gas properties (and/or, to the extent applicable, the Company’s other assets) (for the avoidance of doubt, excluding the $10,707,000 impairment previously taken by the Company in respect of the quarter ended March 31, 2013) which in the aggregate equal or exceed $150 million; provided that in the event that (A) the Impairment Analysis and Reserve Report delivered to the Investors in accordance with Section 5(i) indicates an aggregate amount of such impairments exceeding $150 million (such indicated aggregate amount of such impairments, the “Applicable Amount”) and (B) the Investors nonetheless elect to exercise their right to waive this Section 7(a)(xi) in order to effect the Closing, then the reference to $150 million in Section 3(j) shall instead to be deemed to be the Applicable Amount.

 

  (b) Conditions to the Company’s Obligations under this Agreement. The obligations of the Company to issue the Investor Offered Shares and the Investor Over-Subscription Shares and consummate the Rights Offering and the other transactions contemplated by this Agreement shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions (which (other than in the case of Section 7(b)(iii) and Section 7(b)(iv)) may not be waived, in whole or in part, without the prior written consent of the Investors):

 

  (i) Registration Statement Effectiveness. The Rights Offering Registration Statement shall continue to be effective and no stop order shall have been entered by the Commission with respect thereto.

 

  (ii) No Legal Impediment to Issuance. No statute, rule, regulation, order or other legal restraint shall have been enacted, adopted, or issued by any Governmental Entity, and no judgment, injunction, decree or order of any Governmental Entity shall have been issued that, in each case, prohibits the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements, and no action or proceeding by or before any Governmental Entity shall be pending or threatened wherein an adverse judgment, decree, or order would be reasonably likely to result in the prohibition of the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements.

 

  (iii) Representations and Warranties. The representations and warranties of the Investors contained in this Agreement shall be true and correct as of the date hereof and as of the Closing Date with the same effect as if made on the Closing Date (except for the representations and warranties made as of a specified date, which shall be true and correct only as such specified date), except where the failure to be so true and correct would not reasonably be expected to prohibit or materially and adversely affect the Investors performance of their obligations under this Agreement.

 

  (iv) Covenants. The Investors shall have performed and complied in all material respects with all of their covenants and agreements contained in this Agreement and in any other Transaction Agreement required to be performed or complied with on or prior to the Closing Date.

 

  (v) NYSE. The Offered Shares shall have been approved for listing on the NYSE, subject to official notice of issuance.

 

21


  (vi) HSR Clearance. Any waiting period (including any extension thereof) applicable to the acquisition of Offered Shares and/or Remaining Offered Shares by any Investor (or any Affiliated Purchaser of any Investor) or any Other Applicable Shareholder (or any Affiliated Entity of any Other Applicable Shareholder) under the HSR Act shall have expired or early termination thereof shall have been granted.

 

  8. Indemnification and Contribution .

 

  (a) Whether or not the Rights Offering or the other transactions contemplated hereby are consummated or this Agreement is terminated, the Company (in such capacity, the “Indemnifying Party”) shall indemnify and hold harmless each Investor, its Affiliates, and their respective officers, directors, members, partners, employees, agents and controlling persons (each, an “Indemnified Person”) from and against any and all losses, claims, suits, proceedings, damages, liabilities, costs, and expenses (including reasonable fees of counsel), joint or several, arising out of, or related to circumstances existing on or prior to the Closing Date (“Losses”) to which any the Indemnified Person may become subject arising out of or in connection with any action, claim, challenge, litigation, suit, investigation, inquiry or proceeding (“Proceedings”) with respect to the Rights Offering, this Agreement or the other Transaction Agreements, any SEC Transaction Document (for the avoidance of doubt, including any amendment or supplement thereto), or the transactions contemplated by any of the foregoing and shall reimburse the Indemnified Persons for any reasonable legal or other out-of-pocket expenses incurred in connection with investigating, responding to or defending any of the foregoing; provided that the foregoing indemnification will not apply to Losses to the extent that they resulted directly from (i) any breach by such Indemnified Person of this Agreement (ii) gross negligence, bad faith or willful misconduct on the part of the Indemnified Person, or (iii) statements or omissions in the SEC Transaction Documents made in reliance upon written information relating to the Indemnified Person furnished to the Company in writing by or on behalf of the Indemnified Person expressly for use in such SEC Transaction Documents. If for any reason the foregoing indemnification is unavailable to any Indemnified Person or insufficient to hold it harmless, then the Indemnifying Party shall contribute amounts in respect of such Losses in such proportion as is appropriate to reflect not only the relative benefits received by the Indemnifying Party, on the one hand, and the Indemnified Person, on the other hand, but also the relative fault of the Indemnifying Party, on the one hand and the Indemnified Person, on the other hand, as well as any relevant equitable considerations. The indemnity, reimbursement and contribution obligations of the Indemnifying Party under this Section 8 shall be in addition to any liability that the Indemnifying Party may otherwise have to an Indemnified Person and shall bind and inure to the benefit of any successors, assigns, heirs and personal representatives of the Indemnifying Party and any Indemnified Person.

 

  (b)

Reasonably promptly after receipt by an Indemnified Person of notice of the commencement of any Proceedings with respect to which the Indemnified Person may be entitled to indemnification hereunder, such Indemnified Person will, if a claim is to be made hereunder against the Indemnifying Party in respect thereof, notify the Indemnifying Party in writing of the commencement thereof; provided that (i) the omission to so notify the Indemnifying Party will not relieve the Indemnifying Party from any liability that it may have hereunder except to the extent it has been actually prejudiced by such failure and (ii) the omission to so notify the Indemnifying Party will not relieve it from any liability that it may have to an Indemnified Person otherwise than on account of this Section 8. In case any such Proceeding is brought against any Indemnified Person and it notifies the Indemnifying Party of the commencement thereof, the Indemnifying Party will be entitled to participate therein, and, to the extent that it may elect by written notice delivered to such

 

22


  Indemnified Person, to assume the defense thereof, with counsel reasonably satisfactory to such Indemnified Person; provided, that if the defendants in any such Proceeding include both such Indemnified Person and the Indemnifying Party and such Indemnified Person shall have concluded that there may be legal defenses available to it that are different from or additional to those available to the Indemnifying Party, or that there otherwise exists or may exist a conflict of interest, such Indemnified Person shall have the right to select, at the expense of the Indemnifying Party, one separate counsel (as well as one or more local counsels), to assert such legal defenses and to otherwise participate in the defense of such Proceeding on behalf of such Indemnified Person; provided, further, that the right of the Indemnifying Party to so assume the defense of any such Proceeding shall not apply, and the Indemnified Person shall be permitted to instead assume the defense of any such Proceeding with separate counsel (including one or more local counsels) of its choosing, at the expense of the Indemnifying Party, to the extent that (w) the Indemnifying Party shall not have employed counsel satisfactory to such Indemnified Person to represent such Indemnified Person within a reasonable time after notice of commencement of such Proceeding, (x) the Indemnifying Party is not, in the reasonable determination of such Indemnified Person, diligently pursuing such defense, (y) the Indemnifying Party shall not have elected to assume such defense pursuant to written notice delivered to such Indemnified Person within ten (10) calendar days after notice of commencement of such Proceeding or (z) such Proceeding relates to any criminal action, indictment, allegation or investigation or does not solely seek (and continue to solely seek) monetary damages.

 

  (c) The Indemnifying Party shall not be liable under this Section 8 to an Indemnified Person for any settlement of any Proceedings effected by such Indemnified Person without the Indemnifying Party’s written consent (which consent shall not be unreasonably withheld, delayed or conditioned). The Indemnifying Party shall not, without the prior written consent of an Indemnified Person, effect any settlement of any pending or threatened Proceedings in respect of which indemnity has been sought hereunder by such Indemnified Person unless (i) such settlement includes an unconditional release of such Indemnified Person in form and substance satisfactory to such Indemnified Person from all liability on the claims that are the subject matter of such Proceedings and (ii) such settlement does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.

 

  9. Termination .

 

  (a) This Agreement may be terminated at any time prior to the Closing Date:

 

  (i) by mutual written consent of the Company and the Investors;

 

  (ii) by either the Company or the Investors, if any statute, rule, regulation, order or other legal restraint shall have been enacted, adopted, or issued by any Governmental Entity, or any judgment, injunction, decree or order of any Governmental Entity shall have been issued that, in any case, prohibits the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements, and such action, statute, rule, regulation, order, legal restraint, judgment, injunction or decree has become final, binding and non-appealable;

 

  (iii)

by either the Company or the Investors, if (A) the Commission shall have entered a stop order with respect to the Rights Offering Registration Statement or (B) there shall have occurred a suspension of trading in shares of Common Stock on

 

23


  the NYSE; provided that, a suspension shall not count for purposes of the foregoing subclause (B) if (x) it lasts for a period of less than 24 hours and does not result in a material impairment in the trading price of Common Stock, or (y) it lasts for a period of less than 72 hours, relates to securities generally on the NYSE and does not disproportionately affect the trading or price of shares of Common Stock;

 

  (iv) by the Company:

 

  (A) if there has been a breach of any covenant or a breach of any representation or warranty of an Investor, which breach would cause the failure of any condition precedent set forth in Section 7(b), provided that any such breach of a covenant or representation or warranty (A) is not cured by such Investor within ten (10) calendar days following delivery by the Company to such Investors of written notice thereof or (B) is not capable of cure on or prior to the Outside Date; or

 

  (B) if there shall have occurred any event that results in a failure to satisfy any of the conditions set forth in Section 7(b), which failure is not (i) cured within ten (10) calendar days following delivery by the Company to the Investors of written notice thereof or (ii) capable of cure on or prior to the Outside Date; provided, that the right to terminate this Agreement under this Section 9(a)(iv)(B) shall not be available to the Company if the Company’s failure to comply with any provision of this Agreement has been the cause of, or resulted in, the failure to satisfy any such condition;

 

  (v) by the Investors:

 

  (A) if there has been a breach of any covenant or a breach of any representation or warranty of the Company, which breach would cause the failure of any condition precedent set forth in Section 7(a), provided that any such breach of a covenant or representation or warranty (i) is not cured by the Company within ten (10) calendar days following delivery by any Investor to the Company of written notice thereof or (ii) is not capable of cure on or prior to the Outside Date; or

 

  (B) if there shall have occurred any event that results in a failure to satisfy any of the conditions set forth in Section 7(a), which failure is not (i) cured within ten (10) calendar days following delivery by any Investor to the Company of written notice thereof or (ii) capable of cure on or prior to the Outside Date; provided, that the right to terminate this Agreement under this Section 9(a)(v)(B) shall not be available to the Investors if the failure of any of them to comply with any provision of this Agreement has been the cause of, or resulted in, the failure to satisfy any such condition;

 

  (C) if there shall have occurred any Material Adverse Effect since November 22, 2013;

 

  (D)

if (1) the Rights Offering Registration Statement is not filed with the Commission prior to the close of business on the date of this Agreement,

 

24


  (2) the Rights Offering shall not have been consummated by March 31, 2014 (the “Outside Date”) or (3) the issuance and sale of the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers shall not have been consummated (x) prior to April 7, 2014 or (y) if earlier, on or prior to the sixth (6th) Business Day after the Expiration Date; or

 

  (E) if there shall have occurred any breach or default, or threatened breach or default, under the terms and conditions of any Other Applicable Agreement by any party thereto, on the basis of which any party thereto has terminated such Other Applicable Agreement.

 

  (b) A termination pursuant to and in accordance with this Section 9 shall be effective upon giving written notice to the other party specifying the provision under which the Agreement is terminated. Upon termination in accordance with this Section 9, all rights and obligations of the parties under this Agreement shall terminate without any liability of any party to any other party except that the covenants and agreements made by the parties herein in Section 2(f) and Sections 8 through 18 will survive indefinitely in accordance with their terms.

 

  10. Notices . All notices and other communications in connection with this Agreement will be in writing and will be deemed given (and will be deemed to have been duly given upon receipt) (a) on the date of delivery, if delivered personally, (b) upon confirmation of receipt, if sent via electronic transmission, (c) on the first business day following the date of dispatch if delivered by a recognized next-day courier service or (d) on the fifth business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid to the parties to the Agreement at the following addresses (or at such other address for a party as will be specified by like notice):

 

  (a) If to the Company:

EXCO Resources, Inc.

12377 Merit Drive, Suite 1700

Dallas, Texas 75251

Email: lboeing@excoresources.com

Attention: William L. Boeing

with copies (which shall not constitute notice) to:

Haynes and Boone, LLP

2323 Victory Avenue, Suite 700

Dallas, Texas 75219

Email: scott.wallace@haynesboone.com

            jennifer.wisinski@haynesboone.com

Attention: W. Scott Wallace, Esq.

                 Jennifer T. Wisinski, Esq.

and:

 

  (b) If to any Investor:

c/o WL Ross & Co. LLC

1166 Avenue of the Americas

New York, NY 10036

 

25


Email: Ben_Gruder@invesco.com

Attention: Benjamin Gruder

with copies (which shall not constitute notice) to:

Wachtell, Lipton, Rosen & Katz

51 West 52 nd Street

New York, NY 10019

Email: deshapiro@wlrk.com

            klcain@wlrk.com

Attention: David E. Shapiro, Esq.

                  Karessa L. Cain, Esq.

 

  11. Assignment; Third Party Beneficiaries . Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of law or otherwise) without the prior written consent of the other parties, except that each Investor may assign its rights, interests and/or obligations under this Agreement to any of its Affiliated Purchasers pursuant to Section 2(c). Notwithstanding the foregoing or anything to the contrary contained herein, subject to Section 2(c), this Agreement, and any Investor’s rights, interests or obligations hereunder, including any Rights, may be assigned, delegated or transferred, in whole or in part, by such Investor to one or more of such Investor’s Affiliated Purchasers without the prior written consent of the Company, provided that any such assignee assumes the obligations of such Investor hereunder and agrees in writing to be bound by the terms of this Agreement in the same manner as such Investor; provided, that no such assignment will relieve such Investor of its obligations hereunder if such assignee fails to perform such obligations. Except as provided in Section 8 with respect to the Indemnified Persons and Section 13(b) with respect to Non-Recourse Parties, this Agreement is not intended to and does not confer upon any person other than the parties hereto any rights or remedies under this Agreement and nothing set forth in this Agreement shall confer upon or give to, or be construed to confer upon or give to, any other person (including any Affiliates of the Company or any of its respective members, shareholders, partners, directors, employees, officers or creditors or any successor thereto or assignee thereof, or any third party claiming by or through any of the foregoing) any benefits, rights or remedies under or by reason of, or any rights to enforce or cause the Company to enforce, the obligations of any Investor or its permitted assignees hereunder or any other provisions of this Agreement. Any Indemnified Persons and any Non-Recourse Parties shall be entitled to enforce and rely on the provisions listed in the immediately preceding sentence as if they were a party to this Agreement.

 

  12. Prior Negotiations; Entire Agreement . This Agreement, together with the documents and instruments attached as schedules, annexes or exhibits to and referred to in this Agreement, constitutes the entire agreement of the parties with respect to the Rights Offering and supersedes all prior agreements (including the Prior Agreement), arrangements or understandings, whether written or oral, between the parties or any of their respective Affiliates with respect to the transactions contemplated hereby.

 

  13. GOVERNING LAW; VENUE; Non-Recourse Parties .

 

  (a)

THIS AGREEMENT WILL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE PARTIES HERETO CONSENTS TO SUBMIT ITSELF TO THE EXCLUSIVE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK LOCATED IN THE BOROUGH OF MANHATTAN AND ANY UNITED STATES FEDERAL COURTS LOCATED IN SOUTHERN DISTRICT OF NEW YORK,

 

26


  WITH RESPECT TO ANY CLAIM OR CAUSE OF ACTION ARISING UNDER OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY, AND WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS UPON IT, AND AGREES THAT ALL SERVICE OF PROCESS MAY BE MADE BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED, DIRECTED TO IT AT ITS ADDRESS AS SET FORTH IN SECTION 10, AND THAT SERVICE SO MADE SHALL BE TREATED AS COMPLETED WHEN RECEIVED. EACH OF THE PARTIES HERETO WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS AND WAIVES ANY OBJECTION TO VENUE OF ANY ACTION INSTITUTED IN ANY SUCH COURT. THE COMPANY AND THE INVESTORS HEREBY IRREVOCABLY WAIVE ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT, PROCEEDING, OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THE NEGOTIATION, ADMINISTRATION, PERFORMANCE, AND ENFORCEMENT HEREOF. NOTHING IN THIS PARAGRAPH SHALL AFFECT THE RIGHT OF THE PARTIES HERETO TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. NOTWITHSTANDING THE FOREGOING, EACH OF THE PARTIES HERETO AGREES THAT EACH OF THE OTHER PARTIES HERETO SHALL HAVE THE RIGHT TO BRING ANY ACTION OR PROCEEDING FOR ENFORCEMENT OF A JUDGMENT ENTERED BY A COURT PERMITTED BY THIS SECTION 13 IN ANY OTHER COURT OR JURISDICTION.

 

  (b) Notwithstanding anything that may be otherwise expressed or implied in this Agreement, the Company, by its acceptance of the benefits hereof, covenants, agrees and acknowledges for itself and its Affiliates that no person other than the Investors and their respective permitted successors and assigns, including their respective applicable Affiliated Purchasers, if any, who acquire Investor Over-Subscription Shares or Investor Offered Shares from the Company pursuant to this Agreement, shall have any obligation hereunder or in connection with the transactions contemplated hereby and that no recourse hereunder or in respect of any oral representations made or alleged to be made in connection herewith or therewith shall be had against any former, current or future equity holder, controlling person, director, officer, employee, agent, affiliate, member, manager, general or limited partner, representative or successor or assignee of any Investor (or any such applicable Affiliated Purchaser) or any former, current or future equity holder, controlling person, director, officer, employee, agent, affiliate, member, manager, general or limited partner, representative or successor or assignee of any of the foregoing (such persons, collectively, but excluding the Investors and their respective applicable Affiliated Purchasers, if any, who acquire Investor Over-Subscription Shares or Investor Offered Shares from the Company pursuant to this Agreement, the “Non-Recourse Parties”), whether by the enforcement of any assessment or by any legal or equitable proceedings, or by virtue of any statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on, or otherwise be incurred by any Non-Recourse Party, as such, for any obligations of any Investor under this Agreement or any documents or instruments delivered in connection herewith or in respect of any oral representations made or alleged to be made in connection herewith or therewith or for any claim based on, in respect of, or by reason of, such obligations or their creation.

 

  14. Counterparts . This Agreement may be executed in any number of counterparts, all of which will be considered one and the same agreement and will become effective when counterparts have been signed by each of the parties and delivered to the other party (including via electronic transmission), it being understood that each party need not sign the same counterpart.

 

27


  15. Waivers and Amendments . This Agreement may be amended, modified, superseded, cancelled, renewed or extended, and the terms and conditions of this Agreement may be waived, only by a written instrument signed by all the parties or, in the case of a waiver, by the party waiving compliance. No delay on the part of any party in exercising any right, power or privilege pursuant to this Agreement will operate as a waiver thereof, nor will any waiver on the part of any party of any right, power or privilege pursuant to this Agreement, nor will any single or partial exercise of any right, power or privilege pursuant to this Agreement, preclude any other or further exercise thereof or the exercise of any other right, power or privilege pursuant to this Agreement. The rights and remedies provided pursuant to this Agreement are cumulative and are not exclusive of any rights or remedies which any party otherwise may have at law or in equity.

 

  16. Interpretation; Severability .

 

  (a) When a reference is made in this Agreement to “Sections,” “Annexes,” “Schedules” or “Exhibits” such reference shall be to a Section of, or Annex, Schedule or Exhibit to, this Agreement unless otherwise indicated. The terms defined in the singular have a comparable meaning when used in the plural, and vice versa. References to “herein,” “hereof,” “hereunder” and the like refer to this Agreement as a whole and not to any particular section or provision, unless the context requires otherwise. The headings contained in this Agreement are for reference purposes only and are not part of this Agreement. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed followed by the words “without limitation.” No rule of construction against the draftsperson shall be applied in connection with the interpretation or enforcement of this Agreement, as this Agreement is the product of negotiation between sophisticated parties advised by counsel. Except as expressly stated in this Agreement, all references to any statute, rule or regulation are to the statute, rule or regulation as amended, modified, supplemented or replaced from time to time (and, in the case of statutes, include any rules and regulations promulgated under the statute) and to any section of any statute, rule or regulation include any successor to the section.

 

  (b) It is the intent of the parties that the provisions of this Agreement shall be enforced to the fullest extent permissible under applicable law and public policies applied in each jurisdiction in which enforcement is sought. If any particular provision or portion of this Agreement shall be adjudicated to be invalid or unenforceable, such provision or portion thereof shall be deemed amended to the minimum extent necessary to render such provision or portion valid and enforceable, and such amendment will apply only with respect to the operation of such provision or portion in the particular jurisdiction in which such adjudication is made.

 

  17. Adjustment to Shares . If, prior to the Closing Date, the Company effects a reclassification, stock split (including a reverse stock split), stock dividend or distribution, recapitalization, merger, issuer tender or exchange offer, or other similar transaction with respect to any shares of its capital stock (excluding the distribution of the Rights in connection with the Rights Offering, as contemplated herein), references to the numbers of such shares and the prices therefore shall be equitably adjusted to reflect such change and, as adjusted, shall, from and after the date of such event, be subject to further adjustment in accordance herewith.

 

  18. Survival . The representations and warranties made in this Agreement will survive until the earlier of (i) the termination of this Agreement in accordance with Section 9 and (ii) the 18-month anniversary of the Closing.

The remainder of this page left intentionally blank.

 

28


IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be signed by their respective officers thereunto duly authorized, all as of the date first written above.

 

EXCO RESOURCES, INC.
 

/s/ William L. Boeing

Name:   William L. Boeing
Title:   Vice President and General Counsel
WLR RECOVERY FUND IV XCO AIV I, L.P.
By:   WLR Recovery Associates IV LLC,
  its General Partner
By:   WL Ross Group, L.P.,
  its Managing Member
By:   El Vedado, LLC,
  its General Partner
By:  

/s/ Michael J. Gibbons

  Michael J. Gibbons, authorized person
WLR RECOVERY FUND IV XCO AIV II, L.P.
By:   WLR Recovery Associates IV LLC,
  its General Partner
By:   WL Ross Group, L.P.,
  its Managing Member
By:   El Vedado, LLC,
  its General Partner
By:  

/s/ Michael J. Gibbons

 

Michael J. Gibbons, authorized person

[ Signature Page for the WLR Investment Agreement ]


WLR RECOVERY FUND IV XCO AIV III, L.P.
By:   WLR Recovery Associates IV LLC,
  its General Partner
By:   WL Ross Group, L.P.,
  its Managing Member
By:   El Vedado, LLC,
  its General Partner
By:  

/s/ Michael J. Gibbons

  Michael J. Gibbons, authorized person
WLR SELECT CO-INVESTMENT XCO AIV, L.P.
By:   WLR Select Associates LLC,
  its General Partner
By:   WL Ross Group, L.P.,
  its Managing Member
By:   El Vedado, LLC,
  its General Partner
By:  

/s/ Michael J. Gibbons

  Michael J. Gibbons, authorized person
WLR/GS MASTER CO-INVESTMENT XCO AIV, L.P.
By:   WLR Master Co-Investment GP, LLC,
  its General Partner
By:   WL Ross Group, L.P.,
  its Managing Member
By:   El Vedado, LLC,
  its General Partner
By:  

/s/ Michael J. Gibbons

  Michael J. Gibbons, authorized person

[ Signature Page for the WLR Investment Agreement ]


WLR IV PARALLEL ESC, L.P.
By:   INVESCO WLR IV ASSOCIATES LLC,
  its General Partner
By:   INVESCO Private Capital, Inc.,
  its Managing Member
By:  

/s/ Michael J. Gibbons

  Michael J. Gibbons, authorized person

[ Signature Page for the WLR Investment Agreement ]

Exhibit 4.14

INVESTMENT AGREEMENT

This INVESTMENT AGREEMENT (this “Agreement”), dated as of December 17, 2013, is made by and among Hamblin Watsa Investment Counsel Ltd., as representative (the “Representative”) of the several investors to be named by the Representative (each of which shall be an Affiliated Entity) at least one (1) Business Day prior to the Closing Date (each an “Investor” and, collectively, the “Investors”), on the one hand, and EXCO Resources, Inc., a Texas corporation (the “Company”), on the other hand.

WHEREAS, the Representative and the Company are parties to that certain letter agreement (the “Prior Agreement”), dated as of November 22, 2013, and desire to supersede, amend and restate the Prior Agreement in its entirety;

WHEREAS, (i) the Board of Directors of the Company (the “Board”) generally authorized a rights offering by the Company, (ii) the directors of the Board who are not affiliated with the Investors or with any other shareholder (each, an “Other Applicable Shareholder”) who is entering into an agreement (each, an “Other Applicable Agreement”) with the Company in connection with the rights offering that is substantially similar to this Agreement (the “Disinterested Directors”) unanimously approved the Prior Agreement and (iii) the Disinterested Directors delegated all authority of the Board in connection with the rights offering to a newly formed Rights Committee, comprised entirely of Disinterested Directors (the “Rights Committee”);

WHEREAS, the Rights Committee has approved the distribution, at no charge, to each holder of record of shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) as of 5:00 p.m., New York City time, on December 19, 2013 (such time and date, the “Record Date”), transferable rights (the “Rights”) to subscribe for and purchase shares of Common Stock, with one (1) Right to be distributed for each share of Common Stock (the “Rights Offering”);

WHEREAS, each holder of a Right will be entitled (the “Basic Subscription Right”) to subscribe for and purchase 0.25 of a share of Common Stock per Right at a subscription price of $5.00 per whole share of Common Stock (the “Subscription Price” and such shares of Common Stock purchasable pursuant to the Basic Subscription Right, the “Offered Shares”), with fractional shares of Common Stock resulting from the exercise of the Basic Subscription Right to be eliminated by rounding down to the nearest whole share of Common Stock with respect to the exercise by any holder;

WHEREAS, to the extent that holders of Rights do not timely and fully exercise their rights to subscribe for and purchase all of the Offered Shares available under the Basic Subscription Right, each holder of Rights that exercises in full its Basic Subscription Right will be entitled to subscribe for additional shares of Common Stock at the Subscription Price (the “Over-Subscription Privilege”), with fractional shares of Common Stock resulting from the exercise of the Over-Subscription Privilege right to be eliminated by rounding down to the nearest whole share of Common Stock with respect to the exercise of any holder;

WHEREAS, in order to facilitate the Rights Offering, the Representative and the Company entered into the Prior Agreement and wish to enter into this Agreement, pursuant to which, and upon the terms and subject to the conditions set forth herein, the Investors have agreed to subscribe for and purchase, in a private placement, shares of Common Stock pursuant to their Basic Subscription Right and Over-Subscription Privilege; and

WHEREAS, the Rights Committee has unanimously approved the Rights Offering, this Agreement and the transactions contemplated hereby.

 

1


NOW, THEREFORE, in consideration of the mutual promises, agreements, representations, warranties and covenants contained herein, it is hereby agreed that the Prior Agreement is superseded, amended and restated in its entirety by this Agreement, and each of the parties hereto hereby agrees as follows:

 

  1. Rights Offering .

 

  (a) On the terms and subject to the conditions set forth herein and in the Rights Offering Registration Statement, the Company shall distribute, at no charge, to the holders of record of each share of Common Stock as of the Record Date (each, an “Eligible Holder”) one (1) Right for each whole share of Common Stock owned by the Eligible Holder as of the close of business on the Record Date. Each Right shall entitle the Eligible Holder to purchase, at the Subscription Price per whole share, 0.25 of a share of Common Stock. Fractional shares resulting from the exercise of the Rights will be eliminated by rounding down to the nearest whole share with respect to the exercise by any holder. No Rights will be distributed or issued with respect to any treasury stock. To the extent permitted by the New York Stock Exchange, each Right will be transferable separately from the underlying shares of Common Stock in respect of which such Right was distributed. Eligible Holders (to the extent they continue to own Rights during the duration of the Rights Offering) and holders to whom Rights have been validly transferred are collectively referred to as “Holders,” each individually being a “Holder.”

 

  (b) The Company will commence the Rights Offering on the date hereof by filing the Rights Offering Registration Statement with the Commission and mailing a prospectus and related materials to record and beneficial owners of Common Stock. The Rights (including under both the Basic Subscription Rights and the Over-Subscription Privilege) may be exercised during a period (the “Rights Exercise Period”) beginning from and after the Record Date and ending at 5:00 p.m. New York City Time on January 9, 2014, subject to extension (i) solely to the extent necessary to permit the satisfaction prior to the Closing Date of the conditions set forth in Sections 7(a)(i) and (viii) and Sections 7(b)(i) and (vi) or (ii) with the prior written consent of the Representative (5:00 p.m. New York City Time on January 9, 2014, as may be so extended, the “Expiration Date”). “Business Day” has the meaning ascribed to such term in Rule 14d-1(g) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

  (c) As described in the Rights Offering Prospectus, each Holder that wishes to exercise all or a portion of its Rights under the Basic Subscription Right shall (i) during the Rights Exercise Period return a duly executed document to Continental Stock Transfer & Trust Company (the “Subscription Agent”), electing to exercise all or a portion of the Rights held by such Holder and (ii) pay in immediately available funds (or such other method as set forth in the Rights Offering Prospectus) an amount equal to the full Subscription Price for the whole number of shares of Common Stock that such Holder elects to purchase pursuant to the instructions set forth in the Rights Offering Registration Statement and related materials by the Expiration Date to an escrow account established by the Subscription Agent for the Rights Offering. On or promptly after the Closing Date, subject to the satisfaction (or, to the extent permitted, waiver) of the conditions to the Rights Offering, the Company shall issue to each Holder that validly exercised its Rights under the Basic Subscription Right the number of Offered Shares to which such Holder is entitled based on such exercise.

 

  (d)

Each Holder that timely exercises in full its Basic Subscription Right will be entitled under the Over-Subscription Privilege to subscribe (at the Subscription Price pursuant to the instructions set forth in the Rights Offering Registration Statement and related materials) for any or all additional shares of Common Stock to the extent that other Holders elect not to exercise all of their respective Rights to subscribe for and purchase all of the Offered Shares under the Basic Subscription Right. If the number of Offered Shares remaining after the exercise of Rights under the Basic

 

2


  Subscription Right (the “Remaining Offered Shares”) is not sufficient to satisfy all requests for Offered Shares under the Over-Subscription Privilege, including the election of the Investors to purchase Remaining Offered Shares pursuant to the Over-Subscription Privilege, the Holders that exercised their Rights under the Over-Subscription Privilege will be allocated such Remaining Offered Shares pro rata among such Holders exercising the Over-Subscription Privilege in proportion to the number of shares of Common Stock each such Holder (including, in the case of the Investors or any Other Applicable Shareholders, their respective Affiliated Entities) owned as of 5:00 p.m., New York City time, on the Record Date, relative to the number of shares of Common Stock owned as of 5:00 p.m., New York City time, on the Record Date by all such Holders (including, in the case of the Investors or any Other Applicable Shareholders, their respective Affiliated Entities) exercising the Over-Subscription Privilege. If such pro rata allocation would result in any Holder receiving a greater number of Remaining Offered Shares than any Holder subscribed for pursuant to the exercise of the Over-Subscription Privilege, then such Holder will be allocated only that number of Remaining Offered Shares for which such Holder subscribed for pursuant to the exercise of the Over-Subscription Privilege, and the remaining shares will be allocated among all other Holders exercising the Over-Subscription Privilege on the same pro rata allocation basis described above. Such pro rata allocation process shall be repeated until all of the Remaining Offered Shares have been allocated.

 

  2. Agreement to Purchase Investor Offered Shares and Investor Over-Subscription Shares; Fees and Expenses .

 

  (a) Upon the terms and subject to the conditions set forth in this Agreement, each of the Investors hereby agrees, severally and on behalf of and with respect to itself only, and not jointly with any other Investor, to subscribe for and purchase in a private placement (i) shares of Common Stock pursuant to the Basic Subscription Right (the “Investor Offered Shares”) and (ii) shares of Common Stock under the Over-Subscription Privilege for all Remaining Offered Shares (any such Remaining Offering Shares purchased by the Investors, the “Investor Over-Subscription Shares”); provided, however, that in no event shall the Investors under this Agreement, taken together, be required to acquire, in the aggregate, a number of Investor Over-Subscription Shares exceeding the lesser of (1) 100% of the Remaining Offered Shares and (2) a number of Investor Over-Subscription Shares which, when taken together with the aggregate number of Investor Offered Shares, is equal to 50% of the total number of Offered Shares; and provided, further, that such percentages and amounts may be reduced by mutual agreement of the Company and the Representative in the event that any other existing shareholder of the Company provides an exercise commitment in connection with the Rights Offering. For the avoidance of doubt, (A) any Investor Offered Shares and Investor Over-Subscription Shares acquired by the Investors shall be purchased at a per share price equal to the Subscription Price and (B) the Investor Offered Shares shall be included when determining the number of shares of Common Stock validly subscribed for and purchased under the Basic Subscription Right, and the Investor Over-Subscription shares shall be included when determining the number of shares of Common Stock validly subscribed for under the Over-Subscription Privilege.

 

  (b) The Company hereby agrees and undertakes to notify the Representative as promptly as practicable and, in any event, by noon, New York City Time, on the fourth (4th) Business Day after the Expiration Date by electronic or facsimile transmission of (i) the aggregate number of Rights validly exercised by Holders under the Basic Subscription Right and Over-Subscription Privilege pursuant to the Rights Offering as of the Expiration Date and the aggregate Subscription Price therefor, and (ii) a true and accurate determination of the aggregate number of Investor Over-Subscription Shares, if any, (such notification, the “Notice of Offering Results”).

 

3


  (c) Subject to applicable law, each Investor shall have the right to arrange for one or more of its Affiliated Entities (each, an “Affiliated Purchaser”) to purchase all or any portion of such Investor’s Investor Offered Shares and/or Investor Over-Subscription Shares, on the terms and subject to the conditions in this Agreement, by written notice to the Company at least one (1) Business Day prior to the Closing Date, which notice shall be signed by the applicable Investor and each of its applicable Affiliated Purchasers (i.e., for clarity, those purchasing all or any portion of such Investor’s Investor Offered Shares and/or Investor Over-Subscription Shares) and pursuant to which each such Affiliated Purchaser shall agree to all the terms of this Agreement as if it were an Investor, including that it can make each representation in Section 4 of this Agreement as if it were an Investor. In no event will any such arrangement relieve such Investor of its obligations under this Agreement if its Affiliated Purchaser(s) fail to perform such obligations in accordance with the terms and conditions of this Agreement. The term “Affiliated Entity”, with respect to any person, means any fund or other entity that is directly or indirectly controlled by the same manager or other person(s) as such first person.

 

  (d) The closing of the purchase of the Offered Shares to be purchased in the Rights Offering, including, subject to the terms and conditions of this Agreement, the purchase of the Investor Offered Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, and, if applicable, the purchase of the Investor Over-Subscription Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder (the “Closing”), will occur at the offices of Haynes and Boone, LLP, 2323 Victory Avenue, Suite 700, Dallas, Texas 75219, 9:00 a.m., Central Time, as promptly as practicable (but in no event later than on the sixth (6 th ) Business Day) following later of the (i) the Expiration Date and (ii) the satisfaction (or, to the extent permitted, waiver) of the conditions set forth in Section 7 (other than those conditions that by their terms are to be satisfied at the Closing, but subject to the satisfaction (or, to the extent permitted, waiver) of those conditions at such time) (the “Closing Date”), or such other time as shall be agreed upon by the Company and the Representative. On the Closing Date, subject to the terms and conditions of this Agreement, the Investors will purchase, and the Company will sell, only such number of Investor Over-Subscription Shares as is listed in the Notice of Offering Results, without prejudice to the rights of the Investors to seek later an upward or downward adjustment if the number of Investor Over-Subscription Shares in such Notice of Offering Results is inaccurate. Delivery of the Investor Over-Subscription Shares and Investor Offered Shares will be made by the Company on the Closing Date by delivering stock certificates representing shares of Common Stock with a Securities Act legend to the Investors and/or Affiliated Purchasers, as applicable, against payment by the Investors and/or the Affiliated Purchasers, as applicable, of the Subscription Price therefor by wire transfer of immediately available funds to the account designated in writing by the Company. On the Closing Date, the Company will also deliver to the Investors a certificate, dated as of the Closing Date, of the transfer agent of the Company confirming the issuance to the Investors and/or the Affiliated Purchasers, as applicable, of the Investor Over-Subscription Shares, if any, and the issuance to the Investors and/or the Affiliated Purchasers, as applicable, of the Investor Offered Shares, and all other documents and certificates required to be delivered to the Investors pursuant to Section 7(a).

 

  (e) The Company shall notify, or cause the Subscription Agent to notify, the Representative on each Friday during the Rights Exercise Period and on each Business Day during the five Business Days prior to any then-scheduled Expiration Date (or, if reasonably requested by the Investors, use reasonable best efforts to provide such information more frequently, to the extent so reasonably requested), of the aggregate number of Rights known by the Company or the Subscription Agent to have been validly exercised pursuant to the Rights Offering as of the close of business on the preceding Business Day or the most recent practicable time before such request, as the case may be.

 

4


  (f) The Company shall pay all of its own fees and expenses associated with the Rights Offering, including filing and printing fees, fees and expenses of any subscription and information agents, its counsel and financial advisor(s) and/or dealer-managers (if any) and accounting fees and expenses, costs associated with clearing the Offered Shares for sale under applicable state securities laws, and listing fees.

 

  (g) The Investors and the Company hereby agree that it is the intent of all parties that none of the Investors, by virtue of acting hereunder, shall be deemed an “underwriter” within the definition of Section 2(a)(11) of the Securities Act or be deemed to be engaged in broker-dealer activity requiring registration under Section 15 of the Exchange Act, and the Investors and the Company shall in the fulfillment of their obligations hereunder act in accordance with this mutual understanding.

 

  (h) No public release or announcement (for the avoidance of doubt, excluding in respect of any Schedule 13D (or 13G), Form 4 or similar Commission filing requirements of the Investors or their Affiliates so long as the Company is provided a reasonable opportunity to comment on such disclosure in advance) concerning the Rights Offering, the purchase of shares of Common Stock by the Investors pursuant to this Agreement, or the other transactions contemplated hereby, shall be issued by any party hereto without the prior consent of the other party (which consent shall not be unreasonably withheld, conditioned or delayed), except as such release or announcement may be required by law, regulation or stock exchange rule, in which case the party required to make the release or announcement shall, to the extent reasonably practicable, allow the other party reasonable time to comment on such release or announcement in advance of such issuance; provided that in no event shall any such press release or announcement name the Investors or any of their Affiliates without their prior written consent, except to the extent necessary to comply with law, regulation or stock exchange rule. The provisions of this subsection (h) shall not restrict the ability of the Company to summarize or describe the transactions contemplated by this Agreement in any prospectus or similar offering document or other report, in each case to the extent required by law, regulation or stock exchange rule, so long as the other party is provided a reasonable opportunity to comment on such disclosure in advance.

 

  3. Representations and Warranties of the Company . The Company represents and warrants to, and agrees with, the Investors as set forth below. Except for representations, warranties and agreements that are expressly limited as to a particular date, each representation, warranty and agreement is made as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby:

 

  (a)

Organization and Qualification. The Company has been duly incorporated and is validly existing as a corporation in good standing under the laws of the State of Texas, with the corporate power and authority to own its properties and conduct its business as currently conducted, and, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, has been duly qualified as a foreign corporation for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties, or conducts any business so as to require such qualification. Each subsidiary of the Company that is a “significant subsidiary” within the meaning of Rule 1-02(w) of Regulation S-X under the Securities Act of 1933, as amended (the “Securities Act”) has been duly organized and is validly existing in good standing under the laws of its jurisdiction of organization, with the corporate or analogous power and authority to own its properties and conduct its business as currently conducted, and, except as has not had and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, has been duly qualified as a foreign corporation, limited liability company or partnership, as applicable, for the transaction of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties,

 

5


  or conducts any business so as to require such qualification. For the purpose of this Agreement, “Material Adverse Effect” means any change, effect, event, development (including, for the avoidance of doubt, the discovery of new or previously unknown information), circumstance or occurrence, or any of the foregoing involving a prospective change, effect, event, development, circumstance or occurrence, in the condition (financial or otherwise) or in the earnings, business or operations of Company or its subsidiaries, taken as a whole, that, as determined by the Investors acting reasonably, is material and adverse and makes it, in the reasonable determination of the Investors, impracticable to proceed with the Rights Offering.

 

  (b) Corporate Power and Authority. The Company has the requisite corporate power and authority to enter into, execute and deliver this Agreement, the Registration Rights Joinder Agreement and each other agreement, document, and instrument to which it is or will be a party or which it has executed and delivered, or will execute and deliver, in connection with the Rights Offering and the transactions contemplated by this Agreement (this Agreement, the Registration Rights Joinder Agreement and such other agreements, documents, and instruments, collectively, the “Transaction Agreements”) and to perform its obligations and consummate the transactions contemplated hereunder and thereunder, including the issuance of the Rights and the Offered Shares (including the Investor Offered Shares and Investor Over-Subscription Shares). The Company has taken all necessary action required for the due authorization of the Transaction Agreements, the performance of its obligations thereunder and the consummation of the transactions contemplated thereby, including the issuance of the Rights and the Offered Shares (including the Investor Offered Shares and Investor Over-Subscription Shares).

 

  (c) Execution and Delivery; Enforceability. Each Transaction Agreement to which the Company is a party has been duly and validly authorized, executed and delivered by the Company, and constitutes a valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as may be limited by the effect of bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or similar laws affecting the enforcement of creditors’ rights generally, subject to principles of equity and public policy and except to the extent that the indemnification and contribution provisions in this Agreement may be limited by federal or state securities laws (the “Exceptions”).

 

  (d)

Capitalization. The authorized capital stock of the Company consists of 350,000,000 shares of Common Stock of which, as of the date of this Agreement, 218,298,938 shares were issued and outstanding, of which 3,007,110 are shares of restricted stock issued pursuant to and subject to the vesting requirements of compensatory equity plans of the Company in effect as of the date hereof and set forth in Schedule A hereto (the “Company Stock Plans”) (excluding, for the avoidance of doubt, shares held in treasury), and 10,000,000 shares of Preferred Stock, par value $0.001 per share (the “Preferred Stock”), of which, as of the date of this Agreement, no shares are either designated or issued and outstanding. As of the date of this Agreement, the Company held 539,221 shares of Common Stock in its treasury. As of the date of this Agreement, no shares of Common Stock or Preferred Stock were reserved for issuance, except for 55,574,734 shares of Common Stock reserved for issuance for the Rights Offering and 14,014,393 shares of Common Stock reserved for issuance under the Company Stock Plans upon the exercise of stock options outstanding as of such date and granted under the Company Stock Plans, with a weighted average exercise price of $12.06 per share. The outstanding shares of Common Stock have been duly authorized and are validly issued and outstanding, fully paid and nonassessable, and subject to no preemptive rights (and were not issued in violation of any preemptive rights, the Company’s articles of incorporation or by-laws, or any applicable laws). Except as set forth above or pursuant to this Agreement, there are no (A) shares of capital stock or other equity interests or voting securities of the Company authorized, reserved for issuance, issued or outstanding, (B) options,

 

6


  warrants, calls, preemptive rights, subscription or other rights, instruments, agreements, arrangements or commitments of any character, obligating the Company or any of its subsidiaries to issue, transfer or sell or cause to be issued, transferred or sold any shares of capital stock or other equity interest or voting security in the Company or any securities or instruments convertible into or exchangeable for such shares of capital stock or other equity interests or voting securities, or obligating the Company or any of its subsidiaries to grant, extend or enter into any such option, warrant, call, preemptive right, subscription or other right, instrument, agreement, arrangement or commitment, (C) outstanding contractual obligations of the Company or any of its subsidiaries to repurchase, redeem or otherwise acquire any capital stock or other equity interest or voting securities of the Company or (D) issued or outstanding restricted stock awards, units, rights to receive any capital stock or other equity interest or voting securities of the Company on a deferred basis, or rights to purchase or receive any capital stock or equity interest or voting securities issued or granted by the Company to any current or former director, officer, employee or consultant of the Company. No subsidiary of the Company owns any shares of capital stock or other equity interest or voting securities of the Company. Expect as set forth on Schedule A hereto, there are no voting trusts or other agreements or understandings to which the Company or any of its subsidiaries is a party with respect to the voting of the capital stock or other equity interest or voting securities of the Company.

 

  (e) Issuance. The distribution of the Rights and the issuance of the Offered Shares, including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares, have been duly and validly authorized and, when such Offered Shares are issued and delivered against payment therefor, will be duly authorized, validly issued and delivered and fully paid and nonassessable, free and clear of all taxes, liens, preemptive rights, rights of first refusal, subscription and similar encumbrances, other than liens arising as a matter of applicable securities law. Upon the distribution by the Company of the Rights, such Rights will be duly and validly issued, free and clear of all taxes, liens, preemptive rights, rights of first refusal and similar encumbrances, other than liens arising as a matter of applicable securities law, and enforceable in accordance with their terms, and holders of Rights will be entitled to the rights described in the Rights certificates.

 

  (f) No Conflict. The distribution of the Rights, the sale, issuance and delivery of the Offered Shares upon exercise of the Rights (including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares), the consummation of the Rights Offering by the Company, and the execution and delivery by the Company of the Transaction Agreements and performance of and compliance with all of the provisions thereof by the Company and the consummation of the transactions contemplated therein (i) will not conflict with, or result in a breach or violation of, any of the terms or provisions of, or constitute a default under (in each case, with or without notice or lapse of time, or both), or result in the acceleration of, or the creation of any lien under, any indenture, mortgage, deed of trust, loan agreement or other agreement, instrument, contract or other arrangement to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any of the property or assets of the Company or any of its subsidiaries is subject, (ii) will not result in any violation of the provisions of the Company’s articles of incorporation or by-laws or any of the organizational or governance documents of any of its subsidiaries, and (iii) will not result in any violation of, or any termination or impairment of any rights under, any applicable law, including any license, authorization, injunction, judgment, order, decree, rule or regulation of any Governmental Entity. For purposes of this Agreement, “Governmental Entity” means any federal, state, local, domestic, foreign or supranational court, administrative or regulatory agency or commission or other federal, state, local, domestic, foreign or supranational governmental authority or instrumentality, except, in any such case in clauses (i) and (iii), for any conflict, breach, violation, default, acceleration, lien, termination or impairment which would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect.

 

7


  (g) Consents and Approvals. No consent, approval, authorization, order, registration or qualification of or with any third party or any Governmental Entity is required for the distribution of the Rights, the sale, issuance and delivery of the Offered Shares upon exercise of the Rights (including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares), the consummation of the Rights Offering, and the execution and delivery by the Company of the Transaction Agreements and performance of and compliance by the Company with all of the provisions thereof and the consummation of the transactions contemplated therein, except (i) the registration under the Securities Act of the issuance of the Offered Shares (excluding any Investor Offered Shares and any Investor Over-Subscription Shares) pursuant to the exercise of Rights, (ii) such consents, approvals, authorizations, registrations or qualifications as may be required under state securities or “blue sky” laws in connection with distribution of the Rights and the issuance of the Offered Shares (including any Investor Offered Shares and any Investor Over-Subscription Shares) pursuant to the exercise of Rights, (iii) if applicable, filings required under, and compliance with other applicable requirements of, the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and regulations promulgated thereunder (the “HSR Act”), (iv) filings required with the New York Stock Exchange in connection with listing of the Rights and the shares to be issued in the Rights Offering and pursuant to this Agreement and (v) the registration of the resale of the shares issued to the Investors pursuant to this Agreement, including such “blue sky” consents, approval authorizations, registrations or qualifications as may be necessary or appropriate.

 

  (h) Arm’s Length. In connection with all aspects of each transaction contemplated by this Agreement, the Company acknowledges and agrees that: (i) the Rights Offering and other the transactions contemplated by this Agreement are arm’s-length commercial transactions between the Company and the Investors, (ii) the Company is capable of evaluating, and understands and accepts, the terms, risks and conditions of the Rights Offering and other the transactions contemplated by this Agreement, (iii) in connection with the Rights Offering and other the transactions contemplated by this Agreement and the process leading to the foregoing, the Investors have been, are, and will be acting solely as principals and have not been, are not, and will not be acting as an advisor, agent or fiduciary for the Company or any of the Company’s Affiliates, shareholders, creditors or employees or any other person, and (iv) the Investors have no obligation to the Company or the Company’s Affiliates, shareholders, creditors or employees or any other person with respect to the Rights Offering and the other transactions contemplated hereby except those obligations expressly set forth in this Agreement. To the fullest extent permitted by law, the Company hereby waives and releases any claims that the Company or the Company’s Affiliates, shareholders, creditors or employees or any other person may have against the Investors or any of their Affiliates with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated by this Agreement. The term “Affiliate” has the meaning ascribed to such term in Rule 12b-2 under the Exchange Act.

 

  (i)

Company SEC Documents. Since January 1, 2011, the Company has filed or furnished all required reports, schedules, forms, statements and other documents (including exhibits and all other information incorporated therein) (the “Company SEC Documents”) with the United States Securities and Exchange Commission (the “Commission”). As of their respective dates, each of the Company SEC Documents complied in all material respects with the requirements of the Securities Act or the Exchange Act, as applicable, and the rules and regulations of the Commission promulgated thereunder applicable to such Company SEC Documents. The Company has filed with the Commission all “material contracts” (as such term is defined in Item 601(b)(10) of Regulation S-K under the Exchange Act) that are required to be filed as exhibits to the Company

 

8


  SEC Documents. No Company SEC Document filed after December 31, 2010, when filed, and, in the case of any Company SEC Document amended or superseded prior to the date of this Agreement, on the date of such amending or superseding filing, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading. Any Company SEC Documents filed with the Commission after the date hereof but prior to the Closing Date, when filed, will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they are made, not misleading. As of the date of this Agreement, the Company is and shall remain a Well Known Seasoned Issuer. For purposes of this Agreement, “Well Known Seasoned Issuer” means a “well known seasoned issuer”, and not an “ineligible issuer”, under Rule 405 promulgated under the Securities Act.

 

  (j)

Financial Statements. Each of (i) the financial statements and the related notes of the Company and its consolidated subsidiaries included or incorporated by reference in the Company SEC Documents, and (ii) the financial statements and the related notes of the Company and its consolidated subsidiaries to be included or incorporated by reference in the Rights Offering Registration Statement and the Rights Offering Prospectus, comply or will comply, as the case may be, in all material respects with the applicable requirements of the Securities Act, the Exchange Act, and the rules and regulations of the Commission thereunder, and fairly present, or will fairly present, as the case may be, in all material respects the financial position, results of operations and cash flows of the Company and its subsidiaries as of the dates indicated and for the periods specified, subject, in the case of the unaudited financial statements, to the absence of disclosures normally made in footnotes and to customary year-end adjustments that are not and shall not be material; such financial statements have been prepared, or will be prepared, as the case may be, in conformity with U.S. generally accepting accounting principles applied on a consistent basis throughout the periods covered thereby (except as disclosed in the Company SEC Documents filed before the date of this Agreement), and each of (A) the supporting schedules included or incorporated by reference in the Company SEC Documents, and (B) the supporting schedules to be included or incorporated by reference in the Rights Offering Registration Statement and the Rights Offering Prospectus, fairly present, or will fairly present, as the case may be, in all material respects, the information required to be stated therein; and each of (x) the other financial information included or incorporated by reference in the Company SEC Documents, and (y) the other financial information to be included or incorporated by reference in the Rights Offering Registration Statement and the Rights Offering Prospectus, has been, or will be, as the case may be, derived from the accounting records of the Company and its subsidiaries and presents fairly, or will present fairly, as the case may be, the information shown thereby. Neither the Company nor any of the Company’s subsidiaries is a party to, or has any commitment to become a party to, any joint venture, off-balance sheet partnership or any similar agreement or arrangement, where the result, purpose or effect of such agreement or arrangement is to avoid disclosure of any material transaction involving, or material liabilities of, the Company or any of its subsidiaries in the Company SEC Documents (including the financial statements contained therein). Except to the extent specifically reflected or reserved against on the September 30, 2013 consolidated balance sheet of the Company (including the notes thereto) included in the Company’s Form 10-Q as filed with the Commission on October 30, 2013, neither the Company nor any of its subsidiaries has any (i) liabilities (whether or not accrued, fixed, contingent, asserted or known) or (ii) any impairments (including impairments that would reasonably be expected to occur or be taken) to assets or reserves, except for liabilities or impairments, respectively, that would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect (provided, that for purposes of clause (ii), the definition of “Material Adverse Effect” shall be deemed to exclude the phrases “as determined by the Investors acting reasonably” and “in the reasonable determination of the Investors,” and any impairments or writedowns to the Company’s oil and natural gas properties (and/or, to the extent applicable, the Company’s other assets) (for the avoidance of doubt, excluding the $10,707,000 impairment previously taken by the Company in respect of the quarter ended March 31, 2013) which in the aggregate equal or exceed $150 million shall be deemed a Material Adverse Effect). The Company has designed and maintains a system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange

 

9


  Act) sufficient to provide reasonable assurances regarding the reliability of financial reporting. The Company (1) has designed and maintains disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act) to provide reasonable assurance that information required to be disclosed by the Company in the reports that it files or submits with the Commission is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules, regulations and forms, and is accumulated and communicated to the Company’s management as appropriate to allow timely decisions regarding required disclosure, and (2) has disclosed, based on its most recent evaluation of internal control over financial reporting, to the Company’s outside auditors and the Audit Committee of the Board (I) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that would reasonably be expected to adversely affect the Company’s ability to record, process, summarize and report financial information and (II) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company’s internal control over financial reporting, all of which information described in clauses (I) and (II) above has been disclosed by the Company to the Investors prior to the date hereof. Any material change in internal control over financial reporting required to be disclosed in any Company SEC Document has been so disclosed. Since December 31, 2011, to the knowledge of the Company, neither the Company nor any of its subsidiaries has received any complaint, allegation, assertion or claim regarding the accounting or auditing practices, procedures, methodologies or methods of the Company or any of its subsidiaries or their respective internal accounting controls relating to periods after December 31, 2011, except for any complaints, allegations, assertions or claims that have not had, and would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. Each of the principal executive officer of the Company and the principal financial officer of the Company (or each former principal executive officer of the Company and each former principal financial officer of the Company, as applicable) has made all certifications required by Rules 13a-14 and 15d-14 under the Exchange Act and Sections 302 and 906 of the Sarbanes-Oxley Act of 2002, as amended (“SOX”), with respect to the Company SEC Documents, and the statements contained in such certifications are true and complete. For purposes of this Agreement, “principal executive officer” and “principal financial officer” shall have the meanings given to such terms in SOX.

 

  (k) Rights Offering Registration Statement and Rights Offering Prospectus. The Rights Offering Registration Statement, as of the Securities Act Effective Date, and each Issuer Free Writing Prospectus, if any, at the time of use thereof, will comply in all material respects with the Securities Act and the rules and regulations promulgated thereunder and will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading; and as of the applicable date of the Rights Offering Prospectus and any amendment or supplement thereto and as of the Closing Date, the Rights Offering Prospectus will not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. At the time of its distribution and at the Expiration Date, the Investment Decision Package will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, the Company makes no representation and warranty with respect to any statements or omissions made in reliance on and in conformity with information regarding the Investors furnished to the Company in writing by the Representative expressly for use in the Rights Offering Registration Statement and the Rights Offering Prospectus, and any amendment or supplement thereto.

 

10


For the purposes of this Agreement, (i) the term “Rights Offering Registration Statement” means an automatically effective Shelf Registration Statement on Form S-3ASR to be filed with the Commission relating to the Rights Offering, including all exhibits thereto and any documents incorporated by reference therein, as amended as of the Securities Act Effective Date, and any post-effective amendment thereto that becomes effective; (ii) the term “Rights Offering Prospectus” means the final prospectus contained in the Rights Offering Registration Statement at the Securities Act Effective Date (including information, if any, omitted pursuant to Rule 430A and subsequently provided pursuant to Rule 424(b) under the Securities Act), and any amended form of such prospectus provided under Rule 424(b) under the Securities Act or contained in a post-effective amendment to the Rights Offering Registration Statement, including any documents incorporated by reference therein; (iii) the term “Investment Decision Package” means the Rights Offering Prospectus, together with any Issuer Free Writing Prospectus used by the Company to offer the Offered Shares to Holders pursuant to the Rights Offering; (iv) the term “Issuer Free Writing Prospectus” means each “issuer free writing prospectus” (as defined in Rule 433 of the rules promulgated under the Securities Act) prepared by or on behalf of the Company or used or referred to by the Company in connection with the Rights Offering, including any documents incorporated by reference therein; (v) the term “Securities Act Effective Date” means the date and time as of which the Rights Offering Registration Statement, or the most recent post-effective amendment thereto, was declared effective by the Commission; and (vi) the term “SEC Transaction Documents” means the Rights Offering Registration Statement, the Rights Offering Prospectus, the Investment Decision Package and any Issuer Free Writing Prospectuses.

 

  (l) No Registration Rights Agreements.

 

  (i) Other than the 2005 Registration Rights Agreement and the 2007 Registration Rights Agreement, the Company is not bound by any agreement, contract or other arrangement with respect to its equity securities granting any demand, shelf, incidental/piggyback or other registration rights (“Registration Rights”) to any person. Except as expressly disclosed in writing to the Investors prior to the date hereof, there have not been any amendments, modification or supplements to, or any waivers under, either the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement. Other than persons who would not be adversely affected and would not reasonably be expected to have or bring any material claim, no person has the right to require the Company or any of its subsidiaries to register any securities for sale under the Securities Act by reason of the filing of the Rights Offering Registration Statement. Schedule B hereto sets forth a true, complete and correct list of each person who delivered to the company a binding written waiver with respect to any such right, which binding written waivers are in full force and effect and copies of which have been provided to the Investors.

 

  (ii)

Schedule C hereto sets forth to the best of the Company’s knowledge, a true, complete and correct list of the names of each person (i) named as a selling shareholder in the Registration Statement on Form S-3 filed by the Company on April 16, 2010 or (ii) that the Company expects will be named as a selling shareholder on the Initial Shelf Registration Statement, and, in the case of either of clauses (i) or (ii), with respect to each such person, the number of Registrable Securities or Registrable Shares (as defined in the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement, respectively), respectively, owned by each such person as set forth in filings with the Commission with respect to the Common Stock. For purposes of this Agreement, the “2005 Registration Rights Agreement” means the First Amended and Restated Registration

 

11


  Rights Agreement of the Company, originally dated as of October 3, 2005, as amended and restated as of December 30, 2005, and the “2007 Registration Rights Agreement” means the Registration Rights Agreement of the Company, dated March 28, 2007, in respect of 7.0% Cumulative Convertible Perpetual Preferred Stock and Hybrid Preferred Stock.

 

  (iii) The entry by the Investors and the Company into the Registration Rights Joinder Agreement, and the Investors accordingly becoming parties to the 2005 Registration Rights Agreement as “Holders” and “Investor Holders” thereunder, will not conflict with, or result in a breach or violation of, or require any consent under, any of the terms or provisions of either the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement. After giving effect to the entry by the Investors and the Company into the Registration Rights Joinder Agreement as contemplated hereby, the Investors will become parties to the 2005 Registration Rights Agreement as “Holders” and “Investor Holders” thereunder, and the 2005 Registration Rights Agreement will be in full force and effect, and constitute a valid and binding obligation of the Company, enforceable against the Company by the Investors in accordance with its terms, except as may be limited by the Exceptions, and the Company has not granted, and will not grant, to any person any Registration Rights that conflict with, are inconsistent with or violate the rights to be granted to the Investors under the 2005 Registration Rights Agreement.

 

  (m) No Material Adverse Effect. Since January 1, 2013, other than as disclosed in the Company SEC Documents filed prior to the date hereof and except for actions to be taken in connection with the transactions contemplated under this Agreement, there has not occurred any Material Adverse Effect.

 

  (n) No Broker’s Fees. Neither the Company nor any of its subsidiaries is a party to any contract, agreement or understanding with any person that would give rise to a claim against the Company or the Investors for a financial advisory fee, brokerage commission, finder’s fee or like payment in connection with the Rights Offering, including the issuance of the Offered Shares upon exercise of Rights (including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares), or the other transactions contemplated in any of the Transaction Agreements.

 

  (o) Anti-takeover Provisions. The actions taken by the Disinterested Directors and the Board to approve this Agreement, the other Transaction Agreements and the transactions contemplated hereby and thereby constitute all the action necessary to render inapplicable to this Agreement, the other Transaction Agreements, the purchase of the Investor Offered Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, and, if applicable, the purchase of the Investor Over-Subscription Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, the provisions of any potentially applicable anti-takeover, control share, fair price, moratorium, interested shareholder or similar law and any potentially applicable provision of the Company’s articles of incorporation or by-laws (collectively, “Anti-takeover Provisions”).

 

  4.

Representations and Warranties of the Investors and the Affiliated Purchasers . Each of the Investors, severally on behalf of and with respect to itself only, and not jointly with any other Investor, represents and warrants and agrees with the Company as set forth below. To the extent that an Affiliated Purchaser acquires Investor Over-Subscription Shares or Investor Offered Shares from the Company pursuant to this Agreement, such Affiliated Purchaser shall be deemed to have made each of the representations and warranties below substituting “Affiliated Purchaser” for “Investor” in this Section 4. Except for representations, warranties and agreements that are

 

12


  expressly limited as to a particular date, each representation, warranty and agreement is made as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby:

 

  (a) Formation. Such Investor has been duly organized and is validly existing in good standing under the laws of the jurisdiction of its formation.

 

  (b) Power and Authority. Such Investor has the requisite corporate (or analogous) power and authority to enter into, execute and deliver this Agreement and the other Transaction Agreements to which it is or will be a party and to perform its obligations and consummate the transactions contemplated hereunder and thereunder and has taken all necessary corporate (or analogous) action required for the due authorization of the Transaction Agreements, the performance of its obligations thereunder and the consummation of the transaction contemplated thereby.

 

  (c) Execution and Delivery. Each Transaction Agreement to which such Investor is a party has been duly and validly authorized, executed and delivered by such Investor, and constitutes a valid and binding obligation of such Investor, enforceable against such Investor in accordance with its terms, except as may be limited by the Exceptions.

 

  (d) Restricted Securities. Such Investor understands that the Investor Offered Shares and Investor Over-Subscription Shares have not been registered under the Securities Act and may not be resold without registration under the Securities Act except pursuant to a specific exemption from the registration provisions of the Securities Act. As a result, such Investor acknowledges and understands that, upon the original issuance thereof and until such time as the same is no longer required under any applicable requirements of the Securities Act or applicable state securities laws, the Company and its transfer agent shall make such notation in the stock book and transfer records of the Company as may be necessary to record that the Investor Offered Shares and Over-Subscription Shares have not been registered under the Securities Act and may not be resold without registration under the Securities Act except pursuant to a specific exemption from the registration provisions of the Securities Act.

 

  (e) Investment Intent. Except as provided in Section 2(c), such Investor is acquiring its portion of the Investor Offered Shares and Investor Over-Subscription Shares for investment for its own account, and not with the view to, or for resale in connection with, any distribution thereof not in compliance with the Securities Act and any applicable state securities or “blue sky” laws, and such Investor has no present intention of selling, granting any participation in, or otherwise distributing the same, except in compliance with the Securities Act and any applicable state securities or “blue sky” laws.

 

  (f) Securities Laws Compliance. The Investor Offered Shares and Investor Over-Subscription Shares will not be offered for sale, sold or otherwise transferred by such Investor except pursuant to a registration statement or in a transaction exempt from, or not subject to, registration under the Securities Act and any applicable state securities or “blue sky” laws. Such Investor further acknowledges that Rule 144 promulgated under the Securities Act may not be applicable to the Investor Offered Shares and Investor Over-Subscription Shares. Such Investor further recognizes that the Company is under no obligation to register the Investor Offered Shares and Investor Over-Subscription Shares except pursuant to the Registration Rights Joinder Agreement to be entered into in accordance with the terms of this Agreement (and, accordingly, the 2005 Registration Rights Agreement). Such Investor understands that the certificates representing the Investor Offered Shares and Investor Over-Subscription Shares may carry one or more legends incorporating such restrictions. Such Investor acknowledges that applicable securities laws provide certain restrictions on the ability of stockholders to sell, transfer, assign, mortgage, hypothecate, or otherwise encumber their Investor Offered Shares and Investor Over-Subscription Shares.

 

13


  (g) Sophistication. Such Investor is an “accredited investor” within the meaning of Rule 501(a) promulgated under the Securities Act, and such Investor has such knowledge and experience in financial and business matters that it is capable of evaluating the merits and risks of its investment in the Investor Offered Shares and Investor Over-Subscription Shares being acquired hereunder. Such Investor understands and is able to bear any economic risks associated with such investment. With the assistance of such Investor’s own professional advisors, to the extent that such Investor has deemed appropriate, such Investor has made its own legal, tax, accounting and financial evaluation of the merits and risks of an investment in the Investor Offered Shares and Investor Over-Subscription Shares and the consequences of this Investment Agreement. Such Investor has considered the suitability of the Investor Offered Shares and Investor Over-Subscription Shares as an investment in light of its own circumstances and financial condition and such Investor is able to bear any economic risks associated with such investment. Such Investor agrees to furnish any additional information reasonably requested by the Company or any of its affiliates, to the extent necessary to assure compliance with applicable U.S. federal and state securities laws in connection with such Investor’s purchase of the Investor Offered Shares and Investor Over-Subscription Shares hereunder. Without derogating from or limiting the representations and warranties of the Company, such Investor acknowledges that it has been afforded the opportunity to ask questions and receive answers concerning the Company and to obtain additional information that it has requested to verify the information contained herein. Notwithstanding the foregoing, nothing contained herein will operate to modify or limit in any respect the representations and warranties of the Company or to relieve it from any obligations to such Investor for breach thereof or the making of misleading statements or the omission of material facts in connection with the transactions contemplated herein.

 

  (h) Agency Determinations. Such Investor understands that no federal or state agency has passed upon the merits or risks of an investment in the Investor Offered Shares and Investor Over-Subscription Shares or made any finding or determination concerning the fairness or advisability of this investment.

 

  (i) No Conflict. The purchase of its portion of the Investor Offered Shares and Investor Over-Subscription Shares, the execution and delivery by such Investor of each of the Transaction Agreements to which it is a party and the performance of and compliance with all of the provisions thereof by such Investor, and the consummation of the transactions contemplated therein (i) will not conflict with, or result in a breach or violation of, any of the terms or provisions of, or constitute a default under (in each case, with or without notice or lapse of time, or both), or result, in the acceleration of, or the creation of any lien under, any indenture, mortgage, deed of trust, loan agreement or other agreement, instrument, contract or other arrangement to which such Investor is a party or by which such Investor is bound or to which any of the property or assets of such Investor is subject, (ii) will not result in any violation of the provisions of the certificate of limited partnership, limited partnership agreement, or similar governance documents of such Investor, and (iii) will not result in any material violation of, or any termination or material impairment of any rights under, any applicable law, including any license, authorization, injunction, judgment, order, decree, rule or regulation of any Governmental Entity, except in the case of each of clauses (i) through (iii), for any conflict, breach, violation, default, acceleration, lien, termination or impairment which would not reasonably be expected to prohibit or materially and adversely affect such Investor’s performance of its obligations under this Agreement.

 

  (j)

Consents and Approvals. No consent, approval, authorization, order, registration or qualification of any third party (in the case of third parties, assuming the truth and accuracy in all respects (disregarding all qualifications and exceptions contained therein relating to materiality, Material

 

14


  Adverse Effect or similar qualifications) of the Company’s representations and warranties in Sections 3(f), (g) and (l)) or with any Governmental Entity is required to be obtained or made by such Investor for the purchase of its portion of Investor Offered Shares and Investor Over-Subscription Shares in accordance with the terms hereof and the execution and delivery by such Investor of this Agreement or the other Transaction Agreements to which it is a party and performance of and compliance by such Investor with all of the provisions hereof and thereof and the consummation of the transactions contemplated herein and therein, except for (i) such consents, approvals, authorizations, registrations or qualifications as may be required under state securities or “blue sky” laws in connection with the purchase of the Investor Offered Shares and Investor Over-Subscription Shares by such Investor, (ii) any consent, approval, authorization, registration or qualification which, if not made or obtained, would not reasonably be expected to prohibit or materially and adversely affect such Investor’s performance of its obligations under this Agreement, (iii) if applicable, filings required under, and compliance with other applicable requirements of, the HSR Act, (iv) filings required with the New York Stock Exchange in connection with listing of the Rights and the shares to be issued in the Rights Offering and pursuant to this Agreement and (v) the registration of the resale of the shares issued to the Investors pursuant to this Agreement, including such “blue sky” consents, approval authorizations, registrations or qualifications as may be necessary or appropriate.

 

  (k) Information Furnished. Information relating to such Investor furnished to the Company in writing by such Investor expressly for use in the Rights Offering Registration Statement will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.

 

  (l) Short Sales. Since November 15, 2013 through the date hereof, the Investors have not, directly or indirectly, sold or agreed to sell any shares of Common Stock, effected any short sale, whether or not against the box or established any “put equivalent position” (as defined in Rule 16a-1(b) under the Exchange Act) with respect to shares of Common Stock.

 

  (m) Sufficient Funds. At the Closing, the Investors (or their applicable Affiliated Purchaser(s), as applicable) will have available funds necessary to consummate the Closing on the terms and conditions contemplated by this Agreement.

 

  (n) Brokers and Finders. Neither such Investor nor any of its Affiliates is a party to any contract, agreement or understanding with any person that would give rise to a claim against the Company for a financial advisory fee, brokerage commission, finder’s fee or like payment in connection with the Rights Offering, including the issuance of the Offered Shares upon exercise of Rights (including the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares), or the other transactions contemplated in any of the Transaction Agreements.

 

  (o) Broker Dealer. Such Investor is not a broker-dealer and does not need to be registered as a broker-dealer.

 

  5. Additional Covenants of the Company . Without derogating from the obligations of the Company set forth elsewhere in this Agreement, the Company agrees with the Investors as set forth below.

 

  (a) Rights Offering Registration Statement.

 

15


  (i) On the date of this Agreement, promptly following the execution hereof, the Company shall file with the Commission the Rights Offering Registration Statement (the date of such filing, the “Filing Date”).

 

  (ii) The Rights Offering Registration Statement filed with the Commission shall be consistent in all material respects with the last form of such document provided to the Investors and their counsel to review prior to the filing thereof. Without limiting the foregoing, the Company shall (x) provide the Investors with a reasonable opportunity to review any SEC Transaction Document prior to its filing with the Commission and shall consider in good faith any comments of the Investors and their counsel; (y) advise the Investors promptly of the time when the Rights Offering Registration Statement has been filed and when the Rights Offering Registration Statement has become effective or any other SEC Transaction Document has been filed and shall furnish the Investors with copies thereof; and (z) advise the Investors promptly after it receives notice of any comments or inquiries by the Commission (and promptly furnish the Investors with copies of any correspondence related thereto), of the issuance by the Commission of any stop order or of any order preventing or suspending the use of any SEC Transaction Document, of the initiation or threatening of any proceeding for any such purpose, or of any request by the Commission for amending or supplementing any SEC Transaction Document or for additional information, and in each such case, provide the Investors with a reasonable opportunity to review any such comments, inquiries, request or other communication from the Commission and to review any responses thereto and any amendment or supplement to any SEC Transaction Document before any filing or communication with the Commission, and to consider in good faith any comments of the Investors and their counsel and in the event of the issuance of any stop order or of any order preventing or suspending the use of any SEC Transaction Document, to use promptly its reasonable best efforts to obtain its withdrawal.

 

  (iii) The Company shall use its reasonable best efforts to have the Rights Offering Registration Statement cleared or declared effective, as the case may be, by the Commission as promptly as practicable after it is filed with the Commission. The Company shall take all action as may be necessary or advisable so that the Rights Offering, including the issuance of the Offered Shares (including the Investor Offered Shares and the Investor Over-Subscription Shares), and the other transactions contemplated by this Agreement, may be effected in accordance with the applicable provisions of the Securities Act and the Exchange Act and any state or foreign securities or “blue sky” laws.

 

  (iv) If at any time prior to the Expiration Date, any event occurs as a result of which the Investment Decision Package, as then amended or supplemented, would include an untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it shall be necessary to amend or supplement the Investment Decision Package to comply with applicable law, the Company will promptly notify the Investors of any such event and, subject to Section 5(a)(ii), prepare an amendment or supplement to the Investor Decision Package that will correct such statement or omission or effect such compliance.

 

  (b) Record Date and Listing. The Company shall not amend or modify the Record Date without the prior written consent of the Representative. The Company shall use its reasonable efforts to (A) list and maintain the listing of the Common Stock, including the Offered Shares, on the New York Stock Exchange (the “NYSE”) and (B) list and maintain the listing of the Rights on the NYSE commencing on the first Business Day after the Securities Act Effective Date of the and, in the case of this clause (B), until 4:00 p.m., New York City time on the last trading day immediately preceding the Expiration Date.

 

16


  (c) No Stabilization. The Company will not take, directly or indirectly, any action designed to or that would reasonably be expected to cause or result in any stabilization or manipulation of the price of the shares of Common Stock.

 

  (d) Ordinary Course of Business; Actions Regarding Conditions. During the period from the date of this Agreement to the Closing Date, the Company shall conduct its business, and shall cause its subsidiaries to conduct their business, in the ordinary course and consistent with the Company’s and its subsidiaries’ past practice; and the Company for itself and on behalf of its subsidiaries agrees to use its reasonable best efforts to preserve substantially intact their business organizations and goodwill, to keep available the services of those of their present officers, employees, and consultants who are integral to the operation of their businesses as presently conducted; and the Company shall not take any action or omit to take any action that would reasonably be expected to result in the Company’s failure to satisfy the conditions to the Agreement set forth in Section 7.

 

  (e) Reasonable Best Efforts. The Company shall use its reasonable best efforts (and shall cause its subsidiaries to use their respective reasonable best efforts) to take or cause to be taken all actions, and do or cause to be done all things, necessary, proper or advisable on its or their part to cooperate with the Investors and to consummate and make effective the transactions contemplated by this Agreement, including the Rights Offering and the issuance of the Offered Shares (including the Investor Offered Shares and the Investor Over-Subscription Shares) as promptly as practicable, including by:

 

  (i) preparing and filing as promptly as practicable all documentation to effect all necessary notices, reports and other filings and to obtain as promptly as practicable all consents, registrations, approvals, permits and authorizations necessary or advisable to be obtained from any third party or Governmental Entity;

 

  (ii) using reasonable best efforts to defend any lawsuits or other actions or proceedings, whether judicial or administrative, challenging this Agreement or any other Transaction Agreement or the consummation of the transactions contemplated hereby and thereby, including seeking to have any stay or temporary restraining order entered by any court or other Governmental Entity vacated or reversed;

 

  (iii) executing, delivering and filing, as applicable, any additional ancillary instruments, documents, or agreements necessary to consummate the transactions contemplated by this Agreement and the other Transaction Agreements and to fully carry out the purposes of this Agreement and the transactions contemplated hereby and thereby;

 

  (iv) subject to the requirements of applicable law, not amending, terminating or waiving any term of the Rights Offering as set forth herein, or any other material term of the Rights Offering, without the prior approval of the Company’s Rights Committee, or Board of Directors, as appropriate, and without the prior written consent of the Representative, and, if requested by the Representative, extending the Expiration Date solely to the extent necessary to permit the Closing to occur as contemplated by this Agreement following the satisfaction (or, to the extent permitted, waiver) of the conditions set forth in Section 7; and

 

17


  (v) not taking any action that would cause this Agreement or any of the other Transaction Agreements, or the purchase of the Investor Offered Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, or, if applicable, the purchase of the Investor Over-Subscription Shares to be purchased by the Investors and/or their respective Affiliated Purchasers hereunder, to be subject to any Anti-takeover Provision, or in any manner to any “poison pill” or similar shareholder rights plan or agreement.

 

  (f) Registration Rights Agreement.

 

  (i) Immediately prior to the Closing, the Company shall deliver to the Investors and/or their respective Affiliated Purchasers, as the case may be, the joinder agreement, in the form attached as Annex A hereto (the “Registration Rights Joinder Agreement”), duly and validly executed by the Company.

 

  (ii) The Company agrees to uses its best efforts to file, as a Shelf Registration under the 2005 Registration Rights Agreement and in accordance with the provisions of the 2005 Registration Rights Agreement, within ten (10) Business Days after the Closing Date, a Registration Statement (as defined in the 2005 Registration Rights Agreement) on Form S-3 providing for an offering to be made on a continuous basis pursuant to Rule 415 under the Securities Act relating to the offer and sale, from time to time, of all Registrable Securities (as defined in the 2005 Registration Rights Agreement) then held by the Investors, the Affiliated Purchasers and such other Affiliates of the Investors as designated by the Investors (to the extent that no later than one (1) Business Day prior to the Closing Date, the Investors have provided the Company written notice of the names of such other Affiliates and number of shares to be registered on behalf of such other Affiliates), and such Registration Statement may register for resale any or all of the Registrable Securities of any other Holder (as defined in the 2005 Registration Rights Agreement) (the “Initial Shelf Registration Statement”). To the extent that, as of the filing date of the Initial Shelf Registration Statement, the Company is a Well Known Seasoned Issuer, the Company agrees that the Initial Shelf Registration Statement shall be an “automatic shelf registration statement” as defined in Rule 405 promulgated under the Securities Act. The Investors acknowledge and agree that the Initial Shelf Registration Statement will also register for resale shares of Common Stock of other Holders (as defined in the 2005 Registration Rights Agreement), including those listed on Schedule C.

 

  (iii) In accordance with the terms of the 2005 Registration Rights Agreement, including without limitation Section 4.1 thereof, the Company acknowledges that the obligations of the Company set forth in Section 4.1 of the 2005 Registration Rights Agreement (A) apply to the sale or distribution, including “take-downs” off of an effective Shelf Registration, of Registrable Securities requested from time to time by one or more Holders covered under the applicable Registration Statement, and (B) require the Company to, during any period that the Company fails to comply with its obligation to keep a Shelf Registration continuously effective for the period specified in Section 4.1(b) of the 2005 Registration Rights Agreement, otherwise use its best efforts to expedite and facilitate the registration and disposition of the Holders’ Registrable Securities, including by, upon the request of any Holder, filing and having declared effective a Registration Statement on an appropriate form then available to the Company, and, upon the Company becoming eligible to do so, recommencing the registration of the Holders’ Registrable Securities as a continuously effective Shelf Registration.

 

  (iv) Prior to the effectiveness of the Registration Rights Joinder Agreement and the Investors accordingly becoming parties to the 2005 Registration Rights Agreement as “Holders” and “Investor Holders” thereunder, the Company shall not enter into or agree to any amendment, modification or supplement to, or waiver under, either the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement.

 

18


  (g) Clear Market. Other than (i) the consummation of the Rights Offering in accordance with the terms hereof, (ii) the filing of the Initial Shelf Registration Statement in accordance with the terms hereof or (iii) as required pursuant to the terms of the 2005 Registration Rights Agreement or the 2007 Registration Rights Agreement, in either case only after the filing of the Initial Shelf Registration Statement following the Closing Date in accordance with the terms hereof, without the prior written consent of the Representative, the Company shall not effect any registration of Common Stock or other equity securities of the Company (or securities convertible into or exchangeable or exercisable for Common Stock or other equity securities) for sale under the Securities Act, or public sale or distribution of any Common Stock or other equity securities of the Company (or securities convertible into or exchangeable or exercisable for Common Stock or other equity securities), in each case other than in connection with a registration statement on Form S-4, Form S-8 or any successor forms thereto, whether for its own account or for the account of any other person, during the period beginning on the date hereof and ending ninety calendar days after the Closing Date.

 

  (h) Other Applicable Agreements. Without the prior written consent of the Representative, the Company shall not amend, modify, supplement or waive any provision of any Other Applicable Agreement in a manner that adversely affects the Investors or that gives any Other Applicable Shareholder terms or rights that are more favorable to such person than those afforded to the Investors under this Agreement.

 

  (i) Impairment Analysis and Reserve Report. The Company agrees to use its reasonable best efforts to complete the Impairment Analysis and Reserve Report as soon as reasonably possible (and in any event within five Business Days prior to the Closing), and it shall keep the Investors informed on a timely basis as to the status and results of such Impairment Analysis and Reserve Report. “Impairment Analysis and Reserve Report” means the review and analysis of the Company’s reserve estimates, including, without limitation, analysis of whether the Company will be required to record a non-cash ceiling test impairment to its oil and natural gas properties (including, for the avoidance of doubt, the Haynesville and Eagle Ford assets acquired by the Company in July 2013), and an updated reserve report in respect of such properties.

 

  6. Additional Covenants of the Investor . Each of the Investors, severally on behalf of and with respect to itself only, and not jointly with any other Investor, agrees with the Company as set forth below:

 

  (a) Information. To provide the Company with such information as the Company reasonably requests regarding such Investor for inclusion in the Rights Offering Registration Statement.

 

  (b) Registration Rights Joinder Agreement. To deliver (and/or cause its applicable Affiliated Purchaser(s) to deliver), immediately prior to the Closing, the Registration Rights Joinder Agreement, duly and validly executed by such Investor (and/or such applicable Affiliated Purchaser(s)).

 

  (c) Short Sales. From the date of this Agreement through the Expiration Date, such Investor shall not, directly or indirectly, sell or agree to sell any shares of Common Stock, offer any short sale, whether or not against the box or establish any “put equivalent position” (as defined in Rule 16a-1(b) under the Exchange Act) with respect to shares of Common Stock, in each case so long as (i) the Company has not breached and is not then in breach of its obligations under this Agreement and (ii) there shall not have occurred, since November 22, 2013, any Material Adverse Effect.

 

  (d) Market Stabilization. Such Investor shall not take, directly or indirectly, in connection with the “distribution” of the Rights and Common Stock in the Rights Offering, any action designed to, or that might reasonably be expected to result in, stabilization or manipulation of the price of shares of Common Stock in violation of Regulation M.

 

19


  7. Conditions to the Obligations of the Parties .

 

  (a) Conditions to the Investors’ Obligations under this Agreement. The obligations of each Investor to consummate the transactions contemplated hereby shall be subject to the satisfaction prior to the Closing Date of each of the following conditions (which may be waived with respect to the Investors in whole or in part by the Representative in its sole discretion):

 

  (i) Registration Statement Effectiveness. The Rights Offering Registration Statement shall continue to be effective and no stop order shall have been entered by the Commission with respect thereto.

 

  (ii) Rights Offering. The Rights Offering shall have been conducted in all material respects in accordance with this Agreement without the waiver of any condition thereto.

 

  (iii) No Legal Impediment to Issuance. No statute, rule, regulation, order or other legal restraint shall have been enacted, adopted, or issued by any Governmental Entity, and no judgment, injunction, decree or order of any Governmental Entity shall have been issued that, in each case, prohibits the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements, and no action or proceeding by or before any Governmental Entity shall be pending or threatened wherein an adverse judgment, decree, or order would be reasonably likely to result in the prohibition of the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements.

 

  (iv) Representations and Warranties. The representations and warranties of the Company contained in Sections 3(b), 3(c), 3(d), 3(e), 3(l), 3(n), 3(o) shall be true and correct in all respects, in each case as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby with the same effect as if made on and as of the Closing Date (except for representations and warranties made as of a specified date, which shall be true and correct only as of such specified date). The other representations and warranties of the Company in this Agreement (disregarding all qualifications and exceptions contained therein relating to materiality, Material Adverse Effect or similar qualifications) shall be true and correct in all material respects, in each case as of the date hereof and as of the Closing Date after giving effect to the transactions contemplated hereby with the same effect as if made on and as of the Closing Date (except for representations and warranties made as of a specified date, which shall be true and correct only as of such specified date).

 

  (v) Covenants. The Company shall have performed and complied in all material respects with all of its covenants and agreements contained in this Agreement and in any other Transaction Agreement required to be performed or complied with on or prior to the Closing Date.

 

  (vi) NYSE. The Offered Shares shall have been approved for listing on the NYSE, subject to official notice of issuance.

 

  (vii) Officers Certificate. The Investors shall have received a certificate, dated as of the Closing Date, signed on behalf of the Company by a senior executive officer thereof certifying to the effect that the conditions set forth in Sections 7(a)(iv), (v) and (x) have been satisfied.

 

20


  (viii) HSR Clearance. Any waiting period (including any extension thereof) applicable to the acquisition of Offered Shares and/or Remaining Offered Shares by any Investor (or any Affiliated Purchaser of any Investor) or any Other Applicable Shareholder (or any Affiliated Entity of any Other Applicable Shareholder) under the HSR Act shall have expired or early termination thereof shall have been granted.

 

  (ix) Other Applicable Agreements. There shall not have occurred any breach or default, or threatened breach or default, under the terms and conditions of any Other Applicable Agreement by any party thereto, on the basis of which any party thereto has terminated such Other Applicable Agreement or has refused (or is threatening to refuse) to consummate the transactions contemplated thereunder.

 

  (x) No MAE. Since November 22, 2013, there shall not have occurred any Material Adverse Effect.

 

  (xi) No Material Impairment. The Company shall have completed in all material respects the Impairment Analysis and Reserve Report, and such Impairment Analysis and Reserve Report shall not support or require, and the Company shall not have recognized or reasonably be expected to recognize, any impairments to the Company’s oil and natural gas properties (and/or, to the extent applicable, the Company’s other assets) (for the avoidance of doubt, excluding the $10,707,000 impairment previously taken by the Company in respect of the quarter ended March 31, 2013) which in the aggregate equal or exceed $150 million; provided that in the event that (A) the Impairment Analysis and Reserve Report delivered to the Investors in accordance with Section 5(i) indicates an aggregate amount of such impairments exceeding $150 million (such indicated aggregate amount of such impairments, the “Applicable Amount”) and (B) the Investors nonetheless elect to exercise their right to waive this Section 7(a)(xi) in order to effect the Closing, then the reference to $150 million in Section 3(j) shall instead to be deemed to be the Applicable Amount.

 

  (b) Conditions to the Company’s Obligations under this Agreement. The obligations of the Company to issue the Investor Offered Shares and the Investor Over-Subscription Shares and consummate the Rights Offering and the other transactions contemplated by this Agreement shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions (which (other than in the case of Section 7(b)(iii) and Section 7(b)(iv)) may not be waived, in whole or in part, without the prior written consent of the Representative):

 

  (i) Registration Statement Effectiveness. The Rights Offering Registration Statement shall continue to be effective and no stop order shall have been entered by the Commission with respect thereto.

 

  (ii) No Legal Impediment to Issuance. No statute, rule, regulation, order or other legal restraint shall have been enacted, adopted, or issued by any Governmental Entity, and no judgment, injunction, decree or order of any Governmental Entity shall have been issued that, in each case, prohibits the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements, and no action or proceeding by or before any Governmental Entity shall be pending or threatened wherein an adverse judgment, decree, or order would be reasonably likely to result in the prohibition of the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements.

 

  (iii) Representations and Warranties. The representations and warranties of the Investors contained in this Agreement shall be true and correct as of the date hereof and as of the Closing Date with the same effect as if made on the Closing Date (except for the representations and warranties made as of a specified date, which shall be true and correct only as such specified date), except where the failure to be so true and correct would not reasonably be expected to prohibit or materially and adversely affect the Investors performance of their obligations under this Agreement.

 

21


  (iv) Covenants. The Investors shall have performed and complied in all material respects with all of their covenants and agreements contained in this Agreement and in any other Transaction Agreement required to be performed or complied with on or prior to the Closing Date.

 

  (v) NYSE. The Offered Shares shall have been approved for listing on the NYSE, subject to official notice of issuance.

 

  (vi) HSR Clearance. Any waiting period (including any extension thereof) applicable to the acquisition of Offered Shares and/or Remaining Offered Shares by any Investor (or any Affiliated Purchaser of any Investor) or any Other Applicable Shareholder (or any Affiliated Entity of any Other Applicable Shareholder) under the HSR Act shall have expired or early termination thereof shall have been granted.

 

  8. Indemnification and Contribution .

 

  (a) Whether or not the Rights Offering or the other transactions contemplated hereby are consummated or this Agreement is terminated, the Company (in such capacity, the “Indemnifying Party”) shall indemnify and hold harmless each Investor, its Affiliates, and their respective officers, directors, members, partners, employees, agents and controlling persons (each, an “Indemnified Person”) from and against any and all losses, claims, suits, proceedings, damages, liabilities, costs, and expenses (including reasonable fees of counsel), joint or several, arising out of, or related to circumstances existing on or prior to the Closing Date (“Losses”) to which any the Indemnified Person may become subject arising out of or in connection with any action, claim, challenge, litigation, suit, investigation, inquiry or proceeding (“Proceedings”) with respect to the Rights Offering, this Agreement or the other Transaction Agreements, any SEC Transaction Document (for the avoidance of doubt, including any amendment or supplement thereto), or the transactions contemplated by any of the foregoing and shall reimburse the Indemnified Persons for any reasonable legal or other out-of-pocket expenses incurred in connection with investigating, responding to or defending any of the foregoing; provided that the foregoing indemnification will not apply to Losses to the extent that they resulted directly from (i) any breach by such Indemnified Person of this Agreement (ii) gross negligence, bad faith or willful misconduct on the part of the Indemnified Person, or (iii) statements or omissions in the SEC Transaction Documents made in reliance upon written information relating to the Indemnified Person furnished to the Company in writing by or on behalf of the Indemnified Person expressly for use in such SEC Transaction Documents. If for any reason the foregoing indemnification is unavailable to any Indemnified Person or insufficient to hold it harmless, then the Indemnifying Party shall contribute amounts in respect of such Losses in such proportion as is appropriate to reflect not only the relative benefits received by the Indemnifying Party, on the one hand, and the Indemnified Person, on the other hand, but also the relative fault of the Indemnifying Party, on the one hand and the Indemnified Person, on the other hand, as well as any relevant equitable considerations. The indemnity, reimbursement and contribution obligations of the Indemnifying Party under this Section 8 shall be in addition to any liability that the Indemnifying Party may otherwise have to an Indemnified Person and shall bind and inure to the benefit of any successors, assigns, heirs and personal representatives of the Indemnifying Party and any Indemnified Person.

 

  (b)

Reasonably promptly after receipt by an Indemnified Person of notice of the commencement of any Proceedings with respect to which the Indemnified Person may be entitled to indemnification hereunder, such Indemnified Person will, if a claim is to be made hereunder against the Indemnifying

 

22


  Party in respect thereof, notify the Indemnifying Party in writing of the commencement thereof; provided that (i) the omission to so notify the Indemnifying Party will not relieve the Indemnifying Party from any liability that it may have hereunder except to the extent it has been actually prejudiced by such failure and (ii) the omission to so notify the Indemnifying Party will not relieve it from any liability that it may have to an Indemnified Person otherwise than on account of this Section 8. In case any such Proceeding is brought against any Indemnified Person and it notifies the Indemnifying Party of the commencement thereof, the Indemnifying Party will be entitled to participate therein, and, to the extent that it may elect by written notice delivered to such Indemnified Person, to assume the defense thereof, with counsel reasonably satisfactory to such Indemnified Person; provided, that if the defendants in any such Proceeding include both such Indemnified Person and the Indemnifying Party and such Indemnified Person shall have concluded that there may be legal defenses available to it that are different from or additional to those available to the Indemnifying Party, or that there otherwise exists or may exist a conflict of interest, such Indemnified Person shall have the right to select, at the expense of the Indemnifying Party, one separate counsel (as well as one or more local counsels), to assert such legal defenses and to otherwise participate in the defense of such Proceeding on behalf of such Indemnified Person; provided, further, that the right of the Indemnifying Party to so assume the defense of any such Proceeding shall not apply, and the Indemnified Person shall be permitted to instead assume the defense of any such Proceeding with separate counsel (including one or more local counsels) of its choosing, at the expense of the Indemnifying Party, to the extent that (w) the Indemnifying Party shall not have employed counsel satisfactory to such Indemnified Person to represent such Indemnified Person within a reasonable time after notice of commencement of such Proceeding, (x) the Indemnifying Party is not, in the reasonable determination of such Indemnified Person, diligently pursuing such defense, (y) the Indemnifying Party shall not have elected to assume such defense pursuant to written notice delivered to such Indemnified Person within ten (10) calendar days after notice of commencement of such Proceeding or (z) such Proceeding relates to any criminal action, indictment, allegation or investigation or does not solely seek (and continue to solely seek) monetary damages.

 

  (c) The Indemnifying Party shall not be liable under this Section 8 to an Indemnified Person for any settlement of any Proceedings effected by such Indemnified Person without the Indemnifying Party’s written consent (which consent shall not be unreasonably withheld, delayed or conditioned). The Indemnifying Party shall not, without the prior written consent of an Indemnified Person, effect any settlement of any pending or threatened Proceedings in respect of which indemnity has been sought hereunder by such Indemnified Person unless (i) such settlement includes an unconditional release of such Indemnified Person in form and substance satisfactory to such Indemnified Person from all liability on the claims that are the subject matter of such Proceedings and (ii) such settlement does not include any statement as to or any admission of fault, culpability or a failure to act by or on behalf of any Indemnified Person.

 

  9. Termination .

 

  (a) This Agreement may be terminated at any time prior to the Closing Date:

 

  (i) by mutual written consent of the Company and the Representative;

 

  (ii)

by either the Company or the Representative, if any statute, rule, regulation, order or other legal restraint shall have been enacted, adopted, or issued by any Governmental Entity, or any judgment, injunction, decree or order of any Governmental Entity shall have been issued that, in any case, prohibits the implementation of the Rights Offering, the issuance and sale of the Investor Offered Shares and the Investor Over-Subscription Shares to the Investors and/or their respective

 

23


  Affiliated Purchasers, or the consummation of the others transactions contemplated by any of the Transaction Agreements, and such action, statute, rule, regulation, order, legal restraint, judgment, injunction or decree has become final, binding and non-appealable;

 

  (iii) by either the Company or the Representative, if (A) the Commission shall have entered a stop order with respect to the Rights Offering Registration Statement or (B) there shall have occurred a suspension of trading in shares of Common Stock on the NYSE; provided that, a suspension shall not count for purposes of the foregoing subclause (B) if (x) it lasts for a period of less than 24 hours and does not result in a material impairment in the trading price of Common Stock, or (y) it lasts for a period of less than 72 hours, relates to securities generally on the NYSE and does not disproportionately affect the trading or price of shares of Common Stock;

 

  (iv) by the Company:

 

  (A) if there has been a breach of any covenant or a breach of any representation or warranty of an Investor, which breach would cause the failure of any condition precedent set forth in Section 7(b), provided that any such breach of a covenant or representation or warranty (A) is not cured by such Investor within ten (10) calendar days following delivery by the Company to such Investors of written notice thereof or (B) is not capable of cure on or prior to the Outside Date; or

 

  (B) if there shall have occurred any event that results in a failure to satisfy any of the conditions set forth in Section 7(b), which failure is not (i) cured within ten (10) calendar days following delivery by the Company to the Investors of written notice thereof or (ii) capable of cure on or prior to the Outside Date; provided, that the right to terminate this Agreement under this Section 9(a)(iv)(B) shall not be available to the Company if the Company’s failure to comply with any provision of this Agreement has been the cause of, or resulted in, the failure to satisfy any such condition;

 

  (v) by the Representative:

 

  (A) if there has been a breach of any covenant or a breach of any representation or warranty of the Company, which breach would cause the failure of any condition precedent set forth in Section 7(a), provided that any such breach of a covenant or representation or warranty (i) is not cured by the Company within ten (10) calendar days following delivery by any Investor to the Company of written notice thereof or (ii) is not capable of cure on or prior to the Outside Date; or

 

  (B) if there shall have occurred any event that results in a failure to satisfy any of the conditions set forth in Section 7(a), which failure is not (i) cured within ten (10) calendar days following delivery by any Investor to the Company of written notice thereof or (ii) capable of cure on or prior to the Outside Date; provided, that the right to terminate this Agreement under this Section 9(a)(v)(B) shall not be available to the Investors or Representative if the failure of any of them to comply with any provision of this Agreement has been the cause of, or resulted in, the failure to satisfy any such condition;

 

24


  (C) if there shall have occurred any Material Adverse Effect since November 22, 2013;

 

  (D) if (1) the Rights Offering Registration Statement is not filed with the Commission prior to the close of business on the date of this Agreement, (2) the Rights Offering shall not have been consummated by March 31, 2014 (the “Outside Date”) or (3) the issuance and sale of the Investor Offered Shares and, if applicable, the Investor Over-Subscription Shares to the Investors and/or their respective Affiliated Purchasers shall not have been consummated (x) prior to April 7, 2014 or (y) if earlier, on or prior to the sixth (6th) Business Day after the Expiration Date; or

 

  (E) if there shall have occurred any breach or default, or threatened breach or default, under the terms and conditions of any Other Applicable Agreement by any party thereto, on the basis of which any party thereto has terminated such Other Applicable Agreement.

 

  (b) A termination pursuant to and in accordance with this Section 9 shall be effective upon giving written notice to the other party specifying the provision under which the Agreement is terminated. Upon termination in accordance with this Section 9, all rights and obligations of the parties under this Agreement shall terminate without any liability of any party to any other party except that the covenants and agreements made by the parties herein in Section 2(f) and Sections 8 through 18 will survive indefinitely in accordance with their terms.

 

  10. Notices . All notices and other communications in connection with this Agreement will be in writing and will be deemed given (and will be deemed to have been duly given upon receipt) (a) on the date of delivery, if delivered personally, (b) upon confirmation of receipt, if sent via electronic transmission, (c) on the first business day following the date of dispatch if delivered by a recognized next-day courier service or (d) on the fifth business day following the date of mailing if delivered by registered or certified mail, return receipt requested, postage prepaid to the parties to the Agreement at the following addresses (or at such other address for a party as will be specified by like notice):

 

  (a) If to the Company:

EXCO Resources, Inc.

12377 Merit Drive, Suite 1700

Dallas, Texas 75251

Email: lboeing@excoresources.com

Attention: William L. Boeing

with copies (which shall not constitute notice) to:

Haynes and Boone, LLP

2323 Victory Avenue, Suite 700

Dallas, Texas 75219

Email: scott.wallace@haynesboone.com;

            jennifer.wisinski@haynesboone.com

Attention: W. Scott Wallace, Esq.

                   Jennifer T. Wisinski, Esq.

 

25


and:

 

  (b) If to any Investor:

c/o Hamblin Watsa Investment Counsel Ltd.

95 Wellington Street West, Suite 800

Toronto, Ontario, M5J 2N7

Canada

Email: F_Burke@fairfax.ca and P_Rivett@fairfax.ca

Attention: Frances Burke and Paul Rivett

with copies (which shall not constitute notice) to:

Shearman & Sterling LLP

Commerce Court West

Suite 4405, P.O. Box 247

Toronto, Ontario M5L 1E8

Canada

Email: JLehner@Shearman.com

Attention: Jason R. Lehner, Esq.

 

  11. Assignment; Third Party Beneficiaries . Neither this Agreement nor any of the rights, interests or obligations under this Agreement may be assigned by any of the parties (whether by operation of law or otherwise) without the prior written consent of the other parties, except that each Investor may assign its rights, interests and/or obligations under this Agreement to any of its Affiliated Purchasers pursuant to Section 2(c). Notwithstanding the foregoing or anything to the contrary contained herein, subject to Section 2(c), this Agreement, and any Investor’s rights, interests or obligations hereunder, including any Rights, may be assigned, delegated or transferred, in whole or in part, by such Investor to one or more of such Investor’s Affiliated Purchasers without the prior written consent of the Company, provided that any such assignee assumes the obligations of such Investor hereunder and agrees in writing to be bound by the terms of this Agreement in the same manner as such Investor; provided, that no such assignment will relieve such Investor of its obligations hereunder if such assignee fails to perform such obligations. Except as provided in Section 8 with respect to the Indemnified Persons and Section 13(b) with respect to Non-Recourse Parties, this Agreement is not intended to and does not confer upon any person other than the parties hereto any rights or remedies under this Agreement and nothing set forth in this Agreement shall confer upon or give to, or be construed to confer upon or give to, any other person (including any Affiliates of the Company or any of its respective members, shareholders, partners, directors, employees, officers or creditors or any successor thereto or assignee thereof, or any third party claiming by or through any of the foregoing) any benefits, rights or remedies under or by reason of, or any rights to enforce or cause the Company to enforce, the obligations of any Investor or its permitted assignees hereunder or any other provisions of this Agreement. Any Indemnified Persons and any Non-Recourse Parties shall be entitled to enforce and rely on the provisions listed in the immediately preceding sentence as if they were a party to this Agreement.

 

  12. Prior Negotiations; Entire Agreement . This Agreement, together with the documents and instruments attached as schedules, annexes or exhibits to and referred to in this Agreement, constitutes the entire agreement of the parties with respect to the Rights Offering and supersedes all prior agreements (including the Prior Agreement), arrangements or understandings, whether written or oral, between the parties or any of their respective Affiliates with respect to the transactions contemplated hereby.

 

26


  13. GOVERNING LAW; VENUE; Non-Recourse Parties .

 

  (a) THIS AGREEMENT WILL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF LAW THEREOF. EACH OF THE PARTIES HERETO CONSENTS TO SUBMIT ITSELF TO THE EXCLUSIVE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK LOCATED IN THE BOROUGH OF MANHATTAN AND ANY UNITED STATES FEDERAL COURTS LOCATED IN SOUTHERN DISTRICT OF NEW YORK, WITH RESPECT TO ANY CLAIM OR CAUSE OF ACTION ARISING UNDER OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY, AND WAIVES PERSONAL SERVICE OF ANY AND ALL PROCESS UPON IT, AND AGREES THAT ALL SERVICE OF PROCESS MAY BE MADE BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED, DIRECTED TO IT AT ITS ADDRESS AS SET FORTH IN SECTION 10, AND THAT SERVICE SO MADE SHALL BE TREATED AS COMPLETED WHEN RECEIVED. EACH OF THE PARTIES HERETO WAIVES ANY OBJECTION BASED ON FORUM NON CONVENIENS AND WAIVES ANY OBJECTION TO VENUE OF ANY ACTION INSTITUTED IN ANY SUCH COURT. THE COMPANY AND THE INVESTORS HEREBY IRREVOCABLY WAIVE ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, SUIT, PROCEEDING, OR COUNTERCLAIM (WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THE NEGOTIATION, ADMINISTRATION, PERFORMANCE, AND ENFORCEMENT HEREOF. NOTHING IN THIS PARAGRAPH SHALL AFFECT THE RIGHT OF THE PARTIES HERETO TO SERVE LEGAL PROCESS IN ANY OTHER MANNER PERMITTED BY LAW. NOTWITHSTANDING THE FOREGOING, EACH OF THE PARTIES HERETO AGREES THAT EACH OF THE OTHER PARTIES HERETO SHALL HAVE THE RIGHT TO BRING ANY ACTION OR PROCEEDING FOR ENFORCEMENT OF A JUDGMENT ENTERED BY A COURT PERMITTED BY THIS SECTION 13 IN ANY OTHER COURT OR JURISDICTION.

 

  (b)

Notwithstanding anything that may be otherwise expressed or implied in this Agreement, the Company, by its acceptance of the benefits hereof, covenants, agrees and acknowledges for itself and its Affiliates that no person other than the Investors and their respective permitted successors and assigns, including their respective applicable Affiliated Purchasers, if any, who acquire Investor Over-Subscription Shares or Investor Offered Shares from the Company pursuant to this Agreement, shall have any obligation hereunder or in connection with the transactions contemplated hereby and that no recourse hereunder or in respect of any oral representations made or alleged to be made in connection herewith or therewith shall be had against any former, current or future equity holder, controlling person, director, officer, employee, agent, affiliate, member, manager, general or limited partner, representative or successor or assignee of any Investor (or any such applicable Affiliated Purchaser) or any former, current or future equity holder, controlling person, director, officer, employee, agent, affiliate, member, manager, general or limited partner, representative or successor or assignee of any of the foregoing (such persons, collectively, but excluding the Investors and their respective applicable Affiliated Purchasers, if any, who acquire Investor Over-Subscription Shares or Investor Offered Shares from the Company pursuant to this Agreement, the “Non-Recourse Parties”), whether by the enforcement of any assessment or by any legal or equitable proceedings, or by virtue of any statute, regulation or other applicable law, it being expressly agreed and acknowledged that no personal liability whatsoever shall attach to, be imposed on, or otherwise be incurred by any Non-Recourse Party, as such, for

 

27


  any obligations of any Investor under this Agreement or any documents or instruments delivered in connection herewith or in respect of any oral representations made or alleged to be made in connection herewith or therewith or for any claim based on, in respect of, or by reason of, such obligations or their creation.

 

  14. Counterparts . This Agreement may be executed in any number of counterparts, all of which will be considered one and the same agreement and will become effective when counterparts have been signed by each of the parties and delivered to the other party (including via electronic transmission), it being understood that each party need not sign the same counterpart.

 

  15. Waivers and Amendments . This Agreement may be amended, modified, superseded, cancelled, renewed or extended, and the terms and conditions of this Agreement may be waived, only by a written instrument signed by all the parties or, in the case of a waiver, by the party waiving compliance. No delay on the part of any party in exercising any right, power or privilege pursuant to this Agreement will operate as a waiver thereof, nor will any waiver on the part of any party of any right, power or privilege pursuant to this Agreement, nor will any single or partial exercise of any right, power or privilege pursuant to this Agreement, preclude any other or further exercise thereof or the exercise of any other right, power or privilege pursuant to this Agreement. The rights and remedies provided pursuant to this Agreement are cumulative and are not exclusive of any rights or remedies which any party otherwise may have at law or in equity.

 

  16. Interpretation; Severability .

 

  (a) When a reference is made in this Agreement to “Sections,” “Annexes,” “Schedules” or “Exhibits” such reference shall be to a Section of, or Annex, Schedule or Exhibit to, this Agreement unless otherwise indicated. The terms defined in the singular have a comparable meaning when used in the plural, and vice versa. References to “herein,” “hereof,” “hereunder” and the like refer to this Agreement as a whole and not to any particular section or provision, unless the context requires otherwise. The headings contained in this Agreement are for reference purposes only and are not part of this Agreement. Whenever the words “include,” “includes” or “including” are used in this Agreement, they shall be deemed followed by the words “without limitation.” No rule of construction against the draftsperson shall be applied in connection with the interpretation or enforcement of this Agreement, as this Agreement is the product of negotiation between sophisticated parties advised by counsel. Except as expressly stated in this Agreement, all references to any statute, rule or regulation are to the statute, rule or regulation as amended, modified, supplemented or replaced from time to time (and, in the case of statutes, include any rules and regulations promulgated under the statute) and to any section of any statute, rule or regulation include any successor to the section.

 

  (b) It is the intent of the parties that the provisions of this Agreement shall be enforced to the fullest extent permissible under applicable law and public policies applied in each jurisdiction in which enforcement is sought. If any particular provision or portion of this Agreement shall be adjudicated to be invalid or unenforceable, such provision or portion thereof shall be deemed amended to the minimum extent necessary to render such provision or portion valid and enforceable, and such amendment will apply only with respect to the operation of such provision or portion in the particular jurisdiction in which such adjudication is made.

 

  17. Adjustment to Shares . If, prior to the Closing Date, the Company effects a reclassification, stock split (including a reverse stock split), stock dividend or distribution, recapitalization, merger, issuer tender or exchange offer, or other similar transaction with respect to any shares of its capital stock (excluding the distribution of the Rights in connection with the Rights Offering, as contemplated herein), references to the numbers of such shares and the prices therefore shall be equitably adjusted to reflect such change and, as adjusted, shall, from and after the date of such event, be subject to further adjustment in accordance herewith.

 

28


  18. Survival . The representations and warranties made in this Agreement will survive until the earlier of (i) the termination of this Agreement in accordance with Section 9 and (ii) the 18-month anniversary of the Closing.

The remainder of this page left intentionally blank.

 

29


IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be signed by their respective officers thereunto duly authorized, all as of the date first written above.

 

EXCO RESOURCES, INC.
 

/s/ William L. Boeing

Name:   William L. Boeing
Title:   Vice President and General Counsel
HAMBLIN WATSA INVESTMENT COUNSEL LTD.
On behalf of itself and acting as the Representative of the several Investors
By:   Hamblin Watsa Investment Counsel Ltd.

/s/ Paul Rivett

Name:   Paul Rivett
Title:   Chief Operating Officer

 

30

Exhibit 5.1

[Letterhead of Haynes and Boone, LLP]

December 17, 2013

EXCO Resources, Inc.

12377 Merit Drive, Suite 1700, LB 82

Dallas, TX 75251

 

Re: EXCO Resources, Inc. Registration Statement on Form S-3ASR

Ladies and Gentlemen:

We have acted as counsel to EXCO Resources, Inc., a Texas corporation (the “ Company ”), in connection with the preparation and filing of a Registration Statement on Form S-3ASR, as may be amended from time to time (the “ Registration Statement ”) with the Securities and Exchange Commission (the “ Commission ”) pursuant to the Securities Act of 1933, as amended (the “ Securities Act ”) on December 17, 2013. The Registration Statement includes a prospectus (the “ Prospectus ”) to be furnished to holders of the shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”) in connection with the distribution by the Company to such holders of transferable subscription rights (the “ Rights ”) entitling the holders thereof to purchase additional shares of Common Stock (collectively, the “ Rights Offering ”). The Registration Statement relates to the Rights and the shares of underlying Common Stock (the “ Shares ”).

This opinion is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.

The opinions expressed herein are limited to the laws of the State of Texas as currently in effect (“ Texas Law ”).

In rendering the opinions expressed herein, we have examined and relied upon the originals, or copies certified to our satisfaction, of: (i) the Registration Statement and all exhibits thereto; (ii) the Company’s Third Amended and Restated Articles of Incorporation and any amendments thereto to date certified by the Secretary of State of the State of Texas (the “ Articles of Incorporation ”); (iii) the Company’s Second Amended and Restated Bylaws and any amendments thereto to date certified by an officer of the Company (the “ Bylaws ”); (iv) a specimen stock certificate for the Common Stock; (v) the Company’s form of subscription rights certificate, which will be used by the Company to evidence the Rights; (vi) the minutes and records of the corporate proceedings of the Company with respect to, among other matters, the distribution of the Rights; (vii) a certificate executed by an officer of the Company, dated as of the date hereof; and (viii) such other records, documents and instruments as we have deemed necessary for the expression of the opinion stated herein.


EXCO Resources, Inc.

December 17, 2013

Page 2

 

In making the foregoing examinations, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified or photostatic copies thereof and the authenticity of the originals of such latter documents. As to all questions of fact material to these opinions, where such facts have not been independently established, and as to the content and form of certain minutes, records, resolutions or other documents or writings of the Company, we have relied, to the extent we have deemed reasonably appropriate, upon representations or certificates of officers of the Company or governmental officials without independent check or verification of their accuracy. Finally, we have assumed that any certificates representing the shares of Common Stock, when issued, will comply with Texas Law, the Articles of Incorporation and the Bylaws.

Based upon the foregoing and subject to the qualifications stated herein, we are of the opinion that:

 

  1. The Rights when issued in accordance with the terms of the Rights Offering, will be valid and binding obligations of the Company.

 

  2. The Shares, when issued and delivered in accordance with the terms of the Rights Offering against payment of the consideration for the Shares upon exercise of the Rights as contemplated by the Prospectus, will be validly issued, fully paid and nonassessable.

The opinions set forth above are also subject to the following qualifications and exceptions.

 

  1. The above opinions are subject to: (i) the effect of any applicable bankruptcy, insolvency, reorganization, moratorium or other similar law of general application that affects creditors’ rights, (ii) the provisions of applicable law pertaining to the voidability of preferential or fraudulent transfers and conveyances and (iii) the fact that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to equitable defenses and to the discretion of the court before which any proceeding therefore may be brought.

 

  2. The above opinions are subject to the effect of general principles of equity, including (without limitation) concepts of materiality, reasonableness, good faith and fair dealing, and other similar doctrines affecting the enforceability of agreements generally (regardless of whether considered in a proceeding in equity or at law).


EXCO Resources, Inc.

December 17, 2013

Page 3

 

We hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement and the use of our name under the caption “Legal Matters” in the Prospectus. In giving such consent, we do not thereby concede that our firm is within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

Very truly yours,

/s/ Haynes and Boone, LLP

HAYNES AND BOONE, LLP

Exhibit 8.1

[Letterhead of Haynes and Boone, LLP]

December 17, 2013

EXCO Resources, Inc.

12377 Merit Drive, Suite 1700, LB 82

Dallas, TX 75251

 

Re: EXCO Resources, Inc. Registration Statement on Form S-3ASR

Ladies and Gentlemen:

We have acted as counsel to EXCO Resources, Inc., a Texas corporation (the “ Company ”), in connection with the preparation and filing of a Registration Statement on Form S-3ASR, as may be amended from time to time (the “ Registration Statement ”) with the Securities and Exchange Commission (the “ Commission ”) pursuant to the Securities Act of 1933, as amended (the “ Securities Act ”) on December 17, 2013. The Registration Statement includes a prospectus (the “ Prospectus ”) to be furnished to holders of the shares of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”) in connection with the distribution by the Company to such holders of transferable subscription rights (the “ Rights ”) entitling the holders thereof to purchase additional shares of Common Stock (collectively, the “ Rights Offering ”). The Registration Statement relates to the Rights and the shares of underlying Common Stock (the “ Shares ”). This opinion relates to the discussion set forth under the caption “Material U.S. Federal Income Tax Considerations” of the Registration Statement.

This opinion is being furnished in accordance with the requirements of Item 601(b)(8) of Regulation S-K under the Securities Act.

Our opinion is based on the Internal Revenue Code of 1986, as amended, Treasury regulations, judicial decisions, published positions of the Internal Revenue Service (the “ IRS ”), and such other authorities as we have considered relevant, all as in effect as of the date of this opinion and all of which are subject to differing interpretations or change at any time (possibly with retroactive effect). A change in the authorities or the accuracy or completeness of any of the information, documents, statements, representations, covenants or assumptions upon which our opinion is based could affect the conclusions expressed herein. There can be no assurance, moreover, that our opinion expressed herein will be accepted by the IRS or, if challenged, by a court.

In rendering the opinions expressed herein, we have examined and relied upon the originals, or copies certified to our satisfaction, of: (i) the Registration Statement and all exhibits thereto; (ii) the Company’s Third Amended and Restated Articles of Incorporation and any amendments thereto to date certified by the Secretary of State of the State of Texas; (iii) the Company’s


EXCO Resources, Inc.

December 17, 2013

Page 2

 

Second Amended and Restated Bylaws and any amendments thereto to date certified by an officer of the Company; (iv) a certificate executed by an officer of the Company, dated as of the date hereof; and (v) such other records, documents and instruments as we have deemed necessary for the expression of the opinion stated herein.

In making the foregoing examinations, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified or photostatic copies thereof and the authenticity of the originals of such latter documents. As to all questions of fact material to these opinions, where such facts have not been independently established, and as to the content and form of certain minutes, records, resolutions or other documents or writings of the Company, we have relied, to the extent we have deemed reasonably appropriate, upon representations or certificates of officers of the Company or governmental officials without independent check or verification of their accuracy.

Based upon the foregoing and subject to the qualifications stated herein, we are of the opinion that, the discussion contained in the Registration Statement under the caption “Material U.S. Federal Income Tax Considerations,” subject to the limitations and qualifications referred to therein, accurately sets forth the material U.S. federal income tax consequences of the receipt and exercise (or expiration) of the Rights or, if applicable, the over-subscription privilege, acquired through the Rights Offering and owning and disposing of the Shares received upon exercise of the Rights.

We hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement and the use of our name under the caption “Legal Matters” in the Prospectus. In giving such consent, we do not thereby concede that our firm is within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

Very truly yours,

/s/ Haynes and Boone, LLP

HAYNES AND BOONE, LLP

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

EXCO Resources, Inc.:

We consent to the use of our report dated February 21, 2013, with respect to the consolidated balance sheets of EXCO Resources, Inc. and subsidiaries as of December 31, 2012 and 2011, and the related consolidated statements of operations, changes in shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2012, and the effectiveness of internal control over financial reporting as of December 31, 2012, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Dallas, Texas

December 12, 2013

EXHIBIT 23.2

Consent of Independent Auditors

The Board of Directors

EXCO Resources, Inc.:

We consent to the use of our report dated September 20, 2013 with respect to the statements of revenues and direct operating expenses of EXCO Resources, Inc.’s Acquired Chesapeake Oil and Natural Gas Properties for the years ended December 31, 2012, 2011 and 2010, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Dallas, Texas

December 12, 2013

Exhibit 23.3

LEE KEELING AND ASSOCIATES, INC.

PETROLEUM CONSULTANTS

First Place Tower

15 East Fifth Street • Suite 3500

Tulsa, Oklahoma 74103-4350

(918) 587-5521 • Fax: (918) 587-2881

www.lkaengineers.com

CONSENT OF INDEPENDENT PETROLEUM ENGINEERS

As independent petroleum engineers, Lee Keeling and Associates, Inc. hereby consents to the incorporation by reference in this Registration Statement on Form S-3 and any amendments thereto of information from its reserve report dated January 10, 2013 on the estimated proved oil and natural gas reserve quantities of EXCO Resources, Inc. and its consolidated subsidiaries presented as of December 31, 2012, included in or made a part of the Annual Report on Form 10-K of EXCO Resources, Inc. for the year ended December 31, 2012, filed with the Securities and Exchange Commission on February 21, 2013.

 

/s/ Lee Keeling and Associates, Inc.

LEE KEELING AND ASSOCIATES, INC.

Tulsa, Oklahoma

December 12, 2013

Exhibit 23.4

 

LOGO

CONSENT OF INDEPENDENT PETROLEUM ENGINEERS AND GEOLOGISTS

We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 and any amendments thereto of EXCO Resources, Inc. (the “Company”) of the reference to Netherland, Sewell & Associates, Inc. and the inclusion of the information in our report dated January 4, 2013 in the Registration Statement on Form S-3 of the Company, filed with the U.S. Securities and Exchange Commission.

 

NETHERLAND, SEWELL & ASSOCIATES, INC.
By:   

/s/ C.H. (Scott) Rees III

   C.H. (Scott) Rees III
   Chairman and Chief Executive Officer

Dallas, Texas

December 12, 2013

Exhibit 23.5

 

LOGO

CONSENT OF INDEPENDENT PETROLEUM ENGINEERS

As independent petroleum engineers, Haas Petroleum Engineering Services, Inc. hereby consents to all references to our firm included in or made a part of the EXCO Resources, Inc. Registration Statement on Form S-3 and any amendments thereto and further consents to the incorporation by reference in this EXCO Resources, Inc. Registration Statement on Form S-3 and any amendments thereto of information from our reserve report dated January 26, 2012 on the estimated oil and natural gas reserve quantities of EXCO Resources, Inc. and its consolidated subsidiaries presented as of December 31, 2011.

 

/s/ Haas Petroleum Engineering Services, Inc.

Haas Petroleum Engineering Services, Inc.

Dallas, Texas

December 12, 2013

Exhibit 99.1

FORM OF

INSTRUCTIONS FOR USE OF

EXCO RESOURCES, INC. SUBSCRIPTION RIGHTS CERTIFICATES

PLEASE CONTACT D.F. KING & CO., INC.

OUR INFORMATION AGENT, AS TO ANY QUESTIONS AT 1-800-755-7250

The following instructions relate to a rights offering (the “Rights Offering”) by EXCO Resources, Inc., a Texas corporation (the “Company”), to the holders of record (the “Record Holders”) of its common stock, par value $0.001 per share (the “Common Stock”), as described in the Company’s Prospectus, dated December 17, 2013 (as it may be supplemented from time to time, the “Prospectus”). Record Holders of Common Stock as of 5:00 p.m., New York City time, on December 19, 2013 (the “Record Date”) are receiving transferable subscription rights (the “Rights”) to subscribe for and purchase shares of Common Stock (the “Underlying Shares”). An aggregate of up to 44,995,665 Underlying Shares are being offered by the Prospectus. Each Record Holder will receive one Right for every share of Common Stock owned of record as 5:00 p.m., New York City time, on the Record Date.

The Rights will expire, if not exercised, at 5:00 p.m., New York City time, on January 9, 2014, unless such time and date is extended by the Board of Directors of the Company (as so extended, the “Expiration Date”). After the Expiration Date, unexercised Rights will be void, of no value, and cease to be exercisable for Underlying Shares. The Company will not be obligated to honor any purported exercise of Rights received by Continental Stock Transfer & Trust Company (the “Subscription Agent”) after 5:00 p.m., New York City time, on the Expiration Date, regardless of when the documents relating to such exercise were sent. The Board of Directors of the Company does not intend to extend the Expiration Date of the Rights Offering. The Board of Directors of the Company may (subject to the provisions of the Investment Agreements (as defined in the Prospectus)) extend the Expiration Date by giving oral or written notice to the Subscription Agent on or before the Expiration Date, followed by a press release no later than 9:00 a.m., New York City time, on the next business day after the most recently announced Expiration Date. The Rights are evidenced by Rights certificates (the “Subscription Rights Certificates”).

The Company has entered into two exercise commitment agreements, one with certain affiliates of WL Ross & Co. LLC, and one with Hamblin Watsa Investment Counsel Ltd., a wholly owned subsidiary of Fairfax Financial Holdings Limited, or Fairfax. WL Ross and Fairfax, directly or through certain affiliates, beneficially own approximately 14.4% and 4.95%, respectively, of the outstanding Common Stock prior to giving effect to the Rights Offering. See “The Investment Agreements; Effects of the Transactions” in the Prospectus.

As described in the accompanying Prospectus, each Record Holder will receive one Right for every share of Common Stock owned of record as of 5:00 p.m., New York City time, on the Record Date. Each Right allows the holder thereof to subscribe for 0.25 of a share of Common Stock (the “Basic Subscription Right”) at the cash price of $5.00 per share (the “Subscription Price”). Fractional shares or cash in lieu of fractional shares will not be issued in the Rights Offering. Fractional shares as to any Rights holder will be rounded down to the nearest whole share. For example, if you owned 102 shares of Common Stock as of the Record Date, you would receive 102 subscription rights pursuant to your Basic Subscription Right that would entitle you to purchase 25 shares of Common Stock (25.5 rounded down to the nearest whole share) at the Subscription Price.

In addition, Rights holder that timely and fully exercises its Basic Subscription Right (including in respect of Rights purchased from others) will be eligible to subscribe (the “Over-Subscription Privilege”), at the same subscription price of $5.00 per share, for additional shares of Common Stock if any Underlying Shares are not purchased by other Rights holders under their Basic Subscription Rights as of the Expiration Date (the “Unsubscribed Shares”). Each Rights holder may exercise its Over-Subscription Privilege only if it timely and fully exercised its Basic Subscription Right (including in respect of Rights purchased from others) and other


Rights holders do not timely and fully exercise their Basic Subscription Rights. If the requests for over-subscription exceed the available Underlying Shares, we will allocate the Unsubscribed Shares as described in the Prospectus. See “The Rights Offering—Over-Subscription Privilege” in the Prospectus.

You will be required to submit payment in full for all of the shares of Common Stock you wish to subscribe to purchase pursuant to the exercise of the Basic Subscription Right and the Over-Subscription Privilege to the Subscription Agent no later than 5:00 p.m., New York City time, on the Expiration Date. Any excess subscription payment that you may pay to the Subscription Agent in the Rights Offering will be returned to you by the Subscription Agent, without interest or penalty, as soon as practicable following the completion of the Rights Offering.

Do not send the Subscription Rights Certificate or Notice of Guaranteed Delivery (as defined below) or payment to the Company. If you wish to participate in the Rights Offering, the Subscription Agent must receive your completed Subscription Rights Certificate or Notice of Guaranteed Delivery, with full payment of the total subscription amount, including final clearance of any uncertified personal checks, before 5:00 p.m., New York City time, on the Expiration Date. Once you have exercised your Rights, you cannot revoke the exercise of your Rights, subject to applicable law. If you do not exercise your Rights before the Expiration Date, they will expire and be void, of no value and will cease to be exercisable for shares of Common Stock.

The number of Rights to which you are entitled is printed on the face of your Subscription Rights Certificate. You should indicate your wishes with regard to the exercise of your Rights by completing the appropriate portions of your Subscription Rights Certificate and returning the certificate to the Subscription Agent in the envelope provided pursuant to the procedures described in the Prospectus.

THE COMPLETED AND EXECUTED SUBSCRIPTION RIGHTS CERTIFICATE (OR NOTICE OF GUARANTEED DELIVERY) WITH FULL PAYMENT FOR ALL OF THE SHARES FOR WHICH YOU INTEND TO SUBSCRIBE PURSUANT TO THE BASIC SUBSCRIPTION RIGHT AND THE OVER-SUBSCRIPTION PRIVILEGE, INCLUDING FINAL CLEARANCE OF ANY UNCERTIFIED PERSONAL CHECKS, MUST BE RECEIVED BY THE SUBSCRIPTION AGENT BEFORE 5:00 P.M., NEW YORK CITY TIME, ON JANUARY 9, 2014, THE EXPIRATION DATE, UNLESS EXTENDED BY THE BOARD OF DIRECTORS OF THE COMPANY. ONCE A RECORD HOLDER HAS EXERCISED ANY RIGHTS, SUCH EXERCISE MAY NOT BE REVOKED (EXCEPT AS REQUIRED BY LAW). SUBSCRIPTION RIGHTS THAT ARE NOT EXERCISED PRIOR TO 5:00 P.M., NEW YORK CITY TIME, ON THE EXPIRATION DATE WILL EXPIRE AND BE VOID AND OF NO VALUE.

1. Method of Subscription—Exercise of Rights .

Subject to applicable law, the exercise of Rights is irrevocable and may not be cancelled or modified. You may exercise your Rights as follows:

Subscription by Registered Holders.  If you hold a stock certificate, the number of shares of Common Stock you may subscribe to purchase pursuant to your Basic Subscription Right is indicated on the enclosed Subscription Rights Certificate. You may exercise your Basic Subscription Right and Over-Subscription Privilege, if any, by properly completing and executing the Subscription Rights Certificate, together with any required signature guarantees, and forwarding it (or the Notice of Guaranteed Delivery), together with your full payment, to the Subscription Agent at the address given below. All documents and payments must be received before 5:00 p.m., New York City time, on January 9, 2014.

Subscription by DTC Participants . We expect that the exercise of your Rights may be made through the facilities of the Depository Trust Company (“DTC”). If your Rights are held of record through DTC, you may exercise your Rights by instructing DTC, or having your broker, dealer, custodian bank or other nominee instruct DTC, to transfer your Rights from your account to the account of the Subscription Agent, together with

 

2


certification as to the aggregate number of Rights you are exercising and the number of shares of Common Stock for which you are subscribing under your Basic Subscription Right and your Over-Subscription Privilege, if any, and your full subscription payment.

Subscription by Beneficial Owners.  If you are a beneficial owner of shares of Common Stock that are registered in the name of a broker, dealer, custodian bank or other nominee, you will not receive a Subscription Rights Certificate. Instead, the Company will issue one Right to the nominee record holder for each share of Common Stock that you own on the Record Date. If you are not contacted by your nominee, you should promptly contact your nominee in order to subscribe for shares in the Rights Offering and follow the instructions provided by your nominee. Your Rights will not be considered exercised unless the Subscription Agent receives from you, your broker, dealer, custodian bank, or other nominee, as the case may be, all of the required subscription documents (or Notice of Guaranteed Delivery) and your full subscription payment prior to the expiration of the Rights Offering.

Your payment of the Subscription Price must be made in U.S. dollars for the full number of shares of Common Stock that you wish to acquire in the Rights Offering. Your payment must be delivered in one of the following ways:

 

   

certified or personal check drawn on a U.S. bank payable to “Continental Stock Transfer & Trust Company”;

 

   

postal, telegraphic or express money order payable to “Continental Stock Transfer & Trust Company”; or

 

   

wire transfer of immediately available funds directly to the account maintained by “Continental Stock Transfer & Trust Company as agent for EXCO Resources Rights Offering”; at Bank Name: JP Morgan Chase Bank; ABA #: 021000021; Account #: 475-581202. Any wire transfer should clearly indicate the identity of the subscriber who is paying the subscription price by wire transfer.

If you wish to make payment by wire transfer, you must reference the account number listed on your Subscription Rights Certificate or Notice of Guaranteed Delivery.

Payment received after the expiration of the Rights Offering will not be honored, and the Subscription Agent will return your payment to you, without interest, as soon as practicable. The Subscription Agent will be deemed to receive payment upon:

 

   

clearance of any uncertified personal check deposited by Continental Stock Transfer & Trust Company;

 

   

receipt by Continental Stock Transfer & Trust Company of any certified check bank draft drawn upon a U.S. bank;

 

   

receipt by Continental Stock Transfer & Trust Company of any postal, telegraphic, express money order or a certified or cashier’s check; or

 

   

receipt by Continental Stock Transfer & Trust Company of any wire transfer of immediately available funds.

If you elect to exercise your Rights, we urge you to consider using a certified or cashier’s check, money order or wire transfer of funds to ensure that Continental Stock Transfer & Trust Company receives your funds prior to the Expiration Date.

If you elect to exercise your Rights, you should ensure that Continental Stock Transfer & Trust Company receives your funds before the Rights Offering expires. Any uncertified personal check used to pay for shares of Common Stock must clear the appropriate financial institutions before 5:00 p.m., New York City time, on January 9, 2014. The clearinghouse may require five or more business days. Accordingly, if you wish to pay the subscription price by means of an uncertified personal check, you should make payment sufficiently in advance of the Expiration Date to ensure that the payment is received and clears by that date.

 

3


DO NOT SEND RIGHTS CERTIFICATES, NOTICES OF GUARANTEED DELIVERY OR PAYMENTS DIRECTLY TO EXCO . We will not consider your subscription received until the Subscription Agent has received delivery of a properly completed and duly executed Subscription Rights Certificate (or Notice of Guaranteed Delivery) and payment of the full subscription amount.

The method of delivery of Subscription Rights Certificates and payment of the subscription amount to the Subscription Agent will be at the risk of the Rights holders. If sent by mail, we recommend that you send those certificates and payments by overnight courier or by registered mail, properly insured, with return receipt requested, and that you allow a sufficient number of days to ensure delivery to the Subscription Agent and clearance of payment before the Rights Offering expires.

The address to which the completed Subscription Rights Certificate or Notice of Guaranteed Delivery and payments, other than wire transfers, must be mailed or delivered by overnight courier to the Subscription Agent is provided below:

Continental Stock Transfer & Trust Company

17 Battery Place—8th Floor

New York, NY 10004

Attn: Corporate Actions Department

Telephone: (917) 262-2378

Delivery to any address or by a method other than those set forth above will not constitute valid delivery.

If you are unable to deliver a properly completed Subscription Rights Certificate to the Subscription Agent on or before the Expiration Date, you may cause a written guarantee of delivery substantially in the form of Exhibit 99.2 to EXCO’s Registration Statement on Form S-3, dated December 17, 2013 and filed on December 17, 2013, which is available from the Subscription Agent (the “Notice of Guaranteed Delivery”), from a commercial bank, trust company, securities broker or dealer, credit union, savings association or other eligible guarantor institution which is a member of or a participant in a signature guarantee program acceptable to the Subscription Agent (an “eligible institution”), to be received by the Subscription Agent prior to 5:00 p.m., New York City time, on the Expiration Date together with payment in full of the applicable Subscription Price. Such Notice of Guaranteed Delivery must state your name, the number of Rights represented by your Subscription Rights Certificate and the number of Rights being exercised pursuant to the Basic Subscription Privilege and the number of additional shares being subscribed for pursuant to the Over-Subscription Privilege. The Notice of Guaranteed Delivery may be delivered to the Subscription Agent in the same manner as your Subscription Rights Certificates at the address set forth above, or as otherwise provided in the Notice of Guaranteed Delivery. A Notice of Guaranteed Delivery will guarantee the delivery of your properly completed and executed Subscription Rights Certificate within three business days following the date of the execution of the Notice of Guaranteed Delivery. If this procedure is followed, the Subscription Agent must receive your Subscription Rights Certificate within three business days of the receipt of the Notice of Guaranteed Delivery.

If you have any questions about the Rights Offering, require assistance regarding the method of exercising Rights or require additional copies of relevant documents, please contact the Information Agent, D.F. King & Co., Inc., by calling 1-800-755-7250 toll-free.

When making arrangements with your bank or broker for the delivery of funds on your behalf, you may also request such bank or broker to exercise the Subscription Rights Certificate or Notice of Guaranteed Delivery on your behalf.

 

4


Brokers, dealers, custodian banks and other nominees who exercise the Basic Subscription Right and the Over-Subscription Privilege on behalf of beneficial owners of Rights will be required to certify to the Subscription Agent and the Company, in connection with the exercise of the Over-Subscription Privilege, as to the:

 

  (1) aggregate number of shares of Common Stock held by the beneficial owners of Rights on 5:00 p.m., New York City time, on the Record Date;

 

  (2) the aggregate number of Rights that have been exercised; and

 

  (3) the number of Underlying Shares that are being subscribed for pursuant to the Over-Subscription Privilege, by each beneficial owner of Rights (including such nominee itself) on whose behalf such nominee is acting. If more Unsubscribed Shares are subscribed for pursuant to the Over-Subscription Privilege than are available for sale, the Unsubscribed Shares will be allocated pro rata among those exercising the Over-Subscription Privilege, as described in the Prospectus.

If the aggregate Subscription Price paid by you is insufficient to purchase the number of Underlying Shares subscribed for, or if no number of Underlying Shares to be purchased is specified, then you will be deemed to have exercised your Rights under the Basic Subscription Right to purchase Underlying Shares to the full extent of the payment tendered.

If the aggregate Subscription Price paid by you exceeds the amount necessary to purchase the number of Underlying Shares for which you have indicated an intention to subscribe, then the remaining amount will be returned to you by mail, without interest or deduction, promptly after the Expiration Date and after all pro rata allocations and adjustments contemplated by the terms of the Rights Offering have been effected.

2. Issuance of Common Stock .

Promptly following the expiration of the Rights Offering and the valid exercise of Rights pursuant to the Basic Subscription Right and Over-Subscription Privilege, and after all pro rata allocations and adjustments contemplated by the terms of the Rights Offering have been effected, the following deliveries and payments will be made to the address shown on the face of your Subscription Rights Certificate or Notice of Guaranteed Delivery, as applicable, or, if you hold your shares in book-entry form, such deliveries and payments will be in the form of a credit to your account, unless you provide instructions to the contrary in your Subscription Rights Certificate or Notice of Guaranteed Delivery, as applicable:

 

  a. Basic Subscription Right : The Subscription Agent will deliver to each exercising Rights holder a direct registration account statement for the number of shares of Common Stock purchased pursuant to the Basic Subscription Right. See “The Rights Offering—Basic Subscription Right” in the Prospectus.

 

  b. Over-Subscription Privilege : The Subscription Agent will deliver to each Rights holder who validly exercises the Over-Subscription Privilege a direct registration account statement for shares of Common Stock, if any, allocated to such Rights holder pursuant to the Over-Subscription Privilege. See “The Rights Offering—Over-Subscription Privilege” and “Questions and Answers Relating to the Rights Offering—What are the limitations on the over-subscription privilege?” in the Prospectus.

 

  c. Excess Cash Payments : The Subscription Agent will mail to each Rights holder who exercises the Over-Subscription Privilege any excess amount, without interest or deduction, received in payment of the Subscription Price for Unsubscribed Shares that are subscribed for by such Rights holder but not allocated to such Rights holder pursuant to the Over-Subscription Privilege. See “The Rights Offering—Over-Subscription Privilege” and “Questions and Answers Relating to the Rights Offering—What are the limitations on the over-subscription privilege?” in the Prospectus.

 

5


3. Sale or Transfer of Rights .

The Rights will be transferable during the course of the subscription period, and we expect that the Rights will trade on the New York Stock Exchange (“NYSE”) under the symbol “XCO-RT” until 4:00 pm, New York City time, on January 8, 2014. As a result, you may transfer or sell your Rights if you do not want to purchase any shares of our Common Stock. However, the Rights are a new issue of securities with no prior trading market, and there can be no assurances that the Rights will trade on the NYSE, that a market for the Rights will develop or, if a market does develop, of the prices at which the Rights will trade or whether such market will be sustainable throughout the period when the Rights are transferable.

If you are a beneficial owner of shares of Common Stock on the Record Date or will receive your Rights through a broker, dealer, custodian bank or other nominee, the Company will ask your broker, dealer, custodian bank or other nominee to notify you of the Rights Offering. If you wish to sell your Rights through your broker, dealer, custodian bank or other nominee, you must deliver your order to sell to your broker, dealer, custodian bank or other nominee such that it will be actually received prior the deadline established by such broker, dealer, custodian bank or other nominee. If you sell your Rights through your broker, dealer, custodian bank or other nominee your sales proceeds will be the actual sales price of your Rights less any applicable broker’s commission, taxes or other fees.

If you are a Record Holder of a Subscription Rights Certificate you may take your Subscription Rights Certificate to a broker and request to sell the Rights represented by the Subscription Rights Certificate. The broker will instruct you as to what is required to sell your Rights.

4. Commissions, Fees, and Expenses .

The Company is not charging any fee or sales commission to issue Rights to you or to issue Underlying Shares to you if you exercise your Rights. If you exercise your Rights through the Record Holder of your shares, you are responsible for paying any commissions, fees, taxes or other expenses your Record Holder may charge you. The Company will pay all reasonable fees charged by Continental Stock Transfer & Trust Company as the Subscription Agent and D.F. King as the Information Agent.

5. Execution .

 

  a. Execution by Registered Holder . The signature on the Subscription Rights Certificate or Notice of Guaranteed Delivery must correspond with the name of the registered holder exactly as it appears on the face of the Subscription Rights Certificate or Notice of Guaranteed Delivery without any alteration, enlargement or change whatsoever. Persons who sign the Subscription Rights Certificate or Notice of Guaranteed Delivery in a representative or other fiduciary capacity on behalf of a registered holder must indicate their capacity when signing and, unless waived by the Subscription Agent in its sole and absolute discretion, must present to the Subscription Agent satisfactory evidence of their authority so to act.

 

  b. Signature Guarantees . If you are neither a registered holder (or signing in a representative or other fiduciary capacity on behalf of a registered holder) nor an eligible institution, such as a member firm of a registered national securities exchange or a member of the Financial Industry Regulatory Authority, Inc., or a commercial bank or trust company having an office or correspondent in the United States, your signature must be guaranteed by such an eligible institution.

6. Method of Delivery to Subscription Agent .

The Subscription Agent for this offering is Continental Stock Transfer & Trust Company. The address to which Subscription Rights Certificates and payments, other than wire transfers, should be mailed or delivered by overnight courier is provided above in “Method of Subscription—Exercise of Rights.” If sent by mail, we

 

6


recommend that you send documents and payments by registered mail, properly insured, with return receipt requested, and that you allow a sufficient number of days to ensure delivery to the Subscription Agent. Do not send or deliver these materials to EXCO.

The method of delivery of Subscription Rights Certificates, all other subscription documents and payment of the subscription amount to the Subscription Agent will be at the risk of the Rights holders.

You should direct any questions or requests for assistance concerning the method of subscribing for the shares of Common Stock or for additional copies of this Prospectus to the Information Agent by calling 1-800-755-7250 toll-free or, if you are a bank or broker, 1-212-269-5550.

7. Special Provisions Relating to the Delivery of Rights through the Depository Trust Company .

In the case of Rights that are held of record through the Depository Trust Company (the “DTC”), exercises of the Basic Subscription Right and of the Over-Subscription Privilege may be effected by instructing the DTC to transfer Rights from the DTC account of such holder to the DTC account of the Subscription Agent, together with certification as to the number of shares held by beneficial owners on the Record Date, the aggregate number of Rights exercised and the number of Underlying Shares thereby subscribed for pursuant to the Basic Subscription Right and the Over-Subscription Privilege by each beneficial owner of Rights on whose behalf such nominee is acting, and payment of the Subscription Price for each Underlying Share subscribed for pursuant to the Basic Subscription Right and the Over-Subscription Privilege. See the Company’s “Letter to Shareholders Who Are Record Holders” and the “Nominee Holder Certification.”

8. Determinations Regarding the Exercise of Your Rights .

The Company will resolve, in its sole discretion, all questions regarding the validity and form of the exercise of your Rights, including time of receipt and eligibility to participate in the Rights Offering. The Company’s determination will be final and binding. Once made, subscriptions and directions are irrevocable subject to applicable law, and the Company will not accept any alternative, conditional or contingent subscriptions or directions. The Company reserves the absolute right to reject any subscriptions or directions not properly submitted or the acceptance of which would be unlawful. You must resolve any irregularities in connection with your subscriptions before the Rights Offering expires, unless the Company waives them in its sole discretion. Neither the Company nor the Subscription Agent is under any duty to notify you or your representative of defects in your subscriptions. A subscription will be considered accepted, subject to the Company’s right to withdraw or cancel the Rights Offering, only when the Subscription Agent receives a properly completed and duly executed Subscription Rights Certificate and any other required documents and the full subscription payment. The Company’s interpretations of the terms and conditions of the Rights Offering will be final and binding.

9. Foreign Shareholders .

The Company will mail the Prospectus, but will not mail the Subscription Rights Certificates, to Record Holders with addresses that are outside the United States or that have an army post office or foreign post office address. The Subscription Agent will hold these Subscription Rights Certificates for their account. To exercise Rights, foreign Record Holders must notify the Subscription Agent prior to 11:00 a.m, New York City time, on January 6, 2014, at least three business days prior to the Expiration Date, of their exercise of such Rights, and demonstrate to the satisfaction of the Subscription Agent that the exercise of such Rights does not violate the laws of the jurisdiction of the Record Holders. These procedures do not apply to beneficial owners of Common Stock that are located outside the United States who will receive Rights through a broker, dealer, custodian bank or other nominee that is located in the United States.

 

7

Exhibit 99.2

FORM OF NOTICE OF GUARANTEED DELIVERY FOR RIGHTS CERTIFICATES

ISSUED BY

EXCO RESOURCES, INC.

This form, or one substantially equivalent hereto, must be used to exercise the subscription rights (the “Rights”) pursuant to the rights offering (the “Rights Offering”) described in the prospectus for the Rights Offering (a copy of which accompanies this form) (the “Prospectus”) of EXCO Resources, Inc. (the “Company”), if a holder of Rights cannot deliver the certificate(s) evidencing the Rights (the “Rights Certificate(s)”), to the Subscription Agent (as defined below) prior to 5:00 p.m., New York City time, on January 9, 2014, unless extended by the Board of Directors of the Company (the “Expiration Date”). Such form must be delivered by facsimile transmission, first class mail or overnight courier to the Subscription Agent, and must be received by the Subscription Agent prior to 5:00 p.m., New York City time, the Expiration Date.

Payment of the subscription price of $5.00 per share for each share of the Company’s common stock, par value $0.001 per share (the “Common Stock”) subscribed for upon exercise of such Rights must be received by the Subscription Agent in the manner specified in the Prospectus prior to 5:00 p.m., New York City time, on the Expiration Date, even if the Rights Certificate(s) evidencing such Rights is (are) being delivered pursuant to the Guaranteed Delivery Procedures hereof. See “The Rights Offering—Method of Exercising Rights” and “The Rights Offering—Guaranteed Delivery Procedures” in the Prospectus.

All deliveries must be addressed to Continental Stock Transfer & Trust Company, the subscription agent for the Rights Offering (the “Subscription Agent”), as follows:

By Mail or Overnight Courier:

Continental Stock Transfer & Trust Company

17 Battery Place—8th Floor

New York, NY 10004

Attn: Corporate Actions Department

Telephone: (917) 262-2378

By facsimile transmission (for Eligible Institutions Only):

212-616-7610

Delivery of this instrument to an address other than as set forth above or transmission of this

instrument via facsimile other than as set forth above does not constitute valid delivery.

You should confirm receipt of all facsimile transmissions by calling the Subscription Agent at 917-262-2378.

You may obtain additional information regarding the Rights Offering from the Information Agent, D.F. King & Co., Inc., by calling 1-800-755-7250 toll-free or, if you are a bank or broker, at 1-212-269-5550.

Ladies and Gentlemen:

The undersigned represents that the undersigned is the holder of Rights Certificate(s) representing Right(s) and that the Rights Certificate(s) cannot be delivered to the Subscription Agent prior to the Expiration Date. Upon the terms and subject to the conditions set forth in the Prospectus, receipt of which is acknowledged by execution of this form, the undersigned elects to exercise (i) the Basic Subscription Right to subscribe for                  share(s) of Common Stock and (ii) the Over-Subscription Privilege relating to such Rights, to the extent that there are available shares of Common Stock that are not otherwise purchased pursuant to the exercise of the Basic Subscription Privilege, for an aggregate of up to                  share(s) of Common Stock, subject to adjustment for fractional shares, availability and pro-ration as described in the Prospectus.


The undersigned understands that payment of the subscription price of $5.00 for each share of Common Stock subscribed for pursuant to the Basic Subscription Right and the Over-Subscription Privilege must be received by the Subscription Agent prior to 5:00 p.m., New York City time, on the Expiration Date, and represents that such payment, in the aggregate amount of $                          either (check appropriate box):

 

  ¨ is being delivered to the Subscription Agent herewith

OR

 

  ¨ has been delivered separately to the Subscription Agent in the manner set forth below (check appropriate box and complete information relating thereto):

 

  ¨ certified or personal check drawn on a U.S. bank payable to “Continental Stock Transfer & Trust Company” (Payment by uncertified check will not be deemed to have been received by the Subscription Agent until such check has cleared. Holders paying by such means are urged to make payment sufficiently in advance of the Expiration Date to ensure that such payment clears by 5:00 p.m., New York City time, on such date. Payment will be deemed to have been received by the Subscription Agent upon receipt by the Subscription Agent of any certified check or bank draft drawn upon a U.S. bank.);

 

  ¨ postal, telegraphic or express money order payable to “Continental Stock Transfer & Trust Company”; or

 

  ¨ wire transfer of immediately available funds directly to the account maintained by “Continental Stock Transfer & Trust Company as agent for EXCO Resources Rights Offering”; at Bank Name: JP Morgan Chase Bank; ABA #: 021000021; Account #: 475-581202. Any wire transfer should clearly indicate the identity of the subscriber who is paying the subscription price by wire transfer.

See “The Rights Offering—Payment Method” in the Prospectus and “Method of Subscription—Exercise of Rights” in the Instructions for use of EXCO Resources, Inc. Subscription Rights Certificates for further information on the method of payment.

Date of check, draft or money order:

Check, draft or money order number:

Bank on which check is drawn:

 

Signature(s):

    Address:

Name(s):

   

 

   

 

   

 

  (Please type or print)   (Area code and Tel. No.(s))

 

2


Rights Certificate No(s). (if available):

GUARANTEE OF DELIVERY

(Not To Be Used For Rights Certificate Signature Guarantee)

The undersigned, a member firm of a registered national securities exchange or of the Financial Industry Regulatory Authority, or a commercial bank or trust company having an office or correspondent in the United States, or a bank, stockbroker, savings and loan association or credit union with membership in an approved signature guarantee medallion program, pursuant to Rule 17Ad-15 of the Securities Exchange Act of 1934, as amended, guarantees that the undersigned will deliver to the Subscription Agent the certificates representing the Rights being exercised hereby, with any required signature guarantee and any other required documents, all within three (3) business days after the date hereof.

 

(Authorized Signature)

   Dated:
  

 

(Name of Firm)

  

 

(Address)

  

 

(Area code and Tel. No.)

  

The institution which completes this form must communicate the guarantee to the Subscription Agent and must deliver the Rights Certificate(s) to the Subscription Agent within the time period specified above and in the Prospectus. Failure to do so could result in a financial loss to such institution.

 

3

Exhibit 99.3

FORM OF LETTER TO SHAREHOLDERS WHO ARE RECORD HOLDERS

EXCO RESOURCES, INC.

Up to 44,995,665 Shares of Common Stock

Issuable upon the Exercise of Transferable Subscription Rights at $5.00 Per Share

December 17, 2013

Dear Shareholder resident in the United States:

This letter is being sent by EXCO Resources, Inc. (the “Company”) to shareholders of record of our common stock as of 5:00 p.m., New York City time, on December 19, 2013 (the “Record Date”) in connection with our distribution at no charge of transferable subscription rights to purchase shares of our common stock in a rights offering by the Company. The rights offering is described in the enclosed prospectus dated December 17, 2013 (the “Prospectus”).

As described in the Prospectus, the Company is offering up to 44,995,665 shares of common stock at a cash price of $5.00 per share. For each share of common stock owned as of 5:00 p.m., New York City time, on the Record Date, you may purchase 0.25 of a share of common stock under what we refer to as your “Basic Subscription Right.” In addition, if you exercise your Basic Subscription Right in full (including in respect of subscription rights purchased from others), you will be eligible to purchase any whole shares of common stock that are not purchased by other rights holders under what we refer to as your “Over-Subscription Privilege.” Exercise of your Over-Subscription Privilege is subject to limitation and allocation as further described in the Prospectus. Please note that fractional shares as to any rights holder resulting from exercise of the Basic Subscription Right or proration in the Over-Subscription Privilege will be rounded down to the nearest whole share.

The rights are transferable, and the Company expects that the rights will trade on the New York Stock Exchange under the symbol “XCO-RT” until 4:00 p.m., New York City time, on January 8, 2014, unless extended by the Board of Directors of the Company.

The rights offering will expire at 5:00 p.m., New York City time, on January 9, 2014, unless extended by the Board of Directors of the Company (the “Expiration Date”). Your right to purchase common stock in the rights offering will expire if not exercised by such time. Once submitted, all exercises of the rights are irrevocable, subject to applicable law. You should read the Prospectus carefully before deciding whether to exercise your rights.

Your subscription rights are evidenced by the transferable rights certificate registered in your name (the “Subscription Rights Certificate”). The reverse of the Subscription Rights Certificate contains the form for exercising and/or transferring your rights.

Enclosed is a copy of the Prospectus.

Additionally, the following documents will be distributed as soon as practicable following the Record Date:

 

  1. Your Subscription Rights Certificate;

 

  2. Instructions as to the use of the Subscription Rights Certificates;

 

  3. Notice of Guaranteed Delivery;

 

  4. Notice of Important Tax Information; and

 

  5. A return envelope addressed to Continental Stock Transfer & Trust Company, the subscription agent.


Your prompt action is requested. To exercise your rights, you should deliver the properly completed and duly signed Subscription Rights Certificate (or the Notice of Guaranteed Delivery if you are following the Guaranteed Delivery Procedures), with full payment of the subscription price for each share of common stock subscribed for pursuant to the Basic Subscription Right and the Over-Subscription Privilege, to the subscription agent, as indicated in the Prospectus. The subscription agent must receive the Subscription Rights Certificate (or Notice of Guaranteed Delivery) and all other required subscription documents with payment, including final clearance of any checks, prior to the expiration of the rights offering.

Please contact the D.F. King & Co., Inc., the information agent, for additional copies of the enclosed materials and any questions or requests for assistance concerning the rights offering by calling 1-800-755-7250.

Very truly yours,

EXCO Resources Inc.

NOTHING IN THE PROSPECTUS OR IN THE ENCLOSED DOCUMENTS SHALL CONSTITUTE YOU OR ANY PERSON AS AN AGENT OF EXCO RESOURCES, INC., THE SUBSCRIPTION AGENT OR ANY OTHER PERSON MAKING OR DEEMED TO BE MAKING OFFERS OF THE SECURITIES ISSUABLE UPON VALID EXERCISE OF THE RIGHTS, OR AUTHORIZE YOU OR ANY OTHER PERSON TO MAKE ANY STATEMENTS ON BEHALF OF ANY OF THEM WITH RESPECT TO THE OFFERING EXCEPT FOR STATEMENTS MADE IN THE PROSPECTUS.

 

2

Exhibit 99.4

FORM OF LETTER TO NOMINEE HOLDERS

WHOSE CLIENTS ARE BENEFICIAL HOLDERS

EXCO RESOURCES, INC.

Up to 44,995,665 Shares of Common Stock

Issuable upon the Exercise of Transferable Subscription Rights at $5.00 Per Share

December 17, 2013

To Security Dealers, Commercial Banks,

Trust Companies and Other Nominees:

This letter is being sent by EXCO Resources, Inc. (the “Company”) to securities dealers, commercial banks, trust companies and other nominee holders of our common stock at 5:00 p.m., New York City time, on December 19, 2013 (the “Record Date”) in connection with our distribution at no charge of transferable rights to purchase shares of our common stock in a rights offering by the company. The rights offering is described in the enclosed offering prospectus dated December 17, 2013 (“Prospectus”). We are asking you as nominee for your clients who beneficially hold our common stock to contact the beneficial owners for instructions regarding the rights offering.

As described in the Prospectus, the Company is offering up to 44,995,665 shares of common stock at a cash price of $5.00 per share. For each share of common stock owned as of the Record Date, you may purchase 0.25 of a share of common stock under what we refer to as your “Basic Subscription Right.” In addition, if you exercise your Basic Subscription Right in full (including in respect of subscription rights purchased from others), you will be eligible to purchase any whole shares of common stock that are not purchased by other rights holders under what we refer to as your “Over-Subscription Privilege.” Exercise of your Over-Subscription Privilege is subject to limitation and allocation as further described in the Prospectus. Please note that fractional shares as to any rights holder resulting from exercise of the Basic Subscription Right or proration in the Over-Subscription Privilege will be rounded down to the nearest whole share.

The rights are transferable, and the Company expects that the rights will trade on the New York Stock Exchange under the symbol “XCO-RT” from the commencement of the rights offering until 4:00 p.m., New York City time, on January 8, 2014, unless extended by the Board of Directors of the Company.

The rights offering will expire at 5:00 p.m., New York City time, on January 9, 2014, unless extended by the Board of Directors of the Company (the “Expiration Date”). Your right to purchase common stock in the rights offering will expire if not exercised by such time. Once submitted, all exercises of the rights are irrevocable, subject to applicable law. You should read the Prospectus carefully before deciding whether to exercise your rights.

If you hold shares of our common stock for a client whose address is outside the United States, do not send them information or documents relating to the rights offering or attempt to exercise any rights on their behalf unless you or your client has provided evidence satisfactory to us that the exercise of such rights does not violate the laws of the jurisdiction of such client. This evidence must be provided to us prior to 11:00 a.m., New York City time, at least three business days prior to the expiration of the rights offering.

Enclosed are copies of the following documents:

 

  1. Prospectus;

 

  2. Instructions for use of EXCO Resources, Inc. Subscription Rights Certificates;

 

  3. A form of letter that may be sent to your clients for whose accounts you hold our common stock registered in your name or the name of your nominee;

 

  4. Nominee Holder Certification;


  5. Beneficial Owner Election Form;

 

  6. Notice of Guaranteed Delivery;

 

  7. Notice of Important Tax Information; and

 

  8. A return envelope addressed to Continental Stock Transfer & Trust Company, the Subscription Agent

Your prompt action is requested. To exercise your rights, you should deliver the properly completed and duly signed Beneficial Owner Election Form and the Nominee Holder Certification (or the Notice of Guaranteed Delivery if you are following the Guaranteed Delivery Procedures), with full payment of the subscription price for each share of common stock subscribed for pursuant to the Basic Subscription Right and the Over-Subscription Privilege, to the subscription agent, as indicated in the Prospectus. The subscription agent must receive the Beneficial Owner Election Form and the Nominee Holder Certification or the Notice of Guaranteed Delivery and all other required subscription documents with payment, including final clearance of any checks, prior to the expiration of the rights offering.

Please contact the D.F. King & Co., Inc., the information agent, for additional copies of the enclosed materials and any questions or requests for assistance concerning the rights offering by calling 1-212-269-5550.

 

Very truly yours
EXCO Resources, Inc.

NOTHING IN THE PROSPECTUS OR IN THE ENCLOSED DOCUMENTS SHALL CONSTITUTE YOU OR ANY PERSON AS AN AGENT OF EXCO RESOURCES, INC., THE SUBSCRIPTION AGENT OR ANY OTHER PERSON MAKING OR DEEMED TO BE MAKING OFFERS OF THE SECURITIES ISSUABLE UPON VALID EXERCISE OF THE RIGHTS, OR AUTHORIZE YOU OR ANY OTHER PERSON TO MAKE ANY STATEMENTS ON BEHALF OF ANY OF THEM WITH RESPECT TO THE OFFERING EXCEPT FOR STATEMENTS MADE IN THE PROSPECTUS.

 

2

Exhibit 99.5

FORM OF LETTER TO CLIENTS OF NOMINEE HOLDERS

EXCO RESOURCES, INC.

Up to 44,995,665 Shares of Common Stock

Issuable upon the Exercise of Transferable Subscription Rights at $5.00 Per Share

December 17, 2013

To Our Clients:

EXCO Resources, Inc. (the “Company”) has distributed, at no charge, to its shareholders of record at 5:00 p.m., New York City time, on December 19, 2013 (the “Record Date”) transferable rights to purchase shares of its common stock in a rights offering by the Company. The rights offering is described in the enclosed offering prospectus dated December 17, 2013 (“Prospectus”).

As described in the Prospectus, the Company is offering up to 44,995,665 shares of the Company’s common stock at a cash price of $5.00 per share. You will receive one right for each share of common stock beneficially owned by you as of the Record Date. Each right entitles you to purchase 0.25 of a share of common stock at a cash price of $5.00 per share under what we refer to as your “Basic Subscription Right.” In addition, if you exercise your Basic Subscription Right in full (including in respect of subscription rights purchased from others), you will be eligible to purchase any whole shares of common stock that are not purchased by other rights holders under what we refer to as your “Over-Subscription Privilege.” Exercise of your Over-Subscription Privilege is subject to limitation and allocation as further described in the Prospectus. Please note that fractional shares as to any rights holder resulting from exercise of the Basic Subscription Right or proration in the Over-Subscription Privilege will be rounded down to the nearest whole share.

The rights are transferable, and the Company expects that the rights will trade on the New York Stock Exchange under the symbol “XCO-RT” from the commencement of the rights offering until 4:00 p.m., New York City time, on January 8, 2014, unless extended by the Board of Directors of the Company.

The rights offering will expire at 5:00 p.m., New York City time, on January 9, 2014, unless extended by the Board of Directors of the Company (the “Expiration Date”). Your right to purchase common stock in the rights offering will expire if not exercised by such time. Once submitted, all exercises of the rights are irrevocable, subject to applicable law. You should read the Prospectus carefully before deciding whether to exercise your rights.

Please note that if you are outside of the United States, no offer or invitation to exercise rights and purchase shares is being made to you by the Company, and you must not attempt to exercise or transfer any rights. However, you may exercise your rights if, prior to 11:00 a.m., New York City time, at least three business days prior to the expiration of the rights offering, you provide evidence satisfactory to the Company that the exercise of such rights does not violate the laws of your jurisdiction.

THE BENEFICIAL OWNER ELECTION FORM AND THE OTHER MATERIALS ENCLOSED ARE BEING FORWARDED TO YOU AS THE BENEFICIAL OWNER OF COMMON STOCK HELD BY US IN YOUR ACCOUNT BUT NOT REGISTERED IN YOUR NAME. EXERCISES AND TRANSFERS OF RIGHTS MAY BE MADE ONLY BY US AS THE RECORD OWNER AND PURSUANT TO YOUR INSTRUCTIONS.

Accordingly, we request your instructions as to whether you wish to elect to subscribe for any shares of the Company’s common stock to which you are entitled or to transfer any of your rights pursuant to the terms of the rights offering. However, we urge you to read the Prospectus carefully before instructing us to exercise or transfer your rights.


If you wish to have us, on your behalf, exercise the rights for any shares of the Company’s common stock to which you are entitled or transfer your rights, please so instruct us by completing, executing and returning to us the enclosed Beneficial Owner Election Form. Your Beneficial Owner Election Form should be forwarded to us as promptly as possible in order to permit us to exercise or transfer rights on your behalf in accordance with the terms of the rights offering. Please contact us for our deadline with respect to your submission of the Beneficial Ownership Election Form. Once you have exercised the Basic Subscription Right or the Over-Subscription Privilege, such exercise may not be revoked.

Please contact D.F. King & Co., Inc., the information agent, with any questions or requests for assistance concerning the rights offering by calling 1-800-755-7250. You may also contact us directly.

Very truly yours,

 

2

Exhibit 99.6

FORM OF BENEFICIAL OWNER ELECTION FORM

The undersigned acknowledge(s) receipt of your letter and the enclosed materials referred to therein relating to the distribution of transferable subscription rights (the “Rights”) to purchase shares of common stock (“Common Stock”) of EXCO Resources, Inc. (the “Company”).

With respect to any instructions to exercise (or not to exercise) Rights, the undersigned acknowledges that this form must be completed and returned such that it will actually be received by the deadline established by your nominee, which may be before 5:00 p.m., New York City time, on January 9, 2014, unless extended by the Board of Directors of the Company (the “Expiration Date”).

I (we) hereby instruct you as follows:

Box 1.     ¨         Please DO NOT EXERCISE RIGHTS for shares of Common Stock.

Box 2.     ¨         Please EXERCISE RIGHTS for shares of Common Stock as set forth below:

Basic Subscription Right

 

I exercise

        x    0.25    =     
   (no. of Rights)       (ratio)      

(no. of new shares, rounded

down to nearest whole share)

            

Therefore, I apply

for

        x    $5.00    =   

$

  

(no. of new whole

shares)

     

(subscription

price)

      (amount enclosed)

Over-Subscription Privilege

If you fully exercise your Basic Subscription Right (including in respect of Rights purchased from others), and wish to subscribe for additional shares, you may exercise your Over-Subscription Privilege. Exercise of your Over-Subscription Privilege is subject to limitations and allocations as described in the Prospectus.

 

I apply for

        x    $5.00    =    $                                         
   (no. of whole shares)       (subscription price)       (additional amount enclosed)

Total Payment Required (sum of basic plus over-subscription amounts): $

I am (we are) making the total payment required in the following manner:

Box 3.     ¨         Payment in the following amount is enclosed $                          .

Box 4.     ¨         Please deduct payment from the following account maintained by you as follows:

Type of Account:                                                                                                       

Account No.:                                                                                                             

Amount to be deducted: $                                                                                         

(The total of the above two boxes must equal the “Total Payment Required” specified above.)


Transfer of Rights

Box 5.     ¨         Please sell                           of my (our) Rights.

    (no. of rights)        

 

 

I (we) on my (our) own behalf, or on behalf of any person(s) on whose behalf, or under whose directions, I am (we are) signing this form:

 

  ¨ represent and warrant that I am a (we are) resident(s) of the United States or, if I am (we are) not, have provided evidence satisfactory to EXCO Resources, Inc. that the exercise of my (our) Rights does not violate the laws of my (our) jurisdiction;

 

  ¨ irrevocably elect to purchase the number of shares of Common Stock indicated above on the terms set forth in the Prospectus; and

 

  ¨ I (we) agree that if I (we) fail to pay for the shares I (we) have elected to purchase, you may exercise any remedies available to you under law.

Name(s) of beneficial owner(s):

 

Signature(s) of beneficial owner(s):

 

Name:

 

Capacity:

 

Address (including Zip Code):

 

Telephone Number:

 

2

Exhibit 99.7

FORM OF NOMINEE HOLDER CERTIFICATION

The undersigned, a bank, broker, trustee, depositary or other nominee of transferable rights (the “Rights”) to purchase shares of common stock, par value $0.001 per share, of EXCO Resources, Inc. (the “Company”) pursuant to the rights offering described and provided for in the Company’s Prospectus dated December 17, 2013 (the “Prospectus”), hereby certifies to the Company and to Continental Stock Transfer & Trust Company, as Subscription Agent for the rights offering, that (1) the undersigned has exercised, on behalf of the beneficial owners thereof (which may include the undersigned), the number of Rights specified below pursuant to the basic subscription right (as described in the Prospectus) and, on behalf of beneficial owners of Rights who have subscribed for the purchase of additional shares of common stock pursuant to the over-subscription privilege (as described in the Prospectus), the number of shares specified below pursuant to the over-subscription privilege, listing separately below each such exercised basic subscription right and the corresponding over-subscription privilege (without identifying any such beneficial owner), (2) to the extent a beneficial owner has elected to subscribe for shares pursuant to the over-subscription privilege, each such beneficial owner’s basic subscription right has been timely exercised in full (including in respect of Rights purchased from others), and (3) if a beneficial owner has elected to subscribe for shares pursuant to the over-subscription privilege, the number of shares of common stock beneficially owned by the beneficial owner as of 5:00 p.m., New York City time, on December 19, 2013 (for purposes of proration in connection with the over-subscription privilege).

 

Number of Shares Owned on

Record Date

  

Number of Shares Subscribed

for Pursuant to Basic

Subscription Right

  

Number of Shares Subscribed

for Pursuant to Over-

Subscription Privilege

1.

 

         

2.

 

         

3.

 

         

4.

 

         

5.

 

         

6.

 

         

7.

 

         

8.

 

         

9.

 

         

10.

 

         

Provide the following information if applicable:

 

Name of Nominee Holder      DTC Participant Number
By:       

Name:

    

DTC Subscription Confirmation Numbers

Title:

    

Phone Number:

    

Fax Number:

    

Dated:

Exhibit 99.8

FORM OF NOTICE OF IMPORTANT TAX INFORMATION

The tax information is provided in connection with the prospectus of EXCO Resources, Inc. (the “Company”), dated December 17, 2013 (the “Prospectus”).

Under the United States federal income tax laws, dividend payments that may be made by the Company on shares of its common stock, no par value (the “Common Stock”), issued upon the exercise of transferable subscription rights or the over-subscription privilege (the “Subscription Rights”) may be subject to backup withholding. Generally, such payments will be subject to backup withholding unless the holder (i) is exempt from backup withholding or (ii) furnishes the payer with its correct taxpayer identification number (“TIN”) and certifies, under penalties of perjury, that the number provided is correct and provides certain other certifications. Each holder that exercises Subscription Rights and wants to avoid backup withholding must, unless an exemption applies, provide Continental Stock Transfer & Trust Company (the “Subscription Agent”), as the Company’s agent in respect of the exercised Subscription Rights, with such holder’s correct TIN (or with a certification that such holder is awaiting a TIN) and certain other certifications by completing Substitute Form W-9 below.

Certain holders (including, among others, corporations and certain foreign individuals) are exempt from these backup withholding and reporting requirements. In general, in order for a foreign holder to qualify as an exempt recipient, that holder must submit a properly completed Form W-8, Certificate of Foreign Status (instead of a Substitute Form W-9), signed under penalties of perjury, attesting to such holder’s foreign status. Such Form W-8 may be obtained from the Subscription Agent. Although a foreign holder may be exempt from backup withholding, payments of dividends may be subject to withholding tax, currently at a 30% rate (or, if certain tax treaties apply, such applicable lower rate). Exempt U.S. holders must indicate their exempt status on Substitute Form W-9 to avoid possible erroneous backup withholding. See the enclosed “Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9” for additional instructions. Holders are urged to consult their tax consultants to determine whether they are exempt from withholding and reporting requirements.

If backup withholding applies, the Company or the Subscription Agent, as the case may be, will be required to withhold (currently at a 28% rate) on any dividend payments made to a holder that exercises Subscription Rights. Backup withholding is not an additional tax. Rather, the amount of backup withholding can be credited against the U.S. federal income tax liability of the holder subject to the backup withholding, provided that the required information is provided to the Internal Revenue Service (“IRS”). If backup withholding results in an overpayment of taxes, a refund may be obtained.

A holder that exercises Subscription Rights is required to give the Subscription Agent the TIN of the record owner of the Subscription Rights. If such record owner is an individual, the TIN is generally the taxpayer’s social security number. For most other entities, the TIN is the employer identification number. If the Subscription Rights are in more than one name or are not in the name of the actual owner, consult the enclosed “Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9” for additional guidelines on which number to report. If the Subscription Agent is not provided with the correct TIN in connection with such payments, the holder may be subject to a penalty imposed by the IRS.

If you do not have a TIN, consult the enclosed “Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9” for instructions on applying for a TIN, write “Applied For” in the space for the TIN in Part 1 of the Substitute Form W-9 and, under penalties of perjury, sign and date the Substitute Form W-9 and the Certificate of Awaiting Taxpayer Identification Number set forth herein. If you do not provide your TIN to the Subscription Agent within 60 days, backup withholding will begin and continue until you furnish your TIN to the Subscription Agent. Please note that writing “Applied For” on the form means that you have already applied for a TIN or that you intend to apply for one in the near future.


Substitute

Form W-9

 

Department of the Treasury Internal Revenue Service

 

Payer’s Request for Taxpayer Identification Number (“TIN”) and Certification

 

PART 1 —Taxpayer Identification Number— ENTER YOUR TIN IN THE BOX AT THE RIGHT. (For most individuals, this is your social security number. If you do not have a TIN, see How to Get a TIN in the enclosed Guidelines.) CERTIFY BY SIGNING AND DATING BELOW.

 

Note: If the account is more than one name, see the chart in the enclosed Guidelines to determine which number to give the payer.

 

 

Social Security Number

OR

 

Employer Identification Number

(if awaiting TIN, write “Applied

For”)

 

 

PART 2 —For Payees Exempt from Backup Withholding—Check the box if you are NOT subject to backup withholding.

 

PART 3 —Certification—Under penalties of perjury, I certify that:

 

(1)    The number shown on this form is my correct taxpayer identification number (or I am waiting for a number to be issued to me), and

 

(2)    I am not subject to backup withholding because: (a) I am exempt from backup withholding, or (b) I have not been notified by the Internal Revenue Service (the “IRS”) that I am subject to backup withholding as a result of a failure to report all interest or dividends, or (c) the IRS has notified me that I am no longer subject to backup withholding, and

 

(3)    I am a U.S. person (including a U.S. resident alien).

 

Certification Instructions—You must cross out item (2) of Part 3 above if you have been notified by the IRS that you are subject to backup withholding because you failed to report all interest or dividends on your tax return. However, if after being notified by the IRS that you were subject to backup withholding you received another notification from the IRS that you are no longer subject to backup withholding, do not cross out item (2) of Part 3. (Also see instructions in the enclosed Guidelines). The IRS does not require your consent to any provisions of this document other than the certifications required to avoid backup withholding.

 

Name (please print)

 

Street Address

 

City, State and Zip code

 

Telephone Number

 

Check

appropriate box:

           

 

¨ Individual/Sole Proprietor         ¨   C Corporation         ¨   S Corporation         ¨   Partnership

 

¨   Trust/Estate          ¨   Limited Liability Company. Enter the tax classification (C=C Corporation; S=S Corporation;

                                                                                      P=Partnership)

 

¨    Other

   

Signature                                              

   

Date                      , 201     

             

 

2


YOU MUST COMPLETE THE FOLLOWING CERTIFICATE IF YOU WROTE

“APPLIED FOR” INSTEAD OF A TIN IN THE SUBSTITUTE FORM W-9

 

CERTIFICATE OF AWAITING TAXPAYER IDENTIFICATION NUMBER

I certify under penalties of perjury that a taxpayer identification number has not been issued to me, and either (a) I have mailed or delivered an application to receive a taxpayer identification number to the appropriate Internal Revenue Service Center or Social Security Administration Office or (b) I intend to mail or deliver an application in the near future. I understand that if I do not provide a taxpayer identification number to the Subscription Agent, 28% of all reportable payments made to me will be withheld, but will be refunded to me if I provide a certified taxpayer identification number within 60 days.

 

Signature                                                              Date                          , 201     

NOTE: FAILURE TO COMPLETE AND RETURN THIS SUBSTITUTE FORM W-9 MAY RESULT IN BACKUP WITHHOLDING OF 28% OF ANY PAYMENTS OF DIVIDENDS MADE TO YOU. IN ADDITION, FAILURE TO PROVIDE SUCH INFORMATION MAY RESULT IN A PENALTY IMPOSED BY THE INTERNAL REVENUE SERVICE. PLEASE REVIEW THE ENCLOSED GUIDELINES FOR CERTIFICATION OF TAXPAYER IDENTIFICATION NUMBER ON SUBSTITUTE W-9 FOR ADDITIONAL INFORMATION.


GUIDELINES FOR CERTIFICATION OF TAXPAYER IDENTIFICATION

NUMBER ON SUBSTITUTE FORM W-9

Guidelines For Determining the Proper Identification Number to Give the Payer —Social Security Numbers (“SSNs”) have nine digits separated by two hyphens: i.e., 000-00-0000. Employer Identification Numbers (“EINs”) have nine digits separated by only one hyphen: i.e., 00-0000000. The table below will help determine the number to give the payer. All “section” references are to the Internal Revenue Code of 1986, as amended. “IRS” is the Internal Revenue Service.

 

For this type of account:

  

GIVE THE NAME AND

SOCIAL SECURITY

NUMBER or EMPLOYER

IDENTIFICATION

NUMBER of—

1.       

Individual

   The individual
2.       

Twoor more individuals

(jointaccount)

  

The actual owner of the

account or, if combined funds,

the first individual on the

account(1)

3.        Custodianaccount of a minor (Uniform Gift to Minors Act)    The minor(2)
4.       

a. The usual revocable
savings trust (grantor is
also trustee)

   The grantor-trustee(1)
 

b. The so-called trust account
that is not a legal or valid
trust under state law

   The actual owner(1)
5.       

Soleproprietorship or

disregardedentity owned by an

individual

   The owner(3)
6.       

Grantortrust filing under

OptionalForm 1099 Filing

Method1 (see Treasury

Regulationsection 1.671-4(b)(2)(i)(A))

   The grantor*
For this type of account:   

 

GIVE THE NAME AND
EMPLOYER

IDENTIFICATION

NUMBER of—

7.   Disregarded entity not owned by an individual    The owner
8.        A valid trust, estate or pension trust    Legal entity(4)
9.        Corporation or LLC electing corporate status on IRS Form 8832 or IRS Form 2553    The corporation
10.      Association, club, religious, charitable, educational or other
tax-exempt organization
   The organization
11.      Partnership or multi-member LLC    The partnership
12.      A broker or registered nominee    The broker or nominee
13.      Account with the Department of Agriculture in the name of a public entity (such as a state or local government, school district, or prison) that receives agricultural program payments    The public entity
14.      Grantor trust filing under the Form 1041 Filing Method or the Optional Form 1099 Filing Method 2 (see Treasury Regulation section 1.671-4(b)(2)(i)(B))    The trust
 

 

 

 

 

(1) List first and circle the name of the person whose SSN you furnish. If only one person on a joint account has an SSN, that person’s number must be furnished.
(2) Circle the minor’s name and furnish the minor’s SSN.
(3) You must show your individual name and you may also enter your business or “doing business as” name on the “Business name/disregarded entity” name line. You may use either your SSN or EIN (if you have one), but the IRS encourages you to use your SSN.
(4) List first and circle the name of the legal trust, estate or pension trust. (Do not furnish the Taxpayer Identification Number of the personal representative or trustee unless the legal entity itself is not designated in the account title.)

 

  NOTE: If no name is circled when more than one name is listed, the number will be considered to be that of the first name listed.
  * NOTE: Grantor also must provide a Substitute Form W-9 to trustee of trust.

 

4


Purpose of Form

A person who is required to file an information return with the IRS must obtain your correct Taxpayer Identification Number (“TIN”) to report, for example, income paid to you, real estate transactions, mortgage interest you paid, acquisition or abandonment of secured property, cancellation of debt or contributions you made to an individual retirement account. If you are a U.S. person (including a resident alien), use Substitute Form W-9 to give your correct TIN to the requester (the person requesting your TIN) and, when applicable, (1) to certify the TIN you are giving is correct (or you are waiting for a number to be issued), (2) to certify you are not subject to backup withholding, or (3) to claim exemption from backup withholding if you are an exempt payee. The TIN provided must match the name given on the Substitute Form W-9.

Definition of a U.S. Person: For federal tax purposes, you are considered a U.S. person if you are: (1) an individual who is a U.S. citizen or U.S. resident alien; (2) a partnership, corporation, company or association created or organized in the United States or under the laws of the United States; (3) an estate (other than a foreign estate); or (4) a domestic trust (as defined under Treasury Regulations section 301.7701-7).

Special Rules for Partnerships: Partnerships that conduct a trade or business in the United States are generally required to pay a withholding tax on any foreign partner’s share of income from such business. Further, in certain cases where a Substitute Form W-9 has not been received, a partnership is required to presume that a partner is a foreign person, and pay the withholding tax. Therefore, if you are a U.S. person that is a partner in a partnership conducting a trade or business in the United States, provide a Substitute Form W-9 to the partnership to establish your U.S. status and avoid withholding on your share of partnership income.

The person who gives Substitute Form W-9 to the partnership for purposes of establishing its U.S. status and avoiding withholding on its allocable share of net income from the partnership conducting a trade or business in the United States is, in the following cases: (1) the U.S. owner of a disregarded entity and not the entity; (2) the U.S. grantor or other owner of a grantor trust and not the trust; and (3) the U.S. trust

(other than a grantor trust) and not the beneficiaries of the trust.

How to Get a TIN

If you do not have a TIN, apply for one immediately. To apply for an SSN, obtain Form SS-5, Application for a Social Security Card, at the local office of the Social Security Administration or get this form on-line at www.ssa.gov/online/ss-5.pdf . You may also get this form by calling 1-800-772-1213. You can apply for an EIN online by accessing the IRS website at www.irs.gov/businesses and clicking on Employer Identification Number (EIN) under Starting a Business. Use IRS Form W-7, Application for IRS Individual Taxpayer Identification Number, to apply for an ITIN, or IRS Form SS-4, Application for Employer Identification Number, to apply for an EIN. You can get IRS Forms W-7 and SS-4 from the IRS by calling 1-800-TAX-FORM (1-800-829-3676) or from the IRS website at www.irs.gov .

If you do not have a TIN, write “Applied For” in Part 1 of Substitute Form W-9, sign and date both the form and the Certificate of Awaiting Taxpayer Identification Number set forth therein, and give it to the requester. For interest and dividend payments and certain payments made with respect to readily tradable instruments, you will generally have 60 days to get a TIN and give it to the requester. If the requester does not receive your TIN within 60 days, backup withholding, if applicable, will begin and continue until you furnish your TIN.

Note: Writing “Applied For” on the Substitute W-9 means that you have already applied for a TIN OR that you intend to apply for one soon. As soon as you receive your TIN, complete another Substitute Form W-9, include your TIN, sign and date the form, and give it to the requester.

CAUTION: A disregarded domestic entity that has a foreign owner must use the appropriate IRS Form W-8.

Payees Exempt from Backup Withholding

Individuals (including sole proprietors) are NOT exempt from backup withholding. Corporations are exempt from backup withholding for certain payments, such as interest and dividends.

 

 

5


Note: If you are exempt from backup withholding, you must still complete Substitute Form W-9 to avoid possible erroneous backup withholding. If you are exempt, enter your correct TIN in Part 1, check the “Exempt” box in Part 2 of the form and sign and date the form. If you are a nonresident alien or a foreign entity not subject to backup withholding, give the requester the appropriate completed IRS Form W-8.

The following is a list of payees that may be exempt from backup withholding and for which no information reporting is required. For interest and dividends, all listed payees are exempt except for those listed in item (9). For broker transactions, payees listed in (1) through (5), and (7) through (13), and C corporations are exempt. Payments subject to reporting under sections 6041 and 6041A are generally exempt from backup withholding only if made to payees described in items (1) through (7). However, the following payments made to a corporation and reportable on IRS Form 1099-MISC are not exempt from backup withholding: (i) medical and health care payments, (ii) attorneys’ fees, (iii) gross proceeds paid to an attorney, and (iv) payments for services paid by a federal executive agency. Only payees described in items (1) through (5) are exempt from backup withholding for barter exchange transactions and patronage dividends.

 

(1) An organization exempt from tax under section 501(a), or an individual retirement plan (“IRA”), or a custodial account under section 403(b)(7), if the account satisfies the requirements of section 401(f)(2).

 

(2) The United States or any of its agencies or instrumentalities.

 

(3) A state, the District of Columbia, a possession of the United States, or any of their subdivisions or instrumentalities.

 

(4) A foreign government, a political subdivision of a foreign government, or any of their agencies or instrumentalities.

 

(5) An international organization or any of its agencies or instrumentalities.

 

(6) A corporation.
(7) A foreign central bank of issue.

 

(8) A dealer in securities or commodities required to register in the United States, the District of Columbia, or a possession of the United States.

 

(9) A futures commission merchant registered with the Commodity Futures Trading Commission.

 

(10) A real estate investment trust.

 

(11) An entity registered at all times during the tax year under the Investment Company Act of 1940.

 

(12) A common trust fund operated by a bank under section 584(a).

 

(13) A financial institution.

 

(14) A middleman known in the investment community as a nominee or custodian.

 

(15) An exempt charitable remainder trust described in section 664, or a non-exempt trust described in section 4947.

Exempt payees described above must file Substitute Form W-9 to avoid possible erroneous backup withholding.

FILE THIS FORM WITH THE REQUESTER, FURNISH YOUR TAXPAYER IDENTIFICATION NUMBER, CHECK THE “EXEMPT” BOX IN PART 2 ON THE FACE OF THE FORM IN THE SPACE PROVIDED, SIGN AND DATE THE FORM AND RETURN IT TO THE REQUESTER.

Certain payments that are not subject to information reporting are also not subject to backup withholding. For details, see sections 6041, 6041A, 6042, 6044, 6045, 6049, 6050A and 6050N, and the Treasury regulations thereunder.

Privacy Act Notice . Section 6109 of the Internal Revenue Code requires you to give your correct TIN to persons (including federal agencies) who are required to file information returns with the IRS to report interest, dividends, and certain other income paid to you, mortgage interest you paid, the acquisition or abandonment of secured

 

 

6


property, cancellation of debt, or contributions you made to an IRA or Archer MSA or HSA. The person collecting this form uses the information on the form to file information returns with the IRS, reporting the above information. Routine uses of this information include giving it to the Department of Justice for civil and criminal litigation and to cities, states, the District of Columbia and U.S. possessions for use in administering their laws. The information may also be disclosed to other countries under treaty, to federal and state agencies to enforce civil and criminal laws, or to federal law enforcement and intelligence agencies to combat terrorism.

You must provide your TIN whether or not you are required to file a tax return. Under section 3406, payers must generally withhold a percentage of taxable interest, dividend, and certain other payments to a payee who does not give a TIN to the payer. Certain penalties may also apply for providing false or fraudulent information.

Penalties

Failure to Furnish TIN. If you fail to furnish your correct TIN to a requester, you are subject to a penalty of $50 for each such failure unless your failure is due to reasonable cause and not to willful neglect.

Civil Penalty for False Information With Respect to Withholding. If you make a false statement with no reasonable basis which results in no imposition of backup withholding, you are subject to a penalty of $500.

Criminal Penalty for Falsifying Information. Willfully falsifying certifications or affirmations may subject you to criminal penalties including fines and/or imprisonment.

Misuse of TINs. If the requester discloses or uses TINs in violation of federal law, the requester may be subject to civil and criminal penalties.

FOR ADDITIONAL INFORMATION, CONTACT YOUR TAX ADVISOR OR THE INTERNAL REVENUE SERVICE.

 

 

7

Exhibit 99.9

FORM OF EXCO RESOURCES, INC. 401(k) PLAN

TRANSFERABLE SUBSCRIPTION RIGHTS ELECTION FORM

THIS FORM MUST BE COMPLETED AND RETURNED TO CONTINENTAL STOCK TRANSFER & TRUST COMPANY, THE SUBSCRIPTION AGENT, BY 5:00 P.M., NEW YORK CITY TIME, ON JANUARY 6, 2014 .

THE TERMS AND CONDITIONS OF THE RIGHTS OFFERING ARE SET FORTH IN THE PROSPECTUS OF EXCO RESOURCES, INC. DATED DECEMBER 17, 2013 (THE “PROSPECTUS”) AND ARE INCORPORATED HEREIN BY REFERENCE. COPIES OF THE PROSPECTUS ARE AVAILABLE UPON REQUEST FROM D.F. KING & CO., INC., BY CALLING 1-800-755-7250 TOLL FREE.

FOR ADDITIONAL INFORMATION RELATED TO THE USE OF THIS FORM, PLEASE SEE “THE RIGHTS OFFERING—SPECIAL INSTRUCTIONS FOR PARTICIPANTS IN OUR 401(k) PLAN”

SECTION I. RIGHTS OFFERING ELECTION

As a participant in the EXCO Resources, Inc. (the “Company”) 401(k) Savings Plan (the “401(k) Plan”), I acknowledge receipt of your letter and the enclosed materials relating to the grant of transferable rights (“Rights”) to purchase shares of common stock, par value $0.001 per share (“Common Shares”), of the Company pursuant to the rights offering inducted by the Company (the “Rights Offering”).

I hereby instruct as follows:

(CHECK THE APPLICABLE BOXES AND PROVIDE ALL REQUIRED INFORMATION)

 

Box 1.   ¨    Please DO NOT EXERCISE RIGHTS for shares of Common Shares. I understand that Prudential Bank & Trust, FSB (the “Plan Trustee”) will attempt to sell my Rights on the New York Stock Exchange, but that such attempt may be unsuccessful.
Box 2.   ¨    Please DO NOT EXERCISE RIGHTS for shares of Common Shares and please DO NOT ATTEMPT TO SELL MY RIGHTS. I understand that any subscription rights that are not properly exercised by the appropriate deadline will expire.
Box 3.   ¨    Please EXERCISE RIGHTS for shares of Common Shares as set forth below. I understand that the Plan Trustee will attempt to sell any unexercised Rights on the New York Stock Exchange, but that such attempt may be unsuccessful.
  
Amount of Common Shares Being Purchased (the sum of (A) and (C) below):  

 

Total Subscription Payment Required (the sum of (B) and (D) below):  

                                              

Basic Subscription Right

As described in the accompanying Prospectus, I have received the Rights to purchase 0.25 of a Common Share for each Common Share owned as of 5:00 p.m., New York City time, on December 19, 2013 (the “Record Date”). The basic subscription right under these Rights allows me to subscribe for one Common Share at a subscription price of $5.00 per share.


(A)  I exercise   

 

  x  

0.25

     =  

 

   (no. of Rights)     (ratio)        (no. of new shares, rounded down to nearest whole share)
(B)  Therefore, I apply for   

 

  x  

$5.00

     =  

$

   (no. of new whole shares)     (subscription price)        (amount enclosed)

Over-Subscription Privilege

As described in the accompanying Prospectus, in the event that I purchase all of the Common Shares available to me pursuant to my basic subscription right (including in respect of Rights purchased from others), I may also choose to purchase a portion of any shares of Common Shares that are not purchased by the Company’s other shareholders through the exercise of their basic subscription rights (the “Unsubscribed Shares”).

I have purchased all Common Shares available to me pursuant to my basic subscription right (including in respect of Rights purchased from others) and am entitled to and wish to purchase additional Common Shares pursuant to my over-subscription privilege.

¨   Yes   ¨   No

 

(C)  I exercise  

         

  Rights pursuant to my over-subscription privilege   x  

0.25

  =  

 

        (no. of new shares per Right)     (no. of new shares)

(D) Therefore,

I apply for

 

         

  Unsubscribed Shares pursuant to my over-subscription privilege (rounded down to the nearest whole number)   x  

$5.00

  =  

$

        (subscription price)     (price of new shares)
           
           
           

PAYMENT

If you elect to participate in the Rights Offering, the Company will instruct the Plan Trustee to liquidate funds in your 401(k) Plan account held in the Guaranteed Income Fund in an amount equal to the Total Subscription Payment Required (the sum of (B) and (D) above).

SECTION II. AUTHORIZATION AND CERTIFICATION

By executing this Transferable Subscription Rights Election Form (the “Election Form”):

 

(i) I authorize the Plan Trustee to subscribe for the number of Common Shares listed in Section I of this Election Form in accordance with the Rights Offering and to liquidate funds in my 401(k) Plan account invested in the Guaranteed Income Fund on my behalf in order for me to participate in the Rights Offering, and agree that this election shall remain in effect until the expiration date of the Rights Offering stated in the Prospectus.

 

2


(ii) I acknowledge and agree that:

 

  a. if the value of the investments in the Guaranteed Income Fund does not equal or exceed the Total Subscription Payment Required shown in Section I above, the Rights held by my 401(k) Plan account will be exercised for Common Shares to the fullest extent possible based on the liquidated value of my 401(k) Plan account invested in the Guaranteed Income Fund, rounded down to the nearest whole share;

 

  b. I understand that any purchase of Common Shares will be credited to my 401(k) Plan account and will not be issued to me personally;

 

  c. if I fail to properly complete and duly sign this Election Form or otherwise fail to follow the subscription procedures that apply to the exercise of my Rights before 5:00 p.m., New York City time, on January 6, 2014 which is the third business day prior to the expiration date of the Rights Offering, my subscription will be rejected;

 

  d. if the Prevailing Market Price (as defined in the Prospectus) is less than the subscription price of $5.00 per share, the Plan Trustee will not exercise my Rights notwithstanding my direction in this Election Form to the Plan Trustee to exercise my Rights;

 

  e. if the Prevailing Market Price is greater than or equal to the subscription price of $5.00 per share, the Plan Trustee will follow my direction in this Election Form to exercise my Rights;

 

  f. unless Box 2 of the Section I above is selected, if I fail to exercise any or all of the Rights for any reason or if the liquidated value of my 401(k) Plan account invested in the Guaranteed Income Fund is insufficient to exercise the Rights I have subscribed for, I understand that the Plan Trustee will attempt to sell any unexercised Rights on the New York Stock Exchange, but that such attempt may be unsuccessful;

 

  g. neither the Company nor the Plan Trustee accepts any responsibility to contact me (us) concerning an incomplete or incorrect Election Form, nor are they under any obligation to correct my Election Form;

 

  h. the Company has the sole discretion to determine whether my subscription exercise properly complies with the subscription procedures; and

 

  i. this Election Form, once submitted, is irrevocable, subject to applicable law.

 

(iv) I agree to all of the terms and conditions of this Election Form and also those of the Prospectus, which is incorporated into this Election Form by reference.

 

           
Participant Signature     Date

 

3